date generated: 2021-04-21
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## t0_v_pod pod_crp t0_crp
## A1BG 2.6192564 0.23019048 -3.0045626
## A1BG-AS1 0.5230655 0.62211022 -0.6855588
## A1CF 0.5526173 0.68373998 0.3272035
## A2M -3.3389616 -0.03980079 1.6308274
## A2M-AS1 -3.1580711 -0.04056761 1.0554888
## A2ML1 -0.3535245 0.91485083 1.0055621
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genes_in_profile | 21381 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8367 |
num_profile_genes_not_in_sets | 13014 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used: GMT file of genesets: ReactomePathways.gmt
Gene sets metrics | |
---|---|
num_genesets | 2408 |
num_genesets_excluded | 1046 |
num_genesets_included | 1362 |
t0_v_pod | pod_crp | t0_crp | Count | |
---|---|---|---|---|
1 | -1 | -1 | -1 | 4308 |
2 | 0 | -1 | -1 | 1 |
3 | 1 | -1 | -1 | 881 |
4 | -1 | 0 | -1 | 1 |
5 | -1 | 1 | -1 | 1429 |
6 | 1 | 1 | -1 | 3429 |
7 | 1 | 1 | 0 | 1 |
8 | -1 | -1 | 1 | 3776 |
9 | 1 | -1 | 1 | 873 |
10 | -1 | 1 | 1 | 2503 |
11 | 1 | 1 | 1 | 4179 |
s.t0_v_pod | s.pod_crp | s.t0_crp | Count | |
---|---|---|---|---|
1 | -1 | -1 | -1 | 74 |
2 | 1 | -1 | -1 | 95 |
3 | 1 | 1 | -1 | 304 |
4 | -1 | -1 | 1 | 114 |
5 | 1 | -1 | 1 | 69 |
6 | -1 | 1 | 1 | 2 |
7 | 1 | 1 | 1 | 124 |
All sets with FDR<0.05. Try hovering over the points.
Top N sets irrespective of FDR. Try hovering over the points.
Significance is the -log2(p.adjustMANOVA) and effect size is the s.dist which is the hypotenuse of the s scores.
Top N= 100 gene sets
set | setSize | pMANOVA | p.adjustMANOVA | s.dist | s.t0_v_pod | s.pod_crp | s.t0_crp | p.t0_v_pod | p.pod_crp | p.t0_crp |
---|---|---|---|---|---|---|---|---|---|---|
IRAK4 deficiency (TLR2/4) | 10 | 2.40e-06 | 1.46e-05 | 1.270 | 0.89900 | 0.8260 | 0.34000 | 8.36e-07 | 6.10e-06 | 6.24e-02 |
MyD88 deficiency (TLR2/4) | 10 | 2.40e-06 | 1.46e-05 | 1.270 | 0.89900 | 0.8260 | 0.34000 | 8.36e-07 | 6.10e-06 | 6.24e-02 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 2.90e-05 | 1.25e-04 | 1.030 | 0.78500 | 0.6420 | 0.19800 | 2.48e-06 | 1.18e-04 | 2.35e-01 |
alpha-linolenic acid (ALA) metabolism | 12 | 2.90e-05 | 1.25e-04 | 1.030 | 0.78500 | 0.6420 | 0.19800 | 2.48e-06 | 1.18e-04 | 2.35e-01 |
Regulation of TLR by endogenous ligand | 11 | 1.23e-04 | 4.52e-04 | 1.010 | 0.74300 | 0.6260 | 0.26900 | 1.95e-05 | 3.22e-04 | 1.22e-01 |
Translocation of ZAP-70 to Immunological synapse | 24 | 2.63e-09 | 2.99e-08 | 0.994 | -0.74300 | -0.6600 | -0.00808 | 2.86e-10 | 2.12e-08 | 9.45e-01 |
Peptide chain elongation | 88 | 1.95e-48 | 2.41e-46 | 0.986 | -0.28100 | -0.7020 | -0.63300 | 5.05e-06 | 4.04e-30 | 9.10e-25 |
Eukaryotic Translation Elongation | 93 | 3.79e-51 | 1.03e-48 | 0.980 | -0.27300 | -0.7010 | -0.62900 | 5.39e-06 | 1.34e-31 | 8.59e-26 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 11 | 6.64e-05 | 2.59e-04 | 0.965 | 0.67000 | 0.5760 | -0.38900 | 1.19e-04 | 9.45e-04 | 2.56e-02 |
Selenocysteine synthesis | 92 | 4.47e-45 | 3.31e-43 | 0.948 | -0.29900 | -0.6800 | -0.59000 | 7.43e-07 | 1.63e-29 | 1.27e-22 |
Viral mRNA Translation | 88 | 4.24e-45 | 3.31e-43 | 0.945 | -0.26200 | -0.6790 | -0.60200 | 2.13e-05 | 2.75e-28 | 1.45e-22 |
Eukaryotic Translation Termination | 92 | 5.58e-46 | 5.43e-44 | 0.936 | -0.26500 | -0.6740 | -0.59300 | 1.13e-05 | 4.40e-29 | 7.60e-23 |
Hyaluronan uptake and degradation | 10 | 4.89e-04 | 1.46e-03 | 0.918 | 0.72900 | 0.5140 | -0.21700 | 6.53e-05 | 4.89e-03 | 2.34e-01 |
Formation of a pool of free 40S subunits | 100 | 3.12e-52 | 1.06e-49 | 0.914 | -0.20800 | -0.6770 | -0.57700 | 3.27e-04 | 1.03e-31 | 1.85e-23 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 94 | 2.69e-43 | 1.83e-41 | 0.890 | -0.24400 | -0.6530 | -0.55300 | 4.23e-05 | 6.26e-28 | 1.92e-20 |
Unwinding of DNA | 12 | 8.24e-04 | 2.33e-03 | 0.886 | -0.63700 | -0.6140 | -0.05120 | 1.33e-04 | 2.29e-04 | 7.59e-01 |
Uptake and function of anthrax toxins | 10 | 9.39e-04 | 2.60e-03 | 0.850 | 0.70400 | 0.4330 | -0.20000 | 1.17e-04 | 1.78e-02 | 2.74e-01 |
MET activates RAP1 and RAC1 | 10 | 4.32e-03 | 9.68e-03 | 0.833 | 0.53000 | 0.5150 | 0.38500 | 3.71e-03 | 4.84e-03 | 3.52e-02 |
VLDLR internalisation and degradation | 11 | 3.50e-04 | 1.12e-03 | 0.830 | 0.46800 | 0.4840 | -0.48600 | 7.18e-03 | 5.47e-03 | 5.27e-03 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 100 | 5.74e-41 | 3.72e-39 | 0.827 | -0.22200 | -0.6280 | -0.49000 | 1.28e-04 | 1.65e-27 | 2.35e-17 |
L13a-mediated translational silencing of Ceruloplasmin expression | 110 | 7.42e-50 | 1.26e-47 | 0.812 | -0.14300 | -0.6210 | -0.50300 | 9.49e-03 | 1.83e-29 | 7.74e-20 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 111 | 1.02e-48 | 1.38e-46 | 0.800 | -0.14700 | -0.6190 | -0.48600 | 7.38e-03 | 1.70e-29 | 9.15e-19 |
WNT5A-dependent internalization of FZD4 | 13 | 1.26e-04 | 4.61e-04 | 0.798 | 0.44900 | 0.4250 | -0.50500 | 5.07e-03 | 8.03e-03 | 1.61e-03 |
Advanced glycosylation endproduct receptor signaling | 12 | 1.38e-03 | 3.59e-03 | 0.798 | 0.65000 | 0.4560 | -0.07970 | 9.71e-05 | 6.19e-03 | 6.33e-01 |
Gap junction trafficking | 13 | 7.39e-04 | 2.12e-03 | 0.781 | 0.56400 | 0.4550 | -0.29200 | 4.32e-04 | 4.48e-03 | 6.83e-02 |
PD-1 signaling | 28 | 9.24e-07 | 6.32e-06 | 0.781 | -0.57900 | -0.5240 | 0.00712 | 1.13e-07 | 1.55e-06 | 9.48e-01 |
RNA Polymerase I Promoter Opening | 19 | 4.47e-08 | 3.90e-07 | 0.779 | 0.61600 | 0.1980 | -0.43400 | 3.31e-06 | 1.35e-01 | 1.06e-03 |
Activation of the pre-replicative complex | 32 | 2.09e-08 | 1.96e-07 | 0.771 | -0.48200 | -0.5790 | 0.16600 | 2.37e-06 | 1.45e-08 | 1.05e-01 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 10 | 1.58e-02 | 2.99e-02 | 0.762 | 0.52800 | 0.5490 | 0.01380 | 3.86e-03 | 2.64e-03 | 9.40e-01 |
Formation of the ternary complex, and subsequently, the 43S complex | 51 | 3.07e-23 | 9.95e-22 | 0.759 | -0.08310 | -0.6120 | -0.44100 | 3.05e-01 | 3.87e-14 | 5.15e-08 |
Retrograde neurotrophin signalling | 12 | 1.14e-03 | 3.10e-03 | 0.757 | 0.56600 | 0.3780 | -0.33000 | 6.80e-04 | 2.35e-02 | 4.76e-02 |
DNA strand elongation | 32 | 2.89e-07 | 2.15e-06 | 0.751 | -0.52200 | -0.5350 | 0.07190 | 3.22e-07 | 1.59e-07 | 4.82e-01 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 114 | 1.49e-38 | 8.47e-37 | 0.750 | -0.19500 | -0.5650 | -0.45300 | 3.16e-04 | 1.92e-25 | 6.13e-17 |
Nonsense-Mediated Decay (NMD) | 114 | 1.49e-38 | 8.47e-37 | 0.750 | -0.19500 | -0.5650 | -0.45300 | 3.16e-04 | 1.92e-25 | 6.13e-17 |
Cap-dependent Translation Initiation | 118 | 6.71e-46 | 5.71e-44 | 0.748 | -0.13200 | -0.5810 | -0.45300 | 1.35e-02 | 1.02e-27 | 1.90e-17 |
Eukaryotic Translation Initiation | 118 | 6.71e-46 | 5.71e-44 | 0.748 | -0.13200 | -0.5810 | -0.45300 | 1.35e-02 | 1.02e-27 | 1.90e-17 |
RHO GTPases Activate WASPs and WAVEs | 35 | 1.74e-08 | 1.70e-07 | 0.739 | 0.60800 | 0.4190 | -0.02530 | 4.76e-10 | 1.77e-05 | 7.96e-01 |
RHO GTPases Activate ROCKs | 18 | 6.19e-04 | 1.80e-03 | 0.735 | 0.54100 | 0.4920 | 0.07540 | 7.03e-05 | 3.04e-04 | 5.80e-01 |
Signaling by Leptin | 10 | 2.13e-03 | 5.22e-03 | 0.733 | 0.56500 | 0.2740 | -0.37900 | 1.98e-03 | 1.34e-01 | 3.79e-02 |
RHO GTPases Activate NADPH Oxidases | 21 | 3.51e-05 | 1.49e-04 | 0.732 | 0.55900 | 0.4260 | -0.20500 | 9.31e-06 | 7.34e-04 | 1.04e-01 |
Selenoamino acid metabolism | 114 | 4.37e-34 | 1.92e-32 | 0.731 | -0.22800 | -0.5520 | -0.42000 | 2.52e-05 | 1.98e-24 | 8.73e-15 |
Major pathway of rRNA processing in the nucleolus and cytosol | 180 | 1.52e-47 | 1.60e-45 | 0.725 | -0.30600 | -0.5910 | -0.28600 | 1.30e-12 | 9.56e-43 | 3.47e-11 |
Activation of ATR in response to replication stress | 36 | 9.68e-09 | 1.03e-07 | 0.724 | -0.45200 | -0.5060 | 0.25300 | 2.73e-06 | 1.52e-07 | 8.50e-03 |
rRNA processing in the nucleus and cytosol | 190 | 1.28e-49 | 1.94e-47 | 0.723 | -0.30700 | -0.5870 | -0.28800 | 2.77e-13 | 1.77e-44 | 7.70e-12 |
DNA methylation | 20 | 7.18e-08 | 5.96e-07 | 0.722 | 0.51700 | 0.1090 | -0.49300 | 6.35e-05 | 3.98e-01 | 1.35e-04 |
Erythrocytes take up carbon dioxide and release oxygen | 11 | 1.53e-04 | 5.41e-04 | 0.720 | 0.68000 | 0.2000 | -0.13100 | 9.48e-05 | 2.51e-01 | 4.52e-01 |
O2/CO2 exchange in erythrocytes | 11 | 1.53e-04 | 5.41e-04 | 0.720 | 0.68000 | 0.2000 | -0.13100 | 9.48e-05 | 2.51e-01 | 4.52e-01 |
Dissolution of Fibrin Clot | 12 | 8.61e-03 | 1.75e-02 | 0.715 | 0.56600 | 0.4360 | 0.01510 | 6.87e-04 | 8.84e-03 | 9.28e-01 |
Phosphorylation of CD3 and TCR zeta chains | 27 | 1.58e-05 | 7.65e-05 | 0.714 | -0.53700 | -0.4720 | -0.00537 | 1.39e-06 | 2.21e-05 | 9.62e-01 |
Detoxification of Reactive Oxygen Species | 32 | 8.18e-07 | 5.74e-06 | 0.709 | 0.56100 | 0.4310 | -0.04810 | 3.93e-08 | 2.44e-05 | 6.38e-01 |
Neutrophil degranulation | 457 | 0.00e+00 | 0.00e+00 | 0.706 | 0.58700 | 0.3800 | -0.09810 | 0.00e+00 | 3.14e-44 | 3.28e-04 |
ROS and RNS production in phagocytes | 31 | 1.98e-07 | 1.50e-06 | 0.704 | 0.59700 | 0.3670 | -0.05860 | 8.47e-09 | 3.98e-04 | 5.73e-01 |
Influenza Viral RNA Transcription and Replication | 135 | 1.83e-37 | 9.58e-36 | 0.703 | -0.22500 | -0.5440 | -0.38400 | 6.45e-06 | 8.94e-28 | 1.21e-14 |
SRP-dependent cotranslational protein targeting to membrane | 111 | 5.60e-38 | 3.05e-36 | 0.702 | -0.13400 | -0.5590 | -0.40400 | 1.48e-02 | 2.40e-24 | 1.86e-13 |
Platelet sensitization by LDL | 16 | 1.92e-03 | 4.72e-03 | 0.697 | 0.55200 | 0.4180 | 0.07930 | 1.31e-04 | 3.83e-03 | 5.83e-01 |
Trafficking of GluR2-containing AMPA receptors | 12 | 1.72e-03 | 4.33e-03 | 0.695 | 0.46900 | 0.2780 | -0.43100 | 4.91e-03 | 9.50e-02 | 9.68e-03 |
Diseases associated with the TLR signaling cascade | 23 | 1.43e-04 | 5.12e-04 | 0.694 | 0.53400 | 0.4410 | 0.03190 | 9.12e-06 | 2.47e-04 | 7.91e-01 |
Diseases of Immune System | 23 | 1.43e-04 | 5.12e-04 | 0.694 | 0.53400 | 0.4410 | 0.03190 | 9.12e-06 | 2.47e-04 | 7.91e-01 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 6.02e-03 | 1.27e-02 | 0.693 | 0.55500 | 0.3950 | 0.12400 | 5.28e-04 | 1.36e-02 | 4.40e-01 |
rRNA modification in the nucleus and cytosol | 59 | 7.21e-12 | 1.21e-10 | 0.691 | -0.39700 | -0.5560 | -0.09860 | 1.32e-07 | 1.39e-13 | 1.90e-01 |
Insulin receptor recycling | 21 | 1.16e-04 | 4.31e-04 | 0.689 | 0.56800 | 0.3830 | -0.06510 | 6.47e-06 | 2.36e-03 | 6.06e-01 |
Heme degradation | 10 | 1.73e-02 | 3.23e-02 | 0.687 | 0.40100 | 0.5350 | -0.15600 | 2.80e-02 | 3.41e-03 | 3.92e-01 |
p130Cas linkage to MAPK signaling for integrins | 11 | 1.41e-04 | 5.09e-04 | 0.686 | 0.66600 | 0.1590 | -0.04040 | 1.32e-04 | 3.60e-01 | 8.17e-01 |
rRNA processing | 217 | 3.11e-50 | 6.05e-48 | 0.685 | -0.28900 | -0.5440 | -0.29900 | 2.16e-13 | 1.51e-43 | 3.13e-14 |
Hyaluronan metabolism | 13 | 3.96e-03 | 8.95e-03 | 0.682 | 0.51300 | 0.3690 | -0.25800 | 1.37e-03 | 2.13e-02 | 1.08e-01 |
Lagging Strand Synthesis | 20 | 4.15e-04 | 1.29e-03 | 0.680 | -0.45200 | -0.4870 | 0.14600 | 4.65e-04 | 1.61e-04 | 2.60e-01 |
Josephin domain DUBs | 10 | 1.18e-03 | 3.16e-03 | 0.674 | 0.47000 | 0.0859 | -0.47500 | 1.01e-02 | 6.38e-01 | 9.27e-03 |
Pre-NOTCH Processing in Golgi | 18 | 2.86e-04 | 9.43e-04 | 0.673 | 0.41100 | 0.3990 | -0.35400 | 2.57e-03 | 3.37e-03 | 9.41e-03 |
Translation initiation complex formation | 58 | 4.84e-23 | 1.53e-21 | 0.666 | -0.02010 | -0.5410 | -0.38800 | 7.92e-01 | 9.62e-13 | 3.15e-07 |
COPI-independent Golgi-to-ER retrograde traffic | 33 | 5.17e-07 | 3.73e-06 | 0.661 | 0.56300 | 0.3410 | 0.05300 | 2.13e-08 | 6.93e-04 | 5.99e-01 |
Ribosomal scanning and start codon recognition | 58 | 3.07e-22 | 9.23e-21 | 0.657 | -0.02510 | -0.5360 | -0.37800 | 7.41e-01 | 1.54e-12 | 6.22e-07 |
Processive synthesis on the lagging strand | 15 | 7.14e-03 | 1.48e-02 | 0.656 | -0.43100 | -0.4920 | 0.04780 | 3.86e-03 | 9.65e-04 | 7.48e-01 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 59 | 6.82e-23 | 2.11e-21 | 0.654 | -0.00808 | -0.5250 | -0.38900 | 9.15e-01 | 2.92e-12 | 2.27e-07 |
Golgi Cisternae Pericentriolar Stack Reorganization | 14 | 2.85e-03 | 6.68e-03 | 0.654 | 0.54900 | 0.3150 | 0.16100 | 3.74e-04 | 4.10e-02 | 2.96e-01 |
EPHB-mediated forward signaling | 32 | 8.75e-06 | 4.57e-05 | 0.653 | 0.50400 | 0.3870 | 0.15200 | 8.17e-07 | 1.54e-04 | 1.36e-01 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 3.69e-04 | 1.18e-03 | 0.648 | -0.44500 | -0.4700 | 0.03520 | 1.59e-04 | 6.79e-05 | 7.66e-01 |
Generation of second messenger molecules | 38 | 3.21e-06 | 1.85e-05 | 0.647 | -0.46400 | -0.4500 | -0.01160 | 7.22e-07 | 1.59e-06 | 9.01e-01 |
Mucopolysaccharidoses | 11 | 2.02e-02 | 3.69e-02 | 0.643 | 0.45500 | 0.3730 | -0.25900 | 9.00e-03 | 3.22e-02 | 1.36e-01 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 4.46e-02 | 7.29e-02 | 0.635 | 0.47600 | 0.4200 | -0.01530 | 6.29e-03 | 1.59e-02 | 9.30e-01 |
Nucleobase biosynthesis | 13 | 1.72e-02 | 3.22e-02 | 0.632 | -0.35600 | -0.5070 | -0.12100 | 2.63e-02 | 1.53e-03 | 4.49e-01 |
Transferrin endocytosis and recycling | 26 | 1.31e-04 | 4.78e-04 | 0.629 | 0.50900 | 0.3670 | -0.04370 | 7.03e-06 | 1.19e-03 | 7.00e-01 |
Pentose phosphate pathway | 13 | 1.08e-02 | 2.13e-02 | 0.627 | 0.48800 | 0.3390 | -0.20200 | 2.33e-03 | 3.43e-02 | 2.07e-01 |
PCNA-Dependent Long Patch Base Excision Repair | 21 | 1.82e-03 | 4.57e-03 | 0.624 | -0.42000 | -0.4610 | 0.02740 | 8.64e-04 | 2.52e-04 | 8.28e-01 |
Telomere C-strand synthesis initiation | 13 | 1.59e-02 | 2.99e-02 | 0.624 | -0.36100 | -0.5090 | 0.01130 | 2.43e-02 | 1.48e-03 | 9.44e-01 |
Telomere C-strand (Lagging Strand) Synthesis | 34 | 1.41e-05 | 7.06e-05 | 0.622 | -0.38700 | -0.4860 | 0.02050 | 9.40e-05 | 9.35e-07 | 8.36e-01 |
Removal of the Flap Intermediate | 14 | 1.53e-02 | 2.90e-02 | 0.619 | -0.39900 | -0.4640 | 0.09150 | 9.75e-03 | 2.63e-03 | 5.53e-01 |
Regulation of IFNG signaling | 14 | 1.06e-02 | 2.11e-02 | 0.619 | 0.39600 | 0.3280 | 0.34500 | 1.03e-02 | 3.37e-02 | 2.56e-02 |
Signal transduction by L1 | 20 | 3.18e-03 | 7.37e-03 | 0.615 | 0.43800 | 0.4290 | -0.04680 | 6.90e-04 | 8.86e-04 | 7.17e-01 |
Gap junction trafficking and regulation | 15 | 6.95e-03 | 1.45e-02 | 0.615 | 0.41400 | 0.3800 | -0.24900 | 5.54e-03 | 1.08e-02 | 9.44e-02 |
Influenza Infection | 154 | 5.68e-35 | 2.76e-33 | 0.614 | -0.18100 | -0.4980 | -0.31100 | 1.07e-04 | 1.37e-26 | 2.75e-11 |
Negative regulation of MET activity | 18 | 1.61e-03 | 4.11e-03 | 0.610 | 0.52600 | 0.3100 | -0.01640 | 1.12e-04 | 2.30e-02 | 9.04e-01 |
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 12 | 1.04e-03 | 2.84e-03 | 0.610 | 0.47800 | 0.0954 | -0.36600 | 4.12e-03 | 5.67e-01 | 2.80e-02 |
Diseases of hemostasis | 12 | 1.04e-03 | 2.84e-03 | 0.610 | 0.47800 | 0.0954 | -0.36600 | 4.12e-03 | 5.67e-01 | 2.80e-02 |
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 22 | 1.98e-05 | 9.28e-05 | 0.610 | 0.47100 | 0.1830 | -0.34100 | 1.32e-04 | 1.38e-01 | 5.58e-03 |
HDR through MMEJ (alt-NHEJ) | 10 | 5.15e-02 | 8.26e-02 | 0.606 | -0.42900 | -0.3650 | 0.22500 | 1.88e-02 | 4.58e-02 | 2.19e-01 |
IRAK1 recruits IKK complex | 10 | 2.29e-02 | 4.11e-02 | 0.605 | 0.53300 | 0.2630 | -0.11400 | 3.52e-03 | 1.50e-01 | 5.31e-01 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 10 | 2.29e-02 | 4.11e-02 | 0.605 | 0.53300 | 0.2630 | -0.11400 | 3.52e-03 | 1.50e-01 | 5.31e-01 |
MAP2K and MAPK activation | 34 | 1.76e-06 | 1.10e-05 | 0.605 | 0.51600 | 0.2920 | -0.11600 | 1.87e-07 | 3.17e-03 | 2.43e-01 |
Cargo concentration in the ER | 30 | 7.40e-06 | 3.97e-05 | 0.603 | 0.52000 | 0.2830 | 0.11400 | 8.05e-07 | 7.23e-03 | 2.80e-01 |
Budding and maturation of HIV virion | 26 | 4.06e-05 | 1.67e-04 | 0.602 | 0.52500 | 0.2840 | -0.07800 | 3.50e-06 | 1.23e-02 | 4.91e-01 |
set | setSize | pMANOVA | p.adjustMANOVA | s.dist | s.t0_v_pod | s.pod_crp | s.t0_crp | p.t0_v_pod | p.pod_crp | p.t0_crp |
---|---|---|---|---|---|---|---|---|---|---|
IRAK4 deficiency (TLR2/4) | 10 | 2.40e-06 | 1.46e-05 | 1.2700 | 0.899000 | 0.826000 | 0.340000 | 8.36e-07 | 6.10e-06 | 6.24e-02 |
MyD88 deficiency (TLR2/4) | 10 | 2.40e-06 | 1.46e-05 | 1.2700 | 0.899000 | 0.826000 | 0.340000 | 8.36e-07 | 6.10e-06 | 6.24e-02 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 2.90e-05 | 1.25e-04 | 1.0300 | 0.785000 | 0.642000 | 0.198000 | 2.48e-06 | 1.18e-04 | 2.35e-01 |
alpha-linolenic acid (ALA) metabolism | 12 | 2.90e-05 | 1.25e-04 | 1.0300 | 0.785000 | 0.642000 | 0.198000 | 2.48e-06 | 1.18e-04 | 2.35e-01 |
Regulation of TLR by endogenous ligand | 11 | 1.23e-04 | 4.52e-04 | 1.0100 | 0.743000 | 0.626000 | 0.269000 | 1.95e-05 | 3.22e-04 | 1.22e-01 |
Translocation of ZAP-70 to Immunological synapse | 24 | 2.63e-09 | 2.99e-08 | 0.9940 | -0.743000 | -0.660000 | -0.008080 | 2.86e-10 | 2.12e-08 | 9.45e-01 |
Peptide chain elongation | 88 | 1.95e-48 | 2.41e-46 | 0.9860 | -0.281000 | -0.702000 | -0.633000 | 5.05e-06 | 4.04e-30 | 9.10e-25 |
Eukaryotic Translation Elongation | 93 | 3.79e-51 | 1.03e-48 | 0.9800 | -0.273000 | -0.701000 | -0.629000 | 5.39e-06 | 1.34e-31 | 8.59e-26 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 11 | 6.64e-05 | 2.59e-04 | 0.9650 | 0.670000 | 0.576000 | -0.389000 | 1.19e-04 | 9.45e-04 | 2.56e-02 |
Selenocysteine synthesis | 92 | 4.47e-45 | 3.31e-43 | 0.9480 | -0.299000 | -0.680000 | -0.590000 | 7.43e-07 | 1.63e-29 | 1.27e-22 |
Viral mRNA Translation | 88 | 4.24e-45 | 3.31e-43 | 0.9450 | -0.262000 | -0.679000 | -0.602000 | 2.13e-05 | 2.75e-28 | 1.45e-22 |
Eukaryotic Translation Termination | 92 | 5.58e-46 | 5.43e-44 | 0.9360 | -0.265000 | -0.674000 | -0.593000 | 1.13e-05 | 4.40e-29 | 7.60e-23 |
Hyaluronan uptake and degradation | 10 | 4.89e-04 | 1.46e-03 | 0.9180 | 0.729000 | 0.514000 | -0.217000 | 6.53e-05 | 4.89e-03 | 2.34e-01 |
Formation of a pool of free 40S subunits | 100 | 3.12e-52 | 1.06e-49 | 0.9140 | -0.208000 | -0.677000 | -0.577000 | 3.27e-04 | 1.03e-31 | 1.85e-23 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 94 | 2.69e-43 | 1.83e-41 | 0.8900 | -0.244000 | -0.653000 | -0.553000 | 4.23e-05 | 6.26e-28 | 1.92e-20 |
Unwinding of DNA | 12 | 8.24e-04 | 2.33e-03 | 0.8860 | -0.637000 | -0.614000 | -0.051200 | 1.33e-04 | 2.29e-04 | 7.59e-01 |
Uptake and function of anthrax toxins | 10 | 9.39e-04 | 2.60e-03 | 0.8500 | 0.704000 | 0.433000 | -0.200000 | 1.17e-04 | 1.78e-02 | 2.74e-01 |
MET activates RAP1 and RAC1 | 10 | 4.32e-03 | 9.68e-03 | 0.8330 | 0.530000 | 0.515000 | 0.385000 | 3.71e-03 | 4.84e-03 | 3.52e-02 |
VLDLR internalisation and degradation | 11 | 3.50e-04 | 1.12e-03 | 0.8300 | 0.468000 | 0.484000 | -0.486000 | 7.18e-03 | 5.47e-03 | 5.27e-03 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 100 | 5.74e-41 | 3.72e-39 | 0.8270 | -0.222000 | -0.628000 | -0.490000 | 1.28e-04 | 1.65e-27 | 2.35e-17 |
L13a-mediated translational silencing of Ceruloplasmin expression | 110 | 7.42e-50 | 1.26e-47 | 0.8120 | -0.143000 | -0.621000 | -0.503000 | 9.49e-03 | 1.83e-29 | 7.74e-20 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 111 | 1.02e-48 | 1.38e-46 | 0.8000 | -0.147000 | -0.619000 | -0.486000 | 7.38e-03 | 1.70e-29 | 9.15e-19 |
WNT5A-dependent internalization of FZD4 | 13 | 1.26e-04 | 4.61e-04 | 0.7980 | 0.449000 | 0.425000 | -0.505000 | 5.07e-03 | 8.03e-03 | 1.61e-03 |
Advanced glycosylation endproduct receptor signaling | 12 | 1.38e-03 | 3.59e-03 | 0.7980 | 0.650000 | 0.456000 | -0.079700 | 9.71e-05 | 6.19e-03 | 6.33e-01 |
Gap junction trafficking | 13 | 7.39e-04 | 2.12e-03 | 0.7810 | 0.564000 | 0.455000 | -0.292000 | 4.32e-04 | 4.48e-03 | 6.83e-02 |
PD-1 signaling | 28 | 9.24e-07 | 6.32e-06 | 0.7810 | -0.579000 | -0.524000 | 0.007120 | 1.13e-07 | 1.55e-06 | 9.48e-01 |
RNA Polymerase I Promoter Opening | 19 | 4.47e-08 | 3.90e-07 | 0.7790 | 0.616000 | 0.198000 | -0.434000 | 3.31e-06 | 1.35e-01 | 1.06e-03 |
Activation of the pre-replicative complex | 32 | 2.09e-08 | 1.96e-07 | 0.7710 | -0.482000 | -0.579000 | 0.166000 | 2.37e-06 | 1.45e-08 | 1.05e-01 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 10 | 1.58e-02 | 2.99e-02 | 0.7620 | 0.528000 | 0.549000 | 0.013800 | 3.86e-03 | 2.64e-03 | 9.40e-01 |
Formation of the ternary complex, and subsequently, the 43S complex | 51 | 3.07e-23 | 9.95e-22 | 0.7590 | -0.083100 | -0.612000 | -0.441000 | 3.05e-01 | 3.87e-14 | 5.15e-08 |
Retrograde neurotrophin signalling | 12 | 1.14e-03 | 3.10e-03 | 0.7570 | 0.566000 | 0.378000 | -0.330000 | 6.80e-04 | 2.35e-02 | 4.76e-02 |
DNA strand elongation | 32 | 2.89e-07 | 2.15e-06 | 0.7510 | -0.522000 | -0.535000 | 0.071900 | 3.22e-07 | 1.59e-07 | 4.82e-01 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 114 | 1.49e-38 | 8.47e-37 | 0.7500 | -0.195000 | -0.565000 | -0.453000 | 3.16e-04 | 1.92e-25 | 6.13e-17 |
Nonsense-Mediated Decay (NMD) | 114 | 1.49e-38 | 8.47e-37 | 0.7500 | -0.195000 | -0.565000 | -0.453000 | 3.16e-04 | 1.92e-25 | 6.13e-17 |
Cap-dependent Translation Initiation | 118 | 6.71e-46 | 5.71e-44 | 0.7480 | -0.132000 | -0.581000 | -0.453000 | 1.35e-02 | 1.02e-27 | 1.90e-17 |
Eukaryotic Translation Initiation | 118 | 6.71e-46 | 5.71e-44 | 0.7480 | -0.132000 | -0.581000 | -0.453000 | 1.35e-02 | 1.02e-27 | 1.90e-17 |
RHO GTPases Activate WASPs and WAVEs | 35 | 1.74e-08 | 1.70e-07 | 0.7390 | 0.608000 | 0.419000 | -0.025300 | 4.76e-10 | 1.77e-05 | 7.96e-01 |
RHO GTPases Activate ROCKs | 18 | 6.19e-04 | 1.80e-03 | 0.7350 | 0.541000 | 0.492000 | 0.075400 | 7.03e-05 | 3.04e-04 | 5.80e-01 |
Signaling by Leptin | 10 | 2.13e-03 | 5.22e-03 | 0.7330 | 0.565000 | 0.274000 | -0.379000 | 1.98e-03 | 1.34e-01 | 3.79e-02 |
RHO GTPases Activate NADPH Oxidases | 21 | 3.51e-05 | 1.49e-04 | 0.7320 | 0.559000 | 0.426000 | -0.205000 | 9.31e-06 | 7.34e-04 | 1.04e-01 |
Selenoamino acid metabolism | 114 | 4.37e-34 | 1.92e-32 | 0.7310 | -0.228000 | -0.552000 | -0.420000 | 2.52e-05 | 1.98e-24 | 8.73e-15 |
Major pathway of rRNA processing in the nucleolus and cytosol | 180 | 1.52e-47 | 1.60e-45 | 0.7250 | -0.306000 | -0.591000 | -0.286000 | 1.30e-12 | 9.56e-43 | 3.47e-11 |
Activation of ATR in response to replication stress | 36 | 9.68e-09 | 1.03e-07 | 0.7240 | -0.452000 | -0.506000 | 0.253000 | 2.73e-06 | 1.52e-07 | 8.50e-03 |
rRNA processing in the nucleus and cytosol | 190 | 1.28e-49 | 1.94e-47 | 0.7230 | -0.307000 | -0.587000 | -0.288000 | 2.77e-13 | 1.77e-44 | 7.70e-12 |
DNA methylation | 20 | 7.18e-08 | 5.96e-07 | 0.7220 | 0.517000 | 0.109000 | -0.493000 | 6.35e-05 | 3.98e-01 | 1.35e-04 |
Erythrocytes take up carbon dioxide and release oxygen | 11 | 1.53e-04 | 5.41e-04 | 0.7200 | 0.680000 | 0.200000 | -0.131000 | 9.48e-05 | 2.51e-01 | 4.52e-01 |
O2/CO2 exchange in erythrocytes | 11 | 1.53e-04 | 5.41e-04 | 0.7200 | 0.680000 | 0.200000 | -0.131000 | 9.48e-05 | 2.51e-01 | 4.52e-01 |
Dissolution of Fibrin Clot | 12 | 8.61e-03 | 1.75e-02 | 0.7150 | 0.566000 | 0.436000 | 0.015100 | 6.87e-04 | 8.84e-03 | 9.28e-01 |
Phosphorylation of CD3 and TCR zeta chains | 27 | 1.58e-05 | 7.65e-05 | 0.7140 | -0.537000 | -0.472000 | -0.005370 | 1.39e-06 | 2.21e-05 | 9.62e-01 |
Detoxification of Reactive Oxygen Species | 32 | 8.18e-07 | 5.74e-06 | 0.7090 | 0.561000 | 0.431000 | -0.048100 | 3.93e-08 | 2.44e-05 | 6.38e-01 |
Neutrophil degranulation | 457 | 4.62e-105 | 6.29e-102 | 0.7060 | 0.587000 | 0.380000 | -0.098100 | 1.73e-103 | 3.14e-44 | 3.28e-04 |
ROS and RNS production in phagocytes | 31 | 1.98e-07 | 1.50e-06 | 0.7040 | 0.597000 | 0.367000 | -0.058600 | 8.47e-09 | 3.98e-04 | 5.73e-01 |
Influenza Viral RNA Transcription and Replication | 135 | 1.83e-37 | 9.58e-36 | 0.7030 | -0.225000 | -0.544000 | -0.384000 | 6.45e-06 | 8.94e-28 | 1.21e-14 |
SRP-dependent cotranslational protein targeting to membrane | 111 | 5.60e-38 | 3.05e-36 | 0.7020 | -0.134000 | -0.559000 | -0.404000 | 1.48e-02 | 2.40e-24 | 1.86e-13 |
Platelet sensitization by LDL | 16 | 1.92e-03 | 4.72e-03 | 0.6970 | 0.552000 | 0.418000 | 0.079300 | 1.31e-04 | 3.83e-03 | 5.83e-01 |
Trafficking of GluR2-containing AMPA receptors | 12 | 1.72e-03 | 4.33e-03 | 0.6950 | 0.469000 | 0.278000 | -0.431000 | 4.91e-03 | 9.50e-02 | 9.68e-03 |
Diseases associated with the TLR signaling cascade | 23 | 1.43e-04 | 5.12e-04 | 0.6940 | 0.534000 | 0.441000 | 0.031900 | 9.12e-06 | 2.47e-04 | 7.91e-01 |
Diseases of Immune System | 23 | 1.43e-04 | 5.12e-04 | 0.6940 | 0.534000 | 0.441000 | 0.031900 | 9.12e-06 | 2.47e-04 | 7.91e-01 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 6.02e-03 | 1.27e-02 | 0.6930 | 0.555000 | 0.395000 | 0.124000 | 5.28e-04 | 1.36e-02 | 4.40e-01 |
rRNA modification in the nucleus and cytosol | 59 | 7.21e-12 | 1.21e-10 | 0.6910 | -0.397000 | -0.556000 | -0.098600 | 1.32e-07 | 1.39e-13 | 1.90e-01 |
Insulin receptor recycling | 21 | 1.16e-04 | 4.31e-04 | 0.6890 | 0.568000 | 0.383000 | -0.065100 | 6.47e-06 | 2.36e-03 | 6.06e-01 |
Heme degradation | 10 | 1.73e-02 | 3.23e-02 | 0.6870 | 0.401000 | 0.535000 | -0.156000 | 2.80e-02 | 3.41e-03 | 3.92e-01 |
p130Cas linkage to MAPK signaling for integrins | 11 | 1.41e-04 | 5.09e-04 | 0.6860 | 0.666000 | 0.159000 | -0.040400 | 1.32e-04 | 3.60e-01 | 8.17e-01 |
rRNA processing | 217 | 3.11e-50 | 6.05e-48 | 0.6850 | -0.289000 | -0.544000 | -0.299000 | 2.16e-13 | 1.51e-43 | 3.13e-14 |
Hyaluronan metabolism | 13 | 3.96e-03 | 8.95e-03 | 0.6820 | 0.513000 | 0.369000 | -0.258000 | 1.37e-03 | 2.13e-02 | 1.08e-01 |
Lagging Strand Synthesis | 20 | 4.15e-04 | 1.29e-03 | 0.6800 | -0.452000 | -0.487000 | 0.146000 | 4.65e-04 | 1.61e-04 | 2.60e-01 |
Josephin domain DUBs | 10 | 1.18e-03 | 3.16e-03 | 0.6740 | 0.470000 | 0.085900 | -0.475000 | 1.01e-02 | 6.38e-01 | 9.27e-03 |
Pre-NOTCH Processing in Golgi | 18 | 2.86e-04 | 9.43e-04 | 0.6730 | 0.411000 | 0.399000 | -0.354000 | 2.57e-03 | 3.37e-03 | 9.41e-03 |
Translation initiation complex formation | 58 | 4.84e-23 | 1.53e-21 | 0.6660 | -0.020100 | -0.541000 | -0.388000 | 7.92e-01 | 9.62e-13 | 3.15e-07 |
COPI-independent Golgi-to-ER retrograde traffic | 33 | 5.17e-07 | 3.73e-06 | 0.6610 | 0.563000 | 0.341000 | 0.053000 | 2.13e-08 | 6.93e-04 | 5.99e-01 |
Ribosomal scanning and start codon recognition | 58 | 3.07e-22 | 9.23e-21 | 0.6570 | -0.025100 | -0.536000 | -0.378000 | 7.41e-01 | 1.54e-12 | 6.22e-07 |
Processive synthesis on the lagging strand | 15 | 7.14e-03 | 1.48e-02 | 0.6560 | -0.431000 | -0.492000 | 0.047800 | 3.86e-03 | 9.65e-04 | 7.48e-01 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 59 | 6.82e-23 | 2.11e-21 | 0.6540 | -0.008080 | -0.525000 | -0.389000 | 9.15e-01 | 2.92e-12 | 2.27e-07 |
Golgi Cisternae Pericentriolar Stack Reorganization | 14 | 2.85e-03 | 6.68e-03 | 0.6540 | 0.549000 | 0.315000 | 0.161000 | 3.74e-04 | 4.10e-02 | 2.96e-01 |
EPHB-mediated forward signaling | 32 | 8.75e-06 | 4.57e-05 | 0.6530 | 0.504000 | 0.387000 | 0.152000 | 8.17e-07 | 1.54e-04 | 1.36e-01 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 3.69e-04 | 1.18e-03 | 0.6480 | -0.445000 | -0.470000 | 0.035200 | 1.59e-04 | 6.79e-05 | 7.66e-01 |
Generation of second messenger molecules | 38 | 3.21e-06 | 1.85e-05 | 0.6470 | -0.464000 | -0.450000 | -0.011600 | 7.22e-07 | 1.59e-06 | 9.01e-01 |
Mucopolysaccharidoses | 11 | 2.02e-02 | 3.69e-02 | 0.6430 | 0.455000 | 0.373000 | -0.259000 | 9.00e-03 | 3.22e-02 | 1.36e-01 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 4.46e-02 | 7.29e-02 | 0.6350 | 0.476000 | 0.420000 | -0.015300 | 6.29e-03 | 1.59e-02 | 9.30e-01 |
Nucleobase biosynthesis | 13 | 1.72e-02 | 3.22e-02 | 0.6320 | -0.356000 | -0.507000 | -0.121000 | 2.63e-02 | 1.53e-03 | 4.49e-01 |
Transferrin endocytosis and recycling | 26 | 1.31e-04 | 4.78e-04 | 0.6290 | 0.509000 | 0.367000 | -0.043700 | 7.03e-06 | 1.19e-03 | 7.00e-01 |
Pentose phosphate pathway | 13 | 1.08e-02 | 2.13e-02 | 0.6270 | 0.488000 | 0.339000 | -0.202000 | 2.33e-03 | 3.43e-02 | 2.07e-01 |
PCNA-Dependent Long Patch Base Excision Repair | 21 | 1.82e-03 | 4.57e-03 | 0.6240 | -0.420000 | -0.461000 | 0.027400 | 8.64e-04 | 2.52e-04 | 8.28e-01 |
Telomere C-strand synthesis initiation | 13 | 1.59e-02 | 2.99e-02 | 0.6240 | -0.361000 | -0.509000 | 0.011300 | 2.43e-02 | 1.48e-03 | 9.44e-01 |
Telomere C-strand (Lagging Strand) Synthesis | 34 | 1.41e-05 | 7.06e-05 | 0.6220 | -0.387000 | -0.486000 | 0.020500 | 9.40e-05 | 9.35e-07 | 8.36e-01 |
Removal of the Flap Intermediate | 14 | 1.53e-02 | 2.90e-02 | 0.6190 | -0.399000 | -0.464000 | 0.091500 | 9.75e-03 | 2.63e-03 | 5.53e-01 |
Regulation of IFNG signaling | 14 | 1.06e-02 | 2.11e-02 | 0.6190 | 0.396000 | 0.328000 | 0.345000 | 1.03e-02 | 3.37e-02 | 2.56e-02 |
Signal transduction by L1 | 20 | 3.18e-03 | 7.37e-03 | 0.6150 | 0.438000 | 0.429000 | -0.046800 | 6.90e-04 | 8.86e-04 | 7.17e-01 |
Gap junction trafficking and regulation | 15 | 6.95e-03 | 1.45e-02 | 0.6150 | 0.414000 | 0.380000 | -0.249000 | 5.54e-03 | 1.08e-02 | 9.44e-02 |
Influenza Infection | 154 | 5.68e-35 | 2.76e-33 | 0.6140 | -0.181000 | -0.498000 | -0.311000 | 1.07e-04 | 1.37e-26 | 2.75e-11 |
Negative regulation of MET activity | 18 | 1.61e-03 | 4.11e-03 | 0.6100 | 0.526000 | 0.310000 | -0.016400 | 1.12e-04 | 2.30e-02 | 9.04e-01 |
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 12 | 1.04e-03 | 2.84e-03 | 0.6100 | 0.478000 | 0.095400 | -0.366000 | 4.12e-03 | 5.67e-01 | 2.80e-02 |
Diseases of hemostasis | 12 | 1.04e-03 | 2.84e-03 | 0.6100 | 0.478000 | 0.095400 | -0.366000 | 4.12e-03 | 5.67e-01 | 2.80e-02 |
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 22 | 1.98e-05 | 9.28e-05 | 0.6100 | 0.471000 | 0.183000 | -0.341000 | 1.32e-04 | 1.38e-01 | 5.58e-03 |
HDR through MMEJ (alt-NHEJ) | 10 | 5.15e-02 | 8.26e-02 | 0.6060 | -0.429000 | -0.365000 | 0.225000 | 1.88e-02 | 4.58e-02 | 2.19e-01 |
IRAK1 recruits IKK complex | 10 | 2.29e-02 | 4.11e-02 | 0.6050 | 0.533000 | 0.263000 | -0.114000 | 3.52e-03 | 1.50e-01 | 5.31e-01 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 10 | 2.29e-02 | 4.11e-02 | 0.6050 | 0.533000 | 0.263000 | -0.114000 | 3.52e-03 | 1.50e-01 | 5.31e-01 |
MAP2K and MAPK activation | 34 | 1.76e-06 | 1.10e-05 | 0.6050 | 0.516000 | 0.292000 | -0.116000 | 1.87e-07 | 3.17e-03 | 2.43e-01 |
Cargo concentration in the ER | 30 | 7.40e-06 | 3.97e-05 | 0.6030 | 0.520000 | 0.283000 | 0.114000 | 8.05e-07 | 7.23e-03 | 2.80e-01 |
Budding and maturation of HIV virion | 26 | 4.06e-05 | 1.67e-04 | 0.6020 | 0.525000 | 0.284000 | -0.078000 | 3.50e-06 | 1.23e-02 | 4.91e-01 |
Presynaptic phase of homologous DNA pairing and strand exchange | 39 | 4.72e-08 | 4.10e-07 | 0.6010 | -0.329000 | -0.261000 | 0.431000 | 3.83e-04 | 4.79e-03 | 3.24e-06 |
Homologous DNA Pairing and Strand Exchange | 42 | 2.23e-08 | 2.07e-07 | 0.5990 | -0.354000 | -0.269000 | 0.402000 | 7.31e-05 | 2.60e-03 | 6.46e-06 |
Endosomal Sorting Complex Required For Transport (ESCRT) | 29 | 1.88e-05 | 8.91e-05 | 0.5980 | 0.519000 | 0.290000 | -0.057300 | 1.28e-06 | 6.83e-03 | 5.93e-01 |
GP1b-IX-V activation signalling | 10 | 2.89e-04 | 9.51e-04 | 0.5970 | 0.357000 | -0.190000 | -0.439000 | 5.07e-02 | 2.97e-01 | 1.61e-02 |
RHO GTPases activate IQGAPs | 11 | 6.38e-02 | 9.86e-02 | 0.5960 | 0.434000 | 0.367000 | 0.180000 | 1.27e-02 | 3.50e-02 | 3.01e-01 |
GRB2:SOS provides linkage to MAPK signaling for Integrins | 12 | 5.83e-04 | 1.70e-03 | 0.5950 | 0.581000 | 0.126000 | -0.041700 | 4.97e-04 | 4.50e-01 | 8.03e-01 |
Spry regulation of FGF signaling | 16 | 1.44e-03 | 3.73e-03 | 0.5890 | 0.475000 | 0.216000 | -0.274000 | 1.01e-03 | 1.35e-01 | 5.73e-02 |
Activation of Matrix Metalloproteinases | 22 | 2.51e-04 | 8.34e-04 | 0.5870 | 0.374000 | 0.257000 | -0.372000 | 2.41e-03 | 3.69e-02 | 2.52e-03 |
Collagen degradation | 28 | 1.05e-04 | 3.94e-04 | 0.5850 | 0.394000 | 0.347000 | -0.259000 | 3.10e-04 | 1.47e-03 | 1.77e-02 |
InlB-mediated entry of Listeria monocytogenes into host cell | 12 | 8.11e-03 | 1.66e-02 | 0.5820 | 0.525000 | 0.220000 | -0.122000 | 1.64e-03 | 1.87e-01 | 4.63e-01 |
Signaling by high-kinase activity BRAF mutants | 31 | 1.54e-05 | 7.53e-05 | 0.5760 | 0.498000 | 0.272000 | -0.101000 | 1.59e-06 | 8.77e-03 | 3.29e-01 |
NF-kB is activated and signals survival | 12 | 2.63e-03 | 6.29e-03 | 0.5760 | 0.264000 | -0.039700 | -0.511000 | 1.14e-01 | 8.12e-01 | 2.18e-03 |
AKT phosphorylates targets in the cytosol | 14 | 1.43e-02 | 2.71e-02 | 0.5760 | 0.427000 | 0.298000 | -0.245000 | 5.63e-03 | 5.38e-02 | 1.12e-01 |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models | 20 | 3.80e-04 | 1.21e-03 | 0.5730 | 0.513000 | 0.229000 | -0.115000 | 7.17e-05 | 7.68e-02 | 3.74e-01 |
Neurodegenerative Diseases | 20 | 3.80e-04 | 1.21e-03 | 0.5730 | 0.513000 | 0.229000 | -0.115000 | 7.17e-05 | 7.68e-02 | 3.74e-01 |
Erythropoietin activates RAS | 13 | 5.43e-02 | 8.65e-02 | 0.5730 | 0.423000 | 0.385000 | 0.017800 | 8.22e-03 | 1.61e-02 | 9.11e-01 |
EGFR downregulation | 27 | 1.29e-06 | 8.42e-06 | 0.5720 | 0.460000 | 0.123000 | -0.316000 | 3.48e-05 | 2.67e-01 | 4.44e-03 |
NEP/NS2 Interacts with the Cellular Export Machinery | 32 | 2.16e-05 | 9.90e-05 | 0.5710 | -0.321000 | -0.405000 | 0.242000 | 1.66e-03 | 7.28e-05 | 1.79e-02 |
GAB1 signalosome | 15 | 9.26e-04 | 2.57e-03 | 0.5700 | 0.471000 | 0.136000 | -0.292000 | 1.59e-03 | 3.63e-01 | 5.05e-02 |
Interactions of Rev with host cellular proteins | 37 | 6.53e-06 | 3.54e-05 | 0.5690 | -0.326000 | -0.430000 | 0.179000 | 5.92e-04 | 5.85e-06 | 6.01e-02 |
Establishment of Sister Chromatid Cohesion | 11 | 7.01e-05 | 2.72e-04 | 0.5690 | 0.064700 | -0.438000 | 0.358000 | 7.10e-01 | 1.20e-02 | 4.00e-02 |
Rev-mediated nuclear export of HIV RNA | 35 | 2.30e-05 | 1.04e-04 | 0.5640 | -0.334000 | -0.424000 | 0.165000 | 6.31e-04 | 1.42e-05 | 9.09e-02 |
Signal regulatory protein family interactions | 12 | 3.28e-02 | 5.64e-02 | 0.5640 | 0.409000 | 0.291000 | -0.258000 | 1.43e-02 | 8.13e-02 | 1.22e-01 |
Leading Strand Synthesis | 14 | 2.56e-02 | 4.50e-02 | 0.5630 | -0.364000 | -0.382000 | 0.197000 | 1.84e-02 | 1.34e-02 | 2.03e-01 |
Polymerase switching | 14 | 2.56e-02 | 4.50e-02 | 0.5630 | -0.364000 | -0.382000 | 0.197000 | 1.84e-02 | 1.34e-02 | 2.03e-01 |
Incretin synthesis, secretion, and inactivation | 10 | 5.29e-03 | 1.14e-02 | 0.5610 | 0.163000 | -0.079600 | 0.531000 | 3.73e-01 | 6.63e-01 | 3.64e-03 |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 10 | 5.29e-03 | 1.14e-02 | 0.5610 | 0.163000 | -0.079600 | 0.531000 | 3.73e-01 | 6.63e-01 | 3.64e-03 |
Formation of ATP by chemiosmotic coupling | 18 | 1.04e-03 | 2.85e-03 | 0.5600 | 0.427000 | 0.186000 | -0.311000 | 1.71e-03 | 1.72e-01 | 2.21e-02 |
Regulation of FZD by ubiquitination | 15 | 9.23e-04 | 2.57e-03 | 0.5580 | -0.009250 | -0.355000 | -0.431000 | 9.51e-01 | 1.73e-02 | 3.89e-03 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 7.32e-02 | 1.11e-01 | 0.5580 | 0.443000 | 0.325000 | -0.100000 | 1.10e-02 | 6.21e-02 | 5.65e-01 |
NS1 Mediated Effects on Host Pathways | 40 | 1.37e-06 | 8.81e-06 | 0.5580 | -0.305000 | -0.375000 | 0.278000 | 8.43e-04 | 3.99e-05 | 2.38e-03 |
RHO GTPases activate PKNs | 47 | 1.22e-07 | 9.67e-07 | 0.5570 | 0.480000 | 0.267000 | -0.095900 | 1.24e-08 | 1.55e-03 | 2.55e-01 |
Vpr-mediated nuclear import of PICs | 34 | 2.03e-05 | 9.47e-05 | 0.5570 | -0.309000 | -0.425000 | 0.186000 | 1.85e-03 | 1.81e-05 | 6.01e-02 |
Smooth Muscle Contraction | 31 | 2.43e-06 | 1.47e-05 | 0.5570 | 0.494000 | 0.194000 | -0.168000 | 1.95e-06 | 6.13e-02 | 1.04e-01 |
RHO GTPases activate PAKs | 20 | 1.83e-03 | 4.57e-03 | 0.5560 | 0.484000 | 0.263000 | 0.074700 | 1.78e-04 | 4.20e-02 | 5.63e-01 |
FOXO-mediated transcription of cell death genes | 16 | 3.93e-03 | 8.90e-03 | 0.5540 | 0.332000 | 0.195000 | -0.398000 | 2.15e-02 | 1.77e-01 | 5.78e-03 |
Notch-HLH transcription pathway | 28 | 2.29e-04 | 7.76e-04 | 0.5530 | 0.407000 | 0.290000 | -0.237000 | 1.92e-04 | 7.91e-03 | 3.03e-02 |
Packaging Of Telomere Ends | 20 | 8.09e-06 | 4.27e-05 | 0.5510 | 0.448000 | 0.021400 | -0.321000 | 5.29e-04 | 8.68e-01 | 1.28e-02 |
Platelet Aggregation (Plug Formation) | 28 | 2.94e-06 | 1.73e-05 | 0.5480 | 0.476000 | 0.143000 | -0.232000 | 1.29e-05 | 1.92e-01 | 3.39e-02 |
Amyloid fiber formation | 51 | 2.65e-12 | 4.57e-11 | 0.5480 | 0.482000 | 0.110000 | -0.237000 | 2.59e-09 | 1.74e-01 | 3.38e-03 |
Chondroitin sulfate biosynthesis | 12 | 2.95e-02 | 5.11e-02 | 0.5480 | 0.296000 | 0.321000 | -0.331000 | 7.61e-02 | 5.45e-02 | 4.68e-02 |
Nuclear import of Rev protein | 34 | 3.14e-05 | 1.34e-04 | 0.5470 | -0.306000 | -0.410000 | 0.195000 | 2.03e-03 | 3.47e-05 | 4.96e-02 |
The NLRP3 inflammasome | 15 | 2.01e-02 | 3.68e-02 | 0.5470 | 0.457000 | 0.285000 | 0.095800 | 2.18e-03 | 5.62e-02 | 5.21e-01 |
Regulated proteolysis of p75NTR | 11 | 1.03e-01 | 1.48e-01 | 0.5460 | 0.416000 | 0.349000 | -0.058400 | 1.69e-02 | 4.53e-02 | 7.37e-01 |
Lysosome Vesicle Biogenesis | 32 | 2.33e-04 | 7.82e-04 | 0.5440 | 0.404000 | 0.329000 | -0.158000 | 7.55e-05 | 1.29e-03 | 1.22e-01 |
Response of Mtb to phagocytosis | 22 | 3.94e-04 | 1.24e-03 | 0.5440 | 0.459000 | 0.205000 | -0.209000 | 1.96e-04 | 9.59e-02 | 8.91e-02 |
Prolonged ERK activation events | 13 | 4.64e-02 | 7.55e-02 | 0.5440 | 0.452000 | 0.303000 | -0.009470 | 4.80e-03 | 5.82e-02 | 9.53e-01 |
ATF6 (ATF6-alpha) activates chaperone genes | 10 | 2.52e-03 | 6.05e-03 | 0.5420 | 0.446000 | 0.026800 | 0.307000 | 1.46e-02 | 8.83e-01 | 9.27e-02 |
Postmitotic nuclear pore complex (NPC) reformation | 27 | 1.36e-04 | 4.94e-04 | 0.5400 | -0.263000 | -0.437000 | 0.178000 | 1.81e-02 | 8.37e-05 | 1.09e-01 |
CDC6 association with the ORC:origin complex | 11 | 6.03e-03 | 1.27e-02 | 0.5400 | -0.040600 | -0.249000 | 0.478000 | 8.16e-01 | 1.52e-01 | 6.08e-03 |
SUMOylation of immune response proteins | 11 | 6.90e-02 | 1.05e-01 | 0.5400 | 0.408000 | 0.290000 | -0.203000 | 1.92e-02 | 9.56e-02 | 2.45e-01 |
Integrin signaling | 22 | 1.89e-03 | 4.68e-03 | 0.5390 | 0.456000 | 0.266000 | -0.108000 | 2.10e-04 | 3.06e-02 | 3.83e-01 |
Biotin transport and metabolism | 11 | 7.44e-02 | 1.13e-01 | 0.5370 | -0.439000 | -0.279000 | -0.135000 | 1.17e-02 | 1.09e-01 | 4.39e-01 |
Interactions of Vpr with host cellular proteins | 37 | 1.41e-05 | 7.06e-05 | 0.5370 | -0.285000 | -0.436000 | 0.130000 | 2.71e-03 | 4.36e-06 | 1.72e-01 |
Recycling pathway of L1 | 26 | 1.32e-03 | 3.49e-03 | 0.5370 | 0.426000 | 0.302000 | -0.123000 | 1.70e-04 | 7.62e-03 | 2.78e-01 |
ERKs are inactivated | 13 | 4.42e-02 | 7.25e-02 | 0.5360 | 0.432000 | 0.289000 | -0.129000 | 6.97e-03 | 7.08e-02 | 4.21e-01 |
Transport of Ribonucleoproteins into the Host Nucleus | 32 | 5.88e-05 | 2.35e-04 | 0.5360 | -0.288000 | -0.384000 | 0.238000 | 4.84e-03 | 1.73e-04 | 1.96e-02 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | 15 | 1.95e-02 | 3.57e-02 | 0.5330 | 0.281000 | 0.446000 | -0.077300 | 5.99e-02 | 2.78e-03 | 6.04e-01 |
Signaling by RAF1 mutants | 34 | 2.09e-05 | 9.64e-05 | 0.5320 | 0.471000 | 0.241000 | -0.062800 | 2.03e-06 | 1.51e-02 | 5.26e-01 |
Metabolism of non-coding RNA | 53 | 1.64e-08 | 1.62e-07 | 0.5300 | -0.255000 | -0.417000 | 0.204000 | 1.31e-03 | 1.49e-07 | 1.00e-02 |
snRNP Assembly | 53 | 1.64e-08 | 1.62e-07 | 0.5300 | -0.255000 | -0.417000 | 0.204000 | 1.31e-03 | 1.49e-07 | 1.00e-02 |
Growth hormone receptor signaling | 20 | 1.29e-02 | 2.49e-02 | 0.5290 | 0.421000 | 0.320000 | -0.017100 | 1.13e-03 | 1.31e-02 | 8.94e-01 |
Extension of Telomeres | 51 | 3.26e-06 | 1.88e-05 | 0.5280 | -0.311000 | -0.426000 | -0.000978 | 1.21e-04 | 1.41e-07 | 9.90e-01 |
Pexophagy | 11 | 8.95e-03 | 1.82e-02 | 0.5270 | 0.357000 | 0.024000 | -0.388000 | 4.06e-02 | 8.91e-01 | 2.59e-02 |
activated TAK1 mediates p38 MAPK activation | 19 | 6.14e-03 | 1.29e-02 | 0.5270 | 0.455000 | 0.259000 | -0.061800 | 5.93e-04 | 5.07e-02 | 6.41e-01 |
Membrane binding and targetting of GAG proteins | 13 | 1.79e-02 | 3.32e-02 | 0.5230 | 0.445000 | 0.193000 | -0.193000 | 5.43e-03 | 2.27e-01 | 2.28e-01 |
Synthesis And Processing Of GAG, GAGPOL Polyproteins | 13 | 1.79e-02 | 3.32e-02 | 0.5230 | 0.445000 | 0.193000 | -0.193000 | 5.43e-03 | 2.27e-01 | 2.28e-01 |
Platelet Adhesion to exposed collagen | 13 | 6.39e-05 | 2.54e-04 | 0.5220 | 0.500000 | -0.055100 | -0.141000 | 1.80e-03 | 7.31e-01 | 3.77e-01 |
Translesion synthesis by REV1 | 16 | 2.71e-02 | 4.73e-02 | 0.5220 | -0.294000 | -0.431000 | 0.015600 | 4.15e-02 | 2.82e-03 | 9.14e-01 |
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 31 | 3.00e-04 | 9.75e-04 | 0.5200 | -0.309000 | -0.361000 | 0.212000 | 2.93e-03 | 5.04e-04 | 4.06e-02 |
Regulation of Glucokinase by Glucokinase Regulatory Protein | 31 | 3.00e-04 | 9.75e-04 | 0.5200 | -0.309000 | -0.361000 | 0.212000 | 2.93e-03 | 5.04e-04 | 4.06e-02 |
Purine ribonucleoside monophosphate biosynthesis | 10 | 9.91e-02 | 1.43e-01 | 0.5200 | -0.266000 | -0.447000 | 0.012500 | 1.46e-01 | 1.44e-02 | 9.45e-01 |
Assembly Of The HIV Virion | 15 | 1.07e-02 | 2.12e-02 | 0.5190 | 0.417000 | 0.192000 | -0.241000 | 5.12e-03 | 1.98e-01 | 1.06e-01 |
Sema4D in semaphorin signaling | 22 | 1.11e-02 | 2.19e-02 | 0.5180 | 0.379000 | 0.344000 | -0.080400 | 2.09e-03 | 5.24e-03 | 5.14e-01 |
Diseases of DNA repair | 10 | 1.83e-01 | 2.35e-01 | 0.5170 | -0.366000 | -0.365000 | 0.029300 | 4.52e-02 | 4.58e-02 | 8.72e-01 |
Export of Viral Ribonucleoproteins from Nucleus | 33 | 1.15e-04 | 4.28e-04 | 0.5170 | -0.285000 | -0.376000 | 0.211000 | 4.58e-03 | 1.82e-04 | 3.60e-02 |
BBSome-mediated cargo-targeting to cilium | 22 | 3.09e-04 | 1.00e-03 | 0.5170 | -0.195000 | -0.455000 | 0.147000 | 1.14e-01 | 2.19e-04 | 2.32e-01 |
Sema4D induced cell migration and growth-cone collapse | 19 | 1.90e-02 | 3.49e-02 | 0.5150 | 0.375000 | 0.328000 | -0.130000 | 4.64e-03 | 1.34e-02 | 3.26e-01 |
Polymerase switching on the C-strand of the telomere | 26 | 3.79e-03 | 8.61e-03 | 0.5120 | -0.305000 | -0.411000 | -0.003220 | 7.06e-03 | 2.82e-04 | 9.77e-01 |
Sealing of the nuclear envelope (NE) by ESCRT-III | 25 | 7.27e-04 | 2.09e-03 | 0.5110 | 0.431000 | 0.219000 | -0.166000 | 1.88e-04 | 5.85e-02 | 1.51e-01 |
A tetrasaccharide linker sequence is required for GAG synthesis | 17 | 1.15e-02 | 2.27e-02 | 0.5110 | -0.158000 | -0.222000 | -0.433000 | 2.61e-01 | 1.13e-01 | 2.00e-03 |
Signaling by Erythropoietin | 24 | 7.84e-03 | 1.61e-02 | 0.5080 | 0.377000 | 0.328000 | -0.090700 | 1.38e-03 | 5.35e-03 | 4.42e-01 |
Glycogen breakdown (glycogenolysis) | 13 | 5.71e-02 | 9.00e-02 | 0.5070 | 0.410000 | 0.262000 | -0.142000 | 1.04e-02 | 1.01e-01 | 3.74e-01 |
tRNA processing in the mitochondrion | 30 | 7.58e-05 | 2.93e-04 | 0.5070 | -0.141000 | -0.117000 | -0.473000 | 1.82e-01 | 2.67e-01 | 7.26e-06 |
Transport of the SLBP independent Mature mRNA | 35 | 6.42e-05 | 2.54e-04 | 0.5070 | -0.270000 | -0.353000 | 0.243000 | 5.64e-03 | 2.98e-04 | 1.27e-02 |
Transport of the SLBP Dependant Mature mRNA | 36 | 2.65e-05 | 1.16e-04 | 0.5040 | -0.246000 | -0.358000 | 0.255000 | 1.07e-02 | 2.00e-04 | 8.17e-03 |
Glycogen synthesis | 13 | 4.69e-03 | 1.04e-02 | 0.5030 | 0.404000 | 0.052500 | -0.295000 | 1.17e-02 | 7.43e-01 | 6.54e-02 |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 16 | 4.13e-04 | 1.28e-03 | 0.5030 | 0.304000 | -0.082800 | -0.391000 | 3.50e-02 | 5.66e-01 | 6.71e-03 |
Infection with Mycobacterium tuberculosis | 26 | 1.76e-04 | 6.11e-04 | 0.5030 | 0.449000 | 0.173000 | -0.145000 | 7.40e-05 | 1.26e-01 | 2.01e-01 |
Cytosolic iron-sulfur cluster assembly | 13 | 1.27e-02 | 2.46e-02 | 0.5020 | -0.187000 | -0.047900 | -0.464000 | 2.43e-01 | 7.65e-01 | 3.79e-03 |
HDR through Single Strand Annealing (SSA) | 37 | 2.24e-05 | 1.01e-04 | 0.5020 | -0.278000 | -0.221000 | 0.354000 | 3.44e-03 | 2.00e-02 | 1.92e-04 |
Late endosomal microautophagy | 30 | 2.94e-04 | 9.60e-04 | 0.5010 | 0.423000 | 0.226000 | -0.147000 | 6.12e-05 | 3.25e-02 | 1.64e-01 |
SHC1 events in EGFR signaling | 12 | 9.14e-03 | 1.84e-02 | 0.5010 | 0.480000 | 0.119000 | -0.081100 | 4.00e-03 | 4.76e-01 | 6.27e-01 |
Common Pathway of Fibrin Clot Formation | 14 | 2.44e-02 | 4.34e-02 | 0.5000 | 0.335000 | 0.183000 | -0.322000 | 2.99e-02 | 2.36e-01 | 3.68e-02 |
EPH-Ephrin signaling | 78 | 8.26e-09 | 8.86e-08 | 0.4990 | 0.399000 | 0.281000 | -0.105000 | 1.13e-09 | 1.79e-05 | 1.08e-01 |
tRNA processing in the nucleus | 59 | 3.05e-07 | 2.24e-06 | 0.4990 | -0.291000 | -0.354000 | 0.197000 | 1.12e-04 | 2.52e-06 | 8.83e-03 |
Antimicrobial peptides | 33 | 2.49e-08 | 2.28e-07 | 0.4980 | 0.459000 | 0.035000 | -0.192000 | 5.09e-06 | 7.28e-01 | 5.66e-02 |
LDL clearance | 17 | 2.95e-02 | 5.11e-02 | 0.4980 | 0.345000 | 0.301000 | -0.196000 | 1.37e-02 | 3.17e-02 | 1.62e-01 |
Response to elevated platelet cytosolic Ca2+ | 108 | 8.42e-19 | 2.16e-17 | 0.4980 | 0.453000 | 0.153000 | -0.138000 | 3.81e-16 | 6.03e-03 | 1.29e-02 |
Diseases of carbohydrate metabolism | 29 | 3.94e-04 | 1.24e-03 | 0.4980 | 0.333000 | 0.214000 | -0.303000 | 1.93e-03 | 4.65e-02 | 4.80e-03 |
RHO GTPases activate CIT | 18 | 4.34e-02 | 7.16e-02 | 0.4970 | 0.369000 | 0.314000 | 0.114000 | 6.79e-03 | 2.11e-02 | 4.02e-01 |
Platelet degranulation | 104 | 3.96e-18 | 9.81e-17 | 0.4940 | 0.451000 | 0.147000 | -0.136000 | 1.74e-15 | 9.52e-03 | 1.63e-02 |
Plasma lipoprotein clearance | 28 | 5.36e-04 | 1.57e-03 | 0.4940 | 0.278000 | 0.224000 | -0.341000 | 1.09e-02 | 4.05e-02 | 1.78e-03 |
Cytochrome c-mediated apoptotic response | 13 | 6.90e-02 | 1.05e-01 | 0.4920 | 0.339000 | 0.235000 | 0.268000 | 3.44e-02 | 1.42e-01 | 9.47e-02 |
GRB2 events in EGFR signaling | 11 | 7.83e-03 | 1.61e-02 | 0.4900 | 0.477000 | 0.070300 | -0.084200 | 6.15e-03 | 6.87e-01 | 6.29e-01 |
Scavenging by Class A Receptors | 11 | 1.89e-01 | 2.41e-01 | 0.4880 | 0.370000 | 0.309000 | 0.073900 | 3.36e-02 | 7.55e-02 | 6.71e-01 |
CD28 dependent PI3K/Akt signaling | 22 | 1.21e-02 | 2.37e-02 | 0.4870 | -0.296000 | -0.259000 | -0.287000 | 1.63e-02 | 3.51e-02 | 1.96e-02 |
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 15 | 6.65e-03 | 1.39e-02 | 0.4860 | 0.454000 | 0.140000 | -0.106000 | 2.34e-03 | 3.48e-01 | 4.79e-01 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 92 | 8.22e-13 | 1.49e-11 | 0.4860 | 0.438000 | 0.201000 | -0.059400 | 3.52e-13 | 8.84e-04 | 3.25e-01 |
Toll Like Receptor 2 (TLR2) Cascade | 92 | 8.22e-13 | 1.49e-11 | 0.4860 | 0.438000 | 0.201000 | -0.059400 | 3.52e-13 | 8.84e-04 | 3.25e-01 |
Toll Like Receptor TLR1:TLR2 Cascade | 92 | 8.22e-13 | 1.49e-11 | 0.4860 | 0.438000 | 0.201000 | -0.059400 | 3.52e-13 | 8.84e-04 | 3.25e-01 |
Toll Like Receptor TLR6:TLR2 Cascade | 92 | 8.22e-13 | 1.49e-11 | 0.4860 | 0.438000 | 0.201000 | -0.059400 | 3.52e-13 | 8.84e-04 | 3.25e-01 |
Mitochondrial tRNA aminoacylation | 21 | 2.26e-02 | 4.06e-02 | 0.4860 | -0.311000 | -0.369000 | 0.057900 | 1.36e-02 | 3.44e-03 | 6.46e-01 |
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 14 | 8.83e-02 | 1.30e-01 | 0.4850 | -0.307000 | -0.368000 | 0.080100 | 4.70e-02 | 1.72e-02 | 6.04e-01 |
RHO GTPases activate KTN1 | 11 | 1.63e-01 | 2.17e-01 | 0.4850 | 0.391000 | 0.281000 | 0.059900 | 2.47e-02 | 1.06e-01 | 7.31e-01 |
Resolution of Abasic Sites (AP sites) | 37 | 1.55e-03 | 3.98e-03 | 0.4850 | -0.348000 | -0.327000 | -0.085100 | 2.50e-04 | 5.79e-04 | 3.71e-01 |
Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 22 | 3.00e-05 | 1.29e-04 | 0.4840 | 0.302000 | -0.080900 | -0.370000 | 1.42e-02 | 5.11e-01 | 2.66e-03 |
COPI-mediated anterograde transport | 78 | 6.29e-08 | 5.29e-07 | 0.4840 | 0.392000 | 0.278000 | 0.058700 | 2.10e-09 | 2.20e-05 | 3.70e-01 |
Butyrophilin (BTN) family interactions | 10 | 1.15e-01 | 1.64e-01 | 0.4830 | -0.423000 | -0.217000 | 0.085500 | 2.04e-02 | 2.35e-01 | 6.40e-01 |
Antigen processing-Cross presentation | 97 | 2.30e-10 | 2.99e-09 | 0.4810 | 0.401000 | 0.258000 | 0.064500 | 8.19e-12 | 1.13e-05 | 2.73e-01 |
Cleavage of the damaged purine | 24 | 3.70e-05 | 1.55e-04 | 0.4810 | 0.352000 | 0.002720 | -0.327000 | 2.80e-03 | 9.82e-01 | 5.51e-03 |
Depurination | 24 | 3.70e-05 | 1.55e-04 | 0.4810 | 0.352000 | 0.002720 | -0.327000 | 2.80e-03 | 9.82e-01 | 5.51e-03 |
Recognition and association of DNA glycosylase with site containing an affected purine | 24 | 3.70e-05 | 1.55e-04 | 0.4810 | 0.352000 | 0.002720 | -0.327000 | 2.80e-03 | 9.82e-01 | 5.51e-03 |
Paradoxical activation of RAF signaling by kinase inactive BRAF | 38 | 2.64e-05 | 1.16e-04 | 0.4810 | 0.432000 | 0.199000 | -0.069600 | 4.09e-06 | 3.37e-02 | 4.58e-01 |
Signaling by RAS mutants | 38 | 2.64e-05 | 1.16e-04 | 0.4810 | 0.432000 | 0.199000 | -0.069600 | 4.09e-06 | 3.37e-02 | 4.58e-01 |
Signaling by moderate kinase activity BRAF mutants | 38 | 2.64e-05 | 1.16e-04 | 0.4810 | 0.432000 | 0.199000 | -0.069600 | 4.09e-06 | 3.37e-02 | 4.58e-01 |
Signaling downstream of RAS mutants | 38 | 2.64e-05 | 1.16e-04 | 0.4810 | 0.432000 | 0.199000 | -0.069600 | 4.09e-06 | 3.37e-02 | 4.58e-01 |
Signal amplification | 28 | 3.07e-04 | 9.97e-04 | 0.4800 | 0.440000 | 0.187000 | 0.049100 | 5.62e-05 | 8.70e-02 | 6.53e-01 |
Suppression of phagosomal maturation | 12 | 3.56e-02 | 6.05e-02 | 0.4800 | 0.437000 | 0.163000 | -0.111000 | 8.73e-03 | 3.28e-01 | 5.06e-01 |
HuR (ELAVL1) binds and stabilizes mRNA | 10 | 9.41e-02 | 1.38e-01 | 0.4790 | 0.408000 | 0.189000 | 0.163000 | 2.53e-02 | 3.02e-01 | 3.71e-01 |
GPVI-mediated activation cascade | 31 | 4.05e-03 | 9.12e-03 | 0.4780 | 0.329000 | 0.339000 | -0.070700 | 1.52e-03 | 1.10e-03 | 4.96e-01 |
Translesion synthesis by POLI | 17 | 3.42e-02 | 5.84e-02 | 0.4770 | -0.261000 | -0.395000 | 0.063700 | 6.24e-02 | 4.84e-03 | 6.50e-01 |
trans-Golgi Network Vesicle Budding | 69 | 1.69e-06 | 1.06e-05 | 0.4770 | 0.371000 | 0.299000 | -0.027800 | 1.01e-07 | 1.73e-05 | 6.89e-01 |
PKA activation in glucagon signalling | 14 | 2.57e-02 | 4.52e-02 | 0.4760 | 0.345000 | 0.142000 | -0.295000 | 2.53e-02 | 3.56e-01 | 5.63e-02 |
Early Phase of HIV Life Cycle | 14 | 9.97e-03 | 1.99e-02 | 0.4760 | -0.150000 | -0.441000 | 0.095000 | 3.31e-01 | 4.25e-03 | 5.38e-01 |
Pyrimidine salvage | 10 | 1.60e-01 | 2.13e-01 | 0.4750 | 0.345000 | 0.246000 | -0.215000 | 5.90e-02 | 1.77e-01 | 2.39e-01 |
Cross-presentation of soluble exogenous antigens (endosomes) | 47 | 1.36e-05 | 6.89e-05 | 0.4750 | 0.398000 | 0.225000 | 0.129000 | 2.35e-06 | 7.52e-03 | 1.26e-01 |
Interleukin-1 signaling | 97 | 7.01e-13 | 1.36e-11 | 0.4740 | 0.431000 | 0.196000 | -0.015200 | 2.20e-13 | 8.29e-04 | 7.95e-01 |
G-protein beta:gamma signalling | 29 | 5.04e-03 | 1.09e-02 | 0.4730 | 0.375000 | 0.283000 | -0.057300 | 4.69e-04 | 8.40e-03 | 5.93e-01 |
Post-translational protein phosphorylation | 69 | 1.97e-06 | 1.22e-05 | 0.4730 | 0.344000 | 0.313000 | -0.083200 | 7.45e-07 | 6.85e-06 | 2.32e-01 |
E2F mediated regulation of DNA replication | 22 | 4.77e-04 | 1.43e-03 | 0.4710 | -0.120000 | -0.332000 | 0.311000 | 3.28e-01 | 7.07e-03 | 1.14e-02 |
Effects of PIP2 hydrolysis | 24 | 7.93e-03 | 1.63e-02 | 0.4710 | -0.307000 | -0.227000 | -0.275000 | 9.19e-03 | 5.39e-02 | 1.98e-02 |
p75NTR signals via NF-kB | 15 | 5.30e-03 | 1.14e-02 | 0.4710 | 0.291000 | -0.003890 | -0.370000 | 5.07e-02 | 9.79e-01 | 1.32e-02 |
Regulation of expression of SLITs and ROBOs | 159 | 2.70e-26 | 9.94e-25 | 0.4700 | -0.041600 | -0.344000 | -0.318000 | 3.65e-01 | 7.32e-14 | 4.51e-12 |
Gastrin-CREB signalling pathway via PKC and MAPK | 14 | 2.52e-02 | 4.45e-02 | 0.4700 | 0.408000 | 0.158000 | -0.170000 | 8.16e-03 | 3.06e-01 | 2.70e-01 |
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 26 | 8.83e-04 | 2.47e-03 | 0.4690 | -0.243000 | -0.121000 | 0.382000 | 3.17e-02 | 2.87e-01 | 7.36e-04 |
Processive synthesis on the C-strand of the telomere | 19 | 2.87e-02 | 4.99e-02 | 0.4680 | -0.255000 | -0.393000 | 0.010100 | 5.44e-02 | 3.04e-03 | 9.39e-01 |
SUMOylation of DNA methylation proteins | 16 | 1.84e-02 | 3.40e-02 | 0.4680 | -0.040500 | -0.190000 | -0.426000 | 7.79e-01 | 1.89e-01 | 3.15e-03 |
Inflammasomes | 20 | 1.21e-02 | 2.37e-02 | 0.4680 | 0.399000 | 0.212000 | 0.122000 | 1.99e-03 | 1.00e-01 | 3.47e-01 |
G1/S-Specific Transcription | 29 | 2.77e-06 | 1.65e-05 | 0.4670 | -0.084800 | -0.421000 | 0.182000 | 4.29e-01 | 8.57e-05 | 9.00e-02 |
ADP signalling through P2Y purinoceptor 1 | 21 | 1.28e-02 | 2.48e-02 | 0.4660 | 0.406000 | 0.226000 | 0.036300 | 1.29e-03 | 7.35e-02 | 7.74e-01 |
Processing and activation of SUMO | 10 | 1.87e-02 | 3.46e-02 | 0.4660 | 0.060600 | -0.195000 | 0.418000 | 7.40e-01 | 2.85e-01 | 2.20e-02 |
CD22 mediated BCR regulation | 59 | 2.18e-10 | 2.86e-09 | 0.4650 | -0.135000 | -0.432000 | 0.107000 | 7.25e-02 | 9.61e-09 | 1.55e-01 |
rRNA processing in the mitochondrion | 27 | 2.98e-03 | 6.99e-03 | 0.4640 | -0.156000 | -0.231000 | -0.371000 | 1.60e-01 | 3.76e-02 | 8.40e-04 |
Activated NOTCH1 Transmits Signal to the Nucleus | 27 | 2.23e-03 | 5.43e-03 | 0.4630 | 0.268000 | 0.224000 | -0.304000 | 1.61e-02 | 4.35e-02 | 6.26e-03 |
COPII-mediated vesicle transport | 65 | 1.19e-06 | 7.85e-06 | 0.4620 | 0.389000 | 0.242000 | 0.061100 | 5.77e-08 | 7.57e-04 | 3.94e-01 |
ATF6 (ATF6-alpha) activates chaperones | 12 | 7.43e-03 | 1.54e-02 | 0.4610 | 0.416000 | 0.051400 | 0.192000 | 1.26e-02 | 7.58e-01 | 2.49e-01 |
Glycogen storage diseases | 13 | 5.98e-02 | 9.35e-02 | 0.4610 | 0.301000 | 0.169000 | -0.305000 | 6.04e-02 | 2.92e-01 | 5.66e-02 |
Condensation of Prometaphase Chromosomes | 11 | 2.16e-02 | 3.91e-02 | 0.4580 | 0.096300 | -0.111000 | 0.434000 | 5.80e-01 | 5.25e-01 | 1.26e-02 |
SLBP independent Processing of Histone Pre-mRNAs | 10 | 7.22e-02 | 1.10e-01 | 0.4580 | -0.153000 | -0.432000 | 0.002130 | 4.03e-01 | 1.81e-02 | 9.91e-01 |
Energy dependent regulation of mTOR by LKB1-AMPK | 27 | 6.76e-03 | 1.41e-02 | 0.4560 | 0.385000 | 0.241000 | 0.039100 | 5.31e-04 | 3.05e-02 | 7.25e-01 |
Pre-NOTCH Transcription and Translation | 49 | 4.25e-06 | 2.40e-05 | 0.4550 | 0.352000 | 0.170000 | -0.234000 | 2.05e-05 | 4.00e-02 | 4.63e-03 |
Pre-NOTCH Expression and Processing | 65 | 1.54e-07 | 1.19e-06 | 0.4550 | 0.348000 | 0.190000 | -0.223000 | 1.26e-06 | 7.94e-03 | 1.83e-03 |
Metabolism of Angiotensinogen to Angiotensins | 11 | 5.04e-02 | 8.10e-02 | 0.4540 | 0.392000 | 0.111000 | -0.200000 | 2.44e-02 | 5.23e-01 | 2.50e-01 |
Signalling to ERKs | 31 | 1.63e-03 | 4.14e-03 | 0.4540 | 0.397000 | 0.219000 | 0.019700 | 1.30e-04 | 3.47e-02 | 8.50e-01 |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 12 | 9.99e-03 | 2.00e-02 | 0.4530 | 0.275000 | -0.016000 | 0.359000 | 9.85e-02 | 9.23e-01 | 3.13e-02 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 11 | 1.68e-02 | 3.15e-02 | 0.4520 | -0.082600 | -0.441000 | 0.061000 | 6.35e-01 | 1.14e-02 | 7.26e-01 |
NOTCH3 Activation and Transmission of Signal to the Nucleus | 23 | 5.47e-03 | 1.17e-02 | 0.4520 | 0.264000 | 0.167000 | -0.327000 | 2.86e-02 | 1.65e-01 | 6.61e-03 |
Olfactory Signaling Pathway | 57 | 9.32e-07 | 6.32e-06 | 0.4510 | 0.086100 | 0.191000 | 0.400000 | 2.61e-01 | 1.28e-02 | 1.76e-07 |
Frs2-mediated activation | 11 | 1.70e-01 | 2.24e-01 | 0.4510 | 0.377000 | 0.233000 | -0.082200 | 3.02e-02 | 1.82e-01 | 6.37e-01 |
Transcriptional regulation of granulopoiesis | 46 | 8.13e-08 | 6.59e-07 | 0.4510 | 0.419000 | 0.096200 | -0.135000 | 8.80e-07 | 2.59e-01 | 1.13e-01 |
Formation of apoptosome | 11 | 1.20e-01 | 1.69e-01 | 0.4500 | 0.383000 | 0.192000 | 0.139000 | 2.79e-02 | 2.69e-01 | 4.25e-01 |
Regulation of the apoptosome activity | 11 | 1.20e-01 | 1.69e-01 | 0.4500 | 0.383000 | 0.192000 | 0.139000 | 2.79e-02 | 2.69e-01 | 4.25e-01 |
Formation of the cornified envelope | 21 | 2.21e-02 | 4.00e-02 | 0.4500 | 0.372000 | 0.231000 | -0.107000 | 3.19e-03 | 6.74e-02 | 3.96e-01 |
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 22 | 1.36e-03 | 3.57e-03 | 0.4500 | 0.367000 | 0.091300 | -0.244000 | 2.88e-03 | 4.58e-01 | 4.74e-02 |
ER to Golgi Anterograde Transport | 129 | 1.11e-11 | 1.82e-10 | 0.4500 | 0.371000 | 0.248000 | 0.059500 | 3.31e-13 | 1.20e-06 | 2.44e-01 |
ERK/MAPK targets | 22 | 4.46e-03 | 9.94e-03 | 0.4490 | 0.407000 | 0.166000 | -0.090000 | 9.43e-04 | 1.78e-01 | 4.65e-01 |
Gluconeogenesis | 28 | 3.15e-03 | 7.33e-03 | 0.4490 | 0.242000 | 0.293000 | -0.238000 | 2.68e-02 | 7.19e-03 | 2.91e-02 |
Translesion synthesis by POLK | 17 | 5.02e-02 | 8.08e-02 | 0.4480 | -0.240000 | -0.372000 | 0.068300 | 8.61e-02 | 7.94e-03 | 6.26e-01 |
Glycogen metabolism | 23 | 2.47e-03 | 5.94e-03 | 0.4470 | 0.357000 | 0.125000 | -0.237000 | 3.01e-03 | 2.99e-01 | 4.87e-02 |
Inhibition of DNA recombination at telomere | 35 | 1.30e-06 | 8.42e-06 | 0.4470 | 0.343000 | 0.002950 | -0.287000 | 4.49e-04 | 9.76e-01 | 3.33e-03 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 87 | 1.54e-11 | 2.44e-10 | 0.4450 | 0.408000 | 0.153000 | -0.089600 | 4.64e-11 | 1.39e-02 | 1.49e-01 |
Golgi Associated Vesicle Biogenesis | 55 | 5.90e-05 | 2.35e-04 | 0.4450 | 0.367000 | 0.251000 | -0.001390 | 2.49e-06 | 1.29e-03 | 9.86e-01 |
Toll Like Receptor 4 (TLR4) Cascade | 121 | 1.75e-13 | 3.56e-12 | 0.4440 | 0.398000 | 0.193000 | -0.032900 | 3.68e-14 | 2.51e-04 | 5.31e-01 |
Alpha-protein kinase 1 signaling pathway | 11 | 3.33e-03 | 7.68e-03 | 0.4430 | 0.436000 | -0.039800 | -0.065000 | 1.22e-02 | 8.19e-01 | 7.09e-01 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | 89 | 5.63e-11 | 8.07e-10 | 0.4430 | 0.403000 | 0.168000 | -0.076800 | 5.11e-11 | 6.27e-03 | 2.11e-01 |
Response of EIF2AK1 (HRI) to heme deficiency | 14 | 3.49e-03 | 8.01e-03 | 0.4420 | 0.369000 | 0.018200 | 0.243000 | 1.68e-02 | 9.06e-01 | 1.16e-01 |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 12 | 2.47e-02 | 4.39e-02 | 0.4410 | 0.177000 | -0.113000 | -0.388000 | 2.89e-01 | 4.97e-01 | 1.99e-02 |
Nuclear Pore Complex (NPC) Disassembly | 36 | 1.39e-04 | 5.04e-04 | 0.4410 | -0.186000 | -0.339000 | 0.212000 | 5.32e-02 | 4.34e-04 | 2.75e-02 |
Cellular response to hypoxia | 71 | 2.46e-07 | 1.86e-06 | 0.4410 | 0.388000 | 0.209000 | 0.005170 | 1.49e-08 | 2.36e-03 | 9.40e-01 |
Mismatch Repair | 15 | 8.95e-02 | 1.32e-01 | 0.4410 | -0.242000 | -0.363000 | 0.061600 | 1.05e-01 | 1.48e-02 | 6.79e-01 |
Interleukin-6 signaling | 10 | 1.46e-01 | 1.99e-01 | 0.4400 | 0.401000 | 0.180000 | -0.027000 | 2.81e-02 | 3.24e-01 | 8.82e-01 |
HDACs deacetylate histones | 47 | 8.51e-07 | 5.94e-06 | 0.4390 | 0.358000 | 0.096200 | -0.235000 | 2.16e-05 | 2.54e-01 | 5.34e-03 |
Plasma lipoprotein assembly, remodeling, and clearance | 52 | 2.43e-05 | 1.09e-04 | 0.4380 | 0.250000 | 0.259000 | -0.250000 | 1.81e-03 | 1.23e-03 | 1.85e-03 |
Synthesis of PC | 23 | 2.37e-02 | 4.24e-02 | 0.4370 | 0.322000 | 0.224000 | 0.192000 | 7.45e-03 | 6.33e-02 | 1.11e-01 |
mRNA decay by 3’ to 5’ exoribonuclease | 16 | 9.88e-02 | 1.43e-01 | 0.4370 | -0.235000 | -0.360000 | -0.076700 | 1.04e-01 | 1.26e-02 | 5.95e-01 |
Assembly of active LPL and LIPC lipase complexes | 10 | 1.61e-01 | 2.15e-01 | 0.4360 | 0.204000 | 0.223000 | -0.315000 | 2.64e-01 | 2.22e-01 | 8.48e-02 |
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 14 | 1.36e-01 | 1.87e-01 | 0.4360 | -0.254000 | -0.352000 | 0.042000 | 1.00e-01 | 2.24e-02 | 7.85e-01 |
VxPx cargo-targeting to cilium | 19 | 8.64e-02 | 1.28e-01 | 0.4350 | 0.325000 | 0.274000 | 0.094800 | 1.43e-02 | 3.85e-02 | 4.75e-01 |
Transport of Mature mRNA Derived from an Intronless Transcript | 42 | 2.93e-04 | 9.58e-04 | 0.4350 | -0.248000 | -0.277000 | 0.226000 | 5.35e-03 | 1.91e-03 | 1.12e-02 |
mTORC1-mediated signalling | 24 | 3.92e-03 | 8.88e-03 | 0.4350 | 0.397000 | 0.162000 | -0.074000 | 7.71e-04 | 1.69e-01 | 5.30e-01 |
MyD88 dependent cascade initiated on endosome | 88 | 1.09e-10 | 1.46e-09 | 0.4350 | 0.396000 | 0.159000 | -0.082300 | 1.34e-10 | 9.89e-03 | 1.82e-01 |
Fanconi Anemia Pathway | 36 | 3.62e-03 | 8.25e-03 | 0.4350 | -0.354000 | -0.252000 | -0.003880 | 2.37e-04 | 8.87e-03 | 9.68e-01 |
MET activates RAS signaling | 10 | 1.51e-01 | 2.05e-01 | 0.4340 | 0.355000 | 0.164000 | 0.188000 | 5.19e-02 | 3.70e-01 | 3.04e-01 |
Transport of Mature mRNAs Derived from Intronless Transcripts | 43 | 1.61e-04 | 5.63e-04 | 0.4330 | -0.228000 | -0.283000 | 0.236000 | 9.62e-03 | 1.34e-03 | 7.37e-03 |
Hh mutants that don’t undergo autocatalytic processing are degraded by ERAD | 53 | 5.30e-06 | 2.94e-05 | 0.4330 | 0.387000 | 0.179000 | 0.074300 | 1.08e-06 | 2.39e-02 | 3.49e-01 |
Metabolism of porphyrins | 22 | 2.62e-02 | 4.60e-02 | 0.4330 | 0.310000 | 0.233000 | -0.191000 | 1.18e-02 | 5.85e-02 | 1.20e-01 |
RAF activation | 32 | 8.30e-04 | 2.35e-03 | 0.4320 | 0.365000 | 0.169000 | 0.158000 | 3.52e-04 | 9.75e-02 | 1.21e-01 |
tRNA modification in the nucleus and cytosol | 43 | 1.35e-03 | 3.56e-03 | 0.4320 | -0.274000 | -0.329000 | 0.055100 | 1.85e-03 | 1.87e-04 | 5.32e-01 |
Regulation of TP53 Activity through Acetylation | 29 | 9.58e-03 | 1.93e-02 | 0.4320 | -0.198000 | -0.271000 | -0.272000 | 6.55e-02 | 1.14e-02 | 1.13e-02 |
Regulation of ornithine decarboxylase (ODC) | 49 | 1.22e-05 | 6.29e-05 | 0.4320 | 0.386000 | 0.174000 | 0.081900 | 2.90e-06 | 3.49e-02 | 3.21e-01 |
Clathrin-mediated endocytosis | 127 | 4.10e-11 | 6.00e-10 | 0.4320 | 0.357000 | 0.230000 | -0.075600 | 3.49e-12 | 7.66e-06 | 1.41e-01 |
Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 5.98e-02 | 9.35e-02 | 0.4290 | 0.388000 | 0.133000 | 0.126000 | 1.99e-02 | 4.24e-01 | 4.50e-01 |
Translation | 295 | 6.44e-48 | 7.31e-46 | 0.4290 | -0.055800 | -0.394000 | -0.160000 | 9.90e-02 | 2.01e-31 | 2.22e-06 |
Apoptosis induced DNA fragmentation | 10 | 1.73e-01 | 2.26e-01 | 0.4290 | 0.377000 | 0.179000 | 0.101000 | 3.91e-02 | 3.28e-01 | 5.82e-01 |
SUMOylation of SUMOylation proteins | 35 | 8.43e-04 | 2.38e-03 | 0.4290 | -0.212000 | -0.322000 | 0.188000 | 3.00e-02 | 9.71e-04 | 5.45e-02 |
Classical antibody-mediated complement activation | 69 | 7.21e-10 | 9.01e-09 | 0.4290 | -0.135000 | -0.382000 | 0.141000 | 5.18e-02 | 4.21e-08 | 4.23e-02 |
MyD88 cascade initiated on plasma membrane | 82 | 7.03e-11 | 9.68e-10 | 0.4280 | 0.395000 | 0.128000 | -0.105000 | 6.13e-10 | 4.53e-02 | 1.01e-01 |
Toll Like Receptor 10 (TLR10) Cascade | 82 | 7.03e-11 | 9.68e-10 | 0.4280 | 0.395000 | 0.128000 | -0.105000 | 6.13e-10 | 4.53e-02 | 1.01e-01 |
Toll Like Receptor 5 (TLR5) Cascade | 82 | 7.03e-11 | 9.68e-10 | 0.4280 | 0.395000 | 0.128000 | -0.105000 | 6.13e-10 | 4.53e-02 | 1.01e-01 |
Transcription of E2F targets under negative control by DREAM complex | 19 | 7.63e-05 | 2.94e-04 | 0.4280 | 0.011100 | -0.416000 | 0.098900 | 9.33e-01 | 1.69e-03 | 4.55e-01 |
ER-Phagosome pathway | 82 | 1.53e-07 | 1.19e-06 | 0.4280 | 0.366000 | 0.212000 | 0.064300 | 1.02e-08 | 9.10e-04 | 3.14e-01 |
p75NTR recruits signalling complexes | 12 | 5.38e-02 | 8.60e-02 | 0.4270 | 0.246000 | 0.021100 | -0.349000 | 1.40e-01 | 8.99e-01 | 3.65e-02 |
Plasma lipoprotein assembly | 10 | 2.25e-01 | 2.82e-01 | 0.4270 | 0.234000 | 0.298000 | -0.197000 | 1.99e-01 | 1.03e-01 | 2.82e-01 |
Disassembly of the destruction complex and recruitment of AXIN to the membrane | 29 | 5.14e-04 | 1.52e-03 | 0.4270 | 0.301000 | 0.074200 | -0.293000 | 4.99e-03 | 4.89e-01 | 6.29e-03 |
Toll-like Receptor Cascades | 143 | 1.26e-14 | 2.78e-13 | 0.4250 | 0.383000 | 0.184000 | -0.009420 | 2.72e-15 | 1.40e-04 | 8.46e-01 |
tRNA Aminoacylation | 42 | 7.07e-04 | 2.04e-03 | 0.4250 | -0.243000 | -0.321000 | 0.135000 | 6.51e-03 | 3.18e-04 | 1.29e-01 |
Cell-extracellular matrix interactions | 14 | 1.01e-02 | 2.02e-02 | 0.4240 | 0.366000 | 0.021900 | -0.214000 | 1.78e-02 | 8.87e-01 | 1.65e-01 |
TBC/RABGAPs | 45 | 2.31e-04 | 7.77e-04 | 0.4240 | 0.289000 | 0.206000 | -0.231000 | 7.88e-04 | 1.68e-02 | 7.32e-03 |
Signaling by NTRKs | 115 | 1.38e-12 | 2.40e-11 | 0.4230 | 0.363000 | 0.157000 | -0.149000 | 1.67e-11 | 3.57e-03 | 5.90e-03 |
Signaling by BRAF and RAF fusions | 57 | 1.43e-06 | 9.07e-06 | 0.4220 | 0.390000 | 0.160000 | -0.005320 | 3.46e-07 | 3.63e-02 | 9.45e-01 |
Innate Immune System | 965 | 1.02e-85 | 6.95e-83 | 0.4210 | 0.367000 | 0.201000 | -0.042300 | 8.53e-84 | 3.07e-26 | 2.60e-02 |
Signaling by NTRK1 (TRKA) | 100 | 1.86e-11 | 2.82e-10 | 0.4200 | 0.367000 | 0.143000 | -0.146000 | 2.21e-10 | 1.33e-02 | 1.18e-02 |
Negative regulation of FGFR3 signaling | 20 | 4.95e-03 | 1.08e-02 | 0.4200 | 0.338000 | 0.069300 | -0.240000 | 8.93e-03 | 5.92e-01 | 6.36e-02 |
G0 and Early G1 | 27 | 1.56e-06 | 9.84e-06 | 0.4190 | 0.019100 | -0.386000 | 0.162000 | 8.63e-01 | 5.15e-04 | 1.44e-01 |
Removal of the Flap Intermediate from the C-strand | 17 | 7.38e-02 | 1.12e-01 | 0.4190 | -0.216000 | -0.358000 | 0.026200 | 1.24e-01 | 1.06e-02 | 8.52e-01 |
Iron uptake and transport | 52 | 1.54e-05 | 7.53e-05 | 0.4180 | 0.376000 | 0.171000 | -0.068500 | 2.76e-06 | 3.31e-02 | 3.93e-01 |
Translocation of SLC2A4 (GLUT4) to the plasma membrane | 48 | 3.72e-05 | 1.56e-04 | 0.4180 | 0.340000 | 0.162000 | 0.182000 | 4.61e-05 | 5.25e-02 | 2.90e-02 |
Syndecan interactions | 19 | 1.58e-05 | 7.65e-05 | 0.4180 | 0.352000 | -0.155000 | -0.165000 | 7.93e-03 | 2.43e-01 | 2.14e-01 |
Chemokine receptors bind chemokines | 37 | 3.72e-04 | 1.18e-03 | 0.4180 | -0.118000 | -0.337000 | -0.218000 | 2.14e-01 | 3.92e-04 | 2.19e-02 |
Cell recruitment (pro-inflammatory response) | 22 | 2.09e-02 | 3.80e-02 | 0.4170 | 0.359000 | 0.186000 | 0.103000 | 3.55e-03 | 1.32e-01 | 4.01e-01 |
Purinergic signaling in leishmaniasis infection | 22 | 2.09e-02 | 3.80e-02 | 0.4170 | 0.359000 | 0.186000 | 0.103000 | 3.55e-03 | 1.32e-01 | 4.01e-01 |
Activation of the AP-1 family of transcription factors | 10 | 6.72e-02 | 1.03e-01 | 0.4170 | 0.390000 | 0.071700 | -0.129000 | 3.26e-02 | 6.95e-01 | 4.80e-01 |
G beta:gamma signalling through CDC42 | 17 | 4.07e-02 | 6.79e-02 | 0.4170 | 0.359000 | 0.164000 | 0.136000 | 1.05e-02 | 2.41e-01 | 3.32e-01 |
Regulation of activated PAK-2p34 by proteasome mediated degradation | 48 | 2.56e-05 | 1.14e-04 | 0.4170 | 0.377000 | 0.164000 | 0.067900 | 6.02e-06 | 4.98e-02 | 4.16e-01 |
Caspase activation via extrinsic apoptotic signalling pathway | 25 | 4.58e-02 | 7.47e-02 | 0.4160 | 0.304000 | 0.258000 | 0.120000 | 8.58e-03 | 2.54e-02 | 2.98e-01 |
Transcriptional Regulation by E2F6 | 34 | 1.86e-03 | 4.60e-03 | 0.4160 | -0.210000 | -0.312000 | 0.178000 | 3.44e-02 | 1.62e-03 | 7.26e-02 |
HSP90 chaperone cycle for steroid hormone receptors (SHR) | 36 | 1.83e-05 | 8.77e-05 | 0.4150 | 0.404000 | 0.095600 | -0.011800 | 2.73e-05 | 3.21e-01 | 9.03e-01 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 64 | 3.90e-06 | 2.22e-05 | 0.4140 | 0.367000 | 0.187000 | 0.040600 | 3.69e-07 | 9.56e-03 | 5.74e-01 |
MTOR signalling | 39 | 7.03e-04 | 2.04e-03 | 0.4140 | 0.369000 | 0.187000 | -0.014400 | 6.55e-05 | 4.31e-02 | 8.76e-01 |
Negative regulation of FGFR4 signaling | 21 | 3.15e-03 | 7.33e-03 | 0.4140 | 0.313000 | 0.037700 | -0.268000 | 1.29e-02 | 7.65e-01 | 3.38e-02 |
RORA activates gene expression | 18 | 5.88e-02 | 9.23e-02 | 0.4140 | 0.312000 | 0.193000 | -0.192000 | 2.21e-02 | 1.57e-01 | 1.59e-01 |
Recognition of DNA damage by PCNA-containing replication complex | 30 | 1.44e-03 | 3.74e-03 | 0.4130 | -0.165000 | -0.372000 | 0.071200 | 1.18e-01 | 4.16e-04 | 5.00e-01 |
Pausing and recovery of Tat-mediated HIV elongation | 30 | 9.75e-04 | 2.69e-03 | 0.4130 | 0.167000 | 0.017000 | -0.378000 | 1.14e-01 | 8.72e-01 | 3.42e-04 |
Tat-mediated HIV elongation arrest and recovery | 30 | 9.75e-04 | 2.69e-03 | 0.4130 | 0.167000 | 0.017000 | -0.378000 | 1.14e-01 | 8.72e-01 | 3.42e-04 |
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 79 | 7.12e-06 | 3.84e-05 | 0.4130 | 0.307000 | 0.258000 | -0.098500 | 2.30e-06 | 7.52e-05 | 1.30e-01 |
DARPP-32 events | 22 | 1.67e-03 | 4.21e-03 | 0.4120 | 0.401000 | 0.088600 | -0.030600 | 1.11e-03 | 4.72e-01 | 8.04e-01 |
Platelet activation, signaling and aggregation | 219 | 3.92e-22 | 1.13e-20 | 0.4120 | 0.360000 | 0.161000 | -0.119000 | 3.93e-20 | 3.89e-05 | 2.36e-03 |
EPH-ephrin mediated repulsion of cells | 39 | 7.91e-04 | 2.25e-03 | 0.4120 | 0.238000 | 0.193000 | -0.275000 | 1.00e-02 | 3.70e-02 | 2.98e-03 |
Regulation of TP53 Activity through Association with Co-factors | 11 | 1.73e-01 | 2.26e-01 | 0.4110 | -0.074200 | -0.186000 | -0.359000 | 6.70e-01 | 2.84e-01 | 3.93e-02 |
Toll Like Receptor 9 (TLR9) Cascade | 92 | 8.93e-11 | 1.20e-09 | 0.4110 | 0.382000 | 0.135000 | -0.066100 | 2.36e-10 | 2.50e-02 | 2.73e-01 |
Scavenging of heme from plasma | 71 | 5.59e-12 | 9.52e-11 | 0.4100 | -0.069700 | -0.381000 | 0.136000 | 3.10e-01 | 2.87e-08 | 4.79e-02 |
Cargo recognition for clathrin-mediated endocytosis | 90 | 3.02e-07 | 2.24e-06 | 0.4100 | 0.333000 | 0.217000 | -0.098800 | 4.64e-08 | 3.66e-04 | 1.05e-01 |
Signaling by MET | 61 | 8.33e-06 | 4.38e-05 | 0.4100 | 0.366000 | 0.183000 | -0.025100 | 7.71e-07 | 1.36e-02 | 7.35e-01 |
Synthesis of PIPs at the late endosome membrane | 11 | 1.28e-01 | 1.79e-01 | 0.4100 | 0.205000 | 0.086300 | 0.344000 | 2.39e-01 | 6.20e-01 | 4.83e-02 |
Hedgehog ligand biogenesis | 58 | 1.88e-05 | 8.91e-05 | 0.4090 | 0.356000 | 0.184000 | 0.082400 | 2.66e-06 | 1.53e-02 | 2.78e-01 |
Activation of G protein gated Potassium channels | 19 | 5.48e-02 | 8.69e-02 | 0.4090 | 0.323000 | 0.189000 | 0.166000 | 1.48e-02 | 1.54e-01 | 2.09e-01 |
G protein gated Potassium channels | 19 | 5.48e-02 | 8.69e-02 | 0.4090 | 0.323000 | 0.189000 | 0.166000 | 1.48e-02 | 1.54e-01 | 2.09e-01 |
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 19 | 5.48e-02 | 8.69e-02 | 0.4090 | 0.323000 | 0.189000 | 0.166000 | 1.48e-02 | 1.54e-01 | 2.09e-01 |
Hh mutants abrogate ligand secretion | 54 | 1.28e-05 | 6.49e-05 | 0.4090 | 0.367000 | 0.164000 | 0.076500 | 3.12e-06 | 3.73e-02 | 3.31e-01 |
Antiviral mechanism by IFN-stimulated genes | 80 | 5.97e-08 | 5.05e-07 | 0.4090 | -0.185000 | -0.226000 | 0.286000 | 4.23e-03 | 4.85e-04 | 9.55e-06 |
Thrombin signalling through proteinase activated receptors (PARs) | 27 | 9.12e-03 | 1.84e-02 | 0.4080 | 0.354000 | 0.180000 | -0.097500 | 1.47e-03 | 1.06e-01 | 3.81e-01 |
Creation of C4 and C2 activators | 71 | 1.88e-09 | 2.17e-08 | 0.4080 | -0.123000 | -0.361000 | 0.145000 | 7.29e-02 | 1.38e-07 | 3.49e-02 |
Class C/3 (Metabotropic glutamate/pheromone receptors) | 11 | 4.55e-02 | 7.42e-02 | 0.4080 | -0.274000 | 0.034700 | 0.300000 | 1.15e-01 | 8.42e-01 | 8.50e-02 |
Folding of actin by CCT/TriC | 10 | 2.71e-03 | 6.43e-03 | 0.4070 | 0.135000 | -0.380000 | 0.059500 | 4.61e-01 | 3.76e-02 | 7.44e-01 |
Defective CFTR causes cystic fibrosis | 59 | 6.19e-06 | 3.38e-05 | 0.4060 | 0.366000 | 0.167000 | 0.059000 | 1.17e-06 | 2.66e-02 | 4.33e-01 |
MAP3K8 (TPL2)-dependent MAPK1/3 activation | 16 | 1.25e-02 | 2.43e-02 | 0.4060 | 0.366000 | 0.058900 | -0.165000 | 1.12e-02 | 6.83e-01 | 2.52e-01 |
Gap-filling DNA repair synthesis and ligation in GG-NER | 25 | 4.12e-02 | 6.86e-02 | 0.4060 | -0.223000 | -0.329000 | -0.082700 | 5.40e-02 | 4.37e-03 | 4.74e-01 |
Beta-oxidation of very long chain fatty acids | 10 | 3.73e-01 | 4.31e-01 | 0.4050 | 0.278000 | 0.287000 | -0.069100 | 1.28e-01 | 1.17e-01 | 7.05e-01 |
Formation of Fibrin Clot (Clotting Cascade) | 26 | 1.46e-03 | 3.79e-03 | 0.4050 | 0.287000 | 0.042900 | -0.283000 | 1.14e-02 | 7.05e-01 | 1.25e-02 |
RAB geranylgeranylation | 60 | 6.20e-06 | 3.38e-05 | 0.4040 | 0.366000 | 0.168000 | 0.033900 | 9.21e-07 | 2.43e-02 | 6.49e-01 |
Plasma lipoprotein remodeling | 18 | 7.01e-02 | 1.07e-01 | 0.4040 | 0.222000 | 0.276000 | -0.195000 | 1.03e-01 | 4.26e-02 | 1.53e-01 |
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 32 | 4.04e-05 | 1.67e-04 | 0.4030 | 0.242000 | -0.063900 | -0.315000 | 1.76e-02 | 5.32e-01 | 2.05e-03 |
HS-GAG degradation | 16 | 4.14e-02 | 6.89e-02 | 0.4020 | 0.141000 | 0.001570 | -0.377000 | 3.29e-01 | 9.91e-01 | 9.06e-03 |
Nuclear Events (kinase and transcription factor activation) | 53 | 4.79e-06 | 2.68e-05 | 0.4020 | 0.319000 | 0.104000 | -0.222000 | 5.83e-05 | 1.92e-01 | 5.24e-03 |
ADP signalling through P2Y purinoceptor 12 | 18 | 1.73e-02 | 3.22e-02 | 0.4010 | 0.376000 | 0.119000 | 0.074300 | 5.73e-03 | 3.81e-01 | 5.85e-01 |
Interleukin-1 family signaling | 124 | 3.38e-11 | 5.07e-10 | 0.4010 | 0.360000 | 0.177000 | -0.011200 | 4.29e-12 | 6.68e-04 | 8.30e-01 |
TRAF6-mediated induction of TAK1 complex within TLR4 complex | 16 | 2.05e-02 | 3.73e-02 | 0.4010 | 0.364000 | 0.082100 | -0.146000 | 1.16e-02 | 5.70e-01 | 3.12e-01 |
FCGR activation | 76 | 9.80e-09 | 1.03e-07 | 0.4000 | -0.144000 | -0.357000 | 0.111000 | 2.98e-02 | 7.59e-08 | 9.31e-02 |
Beta-catenin phosphorylation cascade | 17 | 4.61e-02 | 7.50e-02 | 0.4000 | 0.365000 | 0.149000 | -0.067800 | 9.25e-03 | 2.86e-01 | 6.29e-01 |
Interferon alpha/beta signaling | 57 | 3.67e-08 | 3.26e-07 | 0.3990 | -0.283000 | 0.001440 | 0.282000 | 2.20e-04 | 9.85e-01 | 2.31e-04 |
Regulation of Apoptosis | 51 | 1.92e-05 | 9.03e-05 | 0.3990 | 0.357000 | 0.145000 | 0.103000 | 1.01e-05 | 7.34e-02 | 2.01e-01 |
Signaling by EGFR | 46 | 4.00e-06 | 2.27e-05 | 0.3990 | 0.334000 | 0.062500 | -0.208000 | 8.69e-05 | 4.63e-01 | 1.46e-02 |
NGF-stimulated transcription | 31 | 4.97e-04 | 1.47e-03 | 0.3980 | 0.247000 | 0.018800 | -0.312000 | 1.73e-02 | 8.56e-01 | 2.65e-03 |
Cohesin Loading onto Chromatin | 10 | 4.35e-03 | 9.73e-03 | 0.3980 | 0.193000 | -0.269000 | 0.221000 | 2.92e-01 | 1.41e-01 | 2.26e-01 |
Biosynthesis of specialized proresolving mediators (SPMs) | 16 | 4.06e-02 | 6.78e-02 | 0.3970 | 0.287000 | 0.078700 | -0.262000 | 4.69e-02 | 5.86e-01 | 6.96e-02 |
IKK complex recruitment mediated by RIP1 | 23 | 1.24e-02 | 2.41e-02 | 0.3960 | 0.357000 | 0.145000 | 0.092000 | 3.03e-03 | 2.28e-01 | 4.45e-01 |
Signaling by PDGFRA extracellular domain mutants | 12 | 6.53e-02 | 1.00e-01 | 0.3960 | 0.287000 | 0.062000 | 0.265000 | 8.47e-02 | 7.10e-01 | 1.13e-01 |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 12 | 6.53e-02 | 1.00e-01 | 0.3960 | 0.287000 | 0.062000 | 0.265000 | 8.47e-02 | 7.10e-01 | 1.13e-01 |
Vif-mediated degradation of APOBEC3G | 52 | 3.76e-05 | 1.57e-04 | 0.3950 | 0.358000 | 0.157000 | 0.061500 | 8.04e-06 | 5.06e-02 | 4.43e-01 |
tRNA processing | 134 | 2.83e-08 | 2.55e-07 | 0.3940 | -0.256000 | -0.300000 | -0.007600 | 3.12e-07 | 2.05e-09 | 8.79e-01 |
IRAK2 mediated activation of TAK1 complex | 10 | 2.04e-02 | 3.72e-02 | 0.3940 | 0.254000 | -0.167000 | -0.250000 | 1.64e-01 | 3.62e-01 | 1.71e-01 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 30 | 4.44e-06 | 2.50e-05 | 0.3930 | 0.391000 | -0.005090 | 0.047000 | 2.13e-04 | 9.62e-01 | 6.56e-01 |
Degradation of DVL | 54 | 2.92e-05 | 1.26e-04 | 0.3930 | 0.360000 | 0.157000 | 0.021400 | 4.80e-06 | 4.58e-02 | 7.85e-01 |
Senescence-Associated Secretory Phenotype (SASP) | 66 | 2.65e-08 | 2.41e-07 | 0.3920 | 0.299000 | 0.044200 | -0.250000 | 2.67e-05 | 5.35e-01 | 4.39e-04 |
PKA activation | 15 | 4.38e-02 | 7.20e-02 | 0.3920 | 0.265000 | 0.043500 | -0.286000 | 7.57e-02 | 7.70e-01 | 5.52e-02 |
Carnitine metabolism | 10 | 4.11e-01 | 4.66e-01 | 0.3900 | 0.281000 | 0.262000 | -0.066600 | 1.24e-01 | 1.51e-01 | 7.15e-01 |
Thromboxane signalling through TP receptor | 20 | 1.22e-02 | 2.39e-02 | 0.3900 | 0.374000 | 0.110000 | -0.017300 | 3.82e-03 | 3.93e-01 | 8.94e-01 |
Intraflagellar transport | 39 | 1.00e-02 | 2.00e-02 | 0.3900 | -0.254000 | -0.292000 | 0.050000 | 6.11e-03 | 1.63e-03 | 5.89e-01 |
Negative regulation of FGFR1 signaling | 24 | 1.93e-02 | 3.53e-02 | 0.3900 | 0.299000 | 0.145000 | -0.204000 | 1.13e-02 | 2.17e-01 | 8.42e-02 |
Regulation of localization of FOXO transcription factors | 11 | 1.16e-01 | 1.64e-01 | 0.3900 | 0.241000 | 0.024800 | -0.305000 | 1.67e-01 | 8.87e-01 | 7.94e-02 |
AUF1 (hnRNP D0) binds and destabilizes mRNA | 53 | 9.21e-06 | 4.79e-05 | 0.3890 | 0.366000 | 0.129000 | 0.007850 | 3.95e-06 | 1.03e-01 | 9.21e-01 |
Constitutive Signaling by AKT1 E17K in Cancer | 25 | 1.24e-02 | 2.41e-02 | 0.3890 | 0.185000 | 0.101000 | -0.327000 | 1.10e-01 | 3.84e-01 | 4.70e-03 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 52 | 1.88e-05 | 8.91e-05 | 0.3880 | 0.350000 | 0.134000 | 0.101000 | 1.24e-05 | 9.41e-02 | 2.08e-01 |
Adenylate cyclase inhibitory pathway | 11 | 2.63e-01 | 3.22e-01 | 0.3880 | 0.216000 | 0.251000 | -0.202000 | 2.14e-01 | 1.50e-01 | 2.45e-01 |
Signaling by NOTCH4 | 78 | 5.74e-06 | 3.15e-05 | 0.3880 | 0.336000 | 0.193000 | -0.000360 | 2.84e-07 | 3.15e-03 | 9.96e-01 |
Regulation of PTEN stability and activity | 66 | 1.56e-05 | 7.58e-05 | 0.3870 | 0.341000 | 0.175000 | 0.052700 | 1.63e-06 | 1.37e-02 | 4.59e-01 |
PINK1-PRKN Mediated Mitophagy | 21 | 2.09e-05 | 9.64e-05 | 0.3870 | 0.187000 | -0.294000 | -0.170000 | 1.39e-01 | 1.97e-02 | 1.79e-01 |
MAP kinase activation | 63 | 1.31e-07 | 1.03e-06 | 0.3870 | 0.366000 | 0.096800 | -0.077100 | 4.93e-07 | 1.84e-01 | 2.90e-01 |
Negative regulation of NOTCH4 signaling | 54 | 3.22e-05 | 1.37e-04 | 0.3870 | 0.353000 | 0.150000 | 0.051400 | 7.32e-06 | 5.73e-02 | 5.14e-01 |
Dectin-2 family | 19 | 5.57e-02 | 8.81e-02 | 0.3860 | 0.161000 | 0.347000 | 0.050200 | 2.25e-01 | 8.75e-03 | 7.05e-01 |
RAB GEFs exchange GTP for GDP on RABs | 87 | 8.41e-06 | 4.40e-05 | 0.3860 | 0.316000 | 0.220000 | -0.023400 | 3.51e-07 | 3.90e-04 | 7.06e-01 |
Calnexin/calreticulin cycle | 26 | 4.36e-03 | 9.73e-03 | 0.3860 | 0.365000 | 0.118000 | -0.042500 | 1.29e-03 | 2.98e-01 | 7.07e-01 |
Metabolism of steroid hormones | 19 | 1.36e-01 | 1.87e-01 | 0.3850 | 0.311000 | 0.225000 | 0.027600 | 1.87e-02 | 8.92e-02 | 8.35e-01 |
RNA Polymerase III Transcription Initiation From Type 1 Promoter | 28 | 6.35e-02 | 9.85e-02 | 0.3850 | -0.259000 | -0.271000 | -0.087400 | 1.77e-02 | 1.32e-02 | 4.23e-01 |
Degradation of the extracellular matrix | 77 | 1.51e-05 | 7.47e-05 | 0.3850 | 0.236000 | 0.258000 | -0.159000 | 3.38e-04 | 8.85e-05 | 1.56e-02 |
Apoptotic factor-mediated response | 18 | 1.01e-01 | 1.46e-01 | 0.3840 | 0.312000 | 0.184000 | 0.129000 | 2.19e-02 | 1.77e-01 | 3.43e-01 |
Presynaptic function of Kainate receptors | 18 | 9.76e-02 | 1.42e-01 | 0.3840 | 0.320000 | 0.184000 | -0.104000 | 1.87e-02 | 1.77e-01 | 4.45e-01 |
G beta:gamma signalling through PLC beta | 17 | 6.82e-02 | 1.04e-01 | 0.3830 | 0.340000 | 0.146000 | -0.100000 | 1.53e-02 | 2.97e-01 | 4.75e-01 |
Glycosphingolipid metabolism | 36 | 9.37e-03 | 1.88e-02 | 0.3830 | 0.253000 | 0.235000 | -0.166000 | 8.55e-03 | 1.48e-02 | 8.50e-02 |
Biosynthesis of DHA-derived SPMs | 14 | 5.47e-02 | 8.69e-02 | 0.3830 | 0.198000 | -0.023300 | -0.327000 | 1.99e-01 | 8.80e-01 | 3.43e-02 |
Rap1 signalling | 13 | 1.28e-01 | 1.79e-01 | 0.3820 | 0.302000 | 0.128000 | 0.197000 | 5.98e-02 | 4.25e-01 | 2.19e-01 |
HDMs demethylate histones | 22 | 6.65e-02 | 1.02e-01 | 0.3820 | 0.244000 | 0.230000 | -0.182000 | 4.78e-02 | 6.18e-02 | 1.39e-01 |
Degradation of GLI1 by the proteasome | 57 | 2.04e-05 | 9.47e-05 | 0.3810 | 0.344000 | 0.144000 | 0.076500 | 6.83e-06 | 6.05e-02 | 3.18e-01 |
ISG15 antiviral mechanism | 72 | 1.10e-06 | 7.30e-06 | 0.3800 | -0.152000 | -0.243000 | 0.249000 | 2.58e-02 | 3.59e-04 | 2.55e-04 |
Heparan sulfate/heparin (HS-GAG) metabolism | 37 | 1.11e-03 | 3.02e-03 | 0.3800 | 0.116000 | 0.049400 | -0.358000 | 2.23e-01 | 6.03e-01 | 1.63e-04 |
Nucleotide salvage | 21 | 6.50e-02 | 1.00e-01 | 0.3800 | 0.316000 | 0.181000 | -0.106000 | 1.22e-02 | 1.50e-01 | 3.99e-01 |
Regulation of signaling by CBL | 18 | 1.77e-01 | 2.30e-01 | 0.3790 | 0.261000 | 0.266000 | -0.068200 | 5.48e-02 | 5.07e-02 | 6.16e-01 |
Defective B3GALT6 causes EDSP2 and SEMDJL1 | 11 | 1.81e-01 | 2.34e-01 | 0.3790 | -0.020900 | -0.199000 | -0.321000 | 9.05e-01 | 2.53e-01 | 6.49e-02 |
Degradation of cysteine and homocysteine | 12 | 1.74e-01 | 2.27e-01 | 0.3790 | 0.153000 | 0.108000 | -0.329000 | 3.58e-01 | 5.18e-01 | 4.84e-02 |
RUNX1 regulates transcription of genes involved in differentiation of HSCs | 82 | 1.83e-08 | 1.76e-07 | 0.3780 | 0.356000 | 0.119000 | -0.044700 | 2.56e-08 | 6.24e-02 | 4.84e-01 |
Golgi-to-ER retrograde transport | 111 | 1.75e-08 | 1.70e-07 | 0.3770 | 0.329000 | 0.175000 | 0.058700 | 1.99e-09 | 1.49e-03 | 2.85e-01 |
Cyclin A/B1/B2 associated events during G2/M transition | 24 | 2.19e-04 | 7.43e-04 | 0.3770 | 0.119000 | -0.170000 | 0.315000 | 3.15e-01 | 1.50e-01 | 7.49e-03 |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 17 | 1.80e-01 | 2.33e-01 | 0.3770 | 0.295000 | 0.222000 | -0.075600 | 3.51e-02 | 1.13e-01 | 5.90e-01 |
Degradation of GLI2 by the proteasome | 56 | 9.34e-06 | 4.84e-05 | 0.3760 | 0.349000 | 0.122000 | 0.062400 | 6.06e-06 | 1.13e-01 | 4.19e-01 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 50 | 6.50e-05 | 2.55e-04 | 0.3750 | 0.345000 | 0.132000 | 0.065500 | 2.40e-05 | 1.06e-01 | 4.23e-01 |
p53-Independent DNA Damage Response | 50 | 6.50e-05 | 2.55e-04 | 0.3750 | 0.345000 | 0.132000 | 0.065500 | 2.40e-05 | 1.06e-01 | 4.23e-01 |
p53-Independent G1/S DNA damage checkpoint | 50 | 6.50e-05 | 2.55e-04 | 0.3750 | 0.345000 | 0.132000 | 0.065500 | 2.40e-05 | 1.06e-01 | 4.23e-01 |
Interleukin-2 signaling | 11 | 1.97e-01 | 2.51e-01 | 0.3750 | 0.038700 | -0.002260 | -0.373000 | 8.24e-01 | 9.90e-01 | 3.23e-02 |
Glucagon signaling in metabolic regulation | 27 | 8.06e-03 | 1.65e-02 | 0.3750 | 0.333000 | 0.122000 | -0.120000 | 2.73e-03 | 2.73e-01 | 2.79e-01 |
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 6.88e-03 | 1.43e-02 | 0.3740 | -0.027300 | -0.358000 | 0.104000 | 8.50e-01 | 1.31e-02 | 4.70e-01 |
Termination of translesion DNA synthesis | 32 | 1.71e-02 | 3.21e-02 | 0.3740 | -0.206000 | -0.300000 | 0.085200 | 4.40e-02 | 3.26e-03 | 4.04e-01 |
Defects in vitamin and cofactor metabolism | 21 | 1.39e-01 | 1.90e-01 | 0.3740 | -0.255000 | -0.269000 | 0.048600 | 4.27e-02 | 3.31e-02 | 7.00e-01 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 27 | 6.23e-03 | 1.30e-02 | 0.3730 | 0.336000 | 0.111000 | -0.120000 | 2.52e-03 | 3.19e-01 | 2.81e-01 |
Endogenous sterols | 16 | 1.74e-01 | 2.27e-01 | 0.3730 | 0.319000 | 0.193000 | -0.006640 | 2.69e-02 | 1.82e-01 | 9.63e-01 |
RNA Polymerase I Transcription Initiation | 44 | 4.91e-03 | 1.07e-02 | 0.3730 | -0.200000 | -0.312000 | -0.044300 | 2.17e-02 | 3.44e-04 | 6.11e-01 |
Long-term potentiation | 14 | 1.56e-01 | 2.09e-01 | 0.3730 | -0.130000 | -0.315000 | -0.152000 | 4.00e-01 | 4.14e-02 | 3.23e-01 |
SUMOylation of DNA replication proteins | 46 | 2.09e-04 | 7.10e-04 | 0.3730 | -0.145000 | -0.274000 | 0.207000 | 8.95e-02 | 1.28e-03 | 1.51e-02 |
SUMOylation of ubiquitinylation proteins | 39 | 2.45e-03 | 5.88e-03 | 0.3720 | -0.178000 | -0.235000 | 0.228000 | 5.46e-02 | 1.12e-02 | 1.37e-02 |
Signaling by EGFR in Cancer | 23 | 7.12e-04 | 2.06e-03 | 0.3720 | 0.344000 | -0.008890 | -0.142000 | 4.31e-03 | 9.41e-01 | 2.38e-01 |
Base-Excision Repair, AP Site Formation | 31 | 4.26e-04 | 1.31e-03 | 0.3710 | 0.252000 | -0.018400 | -0.272000 | 1.51e-02 | 8.59e-01 | 8.82e-03 |
Signaling by NOTCH | 182 | 8.24e-15 | 1.84e-13 | 0.3700 | 0.316000 | 0.143000 | -0.129000 | 1.86e-13 | 8.58e-04 | 2.73e-03 |
Mitotic Telophase/Cytokinesis | 13 | 1.56e-03 | 3.99e-03 | 0.3700 | 0.274000 | -0.178000 | 0.175000 | 8.75e-02 | 2.68e-01 | 2.75e-01 |
Trafficking and processing of endosomal TLR | 13 | 2.63e-01 | 3.22e-01 | 0.3700 | 0.301000 | 0.186000 | 0.108000 | 6.00e-02 | 2.45e-01 | 5.02e-01 |
PCP/CE pathway | 86 | 2.15e-06 | 1.33e-05 | 0.3700 | 0.305000 | 0.167000 | -0.126000 | 1.03e-06 | 7.28e-03 | 4.33e-02 |
Metabolism of amine-derived hormones | 10 | 3.90e-01 | 4.46e-01 | 0.3690 | -0.193000 | -0.314000 | -0.020600 | 2.91e-01 | 8.54e-02 | 9.10e-01 |
O-glycosylation of TSR domain-containing proteins | 25 | 2.25e-02 | 4.04e-02 | 0.3690 | -0.320000 | -0.145000 | -0.112000 | 5.54e-03 | 2.09e-01 | 3.34e-01 |
TNFR1-induced proapoptotic signaling | 12 | 2.94e-01 | 3.54e-01 | 0.3690 | -0.316000 | -0.187000 | 0.033800 | 5.80e-02 | 2.62e-01 | 8.39e-01 |
Signaling by ROBO receptors | 199 | 1.39e-21 | 3.95e-20 | 0.3690 | -0.010200 | -0.263000 | -0.259000 | 8.04e-01 | 1.66e-10 | 3.11e-10 |
Nuclear Receptor transcription pathway | 36 | 2.37e-03 | 5.74e-03 | 0.3680 | 0.006860 | -0.080400 | -0.359000 | 9.43e-01 | 4.04e-01 | 1.90e-04 |
Oncogenic MAPK signaling | 73 | 5.56e-06 | 3.07e-05 | 0.3680 | 0.334000 | 0.153000 | 0.030200 | 8.24e-07 | 2.36e-02 | 6.55e-01 |
G beta:gamma signalling through PI3Kgamma | 22 | 9.20e-02 | 1.35e-01 | 0.3680 | 0.286000 | 0.202000 | -0.114000 | 2.01e-02 | 1.01e-01 | 3.57e-01 |
Amino acids regulate mTORC1 | 50 | 1.49e-03 | 3.85e-03 | 0.3670 | 0.315000 | 0.186000 | -0.041200 | 1.19e-04 | 2.32e-02 | 6.14e-01 |
MASTL Facilitates Mitotic Progression | 10 | 3.67e-02 | 6.23e-02 | 0.3670 | 0.289000 | -0.060000 | 0.218000 | 1.14e-01 | 7.43e-01 | 2.32e-01 |
RMTs methylate histone arginines | 37 | 1.86e-03 | 4.61e-03 | 0.3670 | 0.006530 | -0.116000 | -0.348000 | 9.45e-01 | 2.22e-01 | 2.52e-04 |
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 21 | 2.24e-02 | 4.04e-02 | 0.3660 | 0.192000 | 0.014100 | -0.312000 | 1.28e-01 | 9.11e-01 | 1.34e-02 |
RNA Polymerase III Chain Elongation | 18 | 1.83e-01 | 2.36e-01 | 0.3660 | -0.189000 | -0.284000 | -0.132000 | 1.64e-01 | 3.70e-02 | 3.33e-01 |
MyD88-independent TLR4 cascade | 96 | 1.89e-08 | 1.80e-07 | 0.3660 | 0.339000 | 0.134000 | -0.027900 | 8.95e-09 | 2.36e-02 | 6.37e-01 |
TRIF(TICAM1)-mediated TLR4 signaling | 96 | 1.89e-08 | 1.80e-07 | 0.3660 | 0.339000 | 0.134000 | -0.027900 | 8.95e-09 | 2.36e-02 | 6.37e-01 |
Collagen formation | 64 | 2.76e-05 | 1.20e-04 | 0.3660 | 0.162000 | 0.150000 | -0.292000 | 2.53e-02 | 3.77e-02 | 5.38e-05 |
Transport to the Golgi and subsequent modification | 155 | 6.36e-10 | 8.02e-09 | 0.3660 | 0.312000 | 0.190000 | 0.014500 | 1.87e-11 | 4.55e-05 | 7.55e-01 |
RNA Polymerase III Transcription Initiation From Type 2 Promoter | 27 | 9.46e-02 | 1.38e-01 | 0.3650 | -0.248000 | -0.249000 | -0.099600 | 2.56e-02 | 2.52e-02 | 3.70e-01 |
Interleukin-17 signaling | 68 | 8.84e-07 | 6.11e-06 | 0.3650 | 0.337000 | 0.104000 | -0.095700 | 1.58e-06 | 1.38e-01 | 1.72e-01 |
SUMOylation of RNA binding proteins | 47 | 1.27e-03 | 3.39e-03 | 0.3650 | -0.181000 | -0.304000 | 0.090400 | 3.17e-02 | 3.16e-04 | 2.83e-01 |
Myogenesis | 21 | 1.73e-01 | 2.26e-01 | 0.3650 | 0.270000 | 0.244000 | 0.027100 | 3.23e-02 | 5.28e-02 | 8.30e-01 |
L1CAM interactions | 84 | 3.16e-05 | 1.35e-04 | 0.3650 | 0.303000 | 0.201000 | -0.035200 | 1.63e-06 | 1.48e-03 | 5.77e-01 |
HDR through Homologous Recombination (HRR) | 66 | 1.34e-04 | 4.87e-04 | 0.3640 | -0.232000 | -0.198000 | 0.200000 | 1.10e-03 | 5.51e-03 | 5.04e-03 |
Triglyceride catabolism | 16 | 1.62e-01 | 2.15e-01 | 0.3640 | 0.317000 | 0.173000 | -0.049300 | 2.82e-02 | 2.31e-01 | 7.33e-01 |
Translesion Synthesis by POLH | 18 | 6.10e-02 | 9.50e-02 | 0.3640 | -0.126000 | -0.338000 | -0.051000 | 3.55e-01 | 1.31e-02 | 7.08e-01 |
Cleavage of the damaged pyrimidine | 29 | 4.46e-04 | 1.35e-03 | 0.3640 | 0.274000 | -0.025700 | -0.238000 | 1.06e-02 | 8.11e-01 | 2.66e-02 |
Depyrimidination | 29 | 4.46e-04 | 1.35e-03 | 0.3640 | 0.274000 | -0.025700 | -0.238000 | 1.06e-02 | 8.11e-01 | 2.66e-02 |
Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 29 | 4.46e-04 | 1.35e-03 | 0.3640 | 0.274000 | -0.025700 | -0.238000 | 1.06e-02 | 8.11e-01 | 2.66e-02 |
Downregulation of ERBB2:ERBB3 signaling | 12 | 1.01e-01 | 1.45e-01 | 0.3640 | 0.153000 | -0.077100 | -0.321000 | 3.57e-01 | 6.44e-01 | 5.44e-02 |
Defective B3GAT3 causes JDSSDHD | 11 | 2.22e-01 | 2.79e-01 | 0.3630 | -0.008330 | -0.154000 | -0.329000 | 9.62e-01 | 3.77e-01 | 5.89e-02 |
Defects in cobalamin (B12) metabolism | 13 | 1.93e-01 | 2.46e-01 | 0.3630 | -0.165000 | -0.261000 | 0.192000 | 3.04e-01 | 1.03e-01 | 2.32e-01 |
Vpu mediated degradation of CD4 | 50 | 4.56e-05 | 1.85e-04 | 0.3630 | 0.342000 | 0.110000 | 0.053400 | 2.94e-05 | 1.77e-01 | 5.13e-01 |
NIK–>noncanonical NF-kB signaling | 57 | 1.75e-05 | 8.43e-05 | 0.3620 | 0.339000 | 0.118000 | 0.051300 | 9.72e-06 | 1.24e-01 | 5.03e-01 |
Initial triggering of complement | 78 | 7.45e-08 | 6.15e-07 | 0.3620 | -0.116000 | -0.305000 | 0.156000 | 7.63e-02 | 3.09e-06 | 1.70e-02 |
G beta:gamma signalling through BTK | 15 | 1.45e-01 | 1.97e-01 | 0.3610 | 0.322000 | 0.147000 | 0.069100 | 3.09e-02 | 3.23e-01 | 6.43e-01 |
Deadenylation of mRNA | 22 | 1.49e-04 | 5.31e-04 | 0.3610 | 0.153000 | -0.203000 | 0.256000 | 2.15e-01 | 9.91e-02 | 3.79e-02 |
The role of GTSE1 in G2/M progression after G2 checkpoint | 58 | 2.75e-06 | 1.65e-05 | 0.3600 | 0.331000 | 0.088500 | 0.112000 | 1.31e-05 | 2.44e-01 | 1.40e-01 |
MAPK targets/ Nuclear events mediated by MAP kinases | 31 | 9.02e-04 | 2.52e-03 | 0.3600 | 0.349000 | 0.072400 | -0.051800 | 7.76e-04 | 4.85e-01 | 6.18e-01 |
Cytosolic tRNA aminoacylation | 24 | 1.90e-02 | 3.49e-02 | 0.3600 | -0.130000 | -0.270000 | 0.200000 | 2.71e-01 | 2.22e-02 | 9.00e-02 |
GABA receptor activation | 35 | 4.06e-02 | 6.78e-02 | 0.3600 | 0.270000 | 0.226000 | 0.074000 | 5.78e-03 | 2.05e-02 | 4.48e-01 |
Caspase activation via Death Receptors in the presence of ligand | 16 | 2.09e-01 | 2.65e-01 | 0.3590 | 0.259000 | 0.179000 | 0.172000 | 7.27e-02 | 2.15e-01 | 2.33e-01 |
Membrane Trafficking | 557 | 2.78e-34 | 1.26e-32 | 0.3590 | 0.309000 | 0.183000 | -0.016600 | 1.11e-35 | 1.58e-13 | 5.04e-01 |
Acetylcholine Neurotransmitter Release Cycle | 11 | 3.16e-01 | 3.76e-01 | 0.3590 | -0.105000 | -0.226000 | -0.258000 | 5.48e-01 | 1.94e-01 | 1.38e-01 |
HIV elongation arrest and recovery | 32 | 4.53e-03 | 1.01e-02 | 0.3580 | 0.158000 | 0.023700 | -0.320000 | 1.22e-01 | 8.17e-01 | 1.72e-03 |
Pausing and recovery of HIV elongation | 32 | 4.53e-03 | 1.01e-02 | 0.3580 | 0.158000 | 0.023700 | -0.320000 | 1.22e-01 | 8.17e-01 | 1.72e-03 |
Signaling by NOTCH1 | 66 | 5.88e-05 | 2.35e-04 | 0.3570 | 0.284000 | 0.143000 | -0.162000 | 6.56e-05 | 4.40e-02 | 2.31e-02 |
Signaling by cytosolic FGFR1 fusion mutants | 17 | 1.61e-01 | 2.14e-01 | 0.3570 | 0.288000 | 0.166000 | 0.130000 | 4.01e-02 | 2.35e-01 | 3.53e-01 |
Glutamate and glutamine metabolism | 12 | 1.87e-01 | 2.40e-01 | 0.3560 | -0.097700 | -0.315000 | -0.134000 | 5.58e-01 | 5.90e-02 | 4.22e-01 |
Signaling by NOTCH3 | 42 | 1.91e-03 | 4.71e-03 | 0.3560 | 0.247000 | 0.117000 | -0.228000 | 5.69e-03 | 1.91e-01 | 1.05e-02 |
Activation of GABAB receptors | 30 | 6.24e-02 | 9.68e-02 | 0.3560 | 0.284000 | 0.212000 | 0.031100 | 7.09e-03 | 4.48e-02 | 7.68e-01 |
GABA B receptor activation | 30 | 6.24e-02 | 9.68e-02 | 0.3560 | 0.284000 | 0.212000 | 0.031100 | 7.09e-03 | 4.48e-02 | 7.68e-01 |
Metabolism of polyamines | 57 | 1.46e-05 | 7.26e-05 | 0.3560 | 0.330000 | 0.105000 | 0.082100 | 1.67e-05 | 1.70e-01 | 2.84e-01 |
Ubiquitin-dependent degradation of Cyclin D | 50 | 1.87e-04 | 6.46e-04 | 0.3550 | 0.331000 | 0.125000 | 0.026400 | 5.00e-05 | 1.26e-01 | 7.47e-01 |
Regulation of IFNA signaling | 12 | 3.51e-01 | 4.11e-01 | 0.3550 | 0.185000 | 0.300000 | 0.038000 | 2.66e-01 | 7.17e-02 | 8.20e-01 |
Constitutive Signaling by NOTCH1 HD Domain Mutants | 14 | 1.52e-01 | 2.05e-01 | 0.3540 | 0.027700 | -0.018300 | -0.353000 | 8.58e-01 | 9.06e-01 | 2.23e-02 |
Signaling by NOTCH1 HD Domain Mutants in Cancer | 14 | 1.52e-01 | 2.05e-01 | 0.3540 | 0.027700 | -0.018300 | -0.353000 | 8.58e-01 | 9.06e-01 | 2.23e-02 |
Role of LAT2/NTAL/LAB on calcium mobilization | 74 | 1.03e-09 | 1.22e-08 | 0.3540 | -0.052600 | -0.336000 | 0.098100 | 4.34e-01 | 5.61e-07 | 1.45e-01 |
Condensation of Prophase Chromosomes | 29 | 6.13e-04 | 1.78e-03 | 0.3540 | 0.304000 | 0.001250 | -0.181000 | 4.63e-03 | 9.91e-01 | 9.09e-02 |
Downregulation of ERBB2 signaling | 24 | 1.85e-03 | 4.60e-03 | 0.3540 | 0.216000 | -0.089300 | -0.265000 | 6.66e-02 | 4.49e-01 | 2.44e-02 |
Semaphorin interactions | 57 | 2.26e-03 | 5.49e-03 | 0.3540 | 0.253000 | 0.220000 | -0.113000 | 9.61e-04 | 4.06e-03 | 1.41e-01 |
Interleukin-10 signaling | 34 | 9.05e-03 | 1.83e-02 | 0.3530 | 0.307000 | 0.142000 | -0.100000 | 1.94e-03 | 1.53e-01 | 3.12e-01 |
Collagen chain trimerization | 27 | 1.96e-02 | 3.59e-02 | 0.3520 | 0.003530 | -0.083400 | -0.342000 | 9.75e-01 | 4.53e-01 | 2.08e-03 |
Retinoid metabolism and transport | 24 | 6.60e-02 | 1.01e-01 | 0.3520 | 0.209000 | 0.190000 | -0.210000 | 7.57e-02 | 1.07e-01 | 7.54e-02 |
GLI3 is processed to GLI3R by the proteasome | 57 | 1.76e-05 | 8.43e-05 | 0.3520 | 0.333000 | 0.104000 | 0.043900 | 1.37e-05 | 1.73e-01 | 5.66e-01 |
Dectin-1 mediated noncanonical NF-kB signaling | 58 | 2.14e-05 | 9.83e-05 | 0.3520 | 0.332000 | 0.110000 | 0.034300 | 1.21e-05 | 1.46e-01 | 6.52e-01 |
Aquaporin-mediated transport | 37 | 1.30e-03 | 3.45e-03 | 0.3510 | 0.313000 | 0.091100 | -0.131000 | 9.99e-04 | 3.38e-01 | 1.67e-01 |
NOTCH2 Activation and Transmission of Signal to the Nucleus | 20 | 6.40e-02 | 9.89e-02 | 0.3510 | 0.124000 | 0.083100 | -0.318000 | 3.38e-01 | 5.20e-01 | 1.39e-02 |
G-protein activation | 23 | 2.07e-02 | 3.77e-02 | 0.3510 | 0.325000 | 0.106000 | 0.077800 | 6.91e-03 | 3.78e-01 | 5.18e-01 |
Repression of WNT target genes | 14 | 2.15e-01 | 2.72e-01 | 0.3510 | -0.149000 | -0.119000 | -0.295000 | 3.35e-01 | 4.40e-01 | 5.64e-02 |
Diseases associated with glycosylation precursor biosynthesis | 18 | 2.09e-01 | 2.65e-01 | 0.3510 | 0.290000 | 0.196000 | 0.020600 | 3.34e-02 | 1.49e-01 | 8.79e-01 |
ER Quality Control Compartment (ERQC) | 21 | 3.31e-02 | 5.68e-02 | 0.3500 | 0.333000 | 0.110000 | -0.002120 | 8.31e-03 | 3.84e-01 | 9.87e-01 |
N-Glycan antennae elongation | 13 | 2.61e-01 | 3.21e-01 | 0.3500 | -0.096000 | -0.162000 | -0.295000 | 5.49e-01 | 3.12e-01 | 6.54e-02 |
Interleukin-27 signaling | 11 | 3.81e-01 | 4.37e-01 | 0.3500 | 0.276000 | 0.171000 | 0.131000 | 1.13e-01 | 3.26e-01 | 4.51e-01 |
MET promotes cell motility | 26 | 7.95e-02 | 1.19e-01 | 0.3500 | 0.294000 | 0.189000 | 0.017400 | 9.47e-03 | 9.56e-02 | 8.78e-01 |
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 53 | 1.52e-05 | 7.49e-05 | 0.3490 | 0.256000 | 0.023500 | -0.237000 | 1.26e-03 | 7.67e-01 | 2.89e-03 |
Chondroitin sulfate/dermatan sulfate metabolism | 38 | 2.64e-03 | 6.29e-03 | 0.3480 | 0.079200 | -0.010500 | -0.339000 | 3.98e-01 | 9.11e-01 | 2.98e-04 |
ABC transporter disorders | 70 | 2.85e-05 | 1.24e-04 | 0.3480 | 0.318000 | 0.141000 | -0.000776 | 4.11e-06 | 4.07e-02 | 9.91e-01 |
Defective B4GALT7 causes EDS, progeroid type | 11 | 2.98e-01 | 3.58e-01 | 0.3480 | -0.044600 | -0.139000 | -0.316000 | 7.98e-01 | 4.25e-01 | 7.00e-02 |
Abortive elongation of HIV-1 transcript in the absence of Tat | 23 | 3.37e-02 | 5.77e-02 | 0.3470 | 0.155000 | 0.033600 | -0.309000 | 1.99e-01 | 7.80e-01 | 1.03e-02 |
Interleukin-15 signaling | 14 | 3.45e-01 | 4.06e-01 | 0.3470 | 0.238000 | 0.236000 | -0.088700 | 1.23e-01 | 1.27e-01 | 5.66e-01 |
VEGFA-VEGFR2 Pathway | 90 | 7.93e-06 | 4.22e-05 | 0.3470 | 0.295000 | 0.161000 | -0.083600 | 1.29e-06 | 8.16e-03 | 1.70e-01 |
PPARA activates gene expression | 104 | 3.82e-05 | 1.59e-04 | 0.3460 | 0.270000 | 0.217000 | 0.012800 | 2.03e-06 | 1.32e-04 | 8.22e-01 |
Cristae formation | 31 | 1.74e-03 | 4.38e-03 | 0.3460 | 0.263000 | 0.017100 | -0.224000 | 1.11e-02 | 8.69e-01 | 3.10e-02 |
FCERI mediated Ca+2 mobilization | 89 | 9.54e-10 | 1.14e-08 | 0.3450 | -0.077600 | -0.328000 | 0.073800 | 2.05e-01 | 8.56e-08 | 2.29e-01 |
EPHA-mediated growth cone collapse | 13 | 3.50e-01 | 4.11e-01 | 0.3450 | 0.287000 | 0.185000 | 0.048300 | 7.35e-02 | 2.47e-01 | 7.63e-01 |
The role of Nef in HIV-1 replication and disease pathogenesis | 28 | 1.24e-02 | 2.41e-02 | 0.3450 | 0.229000 | 0.058600 | -0.251000 | 3.63e-02 | 5.92e-01 | 2.13e-02 |
Rab regulation of trafficking | 120 | 1.48e-06 | 9.35e-06 | 0.3430 | 0.269000 | 0.192000 | -0.092200 | 3.41e-07 | 2.84e-04 | 8.11e-02 |
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 27 | 5.78e-03 | 1.22e-02 | 0.3420 | 0.058200 | -0.175000 | -0.288000 | 6.01e-01 | 1.15e-01 | 9.53e-03 |
Integration of energy metabolism | 86 | 2.64e-05 | 1.16e-04 | 0.3420 | 0.287000 | 0.164000 | -0.086900 | 4.19e-06 | 8.60e-03 | 1.64e-01 |
N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 35 | 1.59e-03 | 4.06e-03 | 0.3410 | 0.314000 | 0.076000 | -0.110000 | 1.30e-03 | 4.37e-01 | 2.60e-01 |
Interleukin-3, Interleukin-5 and GM-CSF signaling | 40 | 2.89e-02 | 5.03e-02 | 0.3410 | 0.239000 | 0.230000 | -0.079000 | 8.83e-03 | 1.19e-02 | 3.87e-01 |
Signaling by Insulin receptor | 59 | 4.61e-04 | 1.39e-03 | 0.3410 | 0.295000 | 0.146000 | -0.087000 | 8.65e-05 | 5.32e-02 | 2.48e-01 |
Autodegradation of the E3 ubiquitin ligase COP1 | 49 | 4.47e-04 | 1.35e-03 | 0.3390 | 0.316000 | 0.117000 | 0.040500 | 1.29e-04 | 1.56e-01 | 6.24e-01 |
Assembly of collagen fibrils and other multimeric structures | 42 | 3.21e-03 | 7.43e-03 | 0.3390 | 0.137000 | 0.160000 | -0.267000 | 1.25e-01 | 7.34e-02 | 2.80e-03 |
SIRT1 negatively regulates rRNA expression | 24 | 2.42e-03 | 5.83e-03 | 0.3380 | 0.279000 | -0.033700 | -0.188000 | 1.80e-02 | 7.75e-01 | 1.10e-01 |
TICAM1,TRAF6-dependent induction of TAK1 complex | 11 | 3.71e-02 | 6.28e-02 | 0.3380 | 0.279000 | -0.102000 | -0.161000 | 1.09e-01 | 5.59e-01 | 3.55e-01 |
Resolution of D-loop Structures through Holliday Junction Intermediates | 32 | 1.36e-02 | 2.59e-02 | 0.3370 | -0.175000 | -0.078600 | 0.277000 | 8.63e-02 | 4.41e-01 | 6.59e-03 |
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 19 | 2.77e-02 | 4.83e-02 | 0.3370 | -0.076800 | -0.316000 | 0.088200 | 5.62e-01 | 1.70e-02 | 5.06e-01 |
Defective B3GALTL causes Peters-plus syndrome (PpS) | 24 | 4.38e-02 | 7.20e-02 | 0.3360 | -0.299000 | -0.124000 | -0.092000 | 1.12e-02 | 2.95e-01 | 4.35e-01 |
NRIF signals cell death from the nucleus | 15 | 1.06e-01 | 1.51e-01 | 0.3360 | 0.217000 | 0.021600 | -0.256000 | 1.46e-01 | 8.85e-01 | 8.61e-02 |
Formation of the beta-catenin:TCF transactivating complex | 46 | 1.56e-04 | 5.46e-04 | 0.3360 | 0.212000 | -0.005410 | -0.261000 | 1.30e-02 | 9.49e-01 | 2.23e-03 |
XBP1(S) activates chaperone genes | 47 | 4.67e-03 | 1.03e-02 | 0.3350 | 0.278000 | 0.154000 | -0.107000 | 9.69e-04 | 6.80e-02 | 2.05e-01 |
Collagen biosynthesis and modifying enzymes | 46 | 1.55e-03 | 3.98e-03 | 0.3350 | 0.107000 | 0.082400 | -0.307000 | 2.08e-01 | 3.34e-01 | 3.18e-04 |
Acyl chain remodelling of PI | 10 | 3.94e-01 | 4.50e-01 | 0.3350 | 0.301000 | 0.144000 | -0.031400 | 9.92e-02 | 4.30e-01 | 8.63e-01 |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 12 | 2.26e-01 | 2.83e-01 | 0.3350 | 0.041700 | 0.235000 | 0.236000 | 8.03e-01 | 1.59e-01 | 1.58e-01 |
Uptake and actions of bacterial toxins | 27 | 1.72e-02 | 3.22e-02 | 0.3330 | 0.306000 | 0.095900 | -0.091600 | 5.95e-03 | 3.88e-01 | 4.10e-01 |
Complex I biogenesis | 55 | 4.09e-04 | 1.27e-03 | 0.3330 | 0.251000 | 0.098500 | -0.196000 | 1.30e-03 | 2.06e-01 | 1.19e-02 |
ERBB2 Regulates Cell Motility | 10 | 9.44e-02 | 1.38e-01 | 0.3330 | 0.315000 | -0.020100 | -0.106000 | 8.47e-02 | 9.12e-01 | 5.61e-01 |
Lewis blood group biosynthesis | 13 | 2.29e-01 | 2.87e-01 | 0.3320 | 0.038700 | -0.013800 | -0.329000 | 8.09e-01 | 9.31e-01 | 3.99e-02 |
SHC1 events in ERBB4 signaling | 10 | 8.43e-02 | 1.25e-01 | 0.3320 | 0.331000 | -0.009700 | 0.002790 | 6.96e-02 | 9.58e-01 | 9.88e-01 |
Laminin interactions | 21 | 4.39e-02 | 7.20e-02 | 0.3310 | 0.241000 | 0.047400 | -0.223000 | 5.62e-02 | 7.07e-01 | 7.75e-02 |
PLC beta mediated events | 43 | 4.02e-03 | 9.07e-03 | 0.3310 | 0.270000 | 0.119000 | -0.150000 | 2.19e-03 | 1.77e-01 | 8.92e-02 |
NOTCH1 Intracellular Domain Regulates Transcription | 44 | 3.96e-04 | 1.24e-03 | 0.3310 | 0.297000 | 0.066200 | -0.131000 | 6.57e-04 | 4.48e-01 | 1.34e-01 |
Synthesis of IP3 and IP4 in the cytosol | 22 | 6.02e-02 | 9.39e-02 | 0.3310 | 0.091300 | 0.119000 | -0.295000 | 4.59e-01 | 3.36e-01 | 1.66e-02 |
Costimulation by the CD28 family | 74 | 2.77e-03 | 6.56e-03 | 0.3300 | -0.224000 | -0.236000 | -0.055600 | 8.81e-04 | 4.42e-04 | 4.08e-01 |
Metabolism of fat-soluble vitamins | 28 | 5.20e-02 | 8.34e-02 | 0.3300 | 0.207000 | 0.145000 | -0.212000 | 5.82e-02 | 1.83e-01 | 5.21e-02 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 51 | 1.99e-03 | 4.89e-03 | 0.3300 | 0.288000 | 0.139000 | 0.080500 | 3.72e-04 | 8.52e-02 | 3.20e-01 |
Post-chaperonin tubulin folding pathway | 19 | 1.54e-01 | 2.07e-01 | 0.3300 | 0.280000 | 0.145000 | -0.096200 | 3.46e-02 | 2.72e-01 | 4.68e-01 |
Nuclear signaling by ERBB4 | 24 | 2.24e-02 | 4.04e-02 | 0.3290 | 0.243000 | 0.037400 | -0.219000 | 3.92e-02 | 7.51e-01 | 6.31e-02 |
Regulation of RUNX3 expression and activity | 55 | 3.44e-04 | 1.10e-03 | 0.3290 | 0.307000 | 0.117000 | 0.023700 | 8.41e-05 | 1.33e-01 | 7.61e-01 |
Autophagy | 124 | 7.65e-10 | 9.33e-09 | 0.3290 | 0.310000 | 0.100000 | -0.043500 | 2.38e-09 | 5.46e-02 | 4.03e-01 |
Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 1.24e-04 | 4.55e-04 | 0.3290 | -0.156000 | -0.266000 | 0.115000 | 2.25e-02 | 9.58e-05 | 9.29e-02 |
Oxidative Stress Induced Senescence | 79 | 1.62e-06 | 1.02e-05 | 0.3280 | 0.270000 | 0.067600 | -0.173000 | 3.35e-05 | 2.99e-01 | 7.96e-03 |
Regulation of lipid metabolism by PPARalpha | 106 | 1.04e-04 | 3.91e-04 | 0.3270 | 0.254000 | 0.206000 | 0.004900 | 6.09e-06 | 2.49e-04 | 9.30e-01 |
Telomere Extension By Telomerase | 23 | 6.36e-02 | 9.85e-02 | 0.3270 | -0.126000 | -0.302000 | -0.012300 | 2.96e-01 | 1.23e-02 | 9.19e-01 |
NR1H2 and NR1H3-mediated signaling | 39 | 1.40e-02 | 2.67e-02 | 0.3270 | 0.192000 | 0.147000 | -0.219000 | 3.77e-02 | 1.12e-01 | 1.78e-02 |
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 29 | 8.12e-05 | 3.11e-04 | 0.3260 | 0.318000 | -0.056400 | -0.048400 | 3.06e-03 | 5.99e-01 | 6.52e-01 |
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 36 | 4.43e-03 | 9.87e-03 | 0.3260 | 0.267000 | 0.087300 | 0.166000 | 5.59e-03 | 3.64e-01 | 8.47e-02 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 33 | 3.97e-02 | 6.70e-02 | 0.3260 | 0.185000 | 0.209000 | -0.169000 | 6.54e-02 | 3.79e-02 | 9.37e-02 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 124 | 7.67e-10 | 9.33e-09 | 0.3260 | 0.263000 | 0.067400 | -0.180000 | 4.20e-07 | 1.95e-01 | 5.26e-04 |
Activation of BAD and translocation to mitochondria | 15 | 1.18e-01 | 1.67e-01 | 0.3260 | 0.310000 | 0.083900 | -0.050800 | 3.73e-02 | 5.74e-01 | 7.33e-01 |
G alpha (z) signalling events | 36 | 5.25e-03 | 1.13e-02 | 0.3250 | 0.275000 | 0.082900 | -0.153000 | 4.27e-03 | 3.89e-01 | 1.13e-01 |
E3 ubiquitin ligases ubiquitinate target proteins | 52 | 1.08e-06 | 7.18e-06 | 0.3250 | 0.322000 | 0.004670 | -0.041500 | 5.75e-05 | 9.54e-01 | 6.04e-01 |
Resolution of Sister Chromatid Cohesion | 104 | 4.06e-11 | 6.00e-10 | 0.3240 | -0.007230 | -0.207000 | 0.249000 | 8.99e-01 | 2.57e-04 | 1.13e-05 |
Activation of NF-kappaB in B cells | 65 | 4.35e-05 | 1.77e-04 | 0.3240 | 0.307000 | 0.104000 | 0.015800 | 1.91e-05 | 1.49e-01 | 8.26e-01 |
Other semaphorin interactions | 16 | 1.96e-01 | 2.50e-01 | 0.3240 | 0.165000 | 0.102000 | -0.259000 | 2.53e-01 | 4.80e-01 | 7.27e-02 |
Surfactant metabolism | 21 | 8.67e-02 | 1.28e-01 | 0.3230 | 0.300000 | 0.120000 | -0.004200 | 1.75e-02 | 3.41e-01 | 9.73e-01 |
Respiratory electron transport | 101 | 5.60e-08 | 4.80e-07 | 0.3220 | 0.265000 | 0.067100 | -0.170000 | 4.04e-06 | 2.44e-01 | 3.11e-03 |
G-protein mediated events | 44 | 5.45e-03 | 1.16e-02 | 0.3210 | 0.252000 | 0.115000 | -0.162000 | 3.80e-03 | 1.86e-01 | 6.30e-02 |
p38MAPK events | 13 | 2.56e-01 | 3.17e-01 | 0.3210 | 0.298000 | 0.118000 | 0.006780 | 6.29e-02 | 4.60e-01 | 9.66e-01 |
Role of phospholipids in phagocytosis | 88 | 9.67e-07 | 6.52e-06 | 0.3210 | -0.109000 | -0.296000 | 0.058900 | 7.72e-02 | 1.63e-06 | 3.40e-01 |
SCF-beta-TrCP mediated degradation of Emi1 | 53 | 9.57e-05 | 3.62e-04 | 0.3200 | 0.302000 | 0.076000 | 0.072000 | 1.41e-04 | 3.39e-01 | 3.65e-01 |
IRE1alpha activates chaperones | 49 | 5.08e-03 | 1.10e-02 | 0.3190 | 0.268000 | 0.138000 | -0.106000 | 1.19e-03 | 9.38e-02 | 1.98e-01 |
RUNX3 regulates NOTCH signaling | 14 | 3.49e-01 | 4.10e-01 | 0.3190 | 0.204000 | 0.181000 | -0.167000 | 1.87e-01 | 2.42e-01 | 2.79e-01 |
Diseases of programmed cell death | 27 | 2.52e-02 | 4.45e-02 | 0.3190 | 0.294000 | 0.092500 | -0.081900 | 8.11e-03 | 4.05e-01 | 4.61e-01 |
Dual Incision in GG-NER | 41 | 1.88e-02 | 3.47e-02 | 0.3190 | -0.165000 | -0.266000 | 0.060800 | 6.73e-02 | 3.19e-03 | 5.01e-01 |
Constitutive Signaling by EGFRvIII | 14 | 8.14e-02 | 1.21e-01 | 0.3180 | 0.288000 | 0.034200 | 0.132000 | 6.23e-02 | 8.25e-01 | 3.92e-01 |
Signaling by EGFRvIII in Cancer | 14 | 8.14e-02 | 1.21e-01 | 0.3180 | 0.288000 | 0.034200 | 0.132000 | 6.23e-02 | 8.25e-01 | 3.92e-01 |
Protein ubiquitination | 72 | 2.69e-09 | 3.03e-08 | 0.3180 | 0.317000 | -0.005970 | -0.025100 | 3.21e-06 | 9.30e-01 | 7.12e-01 |
Ca-dependent events | 29 | 3.31e-02 | 5.68e-02 | 0.3180 | 0.246000 | 0.097400 | -0.177000 | 2.19e-02 | 3.64e-01 | 9.85e-02 |
Tryptophan catabolism | 12 | 5.18e-01 | 5.66e-01 | 0.3180 | 0.225000 | 0.194000 | 0.113000 | 1.77e-01 | 2.45e-01 | 4.98e-01 |
Intrinsic Pathway of Fibrin Clot Formation | 16 | 5.10e-02 | 8.19e-02 | 0.3180 | 0.269000 | -0.004110 | -0.169000 | 6.22e-02 | 9.77e-01 | 2.43e-01 |
Vasopressin regulates renal water homeostasis via Aquaporins | 34 | 5.53e-03 | 1.18e-02 | 0.3180 | 0.291000 | 0.073500 | -0.105000 | 3.36e-03 | 4.58e-01 | 2.89e-01 |
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 17 | 7.49e-02 | 1.13e-01 | 0.3170 | -0.080000 | -0.302000 | 0.055700 | 5.68e-01 | 3.10e-02 | 6.91e-01 |
Signaling by Receptor Tyrosine Kinases | 411 | 5.36e-24 | 1.78e-22 | 0.3170 | 0.261000 | 0.122000 | -0.133000 | 1.01e-19 | 2.12e-05 | 3.98e-06 |
Mitophagy | 28 | 1.16e-04 | 4.31e-04 | 0.3170 | 0.184000 | -0.197000 | -0.167000 | 9.21e-02 | 7.11e-02 | 1.26e-01 |
Opioid Signalling | 75 | 4.09e-05 | 1.68e-04 | 0.3170 | 0.287000 | 0.110000 | -0.076300 | 1.69e-05 | 9.89e-02 | 2.54e-01 |
SUMOylation of DNA damage response and repair proteins | 77 | 2.47e-04 | 8.23e-04 | 0.3170 | -0.161000 | -0.252000 | 0.105000 | 1.45e-02 | 1.33e-04 | 1.13e-01 |
CLEC7A (Dectin-1) signaling | 96 | 1.91e-08 | 1.81e-07 | 0.3170 | 0.309000 | 0.070200 | -0.002880 | 1.70e-07 | 2.35e-01 | 9.61e-01 |
Stabilization of p53 | 54 | 8.72e-04 | 2.44e-03 | 0.3160 | 0.284000 | 0.113000 | 0.081100 | 3.01e-04 | 1.51e-01 | 3.03e-01 |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 84 | 3.83e-08 | 3.38e-07 | 0.3160 | -0.062100 | -0.305000 | 0.057300 | 3.25e-01 | 1.35e-06 | 3.64e-01 |
Programmed Cell Death | 178 | 6.12e-11 | 8.68e-10 | 0.3160 | 0.288000 | 0.125000 | 0.034000 | 3.25e-11 | 4.04e-03 | 4.34e-01 |
Toll Like Receptor 3 (TLR3) Cascade | 92 | 7.25e-07 | 5.14e-06 | 0.3160 | 0.299000 | 0.094700 | -0.038400 | 7.41e-07 | 1.16e-01 | 5.24e-01 |
TRAF6 mediated IRF7 activation | 15 | 2.57e-01 | 3.18e-01 | 0.3150 | 0.065700 | 0.190000 | 0.242000 | 6.59e-01 | 2.02e-01 | 1.05e-01 |
Interleukin-4 and Interleukin-13 signaling | 90 | 7.39e-10 | 9.15e-09 | 0.3150 | 0.285000 | -0.002600 | -0.133000 | 2.91e-06 | 9.66e-01 | 2.89e-02 |
Degradation of AXIN | 53 | 7.61e-04 | 2.18e-03 | 0.3140 | 0.290000 | 0.106000 | 0.061000 | 2.66e-04 | 1.83e-01 | 4.42e-01 |
Formation of tubulin folding intermediates by CCT/TriC | 22 | 4.90e-04 | 1.46e-03 | 0.3140 | 0.289000 | -0.111000 | -0.053100 | 1.91e-02 | 3.66e-01 | 6.66e-01 |
FGFR1 mutant receptor activation | 23 | 1.76e-01 | 2.29e-01 | 0.3140 | 0.248000 | 0.161000 | 0.104000 | 3.92e-02 | 1.81e-01 | 3.88e-01 |
Resolution of D-Loop Structures | 33 | 1.91e-02 | 3.52e-02 | 0.3130 | -0.178000 | -0.058300 | 0.250000 | 7.61e-02 | 5.63e-01 | 1.28e-02 |
RA biosynthesis pathway | 13 | 5.18e-01 | 5.66e-01 | 0.3130 | -0.231000 | -0.206000 | -0.049300 | 1.50e-01 | 1.99e-01 | 7.58e-01 |
Signaling by Non-Receptor Tyrosine Kinases | 48 | 8.46e-04 | 2.38e-03 | 0.3130 | 0.277000 | 0.074200 | -0.125000 | 9.02e-04 | 3.74e-01 | 1.35e-01 |
Signaling by PTK6 | 48 | 8.46e-04 | 2.38e-03 | 0.3130 | 0.277000 | 0.074200 | -0.125000 | 9.02e-04 | 3.74e-01 | 1.35e-01 |
SUMOylation of chromatin organization proteins | 57 | 1.79e-03 | 4.50e-03 | 0.3120 | -0.141000 | -0.273000 | 0.053800 | 6.50e-02 | 3.61e-04 | 4.83e-01 |
Metabolism of nitric oxide: NOS3 activation and regulation | 12 | 3.53e-02 | 6.01e-02 | 0.3120 | 0.274000 | -0.098900 | -0.112000 | 1.01e-01 | 5.53e-01 | 5.02e-01 |
Acyl chain remodelling of PC | 19 | 3.33e-01 | 3.93e-01 | 0.3110 | 0.234000 | 0.193000 | 0.072300 | 7.80e-02 | 1.46e-01 | 5.85e-01 |
Asparagine N-linked glycosylation | 269 | 7.29e-14 | 1.50e-12 | 0.3100 | 0.276000 | 0.143000 | 0.006900 | 6.90e-15 | 5.62e-05 | 8.46e-01 |
TGF-beta receptor signaling activates SMADs | 32 | 4.62e-04 | 1.39e-03 | 0.3090 | 0.270000 | -0.043200 | -0.144000 | 8.14e-03 | 6.72e-01 | 1.58e-01 |
TRAF6 mediated NF-kB activation | 23 | 1.32e-01 | 1.84e-01 | 0.3090 | 0.270000 | 0.137000 | -0.058900 | 2.48e-02 | 2.56e-01 | 6.25e-01 |
HSF1-dependent transactivation | 29 | 9.02e-03 | 1.83e-02 | 0.3080 | 0.123000 | -0.094100 | -0.266000 | 2.51e-01 | 3.80e-01 | 1.30e-02 |
Keratinization | 32 | 1.44e-02 | 2.73e-02 | 0.3080 | 0.261000 | 0.069900 | -0.149000 | 1.07e-02 | 4.94e-01 | 1.45e-01 |
Citric acid cycle (TCA cycle) | 22 | 1.77e-01 | 2.30e-01 | 0.3080 | 0.269000 | 0.150000 | 0.009440 | 2.92e-02 | 2.23e-01 | 9.39e-01 |
Tight junction interactions | 18 | 5.41e-02 | 8.62e-02 | 0.3070 | 0.005470 | -0.252000 | -0.176000 | 9.68e-01 | 6.39e-02 | 1.97e-01 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 16 | 4.05e-01 | 4.60e-01 | 0.3070 | 0.246000 | 0.183000 | 0.014200 | 8.85e-02 | 2.04e-01 | 9.22e-01 |
TP53 Regulates Transcription of Death Receptors and Ligands | 11 | 1.09e-01 | 1.55e-01 | 0.3060 | 0.159000 | -0.150000 | -0.214000 | 3.60e-01 | 3.89e-01 | 2.19e-01 |
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 91 | 1.13e-07 | 9.03e-07 | 0.3050 | -0.038900 | -0.197000 | 0.230000 | 5.21e-01 | 1.19e-03 | 1.49e-04 |
Amplification of signal from the kinetochores | 91 | 1.13e-07 | 9.03e-07 | 0.3050 | -0.038900 | -0.197000 | 0.230000 | 5.21e-01 | 1.19e-03 | 1.49e-04 |
NOTCH3 Intracellular Domain Regulates Transcription | 20 | 1.38e-01 | 1.89e-01 | 0.3050 | 0.257000 | 0.102000 | -0.128000 | 4.69e-02 | 4.28e-01 | 3.20e-01 |
Prefoldin mediated transfer of substrate to CCT/TriC | 26 | 4.32e-04 | 1.33e-03 | 0.3050 | 0.289000 | -0.077500 | -0.058300 | 1.08e-02 | 4.94e-01 | 6.07e-01 |
SARS-CoV-2 Infection | 63 | 2.25e-04 | 7.62e-04 | 0.3040 | 0.267000 | 0.083600 | -0.120000 | 2.49e-04 | 2.51e-01 | 9.83e-02 |
Platelet homeostasis | 68 | 9.61e-04 | 2.66e-03 | 0.3040 | 0.270000 | 0.132000 | -0.045500 | 1.20e-04 | 5.92e-02 | 5.16e-01 |
Signaling by SCF-KIT | 40 | 5.75e-02 | 9.05e-02 | 0.3040 | 0.245000 | 0.175000 | -0.040300 | 7.31e-03 | 5.58e-02 | 6.59e-01 |
Metabolism of RNA | 685 | 4.61e-45 | 3.31e-43 | 0.3040 | -0.088600 | -0.286000 | -0.051800 | 7.79e-05 | 2.51e-37 | 2.09e-02 |
Signaling by VEGF | 97 | 5.75e-05 | 2.31e-04 | 0.3030 | 0.254000 | 0.136000 | -0.093600 | 1.50e-05 | 2.10e-02 | 1.11e-01 |
Signaling by Hippo | 18 | 2.62e-01 | 3.21e-01 | 0.3030 | 0.235000 | 0.137000 | 0.133000 | 8.42e-02 | 3.16e-01 | 3.27e-01 |
Attenuation phase | 23 | 6.02e-03 | 1.27e-02 | 0.3030 | 0.208000 | -0.097700 | -0.197000 | 8.35e-02 | 4.17e-01 | 1.03e-01 |
Apoptosis | 166 | 8.90e-10 | 1.07e-08 | 0.3020 | 0.279000 | 0.113000 | 0.027900 | 5.85e-10 | 1.21e-02 | 5.36e-01 |
Heme biosynthesis | 14 | 1.89e-01 | 2.42e-01 | 0.3010 | 0.242000 | 0.042800 | -0.174000 | 1.17e-01 | 7.81e-01 | 2.61e-01 |
Transport of Mature Transcript to Cytoplasm | 81 | 1.47e-04 | 5.27e-04 | 0.3010 | -0.136000 | -0.232000 | 0.134000 | 3.49e-02 | 3.01e-04 | 3.67e-02 |
Chromosome Maintenance | 105 | 2.44e-06 | 1.47e-05 | 0.3010 | -0.108000 | -0.279000 | -0.031500 | 5.64e-02 | 7.94e-07 | 5.77e-01 |
Transcriptional regulation of white adipocyte differentiation | 77 | 1.15e-03 | 3.10e-03 | 0.3000 | 0.250000 | 0.150000 | -0.071800 | 1.48e-04 | 2.26e-02 | 2.76e-01 |
Regulation of mRNA stability by proteins that bind AU-rich elements | 87 | 1.79e-07 | 1.37e-06 | 0.3000 | 0.293000 | 0.054700 | 0.034000 | 2.22e-06 | 3.78e-01 | 5.83e-01 |
Negative regulation of NMDA receptor-mediated neuronal transmission | 14 | 4.19e-01 | 4.74e-01 | 0.3000 | -0.193000 | -0.144000 | -0.179000 | 2.11e-01 | 3.51e-01 | 2.45e-01 |
Glycosaminoglycan metabolism | 92 | 4.84e-05 | 1.95e-04 | 0.3000 | 0.149000 | 0.113000 | -0.235000 | 1.33e-02 | 6.21e-02 | 9.88e-05 |
Arachidonic acid metabolism | 43 | 1.41e-02 | 2.68e-02 | 0.3000 | 0.191000 | 0.102000 | -0.207000 | 3.04e-02 | 2.45e-01 | 1.86e-02 |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 53 | 4.85e-03 | 1.06e-02 | 0.3000 | 0.255000 | 0.120000 | -0.101000 | 1.30e-03 | 1.31e-01 | 2.01e-01 |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | 53 | 4.85e-03 | 1.06e-02 | 0.3000 | 0.255000 | 0.120000 | -0.101000 | 1.30e-03 | 1.31e-01 | 2.01e-01 |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 53 | 4.85e-03 | 1.06e-02 | 0.3000 | 0.255000 | 0.120000 | -0.101000 | 1.30e-03 | 1.31e-01 | 2.01e-01 |
Signaling by NOTCH1 PEST Domain Mutants in Cancer | 53 | 4.85e-03 | 1.06e-02 | 0.3000 | 0.255000 | 0.120000 | -0.101000 | 1.30e-03 | 1.31e-01 | 2.01e-01 |
Signaling by NOTCH1 in Cancer | 53 | 4.85e-03 | 1.06e-02 | 0.3000 | 0.255000 | 0.120000 | -0.101000 | 1.30e-03 | 1.31e-01 | 2.01e-01 |
Intra-Golgi traffic | 43 | 5.99e-02 | 9.35e-02 | 0.2990 | 0.227000 | 0.187000 | -0.051000 | 1.00e-02 | 3.37e-02 | 5.63e-01 |
Intra-Golgi and retrograde Golgi-to-ER traffic | 179 | 5.04e-09 | 5.54e-08 | 0.2980 | 0.268000 | 0.130000 | 0.004300 | 5.92e-10 | 2.66e-03 | 9.21e-01 |
Inactivation of APC/C via direct inhibition of the APC/C complex | 21 | 3.22e-02 | 5.55e-02 | 0.2980 | -0.027600 | -0.225000 | 0.193000 | 8.27e-01 | 7.38e-02 | 1.26e-01 |
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 21 | 3.22e-02 | 5.55e-02 | 0.2980 | -0.027600 | -0.225000 | 0.193000 | 8.27e-01 | 7.38e-02 | 1.26e-01 |
TNFs bind their physiological receptors | 25 | 6.65e-02 | 1.02e-01 | 0.2980 | -0.082000 | -0.268000 | -0.100000 | 4.78e-01 | 2.02e-02 | 3.86e-01 |
Signaling by Interleukins | 383 | 1.59e-21 | 4.43e-20 | 0.2980 | 0.270000 | 0.108000 | -0.062400 | 9.51e-20 | 2.84e-04 | 3.61e-02 |
GRB2 events in ERBB2 signaling | 11 | 3.45e-02 | 5.90e-02 | 0.2980 | 0.244000 | -0.155000 | -0.070200 | 1.61e-01 | 3.73e-01 | 6.87e-01 |
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 14 | 5.16e-01 | 5.66e-01 | 0.2980 | 0.224000 | 0.195000 | -0.015900 | 1.46e-01 | 2.06e-01 | 9.18e-01 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 72 | 8.34e-05 | 3.19e-04 | 0.2970 | 0.265000 | 0.089300 | 0.102000 | 1.04e-04 | 1.90e-01 | 1.35e-01 |
Autodegradation of Cdh1 by Cdh1:APC/C | 64 | 2.06e-04 | 7.07e-04 | 0.2970 | 0.276000 | 0.088200 | 0.064100 | 1.35e-04 | 2.22e-01 | 3.75e-01 |
Signaling by NODAL | 13 | 3.70e-01 | 4.27e-01 | 0.2960 | -0.048400 | -0.152000 | -0.250000 | 7.63e-01 | 3.43e-01 | 1.19e-01 |
Activation of HOX genes during differentiation | 68 | 1.19e-04 | 4.40e-04 | 0.2960 | 0.199000 | 0.034800 | -0.216000 | 4.46e-03 | 6.20e-01 | 2.05e-03 |
Activation of anterior HOX genes in hindbrain development during early embryogenesis | 68 | 1.19e-04 | 4.40e-04 | 0.2960 | 0.199000 | 0.034800 | -0.216000 | 4.46e-03 | 6.20e-01 | 2.05e-03 |
MAPK6/MAPK4 signaling | 81 | 5.26e-06 | 2.92e-05 | 0.2960 | 0.280000 | 0.072700 | 0.063000 | 1.36e-05 | 2.58e-01 | 3.27e-01 |
APC/C:Cdc20 mediated degradation of Securin | 66 | 1.09e-04 | 4.08e-04 | 0.2960 | 0.269000 | 0.079300 | 0.092400 | 1.54e-04 | 2.66e-01 | 1.94e-01 |
Sphingolipid metabolism | 78 | 2.20e-03 | 5.37e-03 | 0.2950 | 0.238000 | 0.160000 | -0.070200 | 2.87e-04 | 1.45e-02 | 2.84e-01 |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 32 | 3.90e-02 | 6.59e-02 | 0.2950 | 0.272000 | 0.108000 | -0.037500 | 7.77e-03 | 2.91e-01 | 7.13e-01 |
NOTCH2 intracellular domain regulates transcription | 11 | 4.99e-01 | 5.51e-01 | 0.2940 | 0.146000 | 0.249000 | -0.055400 | 4.00e-01 | 1.52e-01 | 7.50e-01 |
Hedgehog ‘on’ state | 75 | 4.59e-04 | 1.39e-03 | 0.2940 | 0.267000 | 0.121000 | 0.022000 | 6.36e-05 | 7.01e-02 | 7.42e-01 |
Oncogene Induced Senescence | 33 | 7.82e-02 | 1.17e-01 | 0.2930 | 0.226000 | 0.139000 | -0.125000 | 2.44e-02 | 1.68e-01 | 2.14e-01 |
CaM pathway | 27 | 4.72e-02 | 7.63e-02 | 0.2930 | 0.198000 | 0.039500 | -0.213000 | 7.51e-02 | 7.23e-01 | 5.57e-02 |
Calmodulin induced events | 27 | 4.72e-02 | 7.63e-02 | 0.2930 | 0.198000 | 0.039500 | -0.213000 | 7.51e-02 | 7.23e-01 | 5.57e-02 |
Binding and Uptake of Ligands by Scavenger Receptors | 91 | 5.41e-11 | 7.84e-10 | 0.2920 | 0.022500 | -0.272000 | 0.106000 | 7.10e-01 | 7.45e-06 | 8.07e-02 |
Misspliced GSK3beta mutants stabilize beta-catenin | 15 | 1.34e-01 | 1.85e-01 | 0.2920 | 0.287000 | 0.053600 | 0.011000 | 5.40e-02 | 7.19e-01 | 9.41e-01 |
S33 mutants of beta-catenin aren’t phosphorylated | 15 | 1.34e-01 | 1.85e-01 | 0.2920 | 0.287000 | 0.053600 | 0.011000 | 5.40e-02 | 7.19e-01 | 9.41e-01 |
S37 mutants of beta-catenin aren’t phosphorylated | 15 | 1.34e-01 | 1.85e-01 | 0.2920 | 0.287000 | 0.053600 | 0.011000 | 5.40e-02 | 7.19e-01 | 9.41e-01 |
S45 mutants of beta-catenin aren’t phosphorylated | 15 | 1.34e-01 | 1.85e-01 | 0.2920 | 0.287000 | 0.053600 | 0.011000 | 5.40e-02 | 7.19e-01 | 9.41e-01 |
T41 mutants of beta-catenin aren’t phosphorylated | 15 | 1.34e-01 | 1.85e-01 | 0.2920 | 0.287000 | 0.053600 | 0.011000 | 5.40e-02 | 7.19e-01 | 9.41e-01 |
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 15 | 1.34e-01 | 1.85e-01 | 0.2920 | 0.287000 | 0.053600 | 0.011000 | 5.40e-02 | 7.19e-01 | 9.41e-01 |
CLEC7A (Dectin-1) induces NFAT activation | 11 | 2.16e-01 | 2.73e-01 | 0.2920 | -0.035300 | -0.288000 | -0.036500 | 8.39e-01 | 9.81e-02 | 8.34e-01 |
Vesicle-mediated transport | 646 | 6.88e-33 | 2.84e-31 | 0.2920 | 0.268000 | 0.117000 | 0.001080 | 2.66e-31 | 4.07e-07 | 9.63e-01 |
CDT1 association with the CDC6:ORC:origin complex | 57 | 1.82e-04 | 6.30e-04 | 0.2920 | 0.259000 | 0.056100 | 0.123000 | 7.05e-04 | 4.64e-01 | 1.09e-01 |
Receptor Mediated Mitophagy | 11 | 1.76e-01 | 2.29e-01 | 0.2920 | 0.289000 | 0.020200 | 0.037800 | 9.70e-02 | 9.08e-01 | 8.28e-01 |
Nuclear Envelope Breakdown | 53 | 1.17e-03 | 3.16e-03 | 0.2920 | -0.092600 | -0.245000 | 0.129000 | 2.44e-01 | 2.06e-03 | 1.05e-01 |
Glutathione conjugation | 26 | 2.60e-01 | 3.20e-01 | 0.2910 | 0.175000 | 0.218000 | 0.079800 | 1.22e-01 | 5.46e-02 | 4.81e-01 |
Mitotic Spindle Checkpoint | 108 | 2.42e-08 | 2.23e-07 | 0.2900 | -0.032300 | -0.185000 | 0.222000 | 5.62e-01 | 9.21e-04 | 6.73e-05 |
SHC1 events in ERBB2 signaling | 17 | 1.13e-01 | 1.60e-01 | 0.2900 | 0.279000 | 0.052800 | -0.062400 | 4.67e-02 | 7.06e-01 | 6.56e-01 |
EML4 and NUDC in mitotic spindle formation | 95 | 6.93e-08 | 5.79e-07 | 0.2900 | -0.020200 | -0.193000 | 0.216000 | 7.34e-01 | 1.17e-03 | 2.75e-04 |
ZBP1(DAI) mediated induction of type I IFNs | 20 | 2.96e-01 | 3.56e-01 | 0.2900 | 0.190000 | 0.177000 | -0.130000 | 1.42e-01 | 1.71e-01 | 3.15e-01 |
cGMP effects | 12 | 2.79e-01 | 3.39e-01 | 0.2890 | 0.242000 | 0.043800 | -0.153000 | 1.47e-01 | 7.93e-01 | 3.60e-01 |
Extracellular matrix organization | 216 | 1.12e-10 | 1.48e-09 | 0.2880 | 0.183000 | 0.093800 | -0.202000 | 3.69e-06 | 1.75e-02 | 3.31e-07 |
Regulation of cholesterol biosynthesis by SREBP (SREBF) | 55 | 1.78e-02 | 3.30e-02 | 0.2870 | 0.246000 | 0.148000 | 0.008170 | 1.62e-03 | 5.76e-02 | 9.17e-01 |
PKA-mediated phosphorylation of CREB | 17 | 1.03e-01 | 1.48e-01 | 0.2860 | 0.185000 | -0.033900 | -0.216000 | 1.86e-01 | 8.09e-01 | 1.24e-01 |
SARS-CoV-1 Infection | 47 | 1.16e-02 | 2.28e-02 | 0.2860 | 0.244000 | 0.104000 | -0.109000 | 3.87e-03 | 2.18e-01 | 1.97e-01 |
Cobalamin (Cbl, vitamin B12) transport and metabolism | 16 | 3.21e-01 | 3.80e-01 | 0.2850 | -0.135000 | -0.213000 | 0.134000 | 3.51e-01 | 1.40e-01 | 3.52e-01 |
Telomere Maintenance | 80 | 2.57e-05 | 1.15e-04 | 0.2850 | -0.045900 | -0.249000 | -0.132000 | 4.77e-01 | 1.20e-04 | 4.11e-02 |
PRC2 methylates histones and DNA | 29 | 9.97e-03 | 1.99e-02 | 0.2850 | 0.191000 | -0.047800 | -0.206000 | 7.46e-02 | 6.56e-01 | 5.47e-02 |
Macroautophagy | 110 | 3.44e-07 | 2.50e-06 | 0.2850 | 0.271000 | 0.073100 | -0.046300 | 8.72e-07 | 1.85e-01 | 4.01e-01 |
Regulation of RAS by GAPs | 66 | 1.55e-03 | 3.98e-03 | 0.2850 | 0.252000 | 0.110000 | 0.075000 | 4.06e-04 | 1.21e-01 | 2.92e-01 |
Polo-like kinase mediated events | 15 | 2.27e-02 | 4.07e-02 | 0.2840 | 0.108000 | -0.208000 | 0.161000 | 4.70e-01 | 1.63e-01 | 2.80e-01 |
DNA Damage Bypass | 47 | 3.63e-03 | 8.27e-03 | 0.2840 | -0.091100 | -0.254000 | 0.091000 | 2.80e-01 | 2.64e-03 | 2.81e-01 |
C-type lectin receptors (CLRs) | 128 | 5.82e-07 | 4.17e-06 | 0.2840 | 0.265000 | 0.102000 | 0.013700 | 2.31e-07 | 4.61e-02 | 7.89e-01 |
PI3K events in ERBB2 signaling | 11 | 8.22e-02 | 1.22e-01 | 0.2840 | 0.247000 | -0.097700 | -0.098900 | 1.55e-01 | 5.75e-01 | 5.70e-01 |
Inwardly rectifying K+ channels | 23 | 2.81e-01 | 3.41e-01 | 0.2840 | 0.222000 | 0.154000 | 0.084600 | 6.49e-02 | 2.00e-01 | 4.83e-01 |
ESR-mediated signaling | 160 | 1.29e-14 | 2.79e-13 | 0.2830 | 0.238000 | -0.027100 | -0.152000 | 2.13e-07 | 5.54e-01 | 8.99e-04 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 18 | 2.40e-02 | 4.28e-02 | 0.2830 | 0.279000 | -0.031200 | -0.035200 | 4.02e-02 | 8.19e-01 | 7.96e-01 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 18 | 2.40e-02 | 4.28e-02 | 0.2830 | 0.279000 | -0.031200 | -0.035200 | 4.02e-02 | 8.19e-01 | 7.96e-01 |
Regulation of insulin secretion | 60 | 5.45e-03 | 1.16e-02 | 0.2830 | 0.253000 | 0.122000 | -0.036300 | 7.09e-04 | 1.02e-01 | 6.27e-01 |
Signaling by FGFR3 | 31 | 1.39e-02 | 2.65e-02 | 0.2830 | 0.273000 | 0.047200 | -0.056700 | 8.56e-03 | 6.49e-01 | 5.85e-01 |
Extra-nuclear estrogen signaling | 66 | 1.39e-06 | 8.89e-06 | 0.2820 | 0.234000 | -0.045600 | -0.150000 | 9.85e-04 | 5.22e-01 | 3.48e-02 |
HS-GAG biosynthesis | 20 | 1.42e-01 | 1.95e-01 | 0.2820 | 0.169000 | 0.024200 | -0.225000 | 1.91e-01 | 8.51e-01 | 8.21e-02 |
Negative regulation of FGFR2 signaling | 23 | 4.46e-02 | 7.29e-02 | 0.2820 | 0.213000 | -0.006220 | -0.185000 | 7.73e-02 | 9.59e-01 | 1.25e-01 |
Viral Messenger RNA Synthesis | 44 | 2.64e-02 | 4.63e-02 | 0.2820 | -0.129000 | -0.249000 | 0.028400 | 1.39e-01 | 4.26e-03 | 7.45e-01 |
Asymmetric localization of PCP proteins | 60 | 3.09e-03 | 7.23e-03 | 0.2820 | 0.259000 | 0.108000 | -0.021200 | 5.14e-04 | 1.47e-01 | 7.76e-01 |
Activation of gene expression by SREBF (SREBP) | 42 | 4.29e-02 | 7.10e-02 | 0.2820 | 0.236000 | 0.130000 | -0.081600 | 8.13e-03 | 1.45e-01 | 3.60e-01 |
Transport of bile salts and organic acids, metal ions and amine compounds | 54 | 4.20e-02 | 6.99e-02 | 0.2810 | 0.221000 | 0.173000 | -0.022800 | 5.00e-03 | 2.79e-02 | 7.72e-01 |
Signaling by FGFR4 | 31 | 9.15e-03 | 1.84e-02 | 0.2810 | 0.258000 | 0.017200 | -0.111000 | 1.30e-02 | 8.69e-01 | 2.83e-01 |
Metalloprotease DUBs | 21 | 8.83e-02 | 1.30e-01 | 0.2810 | 0.267000 | 0.066400 | 0.059100 | 3.43e-02 | 5.99e-01 | 6.39e-01 |
APC/C:Cdc20 mediated degradation of mitotic proteins | 74 | 2.86e-06 | 1.69e-05 | 0.2810 | 0.239000 | 0.017400 | 0.147000 | 3.71e-04 | 7.96e-01 | 2.93e-02 |
Striated Muscle Contraction | 23 | 2.34e-01 | 2.92e-01 | 0.2810 | 0.238000 | 0.138000 | -0.060300 | 4.86e-02 | 2.53e-01 | 6.16e-01 |
Interferon Signaling | 177 | 9.79e-09 | 1.03e-07 | 0.2810 | -0.155000 | -0.073400 | 0.223000 | 3.74e-04 | 9.22e-02 | 3.20e-07 |
Phase 4 - resting membrane potential | 10 | 6.52e-01 | 6.93e-01 | 0.2810 | 0.133000 | 0.190000 | 0.158000 | 4.66e-01 | 2.97e-01 | 3.87e-01 |
Signalling to RAS | 18 | 1.34e-01 | 1.85e-01 | 0.2810 | 0.269000 | 0.067100 | 0.042000 | 4.79e-02 | 6.22e-01 | 7.58e-01 |
RIP-mediated NFkB activation via ZBP1 | 17 | 4.00e-01 | 4.56e-01 | 0.2810 | 0.195000 | 0.160000 | -0.123000 | 1.63e-01 | 2.53e-01 | 3.81e-01 |
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 17 | 3.63e-01 | 4.22e-01 | 0.2810 | -0.147000 | -0.229000 | 0.066400 | 2.93e-01 | 1.02e-01 | 6.35e-01 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 75 | 2.78e-06 | 1.65e-05 | 0.2800 | 0.242000 | 0.019800 | 0.141000 | 2.98e-04 | 7.67e-01 | 3.49e-02 |
Mitochondrial translation elongation | 91 | 8.02e-08 | 6.54e-07 | 0.2800 | -0.011100 | -0.269000 | -0.076300 | 8.55e-01 | 9.21e-06 | 2.09e-01 |
FCGR3A-mediated IL10 synthesis | 99 | 9.93e-07 | 6.67e-06 | 0.2790 | -0.072400 | -0.265000 | 0.053100 | 2.13e-01 | 5.36e-06 | 3.62e-01 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 72 | 5.10e-06 | 2.85e-05 | 0.2790 | 0.244000 | 0.020600 | 0.134000 | 3.43e-04 | 7.62e-01 | 4.94e-02 |
Regulation of TP53 Activity through Methylation | 19 | 3.30e-01 | 3.91e-01 | 0.2780 | -0.120000 | -0.128000 | -0.216000 | 3.66e-01 | 3.33e-01 | 1.04e-01 |
RET signaling | 32 | 1.24e-01 | 1.73e-01 | 0.2780 | 0.198000 | 0.140000 | -0.136000 | 5.27e-02 | 1.70e-01 | 1.84e-01 |
Nucleobase catabolism | 28 | 1.30e-01 | 1.81e-01 | 0.2780 | 0.247000 | 0.121000 | -0.039700 | 2.37e-02 | 2.69e-01 | 7.16e-01 |
RAS processing | 19 | 6.21e-03 | 1.30e-02 | 0.2780 | 0.126000 | -0.236000 | -0.073200 | 3.40e-01 | 7.49e-02 | 5.81e-01 |
Initiation of Nuclear Envelope (NE) Reformation | 19 | 7.77e-02 | 1.17e-01 | 0.2770 | 0.255000 | 0.034300 | 0.103000 | 5.41e-02 | 7.96e-01 | 4.35e-01 |
Acyl chain remodelling of PG | 11 | 4.45e-01 | 5.00e-01 | 0.2770 | 0.175000 | 0.067900 | 0.204000 | 3.14e-01 | 6.96e-01 | 2.42e-01 |
NOTCH4 Intracellular Domain Regulates Transcription | 17 | 2.61e-01 | 3.21e-01 | 0.2770 | 0.106000 | 0.194000 | -0.168000 | 4.51e-01 | 1.66e-01 | 2.32e-01 |
Tie2 Signaling | 16 | 2.52e-01 | 3.12e-01 | 0.2770 | 0.260000 | 0.088900 | 0.034900 | 7.23e-02 | 5.38e-01 | 8.09e-01 |
Signaling by PDGFR in disease | 19 | 8.65e-02 | 1.28e-01 | 0.2770 | 0.169000 | -0.005950 | 0.219000 | 2.03e-01 | 9.64e-01 | 9.82e-02 |
RNA Polymerase I Transcription Termination | 27 | 1.18e-01 | 1.67e-01 | 0.2760 | -0.119000 | -0.238000 | 0.072300 | 2.84e-01 | 3.23e-02 | 5.15e-01 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 71 | 8.06e-06 | 4.27e-05 | 0.2750 | 0.245000 | 0.021600 | 0.124000 | 3.54e-04 | 7.53e-01 | 7.13e-02 |
Apoptotic execution phase | 45 | 3.65e-02 | 6.21e-02 | 0.2750 | 0.242000 | 0.126000 | 0.036300 | 4.98e-03 | 1.43e-01 | 6.74e-01 |
Synthesis of very long-chain fatty acyl-CoAs | 21 | 9.26e-02 | 1.36e-01 | 0.2750 | 0.200000 | 0.033900 | 0.186000 | 1.13e-01 | 7.88e-01 | 1.40e-01 |
The citric acid (TCA) cycle and respiratory electron transport | 172 | 3.31e-10 | 4.25e-09 | 0.2750 | 0.239000 | 0.056700 | -0.124000 | 6.56e-08 | 2.00e-01 | 5.18e-03 |
Norepinephrine Neurotransmitter Release Cycle | 13 | 4.03e-01 | 4.59e-01 | 0.2750 | -0.033800 | -0.163000 | -0.218000 | 8.33e-01 | 3.08e-01 | 1.73e-01 |
Disorders of Developmental Biology | 12 | 3.82e-01 | 4.37e-01 | 0.2740 | 0.180000 | 0.036100 | -0.203000 | 2.79e-01 | 8.29e-01 | 2.22e-01 |
Disorders of Nervous System Development | 12 | 3.82e-01 | 4.37e-01 | 0.2740 | 0.180000 | 0.036100 | -0.203000 | 2.79e-01 | 8.29e-01 | 2.22e-01 |
Loss of function of MECP2 in Rett syndrome | 12 | 3.82e-01 | 4.37e-01 | 0.2740 | 0.180000 | 0.036100 | -0.203000 | 2.79e-01 | 8.29e-01 | 2.22e-01 |
Pervasive developmental disorders | 12 | 3.82e-01 | 4.37e-01 | 0.2740 | 0.180000 | 0.036100 | -0.203000 | 2.79e-01 | 8.29e-01 | 2.22e-01 |
Deadenylation-dependent mRNA decay | 53 | 4.63e-05 | 1.88e-04 | 0.2740 | -0.010200 | -0.263000 | 0.078500 | 8.97e-01 | 9.42e-04 | 3.23e-01 |
Signaling by NOTCH2 | 30 | 9.76e-02 | 1.42e-01 | 0.2740 | 0.116000 | 0.123000 | -0.215000 | 2.72e-01 | 2.42e-01 | 4.14e-02 |
Estrogen-dependent gene expression | 98 | 1.36e-08 | 1.38e-07 | 0.2730 | 0.215000 | -0.043700 | -0.164000 | 2.41e-04 | 4.55e-01 | 5.12e-03 |
Nef mediated downregulation of MHC class I complex cell surface expression | 10 | 2.79e-01 | 3.38e-01 | 0.2730 | 0.172000 | -0.072200 | -0.199000 | 3.45e-01 | 6.93e-01 | 2.77e-01 |
CDK-mediated phosphorylation and removal of Cdc6 | 71 | 8.77e-05 | 3.35e-04 | 0.2720 | 0.245000 | 0.054200 | 0.107000 | 3.64e-04 | 4.30e-01 | 1.19e-01 |
BMAL1:CLOCK,NPAS2 activates circadian gene expression | 25 | 3.08e-01 | 3.68e-01 | 0.2720 | 0.203000 | 0.173000 | -0.055400 | 7.89e-02 | 1.35e-01 | 6.31e-01 |
ABC transporters in lipid homeostasis | 14 | 5.79e-01 | 6.23e-01 | 0.2710 | -0.205000 | -0.173000 | 0.041400 | 1.85e-01 | 2.61e-01 | 7.89e-01 |
Degradation of beta-catenin by the destruction complex | 83 | 5.67e-05 | 2.28e-04 | 0.2710 | 0.261000 | 0.074200 | -0.007520 | 3.98e-05 | 2.43e-01 | 9.06e-01 |
Base Excision Repair | 58 | 5.68e-03 | 1.20e-02 | 0.2710 | -0.063400 | -0.209000 | -0.160000 | 4.03e-01 | 5.83e-03 | 3.48e-02 |
SCF(Skp2)-mediated degradation of p27/p21 | 60 | 5.04e-04 | 1.49e-03 | 0.2710 | 0.246000 | 0.056100 | 0.099500 | 1.00e-03 | 4.53e-01 | 1.83e-01 |
Downregulation of TGF-beta receptor signaling | 26 | 1.38e-03 | 3.59e-03 | 0.2710 | 0.193000 | -0.155000 | -0.111000 | 8.91e-02 | 1.72e-01 | 3.28e-01 |
p75 NTR receptor-mediated signalling | 88 | 4.22e-04 | 1.30e-03 | 0.2710 | 0.197000 | 0.090600 | -0.162000 | 1.40e-03 | 1.42e-01 | 8.65e-03 |
Listeria monocytogenes entry into host cells | 17 | 3.04e-01 | 3.63e-01 | 0.2700 | 0.243000 | 0.100000 | -0.062900 | 8.26e-02 | 4.73e-01 | 6.53e-01 |
Signaling by FGFR1 in disease | 30 | 9.94e-02 | 1.44e-01 | 0.2700 | 0.193000 | 0.091200 | 0.165000 | 6.67e-02 | 3.88e-01 | 1.17e-01 |
Translation of structural proteins | 28 | 9.50e-02 | 1.38e-01 | 0.2700 | 0.138000 | 0.038100 | -0.229000 | 2.06e-01 | 7.27e-01 | 3.57e-02 |
Regulation of HSF1-mediated heat shock response | 79 | 9.20e-05 | 3.49e-04 | 0.2700 | -0.079900 | -0.254000 | 0.043200 | 2.20e-01 | 9.33e-05 | 5.07e-01 |
Mitochondrial protein import | 64 | 1.48e-05 | 7.33e-05 | 0.2700 | 0.034300 | -0.228000 | -0.141000 | 6.35e-01 | 1.63e-03 | 5.16e-02 |
Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 13 | 1.50e-01 | 2.03e-01 | 0.2690 | 0.005520 | -0.217000 | 0.159000 | 9.73e-01 | 1.75e-01 | 3.22e-01 |
SUMOylation of intracellular receptors | 25 | 2.06e-01 | 2.62e-01 | 0.2690 | 0.218000 | 0.117000 | -0.104000 | 5.90e-02 | 3.10e-01 | 3.68e-01 |
Regulation of Complement cascade | 94 | 3.43e-07 | 2.50e-06 | 0.2680 | -0.031400 | -0.230000 | 0.134000 | 5.99e-01 | 1.14e-04 | 2.45e-02 |
Constitutive Signaling by Overexpressed ERBB2 | 11 | 2.12e-01 | 2.69e-01 | 0.2670 | 0.246000 | -0.003450 | 0.105000 | 1.58e-01 | 9.84e-01 | 5.46e-01 |
Integrin cell surface interactions | 52 | 4.99e-03 | 1.08e-02 | 0.2670 | 0.208000 | 0.050600 | -0.160000 | 9.46e-03 | 5.28e-01 | 4.57e-02 |
Activation of RAC1 | 11 | 3.60e-01 | 4.20e-01 | 0.2670 | 0.161000 | 0.013900 | 0.213000 | 3.54e-01 | 9.36e-01 | 2.22e-01 |
Nephrin family interactions | 17 | 2.50e-01 | 3.09e-01 | 0.2670 | -0.059600 | -0.235000 | -0.113000 | 6.71e-01 | 9.39e-02 | 4.18e-01 |
Insulin processing | 20 | 1.04e-01 | 1.50e-01 | 0.2670 | 0.162000 | 0.003530 | 0.213000 | 2.11e-01 | 9.78e-01 | 9.92e-02 |
TICAM1, RIP1-mediated IKK complex recruitment | 19 | 6.49e-02 | 9.99e-02 | 0.2670 | 0.248000 | 0.010600 | 0.099800 | 6.15e-02 | 9.36e-01 | 4.52e-01 |
NCAM1 interactions | 23 | 3.70e-01 | 4.27e-01 | 0.2660 | -0.180000 | -0.190000 | 0.051100 | 1.36e-01 | 1.15e-01 | 6.72e-01 |
Mitochondrial translation termination | 91 | 2.76e-07 | 2.06e-06 | 0.2660 | -0.011800 | -0.261000 | -0.052000 | 8.46e-01 | 1.74e-05 | 3.91e-01 |
Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 10 | 4.55e-01 | 5.08e-01 | 0.2660 | 0.011400 | -0.161000 | -0.211000 | 9.50e-01 | 3.77e-01 | 2.48e-01 |
Defective EXT2 causes exostoses 2 | 10 | 4.55e-01 | 5.08e-01 | 0.2660 | 0.011400 | -0.161000 | -0.211000 | 9.50e-01 | 3.77e-01 | 2.48e-01 |
Beta-catenin independent WNT signaling | 136 | 6.64e-06 | 3.59e-05 | 0.2650 | 0.232000 | 0.102000 | -0.079300 | 3.06e-06 | 3.91e-02 | 1.10e-01 |
FCERI mediated MAPK activation | 90 | 1.05e-08 | 1.10e-07 | 0.2650 | 0.012200 | -0.251000 | 0.084100 | 8.41e-01 | 3.84e-05 | 1.68e-01 |
Mitotic Prometaphase | 184 | 1.83e-11 | 2.80e-10 | 0.2640 | -0.047100 | -0.195000 | 0.172000 | 2.70e-01 | 4.86e-06 | 5.91e-05 |
Prostacyclin signalling through prostacyclin receptor | 16 | 1.38e-01 | 1.89e-01 | 0.2640 | 0.262000 | 0.027700 | 0.005870 | 6.95e-02 | 8.48e-01 | 9.68e-01 |
Regulation of TP53 Activity through Phosphorylation | 88 | 3.23e-04 | 1.04e-03 | 0.2630 | -0.093500 | -0.156000 | 0.190000 | 1.30e-01 | 1.14e-02 | 2.01e-03 |
p53-Dependent G1 DNA Damage Response | 63 | 1.23e-03 | 3.28e-03 | 0.2630 | 0.236000 | 0.069400 | 0.093400 | 1.19e-03 | 3.41e-01 | 2.00e-01 |
p53-Dependent G1/S DNA damage checkpoint | 63 | 1.23e-03 | 3.28e-03 | 0.2630 | 0.236000 | 0.069400 | 0.093400 | 1.19e-03 | 3.41e-01 | 2.00e-01 |
Mitochondrial translation initiation | 91 | 2.54e-07 | 1.91e-06 | 0.2630 | -0.006320 | -0.257000 | -0.053900 | 9.17e-01 | 2.18e-05 | 3.75e-01 |
Signaling by FGFR3 in disease | 13 | 1.44e-01 | 1.97e-01 | 0.2630 | 0.017900 | -0.214000 | 0.152000 | 9.11e-01 | 1.82e-01 | 3.44e-01 |
Signaling by FGFR3 point mutants in cancer | 13 | 1.44e-01 | 1.97e-01 | 0.2630 | 0.017900 | -0.214000 | 0.152000 | 9.11e-01 | 1.82e-01 | 3.44e-01 |
Diseases associated with O-glycosylation of proteins | 47 | 3.39e-03 | 7.79e-03 | 0.2620 | -0.218000 | -0.038100 | -0.141000 | 9.67e-03 | 6.51e-01 | 9.51e-02 |
Aggrephagy | 22 | 1.63e-02 | 3.07e-02 | 0.2620 | 0.244000 | -0.053000 | -0.079300 | 4.77e-02 | 6.67e-01 | 5.19e-01 |
Maturation of nucleoprotein | 10 | 3.63e-01 | 4.22e-01 | 0.2620 | -0.169000 | 0.042000 | 0.195000 | 3.53e-01 | 8.18e-01 | 2.86e-01 |
NOD1/2 Signaling Pathway | 32 | 1.10e-01 | 1.56e-01 | 0.2610 | 0.225000 | 0.105000 | 0.081600 | 2.75e-02 | 3.05e-01 | 4.25e-01 |
Regulation of RUNX2 expression and activity | 66 | 4.89e-04 | 1.46e-03 | 0.2610 | 0.233000 | 0.055400 | 0.105000 | 1.08e-03 | 4.36e-01 | 1.40e-01 |
Glycerophospholipid biosynthesis | 106 | 2.45e-04 | 8.19e-04 | 0.2610 | 0.234000 | 0.111000 | -0.030800 | 3.07e-05 | 4.81e-02 | 5.84e-01 |
Hemostasis | 543 | 3.67e-31 | 1.47e-29 | 0.2610 | 0.243000 | 0.048500 | -0.081100 | 3.36e-22 | 5.32e-02 | 1.23e-03 |
Mitochondrial iron-sulfur cluster biogenesis | 13 | 1.23e-01 | 1.73e-01 | 0.2600 | 0.254000 | -0.023300 | 0.054300 | 1.13e-01 | 8.84e-01 | 7.35e-01 |
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 36 | 3.84e-04 | 1.21e-03 | 0.2600 | 0.250000 | -0.054600 | 0.044800 | 9.34e-03 | 5.71e-01 | 6.42e-01 |
RNA Polymerase III Transcription Initiation | 36 | 2.31e-01 | 2.89e-01 | 0.2600 | -0.172000 | -0.191000 | -0.041400 | 7.48e-02 | 4.74e-02 | 6.67e-01 |
Signaling by Activin | 10 | 7.16e-01 | 7.49e-01 | 0.2600 | -0.140000 | -0.210000 | -0.061600 | 4.42e-01 | 2.50e-01 | 7.36e-01 |
Regulation of PTEN gene transcription | 59 | 1.35e-03 | 3.55e-03 | 0.2600 | 0.171000 | -0.000569 | -0.196000 | 2.31e-02 | 9.94e-01 | 9.31e-03 |
Basigin interactions | 23 | 9.90e-02 | 1.43e-01 | 0.2600 | 0.061900 | -0.117000 | -0.224000 | 6.07e-01 | 3.31e-01 | 6.35e-02 |
Signaling by Nuclear Receptors | 216 | 7.84e-15 | 1.78e-13 | 0.2600 | 0.210000 | -0.009470 | -0.152000 | 9.91e-08 | 8.11e-01 | 1.20e-04 |
Carboxyterminal post-translational modifications of tubulin | 26 | 2.98e-01 | 3.58e-01 | 0.2590 | 0.170000 | 0.171000 | -0.095700 | 1.33e-01 | 1.31e-01 | 3.98e-01 |
PIWI-interacting RNA (piRNA) biogenesis | 23 | 5.71e-02 | 9.00e-02 | 0.2590 | 0.039600 | -0.190000 | -0.172000 | 7.42e-01 | 1.16e-01 | 1.53e-01 |
COPI-dependent Golgi-to-ER retrograde traffic | 78 | 2.15e-03 | 5.26e-03 | 0.2590 | 0.229000 | 0.103000 | 0.060900 | 4.61e-04 | 1.15e-01 | 3.52e-01 |
Complement cascade | 98 | 5.99e-07 | 4.27e-06 | 0.2590 | -0.030500 | -0.221000 | 0.131000 | 6.02e-01 | 1.54e-04 | 2.56e-02 |
UCH proteinases | 86 | 4.09e-04 | 1.27e-03 | 0.2580 | 0.234000 | 0.082900 | -0.071800 | 1.81e-04 | 1.84e-01 | 2.50e-01 |
AMER1 mutants destabilize the destruction complex | 14 | 1.68e-01 | 2.21e-01 | 0.2580 | 0.257000 | 0.009510 | -0.018500 | 9.63e-02 | 9.51e-01 | 9.05e-01 |
APC truncation mutants have impaired AXIN binding | 14 | 1.68e-01 | 2.21e-01 | 0.2580 | 0.257000 | 0.009510 | -0.018500 | 9.63e-02 | 9.51e-01 | 9.05e-01 |
AXIN missense mutants destabilize the destruction complex | 14 | 1.68e-01 | 2.21e-01 | 0.2580 | 0.257000 | 0.009510 | -0.018500 | 9.63e-02 | 9.51e-01 | 9.05e-01 |
AXIN mutants destabilize the destruction complex, activating WNT signaling | 14 | 1.68e-01 | 2.21e-01 | 0.2580 | 0.257000 | 0.009510 | -0.018500 | 9.63e-02 | 9.51e-01 | 9.05e-01 |
Truncations of AMER1 destabilize the destruction complex | 14 | 1.68e-01 | 2.21e-01 | 0.2580 | 0.257000 | 0.009510 | -0.018500 | 9.63e-02 | 9.51e-01 | 9.05e-01 |
truncated APC mutants destabilize the destruction complex | 14 | 1.68e-01 | 2.21e-01 | 0.2580 | 0.257000 | 0.009510 | -0.018500 | 9.63e-02 | 9.51e-01 | 9.05e-01 |
Signaling by ERBB4 | 44 | 5.07e-03 | 1.10e-02 | 0.2570 | 0.247000 | 0.037800 | -0.059600 | 4.51e-03 | 6.64e-01 | 4.94e-01 |
G1/S DNA Damage Checkpoints | 65 | 5.83e-04 | 1.70e-03 | 0.2570 | 0.233000 | 0.052500 | 0.094500 | 1.14e-03 | 4.64e-01 | 1.87e-01 |
Interleukin-12 family signaling | 53 | 7.30e-03 | 1.51e-02 | 0.2570 | 0.211000 | 0.068700 | 0.130000 | 7.79e-03 | 3.87e-01 | 1.03e-01 |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 1.72e-01 | 2.25e-01 | 0.2570 | -0.030200 | 0.157000 | -0.202000 | 8.45e-01 | 3.09e-01 | 1.92e-01 |
Sialic acid metabolism | 28 | 2.95e-01 | 3.55e-01 | 0.2570 | 0.210000 | 0.147000 | 0.015400 | 5.43e-02 | 1.77e-01 | 8.88e-01 |
B-WICH complex positively regulates rRNA expression | 44 | 1.51e-04 | 5.36e-04 | 0.2570 | 0.174000 | -0.122000 | -0.145000 | 4.64e-02 | 1.60e-01 | 9.68e-02 |
Chaperone Mediated Autophagy | 20 | 2.46e-02 | 4.37e-02 | 0.2570 | 0.214000 | -0.086100 | -0.113000 | 9.77e-02 | 5.05e-01 | 3.82e-01 |
Elastic fibre formation | 32 | 5.23e-02 | 8.37e-02 | 0.2560 | 0.200000 | 0.036900 | -0.155000 | 4.99e-02 | 7.18e-01 | 1.28e-01 |
Neurexins and neuroligins | 36 | 9.15e-02 | 1.34e-01 | 0.2560 | -0.066000 | -0.068400 | -0.238000 | 4.93e-01 | 4.78e-01 | 1.36e-02 |
Cell junction organization | 57 | 1.32e-03 | 3.50e-03 | 0.2560 | 0.162000 | -0.021400 | -0.197000 | 3.45e-02 | 7.80e-01 | 1.01e-02 |
Phase 0 - rapid depolarisation | 22 | 2.14e-01 | 2.70e-01 | 0.2560 | -0.228000 | -0.083600 | 0.079200 | 6.38e-02 | 4.97e-01 | 5.20e-01 |
Ion channel transport | 131 | 4.18e-04 | 1.29e-03 | 0.2560 | 0.199000 | 0.143000 | -0.072800 | 8.28e-05 | 4.81e-03 | 1.50e-01 |
G2/M DNA damage checkpoint | 67 | 7.26e-04 | 2.09e-03 | 0.2550 | -0.038400 | -0.150000 | 0.203000 | 5.87e-01 | 3.41e-02 | 4.03e-03 |
TP53 Regulates Metabolic Genes | 84 | 1.19e-03 | 3.19e-03 | 0.2550 | 0.235000 | 0.098000 | -0.020400 | 2.01e-04 | 1.21e-01 | 7.47e-01 |
RHO GTPase Effectors | 249 | 7.91e-12 | 1.31e-10 | 0.2550 | 0.242000 | 0.079400 | 0.013100 | 4.79e-11 | 3.10e-02 | 7.22e-01 |
HSF1 activation | 26 | 1.32e-02 | 2.55e-02 | 0.2550 | 0.092600 | -0.184000 | -0.150000 | 4.14e-01 | 1.04e-01 | 1.86e-01 |
Metabolism of carbohydrates | 241 | 4.52e-09 | 5.00e-08 | 0.2540 | 0.154000 | 0.090500 | -0.181000 | 3.85e-05 | 1.56e-02 | 1.33e-06 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 182 | 4.20e-05 | 1.72e-04 | 0.2540 | -0.135000 | -0.194000 | -0.091700 | 1.63e-03 | 6.07e-06 | 3.29e-02 |
Synthesis, secretion, and deacylation of Ghrelin | 11 | 4.24e-01 | 4.78e-01 | 0.2530 | -0.064100 | -0.217000 | 0.115000 | 7.13e-01 | 2.14e-01 | 5.09e-01 |
Mitochondrial translation | 97 | 8.29e-08 | 6.68e-07 | 0.2530 | 0.002610 | -0.251000 | -0.032100 | 9.65e-01 | 1.89e-05 | 5.85e-01 |
Glutamate binding, activation of AMPA receptors and synaptic plasticity | 20 | 3.01e-01 | 3.60e-01 | 0.2530 | 0.163000 | 0.075600 | -0.178000 | 2.06e-01 | 5.58e-01 | 1.68e-01 |
Trafficking of AMPA receptors | 20 | 3.01e-01 | 3.60e-01 | 0.2530 | 0.163000 | 0.075600 | -0.178000 | 2.06e-01 | 5.58e-01 | 1.68e-01 |
APC/C-mediated degradation of cell cycle proteins | 86 | 9.33e-07 | 6.32e-06 | 0.2530 | 0.189000 | -0.025000 | 0.167000 | 2.51e-03 | 6.89e-01 | 7.53e-03 |
Regulation of mitotic cell cycle | 86 | 9.33e-07 | 6.32e-06 | 0.2530 | 0.189000 | -0.025000 | 0.167000 | 2.51e-03 | 6.89e-01 | 7.53e-03 |
Unblocking of NMDA receptors, glutamate binding and activation | 12 | 6.99e-01 | 7.33e-01 | 0.2520 | -0.197000 | -0.157000 | -0.018600 | 2.37e-01 | 3.48e-01 | 9.11e-01 |
Diseases of signal transduction by growth factor receptors and second messengers | 339 | 2.32e-14 | 4.94e-13 | 0.2520 | 0.233000 | 0.086000 | -0.042200 | 1.65e-13 | 6.52e-03 | 1.82e-01 |
Metabolism of cofactors | 19 | 4.24e-01 | 4.78e-01 | 0.2520 | 0.191000 | 0.118000 | 0.114000 | 1.50e-01 | 3.72e-01 | 3.89e-01 |
Elevation of cytosolic Ca2+ levels | 12 | 5.45e-01 | 5.93e-01 | 0.2510 | 0.119000 | 0.078000 | -0.207000 | 4.76e-01 | 6.40e-01 | 2.15e-01 |
Blood group systems biosynthesis | 17 | 1.70e-01 | 2.23e-01 | 0.2510 | 0.150000 | -0.053800 | -0.193000 | 2.84e-01 | 7.01e-01 | 1.67e-01 |
PI-3K cascade:FGFR2 | 12 | 3.57e-01 | 4.17e-01 | 0.2500 | -0.053400 | -0.233000 | 0.070400 | 7.49e-01 | 1.61e-01 | 6.73e-01 |
TCF dependent signaling in response to WNT | 165 | 1.13e-08 | 1.16e-07 | 0.2490 | 0.213000 | 0.036600 | -0.124000 | 2.30e-06 | 4.17e-01 | 6.07e-03 |
PERK regulates gene expression | 30 | 2.78e-03 | 6.58e-03 | 0.2490 | 0.091400 | -0.174000 | 0.153000 | 3.86e-01 | 9.95e-02 | 1.46e-01 |
Downstream signaling events of B Cell Receptor (BCR) | 79 | 3.09e-05 | 1.33e-04 | 0.2480 | 0.243000 | 0.029500 | 0.036900 | 1.84e-04 | 6.51e-01 | 5.70e-01 |
Pyruvate metabolism | 28 | 3.77e-02 | 6.39e-02 | 0.2470 | 0.244000 | 0.027100 | 0.027600 | 2.54e-02 | 8.04e-01 | 8.00e-01 |
Signaling by WNT | 253 | 1.77e-11 | 2.76e-10 | 0.2460 | 0.216000 | 0.059700 | -0.101000 | 3.09e-09 | 1.02e-01 | 5.65e-03 |
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 38 | 9.71e-02 | 1.41e-01 | 0.2460 | -0.107000 | -0.220000 | 0.020100 | 2.54e-01 | 1.87e-02 | 8.30e-01 |
Phosphorylation of the APC/C | 20 | 8.36e-02 | 1.24e-01 | 0.2460 | 0.044700 | -0.137000 | 0.199000 | 7.29e-01 | 2.89e-01 | 1.23e-01 |
Interleukin-12 signaling | 44 | 2.97e-02 | 5.13e-02 | 0.2450 | 0.211000 | 0.070900 | 0.104000 | 1.56e-02 | 4.16e-01 | 2.32e-01 |
Cellular response to heat stress | 93 | 1.40e-04 | 5.06e-04 | 0.2450 | -0.068300 | -0.235000 | -0.010700 | 2.55e-01 | 8.85e-05 | 8.59e-01 |
mRNA decay by 5’ to 3’ exoribonuclease | 15 | 1.77e-01 | 2.30e-01 | 0.2450 | -0.009810 | -0.244000 | -0.016300 | 9.48e-01 | 1.01e-01 | 9.13e-01 |
Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 13 | 5.67e-01 | 6.11e-01 | 0.2450 | 0.129000 | 0.119000 | -0.171000 | 4.21e-01 | 4.57e-01 | 2.86e-01 |
Processing of Intronless Pre-mRNAs | 19 | 3.41e-01 | 4.01e-01 | 0.2450 | -0.084900 | -0.061700 | 0.221000 | 5.22e-01 | 6.41e-01 | 9.54e-02 |
Phase 2 - plateau phase | 11 | 2.94e-01 | 3.54e-01 | 0.2440 | -0.186000 | 0.053300 | 0.149000 | 2.85e-01 | 7.60e-01 | 3.91e-01 |
ABC-family proteins mediated transport | 93 | 1.65e-04 | 5.76e-04 | 0.2440 | 0.232000 | 0.068200 | 0.029800 | 1.08e-04 | 2.56e-01 | 6.19e-01 |
Regulation of APC/C activators between G1/S and early anaphase | 79 | 2.84e-06 | 1.68e-05 | 0.2440 | 0.202000 | -0.026900 | 0.134000 | 1.94e-03 | 6.79e-01 | 3.91e-02 |
RIPK1-mediated regulated necrosis | 29 | 4.33e-02 | 7.14e-02 | 0.2440 | 0.231000 | 0.030800 | 0.072600 | 3.16e-02 | 7.74e-01 | 4.99e-01 |
Regulated Necrosis | 29 | 4.33e-02 | 7.14e-02 | 0.2440 | 0.231000 | 0.030800 | 0.072600 | 3.16e-02 | 7.74e-01 | 4.99e-01 |
Regulation of necroptotic cell death | 29 | 4.33e-02 | 7.14e-02 | 0.2440 | 0.231000 | 0.030800 | 0.072600 | 3.16e-02 | 7.74e-01 | 4.99e-01 |
Caspase-mediated cleavage of cytoskeletal proteins | 12 | 5.53e-01 | 5.99e-01 | 0.2440 | 0.099200 | 0.167000 | -0.148000 | 5.52e-01 | 3.18e-01 | 3.76e-01 |
APC-Cdc20 mediated degradation of Nek2A | 26 | 1.68e-02 | 3.16e-02 | 0.2440 | 0.022400 | -0.224000 | 0.093100 | 8.43e-01 | 4.81e-02 | 4.11e-01 |
Sphingolipid de novo biosynthesis | 42 | 6.76e-02 | 1.03e-01 | 0.2430 | 0.223000 | 0.095700 | 0.012000 | 1.23e-02 | 2.83e-01 | 8.93e-01 |
Signaling by FGFR1 | 38 | 1.83e-01 | 2.35e-01 | 0.2430 | 0.198000 | 0.131000 | -0.051000 | 3.44e-02 | 1.62e-01 | 5.86e-01 |
TRAF3-dependent IRF activation pathway | 13 | 4.91e-01 | 5.43e-01 | 0.2430 | 0.048400 | 0.191000 | 0.141000 | 7.63e-01 | 2.33e-01 | 3.78e-01 |
Interleukin-7 signaling | 21 | 2.61e-01 | 3.21e-01 | 0.2420 | 0.077700 | -0.015000 | -0.229000 | 5.38e-01 | 9.05e-01 | 6.92e-02 |
Assembly and cell surface presentation of NMDA receptors | 18 | 5.11e-01 | 5.61e-01 | 0.2420 | -0.109000 | -0.189000 | -0.106000 | 4.23e-01 | 1.66e-01 | 4.37e-01 |
MHC class II antigen presentation | 101 | 4.32e-03 | 9.68e-03 | 0.2420 | 0.207000 | 0.125000 | 0.009920 | 3.22e-04 | 3.02e-02 | 8.63e-01 |
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 14 | 1.63e-01 | 2.17e-01 | 0.2420 | 0.019200 | -0.205000 | 0.127000 | 9.01e-01 | 1.84e-01 | 4.12e-01 |
Termination of O-glycan biosynthesis | 16 | 3.59e-01 | 4.19e-01 | 0.2420 | 0.034200 | 0.092200 | -0.221000 | 8.13e-01 | 5.23e-01 | 1.26e-01 |
MicroRNA (miRNA) biogenesis | 24 | 1.87e-01 | 2.40e-01 | 0.2410 | 0.067600 | -0.047100 | -0.227000 | 5.66e-01 | 6.90e-01 | 5.43e-02 |
Synthesis of PE | 12 | 6.60e-01 | 6.99e-01 | 0.2410 | -0.182000 | -0.124000 | 0.099700 | 2.76e-01 | 4.58e-01 | 5.50e-01 |
Positive epigenetic regulation of rRNA expression | 59 | 7.01e-05 | 2.72e-04 | 0.2410 | 0.091900 | -0.171000 | -0.143000 | 2.22e-01 | 2.34e-02 | 5.82e-02 |
PTEN Regulation | 138 | 1.99e-05 | 9.34e-05 | 0.2400 | 0.219000 | 0.082700 | -0.055800 | 9.05e-06 | 9.35e-02 | 2.58e-01 |
FOXO-mediated transcription of cell cycle genes | 15 | 2.30e-01 | 2.88e-01 | 0.2400 | 0.011900 | -0.208000 | -0.120000 | 9.37e-01 | 1.64e-01 | 4.20e-01 |
S Phase | 160 | 2.13e-09 | 2.43e-08 | 0.2400 | -0.032200 | -0.203000 | 0.124000 | 4.82e-01 | 9.33e-06 | 6.61e-03 |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 18 | 2.00e-01 | 2.54e-01 | 0.2400 | 0.236000 | 0.038500 | -0.015400 | 8.25e-02 | 7.77e-01 | 9.10e-01 |
SUMOylation of transcription factors | 16 | 5.46e-01 | 5.93e-01 | 0.2400 | 0.132000 | 0.108000 | 0.169000 | 3.61e-01 | 4.54e-01 | 2.42e-01 |
Interleukin-6 family signaling | 18 | 4.07e-01 | 4.63e-01 | 0.2400 | 0.205000 | 0.091300 | -0.083900 | 1.31e-01 | 5.03e-01 | 5.38e-01 |
Signaling by ERBB2 in Cancer | 21 | 1.35e-02 | 2.59e-02 | 0.2400 | 0.217000 | -0.095900 | 0.034800 | 8.51e-02 | 4.47e-01 | 7.83e-01 |
Signaling by FGFR4 in disease | 11 | 2.36e-01 | 2.95e-01 | 0.2400 | 0.064700 | -0.161000 | 0.165000 | 7.10e-01 | 3.55e-01 | 3.42e-01 |
Formation of Incision Complex in GG-NER | 43 | 2.79e-03 | 6.59e-03 | 0.2400 | 0.037900 | -0.149000 | 0.183000 | 6.67e-01 | 8.99e-02 | 3.76e-02 |
N-glycan antennae elongation in the medial/trans-Golgi | 21 | 3.31e-01 | 3.91e-01 | 0.2390 | -0.026800 | -0.114000 | -0.209000 | 8.31e-01 | 3.67e-01 | 9.78e-02 |
Endosomal/Vacuolar pathway | 12 | 6.46e-01 | 6.88e-01 | 0.2390 | -0.098900 | -0.101000 | -0.193000 | 5.53e-01 | 5.46e-01 | 2.47e-01 |
Chaperonin-mediated protein folding | 84 | 3.10e-04 | 1.00e-03 | 0.2370 | 0.229000 | 0.052000 | -0.036400 | 2.89e-04 | 4.10e-01 | 5.64e-01 |
RNA Polymerase III Transcription Termination | 23 | 1.67e-01 | 2.21e-01 | 0.2370 | -0.043500 | -0.222000 | -0.068900 | 7.18e-01 | 6.52e-02 | 5.67e-01 |
Non-integrin membrane-ECM interactions | 37 | 8.01e-03 | 1.64e-02 | 0.2370 | 0.111000 | -0.123000 | -0.169000 | 2.44e-01 | 1.96e-01 | 7.52e-02 |
Metabolism of amino acids and derivatives | 322 | 1.12e-16 | 2.67e-15 | 0.2360 | -0.004800 | -0.199000 | -0.127000 | 8.82e-01 | 8.66e-10 | 8.50e-05 |
Potassium Channels | 62 | 4.44e-02 | 7.26e-02 | 0.2350 | 0.119000 | 0.203000 | -0.008360 | 1.06e-01 | 5.69e-03 | 9.09e-01 |
Pregnenolone biosynthesis | 10 | 5.97e-01 | 6.40e-01 | 0.2350 | 0.063100 | 0.142000 | -0.176000 | 7.30e-01 | 4.37e-01 | 3.35e-01 |
Cell Cycle Checkpoints | 258 | 4.74e-15 | 1.09e-13 | 0.2340 | 0.015300 | -0.137000 | 0.189000 | 6.71e-01 | 1.47e-04 | 1.77e-07 |
Cell-Cell communication | 85 | 1.90e-04 | 6.55e-04 | 0.2340 | 0.143000 | -0.026600 | -0.183000 | 2.24e-02 | 6.72e-01 | 3.57e-03 |
Cellular Senescence | 144 | 1.37e-06 | 8.83e-06 | 0.2340 | 0.192000 | 0.032100 | -0.130000 | 7.23e-05 | 5.06e-01 | 7.04e-03 |
Depolymerisation of the Nuclear Lamina | 15 | 1.26e-01 | 1.77e-01 | 0.2340 | 0.231000 | -0.035500 | -0.006560 | 1.22e-01 | 8.12e-01 | 9.65e-01 |
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 17 | 3.80e-01 | 4.37e-01 | 0.2330 | -0.082300 | -0.214000 | 0.044500 | 5.57e-01 | 1.27e-01 | 7.51e-01 |
Cell death signalling via NRAGE, NRIF and NADE | 69 | 1.03e-02 | 2.05e-02 | 0.2330 | 0.138000 | 0.050900 | -0.180000 | 4.70e-02 | 4.65e-01 | 9.55e-03 |
Stimuli-sensing channels | 71 | 4.37e-02 | 7.20e-02 | 0.2320 | 0.184000 | 0.128000 | -0.060100 | 7.48e-03 | 6.23e-02 | 3.81e-01 |
Mitochondrial calcium ion transport | 22 | 2.77e-02 | 4.83e-02 | 0.2320 | 0.100000 | -0.187000 | -0.092800 | 4.15e-01 | 1.29e-01 | 4.51e-01 |
Fertilization | 12 | 5.98e-01 | 6.41e-01 | 0.2310 | 0.082700 | 0.089300 | -0.196000 | 6.20e-01 | 5.92e-01 | 2.39e-01 |
Selective autophagy | 58 | 8.96e-05 | 3.41e-04 | 0.2310 | 0.219000 | -0.045400 | -0.058600 | 3.98e-03 | 5.49e-01 | 4.40e-01 |
DAG and IP3 signaling | 33 | 1.29e-01 | 1.80e-01 | 0.2310 | 0.117000 | 0.021600 | -0.198000 | 2.44e-01 | 8.30e-01 | 4.96e-02 |
Separation of Sister Chromatids | 167 | 1.78e-11 | 2.76e-10 | 0.2300 | 0.096200 | -0.093500 | 0.187000 | 3.19e-02 | 3.71e-02 | 2.98e-05 |
Serotonin Neurotransmitter Release Cycle | 14 | 5.55e-01 | 6.00e-01 | 0.2300 | -0.040800 | -0.139000 | -0.178000 | 7.91e-01 | 3.67e-01 | 2.48e-01 |
Triglyceride metabolism | 25 | 4.47e-01 | 5.01e-01 | 0.2300 | 0.187000 | 0.131000 | 0.031000 | 1.06e-01 | 2.59e-01 | 7.89e-01 |
Signaling by FGFR2 IIIa TM | 18 | 1.50e-01 | 2.03e-01 | 0.2300 | 0.141000 | -0.081500 | -0.162000 | 3.02e-01 | 5.49e-01 | 2.33e-01 |
Synaptic adhesion-like molecules | 14 | 5.20e-01 | 5.68e-01 | 0.2290 | 0.070000 | 0.103000 | -0.192000 | 6.50e-01 | 5.04e-01 | 2.14e-01 |
DAP12 interactions | 39 | 1.58e-01 | 2.12e-01 | 0.2270 | 0.194000 | 0.097800 | -0.067500 | 3.65e-02 | 2.91e-01 | 4.66e-01 |
Metabolism of steroids | 117 | 3.34e-03 | 7.68e-03 | 0.2270 | 0.189000 | 0.113000 | 0.053800 | 4.00e-04 | 3.55e-02 | 3.15e-01 |
Regulation of TP53 Expression and Degradation | 36 | 2.48e-02 | 4.40e-02 | 0.2260 | -0.014500 | -0.222000 | -0.039500 | 8.80e-01 | 2.10e-02 | 6.82e-01 |
Transport of small molecules | 553 | 1.17e-15 | 2.75e-14 | 0.2260 | 0.193000 | 0.094700 | -0.070600 | 9.37e-15 | 1.40e-04 | 4.55e-03 |
Voltage gated Potassium channels | 24 | 1.20e-01 | 1.69e-01 | 0.2250 | 0.014800 | 0.165000 | -0.153000 | 9.00e-01 | 1.62e-01 | 1.95e-01 |
Gamma carboxylation, hypusine formation and arylsulfatase activation | 34 | 1.22e-01 | 1.71e-01 | 0.2250 | 0.050400 | -0.053300 | -0.213000 | 6.11e-01 | 5.91e-01 | 3.18e-02 |
Signaling by Rho GTPases | 365 | 1.52e-11 | 2.44e-10 | 0.2250 | 0.207000 | 0.085500 | -0.022800 | 1.12e-11 | 5.05e-03 | 4.54e-01 |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 80 | 7.91e-04 | 2.25e-03 | 0.2240 | 0.172000 | 0.007670 | -0.144000 | 7.69e-03 | 9.06e-01 | 2.64e-02 |
Ephrin signaling | 17 | 2.93e-01 | 3.54e-01 | 0.2240 | 0.157000 | -0.012500 | -0.160000 | 2.63e-01 | 9.29e-01 | 2.53e-01 |
RNA Polymerase III Transcription Initiation From Type 3 Promoter | 28 | 4.09e-01 | 4.65e-01 | 0.2240 | -0.127000 | -0.185000 | -0.006470 | 2.44e-01 | 9.07e-02 | 9.53e-01 |
Bile acid and bile salt metabolism | 28 | 4.20e-01 | 4.74e-01 | 0.2240 | 0.156000 | 0.125000 | 0.101000 | 1.53e-01 | 2.51e-01 | 3.53e-01 |
Cytosolic sulfonation of small molecules | 18 | 5.73e-01 | 6.17e-01 | 0.2240 | 0.124000 | 0.185000 | -0.028700 | 3.62e-01 | 1.75e-01 | 8.33e-01 |
Regulation of KIT signaling | 15 | 5.53e-01 | 5.99e-01 | 0.2240 | 0.097800 | 0.110000 | -0.169000 | 5.12e-01 | 4.62e-01 | 2.56e-01 |
DCC mediated attractive signaling | 13 | 3.92e-01 | 4.48e-01 | 0.2240 | 0.001390 | -0.191000 | -0.118000 | 9.93e-01 | 2.34e-01 | 4.62e-01 |
Deactivation of the beta-catenin transactivating complex | 36 | 6.42e-02 | 9.90e-02 | 0.2240 | 0.034500 | -0.123000 | -0.183000 | 7.20e-01 | 2.00e-01 | 5.68e-02 |
Signaling by ERBB2 TMD/JMD mutants | 17 | 4.69e-02 | 7.61e-02 | 0.2240 | 0.189000 | -0.118000 | -0.013800 | 1.77e-01 | 3.99e-01 | 9.22e-01 |
G1/S Transition | 130 | 3.85e-08 | 3.38e-07 | 0.2230 | 0.004980 | -0.187000 | 0.122000 | 9.22e-01 | 2.27e-04 | 1.64e-02 |
Diseases associated with glycosaminoglycan metabolism | 26 | 2.53e-01 | 3.13e-01 | 0.2230 | 0.091200 | 0.014600 | -0.203000 | 4.21e-01 | 8.98e-01 | 7.26e-02 |
Transcriptional regulation by RUNX2 | 100 | 5.59e-03 | 1.19e-02 | 0.2230 | 0.196000 | 0.101000 | 0.035100 | 6.97e-04 | 8.18e-02 | 5.44e-01 |
Rho GTPase cycle | 125 | 5.15e-03 | 1.11e-02 | 0.2230 | 0.158000 | 0.138000 | -0.075100 | 2.25e-03 | 7.52e-03 | 1.47e-01 |
DNA Damage/Telomere Stress Induced Senescence | 44 | 5.38e-03 | 1.15e-02 | 0.2230 | 0.190000 | -0.034100 | -0.111000 | 2.90e-02 | 6.96e-01 | 2.02e-01 |
DNA Replication | 125 | 3.02e-06 | 1.75e-05 | 0.2220 | -0.018700 | -0.159000 | 0.153000 | 7.17e-01 | 2.09e-03 | 3.09e-03 |
Intracellular signaling by second messengers | 271 | 3.67e-10 | 4.67e-09 | 0.2210 | 0.184000 | 0.043800 | -0.116000 | 1.93e-07 | 2.14e-01 | 1.05e-03 |
NRAGE signals death through JNK | 52 | 5.52e-02 | 8.74e-02 | 0.2210 | 0.069500 | 0.040200 | -0.206000 | 3.86e-01 | 6.16e-01 | 1.01e-02 |
PIP3 activates AKT signaling | 239 | 3.24e-09 | 3.61e-08 | 0.2210 | 0.192000 | 0.044800 | -0.101000 | 3.34e-07 | 2.33e-01 | 7.04e-03 |
Nitric oxide stimulates guanylate cyclase | 15 | 3.10e-01 | 3.68e-01 | 0.2210 | 0.184000 | -0.008630 | -0.123000 | 2.18e-01 | 9.54e-01 | 4.10e-01 |
Transcriptional regulation by RUNX3 | 90 | 8.27e-03 | 1.69e-02 | 0.2210 | 0.200000 | 0.094500 | -0.004300 | 1.04e-03 | 1.21e-01 | 9.44e-01 |
HATs acetylate histones | 93 | 1.85e-03 | 4.60e-03 | 0.2210 | -0.016900 | -0.144000 | -0.167000 | 7.78e-01 | 1.63e-02 | 5.38e-03 |
PI3K/AKT Signaling in Cancer | 80 | 2.23e-03 | 5.43e-03 | 0.2210 | 0.110000 | -0.019400 | -0.191000 | 9.01e-02 | 7.65e-01 | 3.14e-03 |
FGFR2 alternative splicing | 25 | 1.17e-01 | 1.66e-01 | 0.2210 | 0.061700 | -0.127000 | -0.170000 | 5.93e-01 | 2.71e-01 | 1.42e-01 |
Processing of DNA double-strand break ends | 71 | 2.13e-03 | 5.22e-03 | 0.2210 | -0.031300 | -0.155000 | 0.154000 | 6.48e-01 | 2.43e-02 | 2.45e-02 |
PI-3K cascade:FGFR4 | 10 | 2.42e-01 | 3.00e-01 | 0.2200 | 0.104000 | -0.187000 | -0.052000 | 5.68e-01 | 3.07e-01 | 7.76e-01 |
Signaling by ERBB2 KD Mutants | 20 | 2.64e-02 | 4.63e-02 | 0.2200 | 0.184000 | -0.116000 | 0.032000 | 1.54e-01 | 3.68e-01 | 8.04e-01 |
Processing of Capped Intron-Containing Pre-mRNA | 238 | 1.17e-11 | 1.89e-10 | 0.2200 | -0.035400 | -0.213000 | 0.042500 | 3.46e-01 | 1.55e-08 | 2.59e-01 |
Synthesis of DNA | 118 | 1.37e-05 | 6.89e-05 | 0.2190 | -0.031500 | -0.171000 | 0.134000 | 5.55e-01 | 1.36e-03 | 1.18e-02 |
FGFR2 mutant receptor activation | 22 | 2.00e-01 | 2.54e-01 | 0.2190 | 0.021400 | -0.155000 | -0.153000 | 8.62e-01 | 2.09e-01 | 2.13e-01 |
Neurotransmitter receptors and postsynaptic signal transmission | 123 | 3.23e-03 | 7.48e-03 | 0.2180 | 0.172000 | 0.105000 | -0.083800 | 1.01e-03 | 4.49e-02 | 1.09e-01 |
FRS-mediated FGFR3 signaling | 11 | 2.58e-01 | 3.18e-01 | 0.2180 | 0.188000 | -0.062700 | 0.090400 | 2.81e-01 | 7.19e-01 | 6.04e-01 |
Signaling by ERBB2 ECD mutants | 15 | 1.13e-01 | 1.60e-01 | 0.2180 | 0.153000 | -0.106000 | 0.114000 | 3.06e-01 | 4.77e-01 | 4.47e-01 |
RAF-independent MAPK1/3 activation | 21 | 2.84e-01 | 3.43e-01 | 0.2170 | 0.145000 | 0.006220 | -0.162000 | 2.49e-01 | 9.61e-01 | 2.00e-01 |
Regulation of beta-cell development | 19 | 5.28e-01 | 5.76e-01 | 0.2170 | 0.122000 | 0.120000 | -0.135000 | 3.58e-01 | 3.67e-01 | 3.10e-01 |
SARS-CoV Infections | 139 | 3.01e-06 | 1.75e-05 | 0.2170 | 0.205000 | 0.030300 | -0.065000 | 3.00e-05 | 5.38e-01 | 1.86e-01 |
Axon guidance | 453 | 5.40e-20 | 1.44e-18 | 0.2170 | 0.120000 | -0.044100 | -0.175000 | 1.17e-05 | 1.08e-01 | 1.60e-10 |
Purine catabolism | 16 | 5.02e-01 | 5.53e-01 | 0.2170 | 0.086900 | 0.015000 | -0.198000 | 5.47e-01 | 9.17e-01 | 1.70e-01 |
FCERI mediated NF-kB activation | 137 | 8.96e-13 | 1.60e-11 | 0.2170 | 0.106000 | -0.176000 | 0.069600 | 3.20e-02 | 3.82e-04 | 1.60e-01 |
Signaling by TGF-beta Receptor Complex | 72 | 6.56e-05 | 2.57e-04 | 0.2170 | 0.194000 | -0.044300 | -0.085400 | 4.42e-03 | 5.16e-01 | 2.10e-01 |
Protein folding | 90 | 1.34e-03 | 3.53e-03 | 0.2160 | 0.207000 | 0.054500 | -0.033100 | 7.08e-04 | 3.71e-01 | 5.87e-01 |
Platelet calcium homeostasis | 21 | 5.06e-01 | 5.56e-01 | 0.2160 | 0.140000 | 0.110000 | -0.122000 | 2.67e-01 | 3.83e-01 | 3.33e-01 |
Inositol phosphate metabolism | 42 | 1.33e-01 | 1.84e-01 | 0.2160 | 0.084400 | 0.082100 | -0.181000 | 3.44e-01 | 3.57e-01 | 4.26e-02 |
SHC-mediated cascade:FGFR2 | 12 | 5.14e-01 | 5.65e-01 | 0.2150 | -0.042700 | -0.167000 | 0.128000 | 7.98e-01 | 3.16e-01 | 4.42e-01 |
EGR2 and SOX10-mediated initiation of Schwann cell myelination | 22 | 2.58e-01 | 3.18e-01 | 0.2140 | 0.020500 | 0.114000 | -0.180000 | 8.68e-01 | 3.54e-01 | 1.43e-01 |
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 17 | 2.49e-01 | 3.09e-01 | 0.2140 | 0.139000 | -0.057000 | -0.153000 | 3.20e-01 | 6.84e-01 | 2.76e-01 |
Immune System | 1887 | 7.63e-51 | 1.73e-48 | 0.2140 | 0.197000 | 0.079800 | -0.024500 | 9.89e-46 | 9.95e-09 | 7.81e-02 |
Processing of Capped Intronless Pre-mRNA | 28 | 1.58e-01 | 2.12e-01 | 0.2140 | -0.049200 | -0.178000 | 0.107000 | 6.52e-01 | 1.02e-01 | 3.27e-01 |
Prolactin receptor signaling | 11 | 2.72e-01 | 3.31e-01 | 0.2140 | 0.082400 | -0.151000 | 0.127000 | 6.36e-01 | 3.86e-01 | 4.67e-01 |
Purine salvage | 12 | 4.69e-01 | 5.22e-01 | 0.2140 | 0.210000 | 0.031800 | 0.022100 | 2.08e-01 | 8.49e-01 | 8.94e-01 |
Metabolism of lipids | 621 | 9.35e-13 | 1.65e-11 | 0.2130 | 0.179000 | 0.115000 | -0.017400 | 2.74e-14 | 9.95e-07 | 4.59e-01 |
Regulation of innate immune responses to cytosolic DNA | 14 | 5.28e-01 | 5.76e-01 | 0.2130 | 0.018700 | -0.101000 | -0.187000 | 9.03e-01 | 5.14e-01 | 2.26e-01 |
Regulation of TP53 Degradation | 35 | 3.18e-02 | 5.48e-02 | 0.2130 | 0.004450 | -0.206000 | -0.053300 | 9.64e-01 | 3.49e-02 | 5.85e-01 |
mRNA Splicing - Minor Pathway | 52 | 2.66e-03 | 6.34e-03 | 0.2130 | 0.045100 | -0.179000 | -0.106000 | 5.74e-01 | 2.56e-02 | 1.86e-01 |
Assembly of the pre-replicative complex | 66 | 1.12e-03 | 3.05e-03 | 0.2130 | 0.193000 | 0.005010 | 0.090300 | 6.82e-03 | 9.44e-01 | 2.04e-01 |
Peroxisomal lipid metabolism | 27 | 3.54e-01 | 4.15e-01 | 0.2130 | 0.173000 | 0.086400 | 0.089300 | 1.21e-01 | 4.37e-01 | 4.22e-01 |
Negative regulation of the PI3K/AKT network | 87 | 1.01e-03 | 2.79e-03 | 0.2120 | 0.139000 | -0.010900 | -0.160000 | 2.47e-02 | 8.60e-01 | 9.88e-03 |
RNA Polymerase I Promoter Escape | 44 | 3.59e-03 | 8.21e-03 | 0.2120 | 0.163000 | -0.078000 | -0.112000 | 6.14e-02 | 3.71e-01 | 2.00e-01 |
Nervous system development | 472 | 2.22e-19 | 5.81e-18 | 0.2120 | 0.114000 | -0.041500 | -0.174000 | 2.22e-05 | 1.23e-01 | 9.51e-11 |
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 36 | 1.53e-01 | 2.06e-01 | 0.2120 | 0.085600 | 0.000619 | -0.194000 | 3.74e-01 | 9.95e-01 | 4.42e-02 |
ECM proteoglycans | 35 | 1.86e-01 | 2.40e-01 | 0.2120 | 0.115000 | 0.037800 | -0.173000 | 2.37e-01 | 6.99e-01 | 7.59e-02 |
CRMPs in Sema3A signaling | 14 | 4.70e-01 | 5.23e-01 | 0.2110 | -0.016100 | 0.070200 | -0.199000 | 9.17e-01 | 6.49e-01 | 1.98e-01 |
Meiotic synapsis | 45 | 4.81e-03 | 1.06e-02 | 0.2110 | 0.171000 | -0.058400 | -0.108000 | 4.66e-02 | 4.98e-01 | 2.09e-01 |
RNA polymerase II transcribes snRNA genes | 72 | 1.51e-02 | 2.86e-02 | 0.2110 | 0.110000 | 0.036100 | 0.176000 | 1.06e-01 | 5.96e-01 | 9.89e-03 |
Regulation of TP53 Activity | 151 | 5.86e-04 | 1.71e-03 | 0.2100 | -0.098500 | -0.182000 | 0.036900 | 3.67e-02 | 1.14e-04 | 4.34e-01 |
Formation of HIV-1 elongation complex containing HIV-1 Tat | 42 | 7.74e-02 | 1.16e-01 | 0.2100 | 0.105000 | -0.015600 | -0.181000 | 2.40e-01 | 8.61e-01 | 4.21e-02 |
HIV Transcription Elongation | 42 | 7.74e-02 | 1.16e-01 | 0.2100 | 0.105000 | -0.015600 | -0.181000 | 2.40e-01 | 8.61e-01 | 4.21e-02 |
Tat-mediated elongation of the HIV-1 transcript | 42 | 7.74e-02 | 1.16e-01 | 0.2100 | 0.105000 | -0.015600 | -0.181000 | 2.40e-01 | 8.61e-01 | 4.21e-02 |
CD28 dependent Vav1 pathway | 12 | 7.42e-01 | 7.72e-01 | 0.2100 | 0.169000 | 0.099200 | 0.074000 | 3.09e-01 | 5.52e-01 | 6.57e-01 |
Class I peroxisomal membrane protein import | 20 | 5.84e-01 | 6.28e-01 | 0.2100 | -0.122000 | -0.157000 | 0.066100 | 3.44e-01 | 2.24e-01 | 6.09e-01 |
Other interleukin signaling | 18 | 4.95e-01 | 5.47e-01 | 0.2090 | 0.051800 | 0.049700 | -0.196000 | 7.03e-01 | 7.15e-01 | 1.49e-01 |
Phospholipid metabolism | 184 | 2.43e-04 | 8.14e-04 | 0.2090 | 0.181000 | 0.099600 | -0.032400 | 2.30e-05 | 1.99e-02 | 4.48e-01 |
Gap-filling DNA repair synthesis and ligation in TC-NER | 64 | 1.32e-02 | 2.55e-02 | 0.2090 | -0.029700 | -0.185000 | -0.093400 | 6.82e-01 | 1.07e-02 | 1.96e-01 |
Circadian Clock | 67 | 2.69e-03 | 6.41e-03 | 0.2080 | 0.173000 | -0.008440 | -0.116000 | 1.46e-02 | 9.05e-01 | 1.00e-01 |
Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 3.42e-02 | 5.84e-02 | 0.2080 | 0.201000 | 0.052000 | 0.016900 | 1.23e-02 | 5.17e-01 | 8.33e-01 |
KSRP (KHSRP) binds and destabilizes mRNA | 17 | 2.98e-01 | 3.58e-01 | 0.2080 | -0.024100 | -0.206000 | 0.010600 | 8.64e-01 | 1.41e-01 | 9.40e-01 |
Interconversion of nucleotide di- and triphosphates | 27 | 1.33e-02 | 2.55e-02 | 0.2060 | 0.097000 | -0.181000 | 0.025000 | 3.83e-01 | 1.04e-01 | 8.22e-01 |
Cellular responses to external stimuli | 505 | 9.85e-28 | 3.83e-26 | 0.2060 | 0.146000 | -0.068600 | -0.128000 | 1.77e-08 | 8.32e-03 | 8.84e-07 |
G alpha (12/13) signalling events | 68 | 6.06e-02 | 9.44e-02 | 0.2060 | 0.158000 | 0.086400 | -0.099900 | 2.43e-02 | 2.18e-01 | 1.54e-01 |
Cellular responses to stress | 499 | 1.33e-27 | 5.04e-26 | 0.2060 | 0.142000 | -0.073900 | -0.129000 | 5.19e-08 | 4.71e-03 | 7.84e-07 |
RNA Polymerase I Promoter Clearance | 63 | 1.50e-03 | 3.87e-03 | 0.2060 | 0.067900 | -0.140000 | -0.135000 | 3.51e-01 | 5.51e-02 | 6.37e-02 |
RNA Polymerase I Transcription | 63 | 1.50e-03 | 3.87e-03 | 0.2060 | 0.067900 | -0.140000 | -0.135000 | 3.51e-01 | 5.51e-02 | 6.37e-02 |
mitochondrial fatty acid beta-oxidation of saturated fatty acids | 11 | 5.52e-01 | 5.99e-01 | 0.2060 | 0.163000 | -0.002170 | -0.126000 | 3.50e-01 | 9.90e-01 | 4.70e-01 |
Activation of BH3-only proteins | 29 | 5.40e-02 | 8.62e-02 | 0.2060 | 0.117000 | -0.101000 | -0.136000 | 2.75e-01 | 3.48e-01 | 2.06e-01 |
APC/C:Cdc20 mediated degradation of Cyclin B | 24 | 3.03e-02 | 5.23e-02 | 0.2050 | 0.082700 | -0.176000 | 0.065100 | 4.83e-01 | 1.35e-01 | 5.81e-01 |
Negative regulation of MAPK pathway | 42 | 7.54e-02 | 1.14e-01 | 0.2050 | 0.192000 | 0.042600 | -0.059100 | 3.13e-02 | 6.33e-01 | 5.08e-01 |
Signaling by ERBB2 | 44 | 2.54e-02 | 4.49e-02 | 0.2050 | 0.167000 | -0.016100 | -0.119000 | 5.59e-02 | 8.53e-01 | 1.74e-01 |
Adherens junctions interactions | 16 | 4.46e-01 | 5.01e-01 | 0.2040 | 0.050800 | 0.175000 | -0.092100 | 7.25e-01 | 2.25e-01 | 5.24e-01 |
Peroxisomal protein import | 57 | 9.10e-02 | 1.34e-01 | 0.2040 | 0.182000 | 0.085100 | 0.036700 | 1.74e-02 | 2.67e-01 | 6.32e-01 |
Transcriptional Regulation by MECP2 | 47 | 7.84e-02 | 1.17e-01 | 0.2040 | 0.146000 | 0.029600 | -0.140000 | 8.39e-02 | 7.26e-01 | 9.71e-02 |
Apoptotic cleavage of cellular proteins | 34 | 3.77e-01 | 4.34e-01 | 0.2030 | 0.173000 | 0.106000 | 0.008590 | 8.03e-02 | 2.84e-01 | 9.31e-01 |
DNA Double-Strand Break Repair | 135 | 2.60e-03 | 6.23e-03 | 0.2030 | -0.102000 | -0.141000 | 0.105000 | 4.03e-02 | 4.69e-03 | 3.50e-02 |
Formation of the Early Elongation Complex | 33 | 1.99e-01 | 2.54e-01 | 0.2030 | 0.124000 | 0.019300 | -0.160000 | 2.17e-01 | 8.47e-01 | 1.13e-01 |
Formation of the HIV-1 Early Elongation Complex | 33 | 1.99e-01 | 2.54e-01 | 0.2030 | 0.124000 | 0.019300 | -0.160000 | 2.17e-01 | 8.47e-01 | 1.13e-01 |
CD209 (DC-SIGN) signaling | 20 | 5.05e-01 | 5.56e-01 | 0.2030 | 0.185000 | 0.080600 | -0.017800 | 1.51e-01 | 5.33e-01 | 8.91e-01 |
mRNA Splicing - Major Pathway | 179 | 6.51e-09 | 7.10e-08 | 0.2030 | -0.003840 | -0.202000 | -0.017700 | 9.29e-01 | 3.12e-06 | 6.83e-01 |
Ras activation upon Ca2+ influx through NMDA receptor | 15 | 7.05e-01 | 7.39e-01 | 0.2030 | -0.109000 | -0.167000 | 0.032100 | 4.63e-01 | 2.62e-01 | 8.29e-01 |
Regulation of pyruvate dehydrogenase (PDH) complex | 15 | 3.68e-01 | 4.26e-01 | 0.2030 | 0.111000 | -0.032800 | 0.167000 | 4.59e-01 | 8.26e-01 | 2.64e-01 |
Aflatoxin activation and detoxification | 14 | 7.84e-01 | 8.11e-01 | 0.2020 | 0.158000 | 0.124000 | 0.024500 | 3.07e-01 | 4.23e-01 | 8.74e-01 |
Cilium Assembly | 180 | 2.91e-04 | 9.55e-04 | 0.2020 | -0.099100 | -0.156000 | 0.081500 | 2.18e-02 | 3.10e-04 | 5.93e-02 |
Cellular hexose transport | 15 | 6.58e-01 | 6.97e-01 | 0.2020 | -0.105000 | -0.068400 | -0.158000 | 4.83e-01 | 6.47e-01 | 2.88e-01 |
Signaling by TGFB family members | 91 | 1.47e-05 | 7.29e-05 | 0.2010 | 0.180000 | -0.048200 | -0.075200 | 2.93e-03 | 4.27e-01 | 2.15e-01 |
Aberrant regulation of mitotic exit in cancer due to RB1 defects | 20 | 3.67e-01 | 4.25e-01 | 0.2010 | 0.013900 | -0.062000 | 0.190000 | 9.14e-01 | 6.31e-01 | 1.41e-01 |
Developmental Biology | 725 | 4.86e-26 | 1.74e-24 | 0.2010 | 0.136000 | -0.011700 | -0.147000 | 4.01e-10 | 5.92e-01 | 1.80e-11 |
Activation of kainate receptors upon glutamate binding | 26 | 2.45e-01 | 3.05e-01 | 0.2000 | 0.180000 | 0.033600 | -0.080500 | 1.11e-01 | 7.67e-01 | 4.77e-01 |
Deposition of new CENPA-containing nucleosomes at the centromere | 40 | 1.21e-02 | 2.37e-02 | 0.2000 | 0.022200 | -0.199000 | 0.006530 | 8.08e-01 | 2.95e-02 | 9.43e-01 |
Nucleosome assembly | 40 | 1.21e-02 | 2.37e-02 | 0.2000 | 0.022200 | -0.199000 | 0.006530 | 8.08e-01 | 2.95e-02 | 9.43e-01 |
Miscellaneous transport and binding events | 20 | 9.38e-02 | 1.37e-01 | 0.2000 | 0.146000 | -0.106000 | -0.084800 | 2.57e-01 | 4.10e-01 | 5.11e-01 |
ATF4 activates genes in response to endoplasmic reticulum stress | 25 | 7.75e-02 | 1.16e-01 | 0.2000 | 0.036200 | -0.163000 | 0.110000 | 7.54e-01 | 1.60e-01 | 3.40e-01 |
Mitotic Metaphase and Anaphase | 224 | 4.42e-13 | 8.86e-12 | 0.2000 | 0.111000 | -0.081200 | 0.145000 | 4.23e-03 | 3.64e-02 | 1.89e-04 |
Gene expression (Transcription) | 1321 | 4.01e-25 | 1.40e-23 | 0.1990 | -0.101000 | -0.172000 | 0.006770 | 8.58e-10 | 7.74e-26 | 6.80e-01 |
VEGFR2 mediated cell proliferation | 18 | 3.64e-01 | 4.23e-01 | 0.1990 | 0.165000 | 0.005990 | -0.111000 | 2.25e-01 | 9.65e-01 | 4.16e-01 |
Ub-specific processing proteases | 170 | 1.49e-08 | 1.49e-07 | 0.1980 | 0.182000 | -0.007460 | 0.078500 | 4.18e-05 | 8.67e-01 | 7.74e-02 |
Mitotic Anaphase | 223 | 6.26e-13 | 1.24e-11 | 0.1980 | 0.116000 | -0.077300 | 0.141000 | 2.93e-03 | 4.68e-02 | 2.81e-04 |
Vitamin B5 (pantothenate) metabolism | 17 | 7.55e-01 | 7.85e-01 | 0.1980 | 0.142000 | 0.129000 | 0.049200 | 3.12e-01 | 3.58e-01 | 7.25e-01 |
TP53 Regulates Transcription of Cell Cycle Genes | 47 | 2.41e-03 | 5.81e-03 | 0.1970 | 0.047400 | -0.185000 | 0.049400 | 5.74e-01 | 2.80e-02 | 5.58e-01 |
Insulin receptor signalling cascade | 39 | 1.32e-01 | 1.84e-01 | 0.1970 | 0.163000 | 0.033300 | -0.106000 | 7.82e-02 | 7.19e-01 | 2.50e-01 |
Orc1 removal from chromatin | 69 | 4.01e-04 | 1.26e-03 | 0.1960 | 0.141000 | -0.055600 | 0.125000 | 4.36e-02 | 4.25e-01 | 7.25e-02 |
Dopamine Neurotransmitter Release Cycle | 19 | 5.02e-01 | 5.53e-01 | 0.1960 | -0.040300 | -0.160000 | -0.105000 | 7.61e-01 | 2.26e-01 | 4.28e-01 |
Cyclin E associated events during G1/S transition | 83 | 1.55e-04 | 5.44e-04 | 0.1960 | 0.175000 | -0.020600 | 0.084100 | 5.71e-03 | 7.45e-01 | 1.85e-01 |
Muscle contraction | 134 | 1.74e-02 | 3.24e-02 | 0.1960 | 0.150000 | 0.119000 | -0.042000 | 2.80e-03 | 1.76e-02 | 4.01e-01 |
Synthesis of bile acids and bile salts | 24 | 4.28e-01 | 4.82e-01 | 0.1950 | 0.143000 | 0.059500 | 0.118000 | 2.25e-01 | 6.14e-01 | 3.15e-01 |
NoRC negatively regulates rRNA expression | 59 | 1.79e-03 | 4.49e-03 | 0.1940 | 0.163000 | -0.056100 | -0.090400 | 3.06e-02 | 4.56e-01 | 2.30e-01 |
mRNA Splicing | 187 | 7.15e-09 | 7.73e-08 | 0.1940 | -0.000579 | -0.194000 | -0.004390 | 9.89e-01 | 4.72e-06 | 9.18e-01 |
Peptide hormone metabolism | 49 | 7.78e-03 | 1.61e-02 | 0.1930 | 0.159000 | -0.032200 | 0.106000 | 5.48e-02 | 6.97e-01 | 2.00e-01 |
FRS-mediated FGFR2 signaling | 14 | 3.64e-01 | 4.22e-01 | 0.1930 | 0.014800 | -0.158000 | 0.110000 | 9.24e-01 | 3.05e-01 | 4.78e-01 |
Acyl chain remodelling of PE | 20 | 2.73e-01 | 3.32e-01 | 0.1930 | 0.187000 | 0.013400 | 0.045400 | 1.47e-01 | 9.18e-01 | 7.25e-01 |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 31 | 9.90e-02 | 1.43e-01 | 0.1930 | 0.006040 | -0.182000 | -0.062300 | 9.54e-01 | 7.88e-02 | 5.48e-01 |
HCMV Late Events | 69 | 3.59e-03 | 8.21e-03 | 0.1930 | 0.169000 | -0.012000 | -0.092400 | 1.54e-02 | 8.63e-01 | 1.84e-01 |
Branched-chain amino acid catabolism | 21 | 5.02e-01 | 5.53e-01 | 0.1930 | -0.056800 | -0.066800 | 0.171000 | 6.52e-01 | 5.96e-01 | 1.74e-01 |
RNA Polymerase II Transcription Termination | 65 | 9.69e-03 | 1.94e-02 | 0.1920 | -0.029500 | -0.179000 | 0.064400 | 6.81e-01 | 1.28e-02 | 3.69e-01 |
RNA Polymerase III Abortive And Retractive Initiation | 41 | 3.09e-01 | 3.68e-01 | 0.1920 | -0.091800 | -0.168000 | -0.017100 | 3.09e-01 | 6.33e-02 | 8.49e-01 |
RNA Polymerase III Transcription | 41 | 3.09e-01 | 3.68e-01 | 0.1920 | -0.091800 | -0.168000 | -0.017100 | 3.09e-01 | 6.33e-02 | 8.49e-01 |
Retrograde transport at the Trans-Golgi-Network | 49 | 1.48e-01 | 2.02e-01 | 0.1920 | 0.176000 | 0.072600 | 0.023100 | 3.30e-02 | 3.79e-01 | 7.80e-01 |
G2/M Checkpoints | 138 | 1.21e-06 | 7.94e-06 | 0.1920 | 0.054000 | -0.102000 | 0.153000 | 2.74e-01 | 3.78e-02 | 1.91e-03 |
Generic Transcription Pathway | 1075 | 2.62e-17 | 6.38e-16 | 0.1910 | -0.102000 | -0.161000 | -0.019300 | 1.87e-08 | 4.36e-19 | 2.86e-01 |
Homology Directed Repair | 110 | 1.30e-02 | 2.50e-02 | 0.1910 | -0.089900 | -0.137000 | 0.099100 | 1.03e-01 | 1.32e-02 | 7.24e-02 |
Transcriptional regulation by RUNX1 | 184 | 2.19e-06 | 1.34e-05 | 0.1910 | 0.152000 | 0.004670 | -0.115000 | 3.60e-04 | 9.13e-01 | 6.95e-03 |
FRS-mediated FGFR4 signaling | 12 | 2.38e-01 | 2.97e-01 | 0.1910 | 0.158000 | -0.107000 | 0.014100 | 3.44e-01 | 5.21e-01 | 9.33e-01 |
Dual incision in TC-NER | 65 | 1.14e-02 | 2.24e-02 | 0.1910 | -0.018100 | -0.184000 | -0.047100 | 8.00e-01 | 1.03e-02 | 5.11e-01 |
Amino acid transport across the plasma membrane | 23 | 4.48e-01 | 5.02e-01 | 0.1900 | 0.147000 | 0.047800 | -0.111000 | 2.23e-01 | 6.92e-01 | 3.56e-01 |
Transport of vitamins, nucleosides, and related molecules | 33 | 5.28e-01 | 5.76e-01 | 0.1900 | 0.147000 | 0.121000 | -0.005620 | 1.45e-01 | 2.30e-01 | 9.55e-01 |
Interferon gamma signaling | 83 | 3.10e-03 | 7.23e-03 | 0.1900 | -0.144000 | 0.011400 | 0.123000 | 2.32e-02 | 8.57e-01 | 5.30e-02 |
Mitochondrial biogenesis | 88 | 1.67e-03 | 4.21e-03 | 0.1890 | 0.165000 | 0.000175 | -0.092600 | 7.61e-03 | 9.98e-01 | 1.33e-01 |
Activation of SMO | 13 | 6.46e-01 | 6.88e-01 | 0.1890 | 0.027000 | 0.084200 | -0.167000 | 8.66e-01 | 5.99e-01 | 2.98e-01 |
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 20 | 3.08e-01 | 3.68e-01 | 0.1890 | -0.016100 | -0.160000 | 0.099500 | 9.01e-01 | 2.17e-01 | 4.41e-01 |
Mitotic G1 phase and G1/S transition | 148 | 1.88e-07 | 1.44e-06 | 0.1890 | 0.032400 | -0.144000 | 0.118000 | 4.96e-01 | 2.55e-03 | 1.34e-02 |
Class I MHC mediated antigen processing & presentation | 348 | 1.12e-09 | 1.31e-08 | 0.1880 | 0.172000 | 0.049200 | 0.057700 | 3.58e-08 | 1.15e-01 | 6.46e-02 |
IRF3-mediated induction of type I IFN | 12 | 6.53e-01 | 6.93e-01 | 0.1870 | -0.034000 | -0.173000 | -0.062400 | 8.39e-01 | 2.98e-01 | 7.08e-01 |
SUMOylation of transcription cofactors | 44 | 1.25e-01 | 1.76e-01 | 0.1870 | 0.063800 | -0.044100 | -0.171000 | 4.64e-01 | 6.13e-01 | 5.04e-02 |
Transcriptional regulation of pluripotent stem cells | 19 | 3.70e-01 | 4.27e-01 | 0.1870 | 0.183000 | 0.025300 | 0.032800 | 1.68e-01 | 8.48e-01 | 8.05e-01 |
Signaling by Hedgehog | 120 | 2.82e-03 | 6.64e-03 | 0.1860 | 0.177000 | 0.058500 | 0.002250 | 8.13e-04 | 2.68e-01 | 9.66e-01 |
Cell surface interactions at the vascular wall | 173 | 7.86e-11 | 1.07e-09 | 0.1860 | 0.116000 | -0.127000 | -0.071000 | 8.64e-03 | 3.91e-03 | 1.07e-01 |
CASP8 activity is inhibited | 11 | 6.88e-01 | 7.25e-01 | 0.1860 | -0.010700 | -0.081700 | 0.167000 | 9.51e-01 | 6.39e-01 | 3.39e-01 |
Dimerization of procaspase-8 | 11 | 6.88e-01 | 7.25e-01 | 0.1860 | -0.010700 | -0.081700 | 0.167000 | 9.51e-01 | 6.39e-01 | 3.39e-01 |
Regulation by c-FLIP | 11 | 6.88e-01 | 7.25e-01 | 0.1860 | -0.010700 | -0.081700 | 0.167000 | 9.51e-01 | 6.39e-01 | 3.39e-01 |
SUMOylation | 165 | 1.64e-04 | 5.72e-04 | 0.1850 | -0.051700 | -0.176000 | -0.016900 | 2.52e-01 | 9.24e-05 | 7.09e-01 |
Downstream signaling of activated FGFR3 | 16 | 2.25e-01 | 2.83e-01 | 0.1840 | 0.135000 | -0.076200 | 0.099700 | 3.50e-01 | 5.98e-01 | 4.90e-01 |
TP53 Regulates Transcription of Caspase Activators and Caspases | 11 | 5.62e-01 | 6.08e-01 | 0.1840 | 0.009810 | -0.132000 | 0.128000 | 9.55e-01 | 4.48e-01 | 4.62e-01 |
Synthesis of PIPs at the early endosome membrane | 16 | 6.52e-01 | 6.93e-01 | 0.1840 | -0.010200 | 0.005210 | 0.184000 | 9.44e-01 | 9.71e-01 | 2.04e-01 |
RUNX3 regulates p14-ARF | 10 | 8.33e-01 | 8.54e-01 | 0.1840 | 0.124000 | 0.076600 | -0.112000 | 4.98e-01 | 6.75e-01 | 5.38e-01 |
Downstream signaling of activated FGFR2 | 19 | 2.77e-01 | 3.36e-01 | 0.1840 | 0.015700 | -0.145000 | 0.112000 | 9.05e-01 | 2.75e-01 | 3.97e-01 |
Phase II - Conjugation of compounds | 66 | 2.29e-01 | 2.87e-01 | 0.1840 | 0.101000 | 0.122000 | 0.094100 | 1.57e-01 | 8.75e-02 | 1.86e-01 |
MET activates PTK2 signaling | 15 | 4.01e-01 | 4.57e-01 | 0.1840 | 0.145000 | -0.039700 | -0.106000 | 3.32e-01 | 7.90e-01 | 4.77e-01 |
Unfolded Protein Response (UPR) | 86 | 1.24e-03 | 3.31e-03 | 0.1840 | 0.183000 | 0.006970 | -0.004750 | 3.28e-03 | 9.11e-01 | 9.39e-01 |
Processing of SMDT1 | 15 | 2.63e-01 | 3.22e-01 | 0.1830 | 0.048900 | -0.177000 | -0.007800 | 7.43e-01 | 2.36e-01 | 9.58e-01 |
Factors involved in megakaryocyte development and platelet production | 115 | 7.95e-04 | 2.25e-03 | 0.1830 | 0.180000 | 0.032300 | -0.012300 | 8.52e-04 | 5.49e-01 | 8.19e-01 |
Gene Silencing by RNA | 87 | 1.06e-03 | 2.90e-03 | 0.1830 | 0.001400 | -0.179000 | -0.038500 | 9.82e-01 | 3.96e-03 | 5.34e-01 |
Intrinsic Pathway for Apoptosis | 52 | 2.91e-02 | 5.06e-02 | 0.1830 | 0.182000 | 0.011800 | -0.016500 | 2.35e-02 | 8.83e-01 | 8.37e-01 |
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 46 | 4.79e-02 | 7.75e-02 | 0.1820 | 0.092000 | -0.071700 | -0.140000 | 2.80e-01 | 4.00e-01 | 9.96e-02 |
RHO GTPases Activate Formins | 117 | 1.51e-04 | 5.35e-04 | 0.1820 | 0.018600 | -0.108000 | 0.145000 | 7.29e-01 | 4.27e-02 | 6.67e-03 |
Chromatin modifying enzymes | 217 | 1.24e-05 | 6.34e-05 | 0.1820 | 0.047800 | -0.049800 | -0.168000 | 2.25e-01 | 2.06e-01 | 1.89e-05 |
Chromatin organization | 217 | 1.24e-05 | 6.34e-05 | 0.1820 | 0.047800 | -0.049800 | -0.168000 | 2.25e-01 | 2.06e-01 | 1.89e-05 |
Neuronal System | 253 | 2.58e-04 | 8.52e-04 | 0.1820 | 0.111000 | 0.108000 | -0.095300 | 2.35e-03 | 3.21e-03 | 9.08e-03 |
Cell Cycle | 622 | 3.12e-22 | 9.23e-21 | 0.1810 | -0.008890 | -0.147000 | 0.105000 | 7.05e-01 | 3.46e-10 | 7.75e-06 |
Lysine catabolism | 11 | 8.28e-01 | 8.50e-01 | 0.1810 | 0.087100 | 0.158000 | -0.006360 | 6.17e-01 | 3.63e-01 | 9.71e-01 |
HCMV Early Events | 74 | 1.11e-03 | 3.01e-03 | 0.1810 | 0.017400 | -0.180000 | -0.001450 | 7.96e-01 | 7.43e-03 | 9.83e-01 |
Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 78 | 5.05e-03 | 1.09e-02 | 0.1800 | -0.007110 | -0.174000 | -0.048700 | 9.14e-01 | 8.01e-03 | 4.57e-01 |
Deubiquitination | 241 | 3.02e-08 | 2.70e-07 | 0.1800 | 0.175000 | 0.020600 | 0.038800 | 2.90e-06 | 5.81e-01 | 2.99e-01 |
Interleukin-37 signaling | 19 | 5.69e-01 | 6.13e-01 | 0.1800 | 0.063000 | 0.168000 | -0.012300 | 6.34e-01 | 2.04e-01 | 9.26e-01 |
Switching of origins to a post-replicative state | 89 | 2.36e-04 | 7.92e-04 | 0.1800 | 0.105000 | -0.065800 | 0.131000 | 8.70e-02 | 2.84e-01 | 3.30e-02 |
Fc epsilon receptor (FCERI) signaling | 190 | 7.39e-13 | 1.42e-11 | 0.1800 | 0.133000 | -0.113000 | 0.045000 | 1.57e-03 | 7.37e-03 | 2.85e-01 |
Protein methylation | 15 | 1.88e-01 | 2.40e-01 | 0.1800 | 0.128000 | -0.126000 | -0.002150 | 3.91e-01 | 3.97e-01 | 9.88e-01 |
Formation of HIV elongation complex in the absence of HIV Tat | 44 | 1.44e-01 | 1.97e-01 | 0.1800 | 0.101000 | -0.009230 | -0.148000 | 2.47e-01 | 9.16e-01 | 8.87e-02 |
Molecules associated with elastic fibres | 22 | 1.79e-01 | 2.31e-01 | 0.1790 | 0.111000 | -0.095000 | -0.104000 | 3.68e-01 | 4.40e-01 | 3.98e-01 |
Synthesis of PIPs at the plasma membrane | 52 | 2.95e-01 | 3.56e-01 | 0.1790 | 0.135000 | 0.094700 | -0.069200 | 9.26e-02 | 2.38e-01 | 3.88e-01 |
Formation of TC-NER Pre-Incision Complex | 53 | 3.29e-03 | 7.60e-03 | 0.1780 | 0.110000 | -0.119000 | -0.075000 | 1.68e-01 | 1.34e-01 | 3.45e-01 |
Lysosphingolipid and LPA receptors | 11 | 6.99e-01 | 7.33e-01 | 0.1780 | -0.015100 | -0.154000 | -0.087100 | 9.31e-01 | 3.75e-01 | 6.17e-01 |
Cyclin A:Cdk2-associated events at S phase entry | 85 | 3.50e-04 | 1.12e-03 | 0.1780 | 0.159000 | -0.030500 | 0.072900 | 1.13e-02 | 6.27e-01 | 2.46e-01 |
O-linked glycosylation of mucins | 47 | 4.15e-01 | 4.70e-01 | 0.1780 | 0.129000 | 0.116000 | -0.036800 | 1.26e-01 | 1.69e-01 | 6.63e-01 |
Nicotinamide salvaging | 14 | 5.64e-01 | 6.09e-01 | 0.1770 | -0.097600 | 0.043900 | 0.141000 | 5.27e-01 | 7.76e-01 | 3.59e-01 |
Transmission across Chemical Synapses | 169 | 7.99e-03 | 1.64e-02 | 0.1770 | 0.139000 | 0.092400 | -0.059000 | 1.77e-03 | 3.82e-02 | 1.86e-01 |
Signaling by FGFR2 | 60 | 1.17e-02 | 2.30e-02 | 0.1770 | 0.103000 | -0.075400 | -0.123000 | 1.70e-01 | 3.13e-01 | 9.85e-02 |
Global Genome Nucleotide Excision Repair (GG-NER) | 84 | 1.45e-02 | 2.75e-02 | 0.1770 | -0.044800 | -0.159000 | 0.063900 | 4.78e-01 | 1.18e-02 | 3.11e-01 |
The phototransduction cascade | 25 | 6.24e-01 | 6.69e-01 | 0.1760 | -0.092100 | -0.150000 | 0.002400 | 4.25e-01 | 1.93e-01 | 9.83e-01 |
SUMO E3 ligases SUMOylate target proteins | 159 | 4.72e-04 | 1.42e-03 | 0.1760 | -0.043700 | -0.167000 | -0.035200 | 3.42e-01 | 2.87e-04 | 4.44e-01 |
MAPK1/MAPK3 signaling | 234 | 1.47e-07 | 1.15e-06 | 0.1760 | 0.169000 | 0.014600 | -0.044500 | 8.07e-06 | 7.00e-01 | 2.41e-01 |
RNA Polymerase II Transcription | 1194 | 3.71e-18 | 9.36e-17 | 0.1760 | -0.085600 | -0.153000 | 0.001230 | 6.32e-07 | 4.51e-19 | 9.43e-01 |
Glyoxylate metabolism and glycine degradation | 24 | 3.02e-01 | 3.61e-01 | 0.1760 | -0.001780 | -0.119000 | 0.129000 | 9.88e-01 | 3.12e-01 | 2.75e-01 |
Mitotic G2-G2/M phases | 180 | 2.14e-08 | 2.00e-07 | 0.1750 | 0.089900 | -0.082000 | 0.126000 | 3.75e-02 | 5.78e-02 | 3.46e-03 |
Death Receptor Signalling | 131 | 6.25e-03 | 1.31e-02 | 0.1750 | 0.142000 | 0.051600 | -0.088800 | 4.98e-03 | 3.08e-01 | 7.92e-02 |
Fatty acid metabolism | 151 | 1.33e-02 | 2.55e-02 | 0.1750 | 0.149000 | 0.086900 | -0.030900 | 1.56e-03 | 6.55e-02 | 5.12e-01 |
Interleukin receptor SHC signaling | 23 | 6.53e-01 | 6.93e-01 | 0.1750 | 0.100000 | 0.123000 | -0.074000 | 4.04e-01 | 3.07e-01 | 5.39e-01 |
Cell Cycle, Mitotic | 500 | 3.34e-20 | 9.11e-19 | 0.1750 | 0.019800 | -0.139000 | 0.105000 | 4.48e-01 | 1.12e-07 | 5.41e-05 |
FRS-mediated FGFR1 signaling | 14 | 6.84e-01 | 7.23e-01 | 0.1750 | 0.143000 | 0.045500 | 0.090500 | 3.54e-01 | 7.68e-01 | 5.58e-01 |
PI3K Cascade | 30 | 2.49e-01 | 3.09e-01 | 0.1750 | 0.056100 | -0.079900 | -0.146000 | 5.95e-01 | 4.49e-01 | 1.68e-01 |
Signal Transduction | 1870 | 3.75e-39 | 2.32e-37 | 0.1750 | 0.153000 | 0.043500 | -0.072400 | 4.52e-28 | 1.85e-03 | 2.20e-07 |
Negative epigenetic regulation of rRNA expression | 62 | 2.82e-03 | 6.64e-03 | 0.1750 | 0.123000 | -0.087800 | -0.087700 | 9.43e-02 | 2.32e-01 | 2.32e-01 |
Constitutive Signaling by Aberrant PI3K in Cancer | 54 | 4.94e-02 | 7.96e-02 | 0.1750 | 0.059700 | -0.086300 | -0.140000 | 4.48e-01 | 2.72e-01 | 7.62e-02 |
DNA Repair | 289 | 4.32e-05 | 1.77e-04 | 0.1750 | -0.082600 | -0.149000 | 0.039500 | 1.57e-02 | 1.37e-05 | 2.48e-01 |
Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 11 | 6.34e-01 | 6.77e-01 | 0.1750 | -0.076200 | 0.079200 | 0.136000 | 6.62e-01 | 6.49e-01 | 4.36e-01 |
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 6.82e-01 | 7.21e-01 | 0.1740 | 0.032300 | -0.108000 | -0.132000 | 8.53e-01 | 5.34e-01 | 4.49e-01 |
Signaling by BMP | 21 | 3.78e-01 | 4.36e-01 | 0.1740 | -0.019100 | -0.146000 | 0.091400 | 8.80e-01 | 2.45e-01 | 4.69e-01 |
WNT ligand biogenesis and trafficking | 21 | 6.71e-01 | 7.10e-01 | 0.1740 | 0.063300 | 0.134000 | 0.090600 | 6.16e-01 | 2.88e-01 | 4.72e-01 |
mRNA 3’-end processing | 56 | 7.88e-02 | 1.18e-01 | 0.1730 | -0.038500 | -0.139000 | 0.096300 | 6.19e-01 | 7.23e-02 | 2.13e-01 |
Recruitment of NuMA to mitotic centrosomes | 79 | 8.80e-02 | 1.30e-01 | 0.1730 | -0.076400 | -0.152000 | 0.031100 | 2.41e-01 | 1.95e-02 | 6.33e-01 |
Protein-protein interactions at synapses | 56 | 1.64e-01 | 2.17e-01 | 0.1730 | 0.005970 | 0.002450 | -0.173000 | 9.38e-01 | 9.75e-01 | 2.53e-02 |
FLT3 Signaling | 243 | 4.02e-07 | 2.91e-06 | 0.1730 | 0.163000 | 0.018800 | -0.055600 | 1.27e-05 | 6.13e-01 | 1.36e-01 |
Regulation of actin dynamics for phagocytic cup formation | 123 | 3.00e-06 | 1.75e-05 | 0.1730 | 0.160000 | -0.044200 | 0.048000 | 2.20e-03 | 3.97e-01 | 3.58e-01 |
RNA Pol II CTD phosphorylation and interaction with CE | 27 | 2.67e-01 | 3.26e-01 | 0.1720 | 0.138000 | -0.012400 | -0.103000 | 2.16e-01 | 9.11e-01 | 3.54e-01 |
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 27 | 2.67e-01 | 3.26e-01 | 0.1720 | 0.138000 | -0.012400 | -0.103000 | 2.16e-01 | 9.11e-01 | 3.54e-01 |
Formation of RNA Pol II elongation complex | 57 | 5.83e-02 | 9.16e-02 | 0.1720 | 0.150000 | 0.011500 | -0.084300 | 5.06e-02 | 8.80e-01 | 2.71e-01 |
RNA Polymerase II Transcription Elongation | 57 | 5.83e-02 | 9.16e-02 | 0.1720 | 0.150000 | 0.011500 | -0.084300 | 5.06e-02 | 8.80e-01 | 2.71e-01 |
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 104 | 2.49e-02 | 4.40e-02 | 0.1720 | -0.064600 | -0.115000 | 0.111000 | 2.55e-01 | 4.35e-02 | 5.07e-02 |
Signaling by the B Cell Receptor (BCR) | 162 | 1.04e-09 | 1.22e-08 | 0.1720 | 0.087200 | -0.141000 | 0.046300 | 5.54e-02 | 1.99e-03 | 3.09e-01 |
MAPK family signaling cascades | 267 | 1.09e-08 | 1.13e-07 | 0.1710 | 0.168000 | 0.009360 | -0.032400 | 2.31e-06 | 7.92e-01 | 3.62e-01 |
G2/M Transition | 178 | 5.96e-08 | 5.05e-07 | 0.1710 | 0.082700 | -0.085400 | 0.123000 | 5.69e-02 | 4.93e-02 | 4.66e-03 |
Regulation of PLK1 Activity at G2/M Transition | 86 | 4.19e-03 | 9.41e-03 | 0.1710 | -0.012200 | -0.152000 | 0.077800 | 8.45e-01 | 1.50e-02 | 2.12e-01 |
RUNX2 regulates bone development | 23 | 3.11e-01 | 3.70e-01 | 0.1710 | 0.013700 | 0.160000 | -0.059600 | 9.10e-01 | 1.85e-01 | 6.21e-01 |
Metabolism of folate and pterines | 16 | 7.12e-01 | 7.46e-01 | 0.1710 | 0.140000 | 0.060300 | 0.076100 | 3.31e-01 | 6.76e-01 | 5.98e-01 |
DNA Replication Pre-Initiation | 82 | 7.75e-04 | 2.21e-03 | 0.1700 | 0.051000 | -0.119000 | 0.111000 | 4.25e-01 | 6.30e-02 | 8.20e-02 |
Keratan sulfate/keratin metabolism | 27 | 6.26e-01 | 6.70e-01 | 0.1700 | 0.116000 | 0.096500 | -0.079300 | 2.97e-01 | 3.86e-01 | 4.76e-01 |
Eicosanoid ligand-binding receptors | 13 | 7.36e-01 | 7.66e-01 | 0.1700 | -0.051500 | -0.160000 | -0.022400 | 7.48e-01 | 3.16e-01 | 8.89e-01 |
ADORA2B mediated anti-inflammatory cytokines production | 73 | 3.62e-02 | 6.15e-02 | 0.1700 | 0.075100 | -0.038500 | -0.148000 | 2.68e-01 | 5.69e-01 | 2.93e-02 |
Interleukin-2 family signaling | 38 | 4.79e-01 | 5.31e-01 | 0.1700 | 0.093400 | 0.137000 | -0.035400 | 3.19e-01 | 1.43e-01 | 7.06e-01 |
Downstream signal transduction | 27 | 2.97e-01 | 3.57e-01 | 0.1690 | 0.163000 | 0.021500 | 0.040500 | 1.42e-01 | 8.47e-01 | 7.16e-01 |
DNA Double Strand Break Response | 47 | 6.37e-02 | 9.86e-02 | 0.1690 | 0.079400 | -0.079500 | -0.127000 | 3.46e-01 | 3.46e-01 | 1.33e-01 |
Infectious disease | 775 | 4.62e-33 | 1.97e-31 | 0.1690 | 0.121000 | -0.076900 | -0.088800 | 8.94e-09 | 2.70e-04 | 2.60e-05 |
Transcriptional regulation by small RNAs | 63 | 4.92e-03 | 1.07e-02 | 0.1680 | 0.074200 | -0.126000 | -0.083700 | 3.09e-01 | 8.44e-02 | 2.51e-01 |
Regulation of FOXO transcriptional activity by acetylation | 10 | 8.21e-01 | 8.44e-01 | 0.1680 | 0.115000 | 0.031800 | -0.118000 | 5.28e-01 | 8.62e-01 | 5.17e-01 |
RAF/MAP kinase cascade | 229 | 1.07e-06 | 7.16e-06 | 0.1670 | 0.160000 | 0.013100 | -0.048100 | 3.15e-05 | 7.32e-01 | 2.09e-01 |
Anchoring of the basal body to the plasma membrane | 96 | 4.85e-02 | 7.83e-02 | 0.1670 | -0.068800 | -0.128000 | 0.081900 | 2.44e-01 | 3.03e-02 | 1.65e-01 |
SHC-mediated cascade:FGFR1 | 12 | 8.49e-01 | 8.68e-01 | 0.1660 | 0.107000 | 0.070800 | 0.106000 | 5.21e-01 | 6.71e-01 | 5.25e-01 |
Metabolism | 1756 | 7.88e-35 | 3.70e-33 | 0.1660 | 0.137000 | 0.030900 | -0.088200 | 1.16e-21 | 3.19e-02 | 8.31e-10 |
Potential therapeutics for SARS | 77 | 7.15e-03 | 1.48e-02 | 0.1660 | 0.163000 | -0.002620 | -0.031300 | 1.34e-02 | 9.68e-01 | 6.35e-01 |
Hedgehog ‘off’ state | 92 | 8.47e-03 | 1.72e-02 | 0.1660 | 0.164000 | 0.023400 | -0.008410 | 6.52e-03 | 6.98e-01 | 8.89e-01 |
Cargo trafficking to the periciliary membrane | 47 | 4.72e-02 | 7.63e-02 | 0.1650 | 0.048100 | -0.092200 | 0.129000 | 5.68e-01 | 2.74e-01 | 1.27e-01 |
Centrosome maturation | 80 | 1.03e-01 | 1.48e-01 | 0.1650 | -0.072400 | -0.142000 | 0.043600 | 2.63e-01 | 2.78e-02 | 5.00e-01 |
Recruitment of mitotic centrosome proteins and complexes | 80 | 1.03e-01 | 1.48e-01 | 0.1650 | -0.072400 | -0.142000 | 0.043600 | 2.63e-01 | 2.78e-02 | 5.00e-01 |
HIV Transcription Initiation | 45 | 4.02e-02 | 6.74e-02 | 0.1650 | 0.140000 | -0.030200 | 0.083300 | 1.05e-01 | 7.26e-01 | 3.34e-01 |
RNA Polymerase II HIV Promoter Escape | 45 | 4.02e-02 | 6.74e-02 | 0.1650 | 0.140000 | -0.030200 | 0.083300 | 1.05e-01 | 7.26e-01 | 3.34e-01 |
RNA Polymerase II Promoter Escape | 45 | 4.02e-02 | 6.74e-02 | 0.1650 | 0.140000 | -0.030200 | 0.083300 | 1.05e-01 | 7.26e-01 | 3.34e-01 |
RNA Polymerase II Transcription Initiation | 45 | 4.02e-02 | 6.74e-02 | 0.1650 | 0.140000 | -0.030200 | 0.083300 | 1.05e-01 | 7.26e-01 | 3.34e-01 |
RNA Polymerase II Transcription Initiation And Promoter Clearance | 45 | 4.02e-02 | 6.74e-02 | 0.1650 | 0.140000 | -0.030200 | 0.083300 | 1.05e-01 | 7.26e-01 | 3.34e-01 |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 45 | 4.02e-02 | 6.74e-02 | 0.1650 | 0.140000 | -0.030200 | 0.083300 | 1.05e-01 | 7.26e-01 | 3.34e-01 |
Signaling by WNT in cancer | 30 | 4.81e-01 | 5.33e-01 | 0.1650 | 0.082200 | 0.028300 | -0.140000 | 4.36e-01 | 7.89e-01 | 1.85e-01 |
Downstream signaling of activated FGFR4 | 17 | 2.15e-01 | 2.72e-01 | 0.1640 | 0.117000 | -0.107000 | 0.045300 | 4.05e-01 | 4.46e-01 | 7.47e-01 |
Metal ion SLC transporters | 21 | 7.74e-01 | 8.03e-01 | 0.1630 | 0.132000 | 0.094700 | 0.015600 | 2.94e-01 | 4.53e-01 | 9.01e-01 |
Fatty acyl-CoA biosynthesis | 33 | 3.21e-01 | 3.80e-01 | 0.1630 | 0.142000 | 0.032300 | 0.074500 | 1.59e-01 | 7.48e-01 | 4.59e-01 |
Neddylation | 218 | 7.84e-07 | 5.53e-06 | 0.1630 | 0.162000 | 0.007030 | 0.002100 | 3.56e-05 | 8.58e-01 | 9.57e-01 |
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) | 10 | 7.19e-01 | 7.51e-01 | 0.1630 | -0.085400 | 0.057800 | 0.126000 | 6.40e-01 | 7.51e-01 | 4.91e-01 |
Regulation of MECP2 expression and activity | 28 | 4.31e-01 | 4.85e-01 | 0.1630 | 0.135000 | 0.027000 | -0.085900 | 2.15e-01 | 8.04e-01 | 4.31e-01 |
TNFR2 non-canonical NF-kB pathway | 95 | 4.07e-04 | 1.27e-03 | 0.1610 | 0.158000 | -0.030700 | 0.015600 | 7.91e-03 | 6.06e-01 | 7.93e-01 |
HCMV Infection | 96 | 4.74e-04 | 1.42e-03 | 0.1610 | 0.150000 | -0.038800 | -0.042400 | 1.09e-02 | 5.12e-01 | 4.73e-01 |
Cholesterol biosynthesis | 24 | 5.81e-01 | 6.25e-01 | 0.1610 | 0.092000 | 0.035300 | 0.127000 | 4.35e-01 | 7.65e-01 | 2.81e-01 |
TP53 Regulates Transcription of Cell Death Genes | 42 | 1.11e-01 | 1.59e-01 | 0.1610 | 0.160000 | 0.005530 | 0.013300 | 7.29e-02 | 9.51e-01 | 8.81e-01 |
PECAM1 interactions | 12 | 7.89e-01 | 8.16e-01 | 0.1600 | -0.007720 | 0.023100 | -0.159000 | 9.63e-01 | 8.90e-01 | 3.42e-01 |
MECP2 regulates neuronal receptors and channels | 13 | 5.57e-01 | 6.03e-01 | 0.1600 | 0.113000 | -0.056600 | -0.097900 | 4.81e-01 | 7.24e-01 | 5.41e-01 |
SHC-mediated cascade:FGFR4 | 10 | 4.69e-01 | 5.22e-01 | 0.1600 | 0.117000 | -0.107000 | 0.017500 | 5.21e-01 | 5.58e-01 | 9.24e-01 |
Phase I - Functionalization of compounds | 61 | 1.80e-01 | 2.33e-01 | 0.1600 | 0.099000 | 0.029200 | -0.122000 | 1.81e-01 | 6.93e-01 | 1.00e-01 |
Adrenaline,noradrenaline inhibits insulin secretion | 24 | 5.29e-01 | 5.76e-01 | 0.1600 | 0.142000 | 0.036100 | -0.062400 | 2.27e-01 | 7.59e-01 | 5.97e-01 |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 37 | 1.52e-01 | 2.05e-01 | 0.1590 | 0.073200 | -0.082400 | -0.115000 | 4.41e-01 | 3.86e-01 | 2.26e-01 |
Class B/2 (Secretin family receptors) | 56 | 2.17e-01 | 2.73e-01 | 0.1590 | 0.020200 | 0.028500 | -0.155000 | 7.94e-01 | 7.12e-01 | 4.49e-02 |
FOXO-mediated transcription | 58 | 4.24e-02 | 7.04e-02 | 0.1590 | 0.147000 | -0.009100 | -0.058700 | 5.24e-02 | 9.05e-01 | 4.39e-01 |
TP53 Regulates Transcription of DNA Repair Genes | 61 | 2.91e-01 | 3.51e-01 | 0.1580 | -0.049100 | -0.102000 | -0.110000 | 5.07e-01 | 1.68e-01 | 1.36e-01 |
Epigenetic regulation of gene expression | 100 | 2.27e-03 | 5.50e-03 | 0.1580 | 0.024200 | -0.139000 | -0.070900 | 6.76e-01 | 1.66e-02 | 2.20e-01 |
NCAM signaling for neurite out-growth | 43 | 5.17e-01 | 5.66e-01 | 0.1560 | -0.087700 | -0.128000 | 0.019700 | 3.20e-01 | 1.47e-01 | 8.23e-01 |
IRS-related events triggered by IGF1R | 35 | 1.45e-01 | 1.97e-01 | 0.1560 | 0.082100 | -0.085500 | -0.102000 | 4.00e-01 | 3.81e-01 | 2.98e-01 |
Signaling by NTRK2 (TRKB) | 20 | 3.39e-01 | 4.00e-01 | 0.1550 | 0.148000 | -0.023400 | 0.037000 | 2.50e-01 | 8.56e-01 | 7.75e-01 |
Post-translational protein modification | 1187 | 6.19e-25 | 2.11e-23 | 0.1540 | 0.152000 | 0.028200 | -0.004590 | 1.37e-18 | 1.01e-01 | 7.90e-01 |
Zinc transporters | 14 | 8.17e-01 | 8.40e-01 | 0.1540 | 0.130000 | 0.059100 | 0.055700 | 3.98e-01 | 7.02e-01 | 7.18e-01 |
Nuclear Envelope (NE) Reassembly | 69 | 1.36e-03 | 3.56e-03 | 0.1540 | 0.116000 | -0.091600 | 0.041800 | 9.60e-02 | 1.88e-01 | 5.48e-01 |
Leishmania infection | 245 | 8.55e-07 | 5.94e-06 | 0.1540 | 0.149000 | 0.000828 | -0.038600 | 6.19e-05 | 9.82e-01 | 2.98e-01 |
Protein localization | 157 | 7.82e-06 | 4.18e-05 | 0.1530 | 0.117000 | -0.063400 | -0.076400 | 1.14e-02 | 1.70e-01 | 9.87e-02 |
RUNX2 regulates osteoblast differentiation | 18 | 3.69e-01 | 4.27e-01 | 0.1530 | -0.066900 | 0.092600 | -0.102000 | 6.23e-01 | 4.97e-01 | 4.53e-01 |
G alpha (q) signalling events | 130 | 1.34e-02 | 2.57e-02 | 0.1520 | 0.097700 | 0.011500 | -0.116000 | 5.43e-02 | 8.21e-01 | 2.19e-02 |
Disorders of transmembrane transporters | 145 | 5.35e-04 | 1.57e-03 | 0.1520 | 0.152000 | 0.009650 | -0.004890 | 1.59e-03 | 8.41e-01 | 9.19e-01 |
CD28 co-stimulation | 33 | 5.96e-01 | 6.39e-01 | 0.1520 | -0.050600 | -0.063800 | -0.129000 | 6.15e-01 | 5.26e-01 | 2.01e-01 |
IGF1R signaling cascade | 36 | 1.64e-01 | 2.17e-01 | 0.1520 | 0.094000 | -0.065000 | -0.100000 | 3.29e-01 | 5.00e-01 | 2.98e-01 |
M Phase | 359 | 5.59e-14 | 1.17e-12 | 0.1520 | 0.089700 | -0.079500 | 0.093200 | 3.51e-03 | 9.71e-03 | 2.43e-03 |
FCGR3A-mediated phagocytosis | 121 | 2.18e-05 | 9.90e-05 | 0.1510 | 0.134000 | -0.060700 | 0.034500 | 1.08e-02 | 2.48e-01 | 5.12e-01 |
Leishmania phagocytosis | 121 | 2.18e-05 | 9.90e-05 | 0.1510 | 0.134000 | -0.060700 | 0.034500 | 1.08e-02 | 2.48e-01 | 5.12e-01 |
Parasite infection | 121 | 2.18e-05 | 9.90e-05 | 0.1510 | 0.134000 | -0.060700 | 0.034500 | 1.08e-02 | 2.48e-01 | 5.12e-01 |
Signaling by FGFR2 in disease | 32 | 1.28e-01 | 1.79e-01 | 0.1510 | 0.042500 | -0.143000 | -0.022800 | 6.77e-01 | 1.61e-01 | 8.23e-01 |
Nonhomologous End-Joining (NHEJ) | 42 | 5.96e-02 | 9.35e-02 | 0.1510 | 0.085300 | -0.078700 | 0.096700 | 3.39e-01 | 3.78e-01 | 2.78e-01 |
AURKA Activation by TPX2 | 71 | 7.36e-02 | 1.11e-01 | 0.1510 | -0.030200 | -0.129000 | 0.072500 | 6.60e-01 | 6.02e-02 | 2.91e-01 |
Disease | 1343 | 4.25e-35 | 2.14e-33 | 0.1510 | 0.127000 | -0.022400 | -0.078400 | 7.33e-15 | 1.68e-01 | 1.43e-06 |
Inactivation, recovery and regulation of the phototransduction cascade | 24 | 6.50e-01 | 6.92e-01 | 0.1500 | -0.059400 | -0.133000 | 0.034200 | 6.15e-01 | 2.60e-01 | 7.72e-01 |
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 10 | 6.32e-01 | 6.75e-01 | 0.1490 | 0.133000 | -0.050500 | -0.044400 | 4.65e-01 | 7.82e-01 | 8.08e-01 |
Nucleotide Excision Repair | 110 | 5.56e-03 | 1.18e-02 | 0.1490 | -0.009150 | -0.147000 | -0.022200 | 8.68e-01 | 7.54e-03 | 6.88e-01 |
Aberrant regulation of mitotic cell cycle due to RB1 defects | 36 | 4.35e-01 | 4.89e-01 | 0.1490 | -0.031800 | -0.072400 | 0.126000 | 7.41e-01 | 4.52e-01 | 1.89e-01 |
Diseases of mitotic cell cycle | 36 | 4.35e-01 | 4.89e-01 | 0.1490 | -0.031800 | -0.072400 | 0.126000 | 7.41e-01 | 4.52e-01 | 1.89e-01 |
Interleukin-20 family signaling | 17 | 8.78e-01 | 8.90e-01 | 0.1490 | 0.111000 | 0.099500 | 0.002210 | 4.28e-01 | 4.78e-01 | 9.87e-01 |
Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 25 | 6.80e-01 | 7.19e-01 | 0.1480 | 0.123000 | 0.058400 | 0.057400 | 2.86e-01 | 6.13e-01 | 6.19e-01 |
Loss of Nlp from mitotic centrosomes | 68 | 1.60e-01 | 2.13e-01 | 0.1480 | -0.048900 | -0.127000 | 0.057200 | 4.86e-01 | 6.92e-02 | 4.15e-01 |
Loss of proteins required for interphase microtubule organization from the centrosome | 68 | 1.60e-01 | 2.13e-01 | 0.1480 | -0.048900 | -0.127000 | 0.057200 | 4.86e-01 | 6.92e-02 | 4.15e-01 |
DNA Damage Recognition in GG-NER | 38 | 3.84e-01 | 4.40e-01 | 0.1480 | -0.010500 | -0.112000 | -0.096200 | 9.10e-01 | 2.33e-01 | 3.05e-01 |
Activation of NMDA receptors and postsynaptic events | 58 | 8.34e-02 | 1.24e-01 | 0.1470 | 0.103000 | -0.033000 | -0.099100 | 1.74e-01 | 6.64e-01 | 1.92e-01 |
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 23 | 4.65e-01 | 5.19e-01 | 0.1460 | 0.090900 | -0.040800 | -0.107000 | 4.50e-01 | 7.35e-01 | 3.73e-01 |
Downstream signaling of activated FGFR1 | 20 | 6.30e-01 | 6.74e-01 | 0.1460 | 0.094300 | 0.011800 | 0.111000 | 4.65e-01 | 9.27e-01 | 3.90e-01 |
Fcgamma receptor (FCGR) dependent phagocytosis | 147 | 1.07e-04 | 4.01e-04 | 0.1460 | 0.145000 | -0.016000 | 0.011000 | 2.44e-03 | 7.38e-01 | 8.18e-01 |
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 18 | 7.99e-01 | 8.25e-01 | 0.1460 | -0.030100 | -0.075800 | -0.121000 | 8.25e-01 | 5.78e-01 | 3.76e-01 |
Metabolism of nucleotides | 86 | 1.84e-03 | 4.59e-03 | 0.1450 | 0.109000 | -0.079000 | -0.055000 | 8.17e-02 | 2.05e-01 | 3.78e-01 |
Ion homeostasis | 40 | 4.34e-01 | 4.88e-01 | 0.1450 | 0.016400 | 0.036300 | -0.139000 | 8.58e-01 | 6.91e-01 | 1.28e-01 |
G alpha (s) signalling events | 140 | 1.08e-01 | 1.54e-01 | 0.1440 | 0.068500 | 0.085200 | 0.093500 | 1.62e-01 | 8.19e-02 | 5.61e-02 |
TICAM1-dependent activation of IRF3/IRF7 | 12 | 8.72e-01 | 8.85e-01 | 0.1430 | 0.074900 | 0.038000 | -0.116000 | 6.53e-01 | 8.20e-01 | 4.87e-01 |
Cell-cell junction organization | 36 | 4.11e-01 | 4.66e-01 | 0.1430 | 0.042900 | -0.049000 | -0.127000 | 6.56e-01 | 6.11e-01 | 1.87e-01 |
Anti-inflammatory response favouring Leishmania parasite infection | 169 | 2.07e-04 | 7.07e-04 | 0.1430 | 0.001800 | -0.141000 | -0.022500 | 9.68e-01 | 1.57e-03 | 6.13e-01 |
Leishmania parasite growth and survival | 169 | 2.07e-04 | 7.07e-04 | 0.1430 | 0.001800 | -0.141000 | -0.022500 | 9.68e-01 | 1.57e-03 | 6.13e-01 |
Synthesis of glycosylphosphatidylinositol (GPI) | 17 | 8.15e-01 | 8.39e-01 | 0.1430 | -0.077000 | -0.051200 | 0.109000 | 5.83e-01 | 7.15e-01 | 4.38e-01 |
Metabolism of proteins | 1709 | 9.51e-54 | 4.32e-51 | 0.1430 | 0.130000 | -0.045600 | -0.035600 | 3.45e-19 | 1.75e-03 | 1.45e-02 |
SLC-mediated transmembrane transport | 179 | 4.21e-02 | 6.99e-02 | 0.1410 | 0.103000 | 0.071300 | -0.064600 | 1.72e-02 | 9.98e-02 | 1.36e-01 |
HIV Infection | 224 | 7.64e-08 | 6.27e-07 | 0.1400 | 0.130000 | -0.043200 | 0.029400 | 7.72e-04 | 2.66e-01 | 4.49e-01 |
Signaling by PDGF | 44 | 2.24e-01 | 2.81e-01 | 0.1390 | 0.138000 | 0.011900 | 0.014200 | 1.13e-01 | 8.91e-01 | 8.70e-01 |
Mitotic Prophase | 98 | 4.42e-04 | 1.35e-03 | 0.1390 | 0.118000 | -0.072900 | 0.015000 | 4.43e-02 | 2.12e-01 | 7.98e-01 |
Post NMDA receptor activation events | 48 | 1.72e-01 | 2.25e-01 | 0.1390 | 0.097900 | -0.032500 | -0.092900 | 2.41e-01 | 6.97e-01 | 2.65e-01 |
Signaling by FGFR in disease | 50 | 1.59e-01 | 2.13e-01 | 0.1380 | 0.135000 | 0.006780 | 0.028700 | 9.81e-02 | 9.34e-01 | 7.26e-01 |
Synthesis of PIPs at the Golgi membrane | 16 | 8.29e-01 | 8.50e-01 | 0.1380 | 0.050100 | 0.126000 | 0.024200 | 7.28e-01 | 3.83e-01 | 8.67e-01 |
Synthesis of substrates in N-glycan biosythesis | 58 | 3.31e-01 | 3.91e-01 | 0.1370 | 0.128000 | 0.047800 | -0.001540 | 9.10e-02 | 5.29e-01 | 9.84e-01 |
Interleukin-35 Signalling | 12 | 7.91e-01 | 8.17e-01 | 0.1360 | -0.022900 | -0.128000 | 0.041000 | 8.91e-01 | 4.42e-01 | 8.06e-01 |
Nucleotide-like (purinergic) receptors | 12 | 5.34e-01 | 5.81e-01 | 0.1360 | 0.091300 | -0.096400 | 0.029900 | 5.84e-01 | 5.63e-01 | 8.58e-01 |
Downstream TCR signaling | 100 | 4.83e-04 | 1.44e-03 | 0.1350 | 0.077100 | -0.110000 | 0.017100 | 1.83e-01 | 5.73e-02 | 7.67e-01 |
Sema3A PAK dependent Axon repulsion | 16 | 8.70e-01 | 8.84e-01 | 0.1350 | 0.076600 | 0.076600 | -0.080800 | 5.96e-01 | 5.96e-01 | 5.76e-01 |
Glutamate Neurotransmitter Release Cycle | 20 | 7.23e-01 | 7.55e-01 | 0.1350 | -0.041700 | -0.122000 | 0.040400 | 7.47e-01 | 3.46e-01 | 7.55e-01 |
CTLA4 inhibitory signaling | 21 | 7.24e-01 | 7.55e-01 | 0.1350 | -0.013900 | -0.100000 | -0.088600 | 9.12e-01 | 4.26e-01 | 4.82e-01 |
RNA Polymerase II Pre-transcription Events | 78 | 2.24e-02 | 4.04e-02 | 0.1340 | 0.130000 | -0.017000 | 0.028500 | 4.69e-02 | 7.95e-01 | 6.64e-01 |
G alpha (i) signalling events | 240 | 2.53e-04 | 8.39e-04 | 0.1330 | 0.111000 | 0.002420 | -0.072600 | 2.98e-03 | 9.48e-01 | 5.29e-02 |
Signaling by FGFR | 69 | 1.51e-01 | 2.05e-01 | 0.1330 | 0.091200 | -0.009530 | -0.095900 | 1.90e-01 | 8.91e-01 | 1.69e-01 |
Meiotic recombination | 38 | 1.60e-01 | 2.14e-01 | 0.1310 | 0.121000 | -0.042400 | -0.027700 | 1.96e-01 | 6.51e-01 | 7.67e-01 |
Host Interactions of HIV factors | 129 | 7.79e-05 | 3.00e-04 | 0.1310 | 0.085100 | -0.099200 | 0.000162 | 9.50e-02 | 5.17e-02 | 9.97e-01 |
O-linked glycosylation | 82 | 1.71e-01 | 2.25e-01 | 0.1310 | -0.063800 | -0.011200 | -0.114000 | 3.18e-01 | 8.61e-01 | 7.55e-02 |
Regulation of PTEN mRNA translation | 13 | 7.71e-01 | 7.99e-01 | 0.1310 | -0.057500 | 0.058000 | 0.102000 | 7.20e-01 | 7.17e-01 | 5.24e-01 |
IRS-mediated signalling | 34 | 2.68e-01 | 3.27e-01 | 0.1300 | 0.064600 | -0.083800 | -0.076100 | 5.14e-01 | 3.98e-01 | 4.42e-01 |
Synthesis of IP2, IP, and Ins in the cytosol | 13 | 9.40e-01 | 9.46e-01 | 0.1300 | 0.080900 | 0.100000 | 0.019400 | 6.14e-01 | 5.33e-01 | 9.03e-01 |
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 13 | 6.90e-01 | 7.26e-01 | 0.1300 | 0.031000 | -0.091900 | 0.086100 | 8.47e-01 | 5.66e-01 | 5.91e-01 |
Transcriptional activation of mitochondrial biogenesis | 51 | 1.82e-01 | 2.34e-01 | 0.1290 | 0.097400 | -0.030300 | -0.079600 | 2.29e-01 | 7.08e-01 | 3.25e-01 |
Kinesins | 39 | 2.74e-01 | 3.33e-01 | 0.1290 | 0.002780 | -0.129000 | -0.009100 | 9.76e-01 | 1.63e-01 | 9.22e-01 |
HIV Life Cycle | 144 | 1.94e-04 | 6.66e-04 | 0.1280 | 0.045100 | -0.109000 | 0.051500 | 3.50e-01 | 2.44e-02 | 2.86e-01 |
Cytochrome P450 - arranged by substrate type | 33 | 8.01e-01 | 8.26e-01 | 0.1260 | 0.098600 | 0.077300 | -0.010600 | 3.27e-01 | 4.42e-01 | 9.16e-01 |
Glucagon-type ligand receptors | 20 | 6.36e-01 | 6.78e-01 | 0.1260 | 0.043200 | -0.076100 | -0.090000 | 7.38e-01 | 5.56e-01 | 4.86e-01 |
PI Metabolism | 79 | 4.77e-01 | 5.30e-01 | 0.1250 | 0.098900 | 0.073900 | -0.021700 | 1.29e-01 | 2.56e-01 | 7.39e-01 |
Glucose metabolism | 83 | 3.59e-01 | 4.19e-01 | 0.1230 | 0.097700 | 0.052100 | -0.053700 | 1.24e-01 | 4.12e-01 | 3.98e-01 |
Nicotinate metabolism | 25 | 4.68e-01 | 5.22e-01 | 0.1220 | -0.012400 | 0.121000 | -0.010000 | 9.15e-01 | 2.94e-01 | 9.31e-01 |
Antigen processing: Ubiquitination & Proteasome degradation | 287 | 3.60e-06 | 2.06e-05 | 0.1210 | 0.112000 | -0.016500 | 0.044400 | 1.15e-03 | 6.31e-01 | 1.96e-01 |
Peptide ligand-binding receptors | 91 | 1.01e-01 | 1.46e-01 | 0.1210 | 0.108000 | 0.004680 | -0.053800 | 7.57e-02 | 9.39e-01 | 3.75e-01 |
Acyl chain remodelling of PS | 14 | 7.62e-01 | 7.92e-01 | 0.1200 | 0.089300 | -0.014000 | 0.079300 | 5.63e-01 | 9.28e-01 | 6.07e-01 |
GABA synthesis, release, reuptake and degradation | 13 | 9.12e-01 | 9.21e-01 | 0.1190 | -0.030600 | -0.092100 | -0.069400 | 8.48e-01 | 5.65e-01 | 6.65e-01 |
Negative regulators of DDX58/IFIH1 signaling | 34 | 4.99e-01 | 5.51e-01 | 0.1190 | -0.014100 | -0.106000 | 0.052200 | 8.87e-01 | 2.86e-01 | 5.99e-01 |
Transport of inorganic cations/anions and amino acids/oligopeptides | 79 | 3.78e-01 | 4.35e-01 | 0.1150 | 0.057700 | 0.024300 | -0.096500 | 3.75e-01 | 7.09e-01 | 1.38e-01 |
Metabolic disorders of biological oxidation enzymes | 23 | 8.65e-01 | 8.83e-01 | 0.1140 | 0.098200 | 0.052900 | -0.024100 | 4.15e-01 | 6.61e-01 | 8.42e-01 |
TCR signaling | 121 | 1.37e-03 | 3.59e-03 | 0.1140 | 0.077600 | -0.082800 | 0.011100 | 1.41e-01 | 1.16e-01 | 8.33e-01 |
SLC transporter disorders | 75 | 1.51e-01 | 2.05e-01 | 0.1140 | -0.004470 | -0.113000 | -0.008710 | 9.47e-01 | 8.93e-02 | 8.96e-01 |
Ion transport by P-type ATPases | 42 | 7.16e-01 | 7.49e-01 | 0.1120 | 0.061100 | 0.054800 | -0.076500 | 4.93e-01 | 5.39e-01 | 3.91e-01 |
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 24 | 4.51e-01 | 5.04e-01 | 0.1120 | 0.096800 | -0.052200 | -0.021200 | 4.12e-01 | 6.58e-01 | 8.57e-01 |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 43 | 1.81e-01 | 2.33e-01 | 0.1110 | 0.063100 | -0.089200 | -0.019700 | 4.74e-01 | 3.12e-01 | 8.23e-01 |
Keratan sulfate biosynthesis | 22 | 8.51e-01 | 8.70e-01 | 0.1110 | -0.016400 | -0.014900 | -0.108000 | 8.94e-01 | 9.03e-01 | 3.78e-01 |
VEGFR2 mediated vascular permeability | 26 | 8.58e-01 | 8.77e-01 | 0.1110 | 0.081100 | 0.052600 | -0.053800 | 4.74e-01 | 6.43e-01 | 6.35e-01 |
Ca2+ pathway | 57 | 2.72e-01 | 3.32e-01 | 0.1100 | 0.109000 | 0.000283 | -0.014800 | 1.54e-01 | 9.97e-01 | 8.46e-01 |
Sulfur amino acid metabolism | 22 | 8.34e-01 | 8.54e-01 | 0.1090 | 0.038200 | -0.006670 | -0.102000 | 7.56e-01 | 9.57e-01 | 4.07e-01 |
Organelle biogenesis and maintenance | 268 | 1.17e-03 | 3.15e-03 | 0.1090 | -0.012300 | -0.105000 | 0.024300 | 7.28e-01 | 3.08e-03 | 4.94e-01 |
Biological oxidations | 132 | 3.21e-01 | 3.81e-01 | 0.1080 | 0.089700 | 0.055300 | -0.025400 | 7.52e-02 | 2.73e-01 | 6.15e-01 |
PKMTs methylate histone lysines | 44 | 8.08e-01 | 8.33e-01 | 0.1080 | -0.072600 | -0.066300 | -0.045400 | 4.05e-01 | 4.47e-01 | 6.02e-01 |
Late Phase of HIV Life Cycle | 131 | 3.04e-03 | 7.11e-03 | 0.1080 | 0.061900 | -0.075800 | 0.045500 | 2.21e-01 | 1.34e-01 | 3.69e-01 |
Cytokine Signaling in Immune system | 732 | 1.39e-08 | 1.41e-07 | 0.1080 | 0.107000 | 0.013700 | 0.004950 | 8.59e-07 | 5.27e-01 | 8.20e-01 |
PI-3K cascade:FGFR1 | 12 | 8.68e-01 | 8.83e-01 | 0.1080 | 0.096200 | 0.004460 | 0.048100 | 5.64e-01 | 9.79e-01 | 7.73e-01 |
Post-translational modification: synthesis of GPI-anchored proteins | 57 | 6.95e-01 | 7.31e-01 | 0.1070 | 0.060100 | 0.086900 | -0.018400 | 4.33e-01 | 2.56e-01 | 8.10e-01 |
Signaling by GPCR | 530 | 1.65e-03 | 4.19e-03 | 0.1070 | 0.083300 | 0.045200 | -0.049800 | 1.04e-03 | 7.48e-02 | 4.97e-02 |
Meiosis | 68 | 8.56e-02 | 1.27e-01 | 0.1070 | 0.036200 | -0.101000 | 0.004440 | 6.05e-01 | 1.52e-01 | 9.50e-01 |
Signaling by KIT in disease | 20 | 8.68e-01 | 8.83e-01 | 0.1060 | -0.040100 | -0.090600 | 0.038400 | 7.56e-01 | 4.83e-01 | 7.67e-01 |
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 20 | 8.68e-01 | 8.83e-01 | 0.1060 | -0.040100 | -0.090600 | 0.038400 | 7.56e-01 | 4.83e-01 | 7.67e-01 |
Visual phototransduction | 58 | 5.65e-01 | 6.10e-01 | 0.1060 | 0.032600 | 0.000644 | -0.101000 | 6.68e-01 | 9.93e-01 | 1.84e-01 |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | 23 | 4.72e-01 | 5.23e-01 | 0.1060 | 0.083000 | -0.063500 | 0.017400 | 4.91e-01 | 5.98e-01 | 8.85e-01 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 73 | 3.34e-01 | 3.93e-01 | 0.1060 | 0.093500 | 0.018500 | 0.045500 | 1.67e-01 | 7.85e-01 | 5.02e-01 |
mRNA Capping | 29 | 4.47e-01 | 5.01e-01 | 0.1050 | 0.088700 | -0.047100 | -0.031300 | 4.09e-01 | 6.61e-01 | 7.70e-01 |
Regulation of TNFR1 signaling | 34 | 8.74e-01 | 8.87e-01 | 0.1040 | -0.060200 | -0.068400 | -0.049800 | 5.44e-01 | 4.90e-01 | 6.15e-01 |
Diseases of glycosylation | 107 | 2.39e-01 | 2.97e-01 | 0.1040 | -0.021100 | 0.011900 | -0.101000 | 7.06e-01 | 8.31e-01 | 7.14e-02 |
Diseases of metabolism | 186 | 1.19e-01 | 1.67e-01 | 0.1020 | 0.026300 | 0.028700 | -0.094300 | 5.36e-01 | 5.00e-01 | 2.66e-02 |
Signaling by NTRK3 (TRKC) | 16 | 7.77e-01 | 8.04e-01 | 0.1010 | 0.072000 | -0.041400 | -0.058000 | 6.18e-01 | 7.74e-01 | 6.88e-01 |
Cyclin D associated events in G1 | 47 | 3.58e-01 | 4.19e-01 | 0.1000 | 0.066000 | -0.032100 | 0.068600 | 4.34e-01 | 7.03e-01 | 4.16e-01 |
G1 Phase | 47 | 3.58e-01 | 4.19e-01 | 0.1000 | 0.066000 | -0.032100 | 0.068600 | 4.34e-01 | 7.03e-01 | 4.16e-01 |
Cytosolic sensors of pathogen-associated DNA | 62 | 4.71e-01 | 5.23e-01 | 0.0990 | 0.035500 | -0.033700 | -0.086000 | 6.29e-01 | 6.46e-01 | 2.42e-01 |
Transcription of the HIV genome | 67 | 1.18e-01 | 1.67e-01 | 0.0983 | 0.083400 | -0.045100 | 0.026200 | 2.38e-01 | 5.23e-01 | 7.11e-01 |
GPCR downstream signalling | 487 | 3.87e-03 | 8.78e-03 | 0.0976 | 0.081900 | 0.033100 | -0.041600 | 1.97e-03 | 2.12e-01 | 1.16e-01 |
Glycolysis | 66 | 3.51e-01 | 4.11e-01 | 0.0967 | 0.093400 | 0.001620 | -0.025000 | 1.89e-01 | 9.82e-01 | 7.25e-01 |
STING mediated induction of host immune responses | 15 | 8.38e-01 | 8.58e-01 | 0.0919 | 0.088600 | -0.010200 | 0.022200 | 5.52e-01 | 9.45e-01 | 8.82e-01 |
Transcriptional Regulation by TP53 | 350 | 1.23e-05 | 6.31e-05 | 0.0896 | 0.041100 | -0.079600 | 0.002150 | 1.87e-01 | 1.05e-02 | 9.45e-01 |
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 17 | 9.41e-01 | 9.46e-01 | 0.0884 | -0.029100 | -0.031900 | 0.077100 | 8.35e-01 | 8.20e-01 | 5.82e-01 |
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 17 | 9.41e-01 | 9.46e-01 | 0.0884 | -0.029100 | -0.031900 | 0.077100 | 8.35e-01 | 8.20e-01 | 5.82e-01 |
Class A/1 (Rhodopsin-like receptors) | 160 | 5.45e-02 | 8.68e-02 | 0.0884 | 0.055400 | -0.036900 | -0.058100 | 2.26e-01 | 4.21e-01 | 2.05e-01 |
Reproduction | 80 | 1.55e-01 | 2.09e-01 | 0.0879 | 0.043300 | -0.072000 | -0.025800 | 5.03e-01 | 2.65e-01 | 6.90e-01 |
IL-6-type cytokine receptor ligand interactions | 12 | 9.53e-01 | 9.56e-01 | 0.0877 | 0.038800 | -0.010100 | -0.078000 | 8.16e-01 | 9.52e-01 | 6.40e-01 |
Netrin-1 signaling | 40 | 4.16e-01 | 4.71e-01 | 0.0871 | 0.042200 | -0.075700 | 0.008080 | 6.44e-01 | 4.07e-01 | 9.30e-01 |
TNFR1-induced NFkappaB signaling pathway | 25 | 9.11e-01 | 9.20e-01 | 0.0870 | -0.037300 | -0.077600 | 0.012700 | 7.47e-01 | 5.02e-01 | 9.12e-01 |
Methylation | 12 | 9.51e-01 | 9.55e-01 | 0.0858 | -0.022700 | -0.082000 | 0.011300 | 8.92e-01 | 6.23e-01 | 9.46e-01 |
Regulation of RUNX1 Expression and Activity | 18 | 9.41e-01 | 9.46e-01 | 0.0847 | -0.072900 | -0.029000 | -0.031900 | 5.92e-01 | 8.31e-01 | 8.15e-01 |
Signaling by Retinoic Acid | 31 | 8.02e-01 | 8.27e-01 | 0.0781 | 0.029100 | -0.043100 | -0.058200 | 7.79e-01 | 6.78e-01 | 5.75e-01 |
Cardiac conduction | 85 | 5.15e-01 | 5.65e-01 | 0.0776 | 0.013000 | 0.076400 | 0.003860 | 8.35e-01 | 2.23e-01 | 9.51e-01 |
Association of TriC/CCT with target proteins during biosynthesis | 37 | 6.96e-01 | 7.32e-01 | 0.0772 | 0.046900 | -0.037800 | -0.048200 | 6.21e-01 | 6.90e-01 | 6.12e-01 |
Adaptive Immune System | 755 | 5.39e-08 | 4.64e-07 | 0.0764 | 0.070700 | -0.028800 | -0.001370 | 9.45e-04 | 1.79e-01 | 9.49e-01 |
Receptor-type tyrosine-protein phosphatases | 12 | 9.89e-01 | 9.89e-01 | 0.0757 | 0.057000 | 0.049700 | 0.001530 | 7.32e-01 | 7.66e-01 | 9.93e-01 |
GPCR ligand binding | 226 | 1.68e-01 | 2.21e-01 | 0.0752 | 0.034000 | -0.014900 | -0.065400 | 3.78e-01 | 6.99e-01 | 9.01e-02 |
Interaction between L1 and Ankyrins | 21 | 8.77e-01 | 8.90e-01 | 0.0730 | 0.006030 | -0.059000 | 0.042700 | 9.62e-01 | 6.40e-01 | 7.35e-01 |
Ovarian tumor domain proteases | 37 | 7.64e-01 | 7.93e-01 | 0.0721 | 0.070700 | -0.001720 | 0.014300 | 4.57e-01 | 9.86e-01 | 8.80e-01 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 63 | 7.29e-01 | 7.60e-01 | 0.0713 | 0.065900 | 0.014900 | 0.023000 | 3.66e-01 | 8.38e-01 | 7.52e-01 |
Neurotransmitter release cycle | 37 | 8.65e-01 | 8.83e-01 | 0.0696 | 0.022800 | -0.008960 | 0.065100 | 8.11e-01 | 9.25e-01 | 4.93e-01 |
TRP channels | 17 | 9.07e-01 | 9.16e-01 | 0.0684 | -0.065400 | 0.013100 | 0.015100 | 6.40e-01 | 9.26e-01 | 9.14e-01 |
Transcriptional Regulation by VENTX | 38 | 9.21e-01 | 9.29e-01 | 0.0678 | -0.058800 | -0.026000 | 0.021500 | 5.30e-01 | 7.82e-01 | 8.18e-01 |
Glutathione synthesis and recycling | 10 | 9.75e-01 | 9.78e-01 | 0.0624 | -0.001390 | 0.047900 | -0.040000 | 9.94e-01 | 7.93e-01 | 8.27e-01 |
Metabolism of vitamins and cofactors | 155 | 7.17e-01 | 7.49e-01 | 0.0623 | 0.037600 | 0.040600 | -0.028700 | 4.20e-01 | 3.83e-01 | 5.37e-01 |
Diseases associated with N-glycosylation of proteins | 17 | 8.99e-01 | 9.10e-01 | 0.0617 | 0.054600 | -0.027100 | 0.009370 | 6.96e-01 | 8.47e-01 | 9.47e-01 |
Xenobiotics | 11 | 9.87e-01 | 9.88e-01 | 0.0580 | -0.007920 | -0.049200 | -0.029700 | 9.64e-01 | 7.77e-01 | 8.65e-01 |
DAP12 signaling | 28 | 8.67e-01 | 8.83e-01 | 0.0527 | 0.041800 | -0.028100 | 0.015600 | 7.02e-01 | 7.97e-01 | 8.86e-01 |
Mitochondrial Fatty Acid Beta-Oxidation | 36 | 9.83e-01 | 9.85e-01 | 0.0460 | 0.026400 | 0.036100 | -0.011000 | 7.84e-01 | 7.08e-01 | 9.09e-01 |
TNF signaling | 43 | 9.00e-01 | 9.10e-01 | 0.0453 | 0.029600 | -0.020800 | -0.027300 | 7.37e-01 | 8.14e-01 | 7.56e-01 |
Metabolism of water-soluble vitamins and cofactors | 109 | 9.00e-01 | 9.10e-01 | 0.0281 | -0.027800 | 0.003360 | -0.002410 | 6.16e-01 | 9.52e-01 | 9.65e-01 |
Synthesis of PA | 32 | 9.91e-01 | 9.91e-01 | 0.0248 | 0.018900 | -0.001940 | 0.016000 | 8.54e-01 | 9.85e-01 | 8.75e-01 |
IRAK4 deficiency (TLR2/4)
metric | value |
---|---|
setSize | 10 |
pMANOVA | 2.4e-06 |
p.adjustMANOVA | 1.46e-05 |
s.dist | 1.27 |
s.t0_v_pod | 0.899 |
s.pod_crp | 0.826 |
s.t0_crp | 0.34 |
p.t0_v_pod | 8.36e-07 |
p.pod_crp | 6.1e-06 |
p.t0_crp | 0.0624 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD36 | 9283 | 11160 |
TLR2 | 8950 | 10582 |
CD14 | 8944 | 10372 |
MYD88 | 8009 | 11413 |
LY96 | 8649 | 9854 |
TLR4 | 8864 | 9225 |
BTK | 7100 | 11184 |
TLR1 | 8782 | 8637 |
TLR6 | 8694 | 7538 |
TIRAP | 5571 | 6784 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BTK | 7100 | 11184 | 8838 |
CD14 | 8944 | 10372 | -5065 |
CD36 | 9283 | 11160 | 9413 |
LY96 | 8649 | 9854 | 7645 |
MYD88 | 8009 | 11413 | 3934 |
TIRAP | 5571 | 6784 | -3461 |
TLR1 | 8782 | 8637 | 7301 |
TLR2 | 8950 | 10582 | 9812 |
TLR4 | 8864 | 9225 | 1420 |
TLR6 | 8694 | 7538 | 2941 |
MyD88 deficiency (TLR2/4)
metric | value |
---|---|
setSize | 10 |
pMANOVA | 2.4e-06 |
p.adjustMANOVA | 1.46e-05 |
s.dist | 1.27 |
s.t0_v_pod | 0.899 |
s.pod_crp | 0.826 |
s.t0_crp | 0.34 |
p.t0_v_pod | 8.36e-07 |
p.pod_crp | 6.1e-06 |
p.t0_crp | 0.0624 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD36 | 9283 | 11160 |
TLR2 | 8950 | 10582 |
CD14 | 8944 | 10372 |
MYD88 | 8009 | 11413 |
LY96 | 8649 | 9854 |
TLR4 | 8864 | 9225 |
BTK | 7100 | 11184 |
TLR1 | 8782 | 8637 |
TLR6 | 8694 | 7538 |
TIRAP | 5571 | 6784 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BTK | 7100 | 11184 | 8838 |
CD14 | 8944 | 10372 | -5065 |
CD36 | 9283 | 11160 | 9413 |
LY96 | 8649 | 9854 | 7645 |
MYD88 | 8009 | 11413 | 3934 |
TIRAP | 5571 | 6784 | -3461 |
TLR1 | 8782 | 8637 | 7301 |
TLR2 | 8950 | 10582 | 9812 |
TLR4 | 8864 | 9225 | 1420 |
TLR6 | 8694 | 7538 | 2941 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism
metric | value |
---|---|
setSize | 12 |
pMANOVA | 2.9e-05 |
p.adjustMANOVA | 0.000125 |
s.dist | 1.03 |
s.t0_v_pod | 0.785 |
s.pod_crp | 0.642 |
s.t0_crp | 0.198 |
p.t0_v_pod | 2.48e-06 |
p.pod_crp | 0.000118 |
p.t0_crp | 0.235 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ACSL1 | 9060 | 10631 |
ACAA1 | 8162 | 11375 |
ACOT8 | 7896 | 10633 |
HSD17B4 | 8710 | 9531 |
ELOVL3 | 8568 | 9494 |
FADS1 | 7583 | 10137 |
ACOX1 | 8711 | 8327 |
ELOVL1 | 6984 | 10145 |
ABCD1 | 7236 | 6071 |
ELOVL5 | 5930 | 2279 |
FADS2 | 1476 | 5602 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ABCD1 | 7236 | 6071 | -8572 |
ACAA1 | 8162 | 11375 | -2561 |
ACOT8 | 7896 | 10633 | -6616 |
ACOX1 | 8711 | 8327 | 6705 |
ACSL1 | 9060 | 10631 | 6892 |
ELOVL1 | 6984 | 10145 | -1725 |
ELOVL3 | 8568 | 9494 | 10343 |
ELOVL5 | 5930 | 2279 | 6278 |
FADS1 | 7583 | 10137 | 5863 |
FADS2 | 1476 | 5602 | 422 |
HSD17B4 | 8710 | 9531 | 7514 |
SCP2 | 4410 | -1743 | 8558 |
alpha-linolenic acid (ALA) metabolism
metric | value |
---|---|
setSize | 12 |
pMANOVA | 2.9e-05 |
p.adjustMANOVA | 0.000125 |
s.dist | 1.03 |
s.t0_v_pod | 0.785 |
s.pod_crp | 0.642 |
s.t0_crp | 0.198 |
p.t0_v_pod | 2.48e-06 |
p.pod_crp | 0.000118 |
p.t0_crp | 0.235 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ACSL1 | 9060 | 10631 |
ACAA1 | 8162 | 11375 |
ACOT8 | 7896 | 10633 |
HSD17B4 | 8710 | 9531 |
ELOVL3 | 8568 | 9494 |
FADS1 | 7583 | 10137 |
ACOX1 | 8711 | 8327 |
ELOVL1 | 6984 | 10145 |
ABCD1 | 7236 | 6071 |
ELOVL5 | 5930 | 2279 |
FADS2 | 1476 | 5602 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ABCD1 | 7236 | 6071 | -8572 |
ACAA1 | 8162 | 11375 | -2561 |
ACOT8 | 7896 | 10633 | -6616 |
ACOX1 | 8711 | 8327 | 6705 |
ACSL1 | 9060 | 10631 | 6892 |
ELOVL1 | 6984 | 10145 | -1725 |
ELOVL3 | 8568 | 9494 | 10343 |
ELOVL5 | 5930 | 2279 | 6278 |
FADS1 | 7583 | 10137 | 5863 |
FADS2 | 1476 | 5602 | 422 |
HSD17B4 | 8710 | 9531 | 7514 |
SCP2 | 4410 | -1743 | 8558 |
Regulation of TLR by endogenous ligand
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.000123 |
p.adjustMANOVA | 0.000452 |
s.dist | 1.01 |
s.t0_v_pod | 0.743 |
s.pod_crp | 0.626 |
s.t0_crp | 0.269 |
p.t0_v_pod | 1.95e-05 |
p.pod_crp | 0.000322 |
p.t0_crp | 0.122 |
Gene | t0_v_pod | pod_crp |
---|---|---|
S100A9 | 9353 | 11235 |
S100A8 | 9341 | 11121 |
CD36 | 9283 | 11160 |
TLR2 | 8950 | 10582 |
CD14 | 8944 | 10372 |
LY96 | 8649 | 9854 |
TLR4 | 8864 | 9225 |
TLR1 | 8782 | 8637 |
TLR6 | 8694 | 7538 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD14 | 8944 | 10372 | -5065 |
CD36 | 9283 | 11160 | 9413 |
HMGB1 | -251 | -7642 | 4980 |
LY96 | 8649 | 9854 | 7645 |
S100A1 | -7825 | 890 | -2805 |
S100A8 | 9341 | 11121 | 2853 |
S100A9 | 9353 | 11235 | 226 |
TLR1 | 8782 | 8637 | 7301 |
TLR2 | 8950 | 10582 | 9812 |
TLR4 | 8864 | 9225 | 1420 |
TLR6 | 8694 | 7538 | 2941 |
Translocation of ZAP-70 to Immunological synapse
metric | value |
---|---|
setSize | 24 |
pMANOVA | 2.63e-09 |
p.adjustMANOVA | 2.99e-08 |
s.dist | 0.994 |
s.t0_v_pod | -0.743 |
s.pod_crp | -0.66 |
s.t0_crp | -0.00808 |
p.t0_v_pod | 2.86e-10 |
p.pod_crp | 2.12e-08 |
p.t0_crp | 0.945 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD247 | -11982 | -9454 |
LCK | -11482 | -9442 |
TRAC | -11130 | -9287 |
CD3E | -10952 | -9335 |
CD3G | -11173 | -9082 |
TRBC1 | -11646 | -8623 |
ZAP70 | -11590 | -8619 |
TRBV12-3 | -10099 | -9681 |
CD3D | -11049 | -8704 |
TRAV19 | -9587 | -9353 |
HLA-DPB1 | -11887 | -7068 |
HLA-DQB2 | -9085 | -8978 |
TRAV29DV5 | -9353 | -8284 |
HLA-DRA | -11649 | -6573 |
HLA-DPA1 | -11954 | -5815 |
TRBV7-9 | -9220 | -6700 |
TRAV8-4 | -7010 | -7565 |
HLA-DQA2 | -4652 | -9364 |
CD4 | -5228 | -4848 |
HLA-DQA1 | -11633 | -1453 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD247 | -11982 | -9454 | -8935 |
CD3D | -11049 | -8704 | 2046 |
CD3E | -10952 | -9335 | 5813 |
CD3G | -11173 | -9082 | 6756 |
CD4 | -5228 | -4848 | -1251 |
HLA-DPA1 | -11954 | -5815 | 946 |
HLA-DPB1 | -11887 | -7068 | -7160 |
HLA-DQA1 | -11633 | -1453 | 9693 |
HLA-DQA2 | -4652 | -9364 | -9927 |
HLA-DQB1 | -6199 | 3626 | 5107 |
HLA-DQB2 | -9085 | -8978 | -9720 |
HLA-DRA | -11649 | -6573 | 2695 |
HLA-DRB1 | -7792 | 1344 | 9366 |
HLA-DRB5 | -4806 | -1108 | 9092 |
LCK | -11482 | -9442 | -4194 |
PTPN22 | -1191 | 5545 | 9392 |
TRAC | -11130 | -9287 | 8688 |
TRAV19 | -9587 | -9353 | -6593 |
TRAV29DV5 | -9353 | -8284 | 4257 |
TRAV8-4 | -7010 | -7565 | 10068 |
TRBC1 | -11646 | -8623 | -1744 |
TRBV12-3 | -10099 | -9681 | -6812 |
TRBV7-9 | -9220 | -6700 | -5268 |
ZAP70 | -11590 | -8619 | -9003 |
Peptide chain elongation
metric | value |
---|---|
setSize | 88 |
pMANOVA | 1.95e-48 |
p.adjustMANOVA | 2.41e-46 |
s.dist | 0.986 |
s.t0_v_pod | -0.281 |
s.pod_crp | -0.702 |
s.t0_crp | -0.633 |
p.t0_v_pod | 5.05e-06 |
p.pod_crp | 4.04e-30 |
p.t0_crp | 9.1e-25 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
EEF1A1 | -9346 | -7605 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
EEF2 | -7032 | -9881 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EEF1A1 | -4918 | -9346 | -7605 |
EEF2 | 304 | -7032 | -9881 |
FAU | -359 | -1018 | -9018 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
UBA52 | 1112 | -1425 | -7104 |
Eukaryotic Translation Elongation
metric | value |
---|---|
setSize | 93 |
pMANOVA | 3.79e-51 |
p.adjustMANOVA | 1.03e-48 |
s.dist | 0.98 |
s.t0_v_pod | -0.273 |
s.pod_crp | -0.701 |
s.t0_crp | -0.629 |
p.t0_v_pod | 5.39e-06 |
p.pod_crp | 1.34e-31 |
p.t0_crp | 8.59e-26 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
EEF1G | -8918 | -9825 |
EEF1B2 | -9047 | -9449 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
EEF1A1 | -9346 | -7605 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
EEF2 | -7032 | -9881 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EEF1A1 | -4918 | -9346 | -7605 |
EEF1A1P5 | -1889 | -6556 | -5446 |
EEF1A2 | -4993 | -1930 | 7579 |
EEF1B2 | -4128 | -9047 | -9449 |
EEF1D | -805 | -4960 | -9517 |
EEF1G | -1364 | -8918 | -9825 |
EEF2 | 304 | -7032 | -9881 |
FAU | -359 | -1018 | -9018 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
UBA52 | 1112 | -1425 | -7104 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2
metric | value |
---|---|
setSize | 11 |
pMANOVA | 6.64e-05 |
p.adjustMANOVA | 0.000259 |
s.dist | 0.965 |
s.t0_v_pod | 0.67 |
s.pod_crp | 0.576 |
s.t0_crp | -0.389 |
p.t0_v_pod | 0.000119 |
p.pod_crp | 0.000945 |
p.t0_crp | 0.0256 |
Gene | t0_v_pod | pod_crp |
---|---|---|
FZD5 | 9350 | 11494 |
CLTC | 8849 | 9216 |
AP2A1 | 6737 | 11502 |
AP2S1 | 7903 | 9372 |
AP2A2 | 7150 | 10268 |
CLTA | 8244 | 7587 |
AP2M1 | 8486 | 7237 |
CLTB | 6002 | 8174 |
FZD2 | 6374 | 3945 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2A1 | 6737 | 11502 | -6569 |
AP2A2 | 7150 | 10268 | -7534 |
AP2B1 | -2641 | -3659 | -3248 |
AP2M1 | 8486 | 7237 | -8627 |
AP2S1 | 7903 | 9372 | -3704 |
CLTA | 8244 | 7587 | 492 |
CLTB | 6002 | 8174 | -8503 |
CLTC | 8849 | 9216 | 1230 |
FZD2 | 6374 | 3945 | -6834 |
FZD5 | 9350 | 11494 | 1416 |
ROR1 | -2323 | 1889 | 3248 |
Selenocysteine synthesis
metric | value |
---|---|
setSize | 92 |
pMANOVA | 4.47e-45 |
p.adjustMANOVA | 3.31e-43 |
s.dist | 0.948 |
s.t0_v_pod | -0.299 |
s.pod_crp | -0.68 |
s.t0_crp | -0.59 |
p.t0_v_pod | 7.43e-07 |
p.pod_crp | 1.63e-29 |
p.t0_crp | 1.27e-22 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EEFSEC | -9700 | -5202 | -5033 |
FAU | -359 | -1018 | -9018 |
PSTK | -9857 | -3048 | -2424 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
SARS1 | -5712 | -6385 | -5849 |
SECISBP2 | -9999 | -6029 | 7107 |
SEPHS2 | 7535 | 7158 | -56 |
SEPSECS | -10939 | -7023 | 6762 |
UBA52 | 1112 | -1425 | -7104 |
Viral mRNA Translation
metric | value |
---|---|
setSize | 88 |
pMANOVA | 4.24e-45 |
p.adjustMANOVA | 3.31e-43 |
s.dist | 0.945 |
s.t0_v_pod | -0.262 |
s.pod_crp | -0.679 |
s.t0_crp | -0.602 |
p.t0_v_pod | 2.13e-05 |
p.pod_crp | 2.75e-28 |
p.t0_crp | 1.45e-22 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DNAJC3 | 8302 | 8189 | 7460 |
FAU | -359 | -1018 | -9018 |
GRSF1 | 5110 | -3098 | 3896 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
UBA52 | 1112 | -1425 | -7104 |
Eukaryotic Translation Termination
metric | value |
---|---|
setSize | 92 |
pMANOVA | 5.58e-46 |
p.adjustMANOVA | 5.43e-44 |
s.dist | 0.936 |
s.t0_v_pod | -0.265 |
s.pod_crp | -0.674 |
s.t0_crp | -0.593 |
p.t0_v_pod | 1.13e-05 |
p.pod_crp | 4.4e-29 |
p.t0_crp | 7.6e-23 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APEH | 989 | 4413 | -8349 |
ETF1 | 7308 | 4260 | 7904 |
FAU | -359 | -1018 | -9018 |
GSPT1 | 6387 | -6536 | 7223 |
GSPT2 | -10067 | -8294 | -945 |
N6AMT1 | -10964 | -8846 | 239 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
TRMT112 | 732 | -366 | -8610 |
UBA52 | 1112 | -1425 | -7104 |
Hyaluronan uptake and degradation
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.000489 |
p.adjustMANOVA | 0.00146 |
s.dist | 0.918 |
s.t0_v_pod | 0.729 |
s.pod_crp | 0.514 |
s.t0_crp | -0.217 |
p.t0_v_pod | 6.53e-05 |
p.pod_crp | 0.00489 |
p.t0_crp | 0.234 |
Gene | t0_v_pod | pod_crp |
---|---|---|
HYAL2 | 8935 | 11497 |
SLC9A1 | 7847 | 11292 |
GUSB | 7607 | 11238 |
CHP1 | 9101 | 9267 |
CD44 | 8201 | 8363 |
HEXB | 8631 | 6847 |
HYAL1 | 4123 | 8509 |
HYAL3 | 5168 | 304 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD44 | 8201 | 8363 | 1308 |
CHP1 | 9101 | 9267 | -2016 |
GUSB | 7607 | 11238 | -5640 |
HEXA | 1251 | -437 | -3967 |
HEXB | 8631 | 6847 | 3887 |
HMMR | 3770 | -3451 | 3745 |
HYAL1 | 4123 | 8509 | 6499 |
HYAL2 | 8935 | 11497 | -6474 |
HYAL3 | 5168 | 304 | -7308 |
SLC9A1 | 7847 | 11292 | -6860 |
Formation of a pool of free 40S subunits
metric | value |
---|---|
setSize | 100 |
pMANOVA | 3.12e-52 |
p.adjustMANOVA | 1.06e-49 |
s.dist | 0.914 |
s.t0_v_pod | -0.208 |
s.pod_crp | -0.677 |
s.t0_crp | -0.577 |
p.t0_v_pod | 0.000327 |
p.pod_crp | 1.03e-31 |
p.t0_crp | 1.85e-23 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
EIF3B | -8831 | -8507 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
EIF3L | -7724 | -8957 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8352 | 8447 |
EIF3A | 2132 | -1524 | 1889 |
EIF3B | -7776 | -8831 | -8507 |
EIF3C | 285 | -3719 | -9547 |
EIF3D | 2605 | -4304 | -5425 |
EIF3E | 1902 | -8557 | 7960 |
EIF3F | 970 | -3717 | -9911 |
EIF3G | 871 | -1661 | -9388 |
EIF3H | 4677 | -5855 | -1314 |
EIF3I | 4649 | -2647 | -7649 |
EIF3J | 1885 | -5962 | 9440 |
EIF3K | 1468 | -294 | -5982 |
EIF3L | 2560 | -7724 | -8957 |
EIF3M | 4533 | -5583 | 8254 |
FAU | -359 | -1018 | -9018 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
UBA52 | 1112 | -1425 | -7104 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
metric | value |
---|---|
setSize | 94 |
pMANOVA | 2.69e-43 |
p.adjustMANOVA | 1.83e-41 |
s.dist | 0.89 |
s.t0_v_pod | -0.244 |
s.pod_crp | -0.653 |
s.t0_crp | -0.553 |
p.t0_v_pod | 4.23e-05 |
p.pod_crp | 6.26e-28 |
p.t0_crp | 1.92e-20 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF4G1 | 7908 | 9779 | -6766 |
ETF1 | 7308 | 4260 | 7904 |
FAU | -359 | -1018 | -9018 |
GSPT1 | 6387 | -6536 | 7223 |
GSPT2 | -10067 | -8294 | -945 |
NCBP1 | -5659 | -1114 | 10474 |
NCBP2 | -9239 | -8170 | 10809 |
PABPC1 | 5290 | -3454 | 4415 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
UBA52 | 1112 | -1425 | -7104 |
UPF1 | 4629 | 6901 | -6523 |
Unwinding of DNA
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.000824 |
p.adjustMANOVA | 0.00233 |
s.dist | 0.886 |
s.t0_v_pod | -0.637 |
s.pod_crp | -0.614 |
s.t0_crp | -0.0512 |
p.t0_v_pod | 0.000133 |
p.pod_crp | 0.000229 |
p.t0_crp | 0.759 |
Gene | t0_v_pod | pod_crp |
---|---|---|
MCM3 | -11839 | -9726 |
MCM7 | -11768 | -7678 |
MCM6 | -9393 | -9254 |
GINS4 | -9903 | -8158 |
MCM8 | -10599 | -6098 |
MCM4 | -8404 | -7585 |
MCM2 | -6973 | -7515 |
GINS3 | -10170 | -3967 |
GINS2 | -4661 | -3252 |
CDC45 | -2594 | -5606 |
GINS1 | -4261 | -966 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CDC45 | -2594 | -5606 | 408 |
GINS1 | -4261 | -966 | 8820 |
GINS2 | -4661 | -3252 | 3986 |
GINS3 | -10170 | -3967 | 4589 |
GINS4 | -9903 | -8158 | 136 |
MCM2 | -6973 | -7515 | -6936 |
MCM3 | -11839 | -9726 | -2416 |
MCM4 | -8404 | -7585 | -850 |
MCM5 | -7039 | 1270 | -7307 |
MCM6 | -9393 | -9254 | 448 |
MCM7 | -11768 | -7678 | -3106 |
MCM8 | -10599 | -6098 | 3359 |
Uptake and function of anthrax toxins
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.000939 |
p.adjustMANOVA | 0.0026 |
s.dist | 0.85 |
s.t0_v_pod | 0.704 |
s.pod_crp | 0.433 |
s.t0_crp | -0.2 |
p.t0_v_pod | 0.000117 |
p.pod_crp | 0.0178 |
p.t0_crp | 0.274 |
Gene | t0_v_pod | pod_crp |
---|---|---|
FURIN | 8922 | 10150 |
MAP2K1 | 8910 | 10086 |
MAP2K6 | 8739 | 10133 |
MAP2K3 | 8604 | 9627 |
PDCD6IP | 6440 | 8445 |
MAP2K2 | 6699 | 5024 |
MAP2K4 | 6770 | 4537 |
ANTXR2 | 7221 | 773 |
MAP2K7 | 1641 | 1095 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ANTXR2 | 7221 | 773 | -4662 |
CALM1 | -2039 | -5114 | 3302 |
FURIN | 8922 | 10150 | -9942 |
MAP2K1 | 8910 | 10086 | -3295 |
MAP2K2 | 6699 | 5024 | -9806 |
MAP2K3 | 8604 | 9627 | -5657 |
MAP2K4 | 6770 | 4537 | 4618 |
MAP2K6 | 8739 | 10133 | 8244 |
MAP2K7 | 1641 | 1095 | -8952 |
PDCD6IP | 6440 | 8445 | 11228 |
MET activates RAP1 and RAC1
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.00432 |
p.adjustMANOVA | 0.00968 |
s.dist | 0.833 |
s.t0_v_pod | 0.53 |
s.pod_crp | 0.515 |
s.t0_crp | 0.385 |
p.t0_v_pod | 0.00371 |
p.pod_crp | 0.00484 |
p.t0_crp | 0.0352 |
Gene | t0_v_pod | pod_crp |
---|---|---|
GRB2 | 9146 | 10742 |
RAC1 | 8647 | 10726 |
HGF | 8715 | 10153 |
CRK | 8756 | 9243 |
GAB1 | 5607 | 9590 |
RAP1A | 7198 | 6943 |
RAP1B | 3179 | 5307 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CRK | 8756 | 9243 | 8031 |
CRKL | 3927 | -235 | -3231 |
DOCK7 | -2317 | -2789 | 6036 |
GAB1 | 5607 | 9590 | 8595 |
GRB2 | 9146 | 10742 | 73 |
HGF | 8715 | 10153 | 7901 |
RAC1 | 8647 | 10726 | 9288 |
RAP1A | 7198 | 6943 | 11289 |
RAP1B | 3179 | 5307 | 7206 |
RAPGEF1 | -9501 | 3813 | -7683 |
VLDLR internalisation and degradation
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.00035 |
p.adjustMANOVA | 0.00112 |
s.dist | 0.83 |
s.t0_v_pod | 0.468 |
s.pod_crp | 0.484 |
s.t0_crp | -0.486 |
p.t0_v_pod | 0.00718 |
p.pod_crp | 0.00547 |
p.t0_crp | 0.00527 |
Gene | t0_crp | pod_crp |
---|---|---|
NR1H2 | -8719 | 9255 |
AP2A2 | -7534 | 10268 |
AP2A1 | -6569 | 11502 |
AP2M1 | -8627 | 7237 |
AP2S1 | -3704 | 9372 |
VLDLR | -4084 | 7505 |
NR1H3 | -4706 | 5401 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2A1 | 6737 | 11502 | -6569 |
AP2A2 | 7150 | 10268 | -7534 |
AP2B1 | -2641 | -3659 | -3248 |
AP2M1 | 8486 | 7237 | -8627 |
AP2S1 | 7903 | 9372 | -3704 |
CLTA | 8244 | 7587 | 492 |
CLTC | 8849 | 9216 | 1230 |
MYLIP | -3870 | -7475 | -4584 |
NR1H2 | 7304 | 9255 | -8719 |
NR1H3 | -3491 | 5401 | -4706 |
VLDLR | -4246 | 7505 | -4084 |
Response of EIF2AK4 (GCN2) to amino acid deficiency
metric | value |
---|---|
setSize | 100 |
pMANOVA | 5.74e-41 |
p.adjustMANOVA | 3.72e-39 |
s.dist | 0.827 |
s.t0_v_pod | -0.222 |
s.pod_crp | -0.628 |
s.t0_crp | -0.49 |
p.t0_v_pod | 0.000128 |
p.pod_crp | 1.65e-27 |
p.t0_crp | 2.35e-17 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ASNS | -8030 | -6156 | 8887 |
ATF2 | 2072 | -4907 | 10911 |
ATF3 | -9357 | -2868 | 434 |
ATF4 | 6151 | -983 | -3406 |
CEBPB | 7875 | 10842 | 597 |
CEBPG | 5401 | 1944 | 10708 |
DDIT3 | 4850 | 3470 | 2876 |
EIF2AK4 | 41 | -1588 | -1986 |
EIF2S1 | 4235 | -3323 | 9204 |
EIF2S2 | 6091 | 297 | 8972 |
EIF2S3 | 6653 | 1299 | 9884 |
FAU | -359 | -1018 | -9018 |
GCN1 | -10036 | -6501 | -4215 |
IMPACT | -3125 | -6727 | 10238 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
TRIB3 | -5649 | -1353 | -1340 |
UBA52 | 1112 | -1425 | -7104 |
L13a-mediated translational silencing of Ceruloplasmin expression
metric | value |
---|---|
setSize | 110 |
pMANOVA | 7.42e-50 |
p.adjustMANOVA | 1.26e-47 |
s.dist | 0.812 |
s.t0_v_pod | -0.143 |
s.pod_crp | -0.621 |
s.t0_crp | -0.503 |
p.t0_v_pod | 0.00949 |
p.pod_crp | 1.83e-29 |
p.t0_crp | 7.74e-20 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
EIF3B | -8831 | -8507 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
EIF3L | -7724 | -8957 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8352 | 8447 |
EIF2S1 | 4235 | -3323 | 9204 |
EIF2S2 | 6091 | 297 | 8972 |
EIF2S3 | 6653 | 1299 | 9884 |
EIF3A | 2132 | -1524 | 1889 |
EIF3B | -7776 | -8831 | -8507 |
EIF3C | 285 | -3719 | -9547 |
EIF3D | 2605 | -4304 | -5425 |
EIF3E | 1902 | -8557 | 7960 |
EIF3F | 970 | -3717 | -9911 |
EIF3G | 871 | -1661 | -9388 |
EIF3H | 4677 | -5855 | -1314 |
EIF3I | 4649 | -2647 | -7649 |
EIF3J | 1885 | -5962 | 9440 |
EIF3K | 1468 | -294 | -5982 |
EIF3L | 2560 | -7724 | -8957 |
EIF3M | 4533 | -5583 | 8254 |
EIF4A1 | 7476 | 5864 | 1477 |
EIF4A2 | -10809 | -9312 | 9673 |
EIF4B | 1237 | -8286 | -6402 |
EIF4E | 4757 | 2088 | 11218 |
EIF4G1 | 7908 | 9779 | -6766 |
EIF4H | 7634 | 7346 | -9456 |
FAU | -359 | -1018 | -9018 |
PABPC1 | 5290 | -3454 | 4415 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
UBA52 | 1112 | -1425 | -7104 |
GTP hydrolysis and joining of the 60S ribosomal subunit
metric | value |
---|---|
setSize | 111 |
pMANOVA | 1.02e-48 |
p.adjustMANOVA | 1.38e-46 |
s.dist | 0.8 |
s.t0_v_pod | -0.147 |
s.pod_crp | -0.619 |
s.t0_crp | -0.486 |
p.t0_v_pod | 0.00738 |
p.pod_crp | 1.7e-29 |
p.t0_crp | 9.15e-19 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
EIF3B | -8831 | -8507 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
EIF3L | -7724 | -8957 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8352 | 8447 |
EIF2S1 | 4235 | -3323 | 9204 |
EIF2S2 | 6091 | 297 | 8972 |
EIF2S3 | 6653 | 1299 | 9884 |
EIF3A | 2132 | -1524 | 1889 |
EIF3B | -7776 | -8831 | -8507 |
EIF3C | 285 | -3719 | -9547 |
EIF3D | 2605 | -4304 | -5425 |
EIF3E | 1902 | -8557 | 7960 |
EIF3F | 970 | -3717 | -9911 |
EIF3G | 871 | -1661 | -9388 |
EIF3H | 4677 | -5855 | -1314 |
EIF3I | 4649 | -2647 | -7649 |
EIF3J | 1885 | -5962 | 9440 |
EIF3K | 1468 | -294 | -5982 |
EIF3L | 2560 | -7724 | -8957 |
EIF3M | 4533 | -5583 | 8254 |
EIF4A1 | 7476 | 5864 | 1477 |
EIF4A2 | -10809 | -9312 | 9673 |
EIF4B | 1237 | -8286 | -6402 |
EIF4E | 4757 | 2088 | 11218 |
EIF4G1 | 7908 | 9779 | -6766 |
EIF4H | 7634 | 7346 | -9456 |
EIF5 | 2162 | -411 | 10513 |
EIF5B | -4487 | -5892 | 9461 |
FAU | -359 | -1018 | -9018 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
UBA52 | 1112 | -1425 | -7104 |
WNT5A-dependent internalization of FZD4
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.000126 |
p.adjustMANOVA | 0.000461 |
s.dist | 0.798 |
s.t0_v_pod | 0.449 |
s.pod_crp | 0.425 |
s.t0_crp | -0.505 |
p.t0_v_pod | 0.00507 |
p.pod_crp | 0.00803 |
p.t0_crp | 0.00161 |
Gene | t0_crp | t0_v_pod |
---|---|---|
AP2M1 | -8627 | 8486 |
PRKCB | -7987 | 6993 |
AP2A2 | -7534 | 7150 |
CLTB | -8503 | 6002 |
AP2A1 | -6569 | 6737 |
ARRB2 | -5123 | 8355 |
AP2S1 | -3704 | 7903 |
PRKCA | -5853 | 1123 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2A1 | 6737 | 11502 | -6569 |
AP2A2 | 7150 | 10268 | -7534 |
AP2B1 | -2641 | -3659 | -3248 |
AP2M1 | 8486 | 7237 | -8627 |
AP2S1 | 7903 | 9372 | -3704 |
ARRB2 | 8355 | 10835 | -5123 |
CLTA | 8244 | 7587 | 492 |
CLTB | 6002 | 8174 | -8503 |
CLTC | 8849 | 9216 | 1230 |
DVL2 | -10804 | -4871 | -9045 |
FZD4 | -11295 | 2975 | 2621 |
PRKCA | 1123 | -5628 | -5853 |
PRKCB | 6993 | 7023 | -7987 |
Advanced glycosylation endproduct receptor signaling
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00138 |
p.adjustMANOVA | 0.00359 |
s.dist | 0.798 |
s.t0_v_pod | 0.65 |
s.pod_crp | 0.456 |
s.t0_crp | -0.0797 |
p.t0_v_pod | 9.71e-05 |
p.pod_crp | 0.00619 |
p.t0_crp | 0.633 |
Gene | t0_v_pod | pod_crp |
---|---|---|
S100A12 | 9352 | 10889 |
MAPK3 | 8803 | 9501 |
LGALS3 | 8608 | 9166 |
MAPK1 | 7381 | 10667 |
CAPZA2 | 8457 | 7902 |
CAPZA1 | 8008 | 7934 |
DDOST | 6831 | 7376 |
APP | 9022 | 3287 |
PRKCSH | 5159 | 5638 |
AGER | 1284 | 7637 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AGER | 1284 | 7637 | 228 |
APP | 9022 | 3287 | -2433 |
CAPZA1 | 8008 | 7934 | 10601 |
CAPZA2 | 8457 | 7902 | 9795 |
DDOST | 6831 | 7376 | -7998 |
HMGB1 | -251 | -7642 | 4980 |
LGALS3 | 8608 | 9166 | 230 |
MAPK1 | 7381 | 10667 | -1770 |
MAPK3 | 8803 | 9501 | -9768 |
PRKCSH | 5159 | 5638 | -9511 |
S100A12 | 9352 | 10889 | 3333 |
S100B | -5273 | -3630 | -217 |
Gap junction trafficking
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.000739 |
p.adjustMANOVA | 0.00212 |
s.dist | 0.781 |
s.t0_v_pod | 0.564 |
s.pod_crp | 0.455 |
s.t0_crp | -0.292 |
p.t0_v_pod | 0.000432 |
p.pod_crp | 0.00448 |
p.t0_crp | 0.0683 |
Gene | t0_v_pod | pod_crp |
---|---|---|
DAB2 | 7985 | 10708 |
GJD3 | 7874 | 10701 |
CLTC | 8849 | 9216 |
CLTCL1 | 8815 | 8901 |
CLTA | 8244 | 7587 |
AP2M1 | 8486 | 7237 |
DNM2 | 6007 | 9598 |
CLTB | 6002 | 8174 |
DNM1 | 3555 | 5772 |
GJC1 | 512 | 5804 |
GJC2 | 1074 | 2370 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2M1 | 8486 | 7237 | -8627 |
CLTA | 8244 | 7587 | 492 |
CLTB | 6002 | 8174 | -8503 |
CLTC | 8849 | 9216 | 1230 |
CLTCL1 | 8815 | 8901 | -5432 |
DAB2 | 7985 | 10708 | -7018 |
DNM1 | 3555 | 5772 | 7505 |
DNM2 | 6007 | 9598 | -9051 |
GJB6 | 4708 | -4124 | -9998 |
GJC1 | 512 | 5804 | 1908 |
GJC2 | 1074 | 2370 | -2725 |
GJD3 | 7874 | 10701 | 1754 |
MYO6 | -11058 | -7648 | 6236 |
PD-1 signaling
metric | value |
---|---|
setSize | 28 |
pMANOVA | 9.24e-07 |
p.adjustMANOVA | 6.32e-06 |
s.dist | 0.781 |
s.t0_v_pod | -0.579 |
s.pod_crp | -0.524 |
s.t0_crp | 0.00712 |
p.t0_v_pod | 1.13e-07 |
p.pod_crp | 1.55e-06 |
p.t0_crp | 0.948 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD247 | -11982 | -9454 |
LCK | -11482 | -9442 |
TRAC | -11130 | -9287 |
CD3E | -10952 | -9335 |
CD3G | -11173 | -9082 |
TRBC1 | -11646 | -8623 |
TRBV12-3 | -10099 | -9681 |
CD3D | -11049 | -8704 |
TRAV19 | -9587 | -9353 |
HLA-DPB1 | -11887 | -7068 |
HLA-DQB2 | -9085 | -8978 |
TRAV29DV5 | -9353 | -8284 |
HLA-DRA | -11649 | -6573 |
HLA-DPA1 | -11954 | -5815 |
TRBV7-9 | -9220 | -6700 |
CD274 | -7301 | -7386 |
TRAV8-4 | -7010 | -7565 |
PDCD1 | -6559 | -7948 |
HLA-DQA2 | -4652 | -9364 |
CD4 | -5228 | -4848 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD247 | -11982 | -9454 | -8935 |
CD274 | -7301 | -7386 | 7660 |
CD3D | -11049 | -8704 | 2046 |
CD3E | -10952 | -9335 | 5813 |
CD3G | -11173 | -9082 | 6756 |
CD4 | -5228 | -4848 | -1251 |
CSK | 5158 | 10149 | -6693 |
HLA-DPA1 | -11954 | -5815 | 946 |
HLA-DPB1 | -11887 | -7068 | -7160 |
HLA-DQA1 | -11633 | -1453 | 9693 |
HLA-DQA2 | -4652 | -9364 | -9927 |
HLA-DQB1 | -6199 | 3626 | 5107 |
HLA-DQB2 | -9085 | -8978 | -9720 |
HLA-DRA | -11649 | -6573 | 2695 |
HLA-DRB1 | -7792 | 1344 | 9366 |
HLA-DRB5 | -4806 | -1108 | 9092 |
LCK | -11482 | -9442 | -4194 |
PDCD1 | -6559 | -7948 | 2964 |
PDCD1LG2 | -3235 | 4094 | 6587 |
PTPN11 | 5253 | 2833 | -599 |
PTPN6 | 6014 | 11061 | -2766 |
TRAC | -11130 | -9287 | 8688 |
TRAV19 | -9587 | -9353 | -6593 |
TRAV29DV5 | -9353 | -8284 | 4257 |
TRAV8-4 | -7010 | -7565 | 10068 |
TRBC1 | -11646 | -8623 | -1744 |
TRBV12-3 | -10099 | -9681 | -6812 |
TRBV7-9 | -9220 | -6700 | -5268 |
RNA Polymerase I Promoter Opening
metric | value |
---|---|
setSize | 19 |
pMANOVA | 4.47e-08 |
p.adjustMANOVA | 3.9e-07 |
s.dist | 0.779 |
s.t0_v_pod | 0.616 |
s.pod_crp | 0.198 |
s.t0_crp | -0.434 |
p.t0_v_pod | 3.31e-06 |
p.pod_crp | 0.135 |
p.t0_crp | 0.00106 |
Gene | t0_v_pod | t0_crp |
---|---|---|
MAPK3 | 8803.0 | -9768.0 |
H2BC12 | 8898.0 | -8447.0 |
H2AJ | 9214.0 | -7261.0 |
H2BC17 | 7178.0 | -8062.0 |
H2BC4 | 7279.0 | -7646.0 |
H3C15 | 6608.5 | -7756.5 |
H2AZ1 | 5955.0 | -8479.0 |
H2BC21 | 9125.0 | -5196.0 |
H2BC11 | 7791.0 | -5526.0 |
H2BC9 | 5332.0 | -6635.0 |
H2AC6 | 7813.0 | -4205.0 |
H2BC5 | 7881.0 | -2937.0 |
H2BC15 | 5251.0 | -4235.0 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
H2AC20 | 4913.0 | 8671.0 | 3752.0 |
H2AC6 | 7813.0 | -1814.0 | -4205.0 |
H2AJ | 9214.0 | 11405.0 | -7261.0 |
H2AZ1 | 5955.0 | 2933.0 | -8479.0 |
H2AZ2 | -1192.0 | -5862.0 | -2370.0 |
H2BC11 | 7791.0 | 3262.0 | -5526.0 |
H2BC12 | 8898.0 | 6037.0 | -8447.0 |
H2BC15 | 5251.0 | 523.0 | -4235.0 |
H2BC17 | 7178.0 | 3760.0 | -8062.0 |
H2BC21 | 9125.0 | 6114.0 | -5196.0 |
H2BC4 | 7279.0 | 4199.0 | -7646.0 |
H2BC5 | 7881.0 | 4394.0 | -2937.0 |
H2BC9 | 5332.0 | -6224.0 | -6635.0 |
H2BU1 | -6332.0 | -2185.0 | 2615.0 |
H3-3A | 8519.0 | 7532.0 | 5003.0 |
H3C15 | 6608.5 | 6537.5 | -7756.5 |
MAPK3 | 8803.0 | 9501.0 | -9768.0 |
MBD2 | 6491.0 | 6444.0 | 9027.0 |
UBTF | -9703.0 | -8842.0 | -7719.0 |
Activation of the pre-replicative complex
metric | value |
---|---|
setSize | 32 |
pMANOVA | 2.09e-08 |
p.adjustMANOVA | 1.96e-07 |
s.dist | 0.771 |
s.t0_v_pod | -0.482 |
s.pod_crp | -0.579 |
s.t0_crp | 0.166 |
p.t0_v_pod | 2.37e-06 |
p.pod_crp | 1.45e-08 |
p.t0_crp | 0.105 |
Gene | pod_crp | t0_v_pod |
---|---|---|
MCM3 | -9726 | -11839 |
POLA1 | -9617 | -11789 |
RPA1 | -9614 | -11644 |
POLE3 | -8881 | -11228 |
MCM7 | -7678 | -11768 |
DBF4 | -8441 | -10581 |
MCM6 | -9254 | -9393 |
PRIM1 | -8226 | -9858 |
ORC3 | -7526 | -10371 |
ORC2 | -8055 | -9594 |
ORC5 | -8047 | -9161 |
POLA2 | -6182 | -11222 |
RPA3 | -8027 | -8609 |
MCM8 | -6098 | -10599 |
MCM4 | -7585 | -8404 |
POLE2 | -6619 | -9613 |
MCM2 | -7515 | -6973 |
PRIM2 | -5615 | -5389 |
RPA2 | -4586 | -6094 |
CDK2 | -3663 | -4840 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CDC45 | -2594 | -5606 | 408 |
CDC6 | 2356 | -5442 | 5857 |
CDC7 | -7583 | 813 | 3389 |
CDK2 | -4840 | -3663 | 2221 |
CDT1 | -285 | -4001 | -2179 |
DBF4 | -10581 | -8441 | 10866 |
GMNN | 1412 | 5224 | 7502 |
MCM10 | 769 | -6736 | 2954 |
MCM2 | -6973 | -7515 | -6936 |
MCM3 | -11839 | -9726 | -2416 |
MCM4 | -8404 | -7585 | -850 |
MCM5 | -7039 | 1270 | -7307 |
MCM6 | -9393 | -9254 | 448 |
MCM7 | -11768 | -7678 | -3106 |
MCM8 | -10599 | -6098 | 3359 |
ORC1 | -2459 | -5122 | 968 |
ORC2 | -9594 | -8055 | 7100 |
ORC3 | -10371 | -7526 | 10738 |
ORC4 | -1988 | -5653 | 9250 |
ORC5 | -9161 | -8047 | 9437 |
ORC6 | 1174 | 8434 | 1504 |
POLA1 | -11789 | -9617 | -2014 |
POLA2 | -11222 | -6182 | 7454 |
POLE | -7317 | -1466 | -857 |
POLE2 | -9613 | -6619 | 10055 |
POLE3 | -11228 | -8881 | -6530 |
POLE4 | 5453 | -1174 | -1480 |
PRIM1 | -9858 | -8226 | 8710 |
PRIM2 | -5389 | -5615 | 5609 |
RPA1 | -11644 | -9614 | -4577 |
RPA2 | -6094 | -4586 | 5338 |
RPA3 | -8609 | -8027 | 2201 |
NOTCH4 Activation and Transmission of Signal to the Nucleus
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.0158 |
p.adjustMANOVA | 0.0299 |
s.dist | 0.762 |
s.t0_v_pod | 0.528 |
s.pod_crp | 0.549 |
s.t0_crp | 0.0138 |
p.t0_v_pod | 0.00386 |
p.pod_crp | 0.00264 |
p.t0_crp | 0.94 |
Gene | pod_crp | t0_v_pod |
---|---|---|
NCSTN | 11510 | 9030 |
PSEN1 | 10691 | 7839 |
ADAM10 | 9006 | 8645 |
JAG1 | 7763 | 8599 |
APH1B | 9075 | 6194 |
PSENEN | 9702 | 5662 |
APH1A | 2189 | 4092 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ADAM10 | 8645 | 9006 | 7606 |
APH1A | 4092 | 2189 | -7794 |
APH1B | 6194 | 9075 | 8475 |
JAG1 | 8599 | 7763 | -5969 |
NCSTN | 9030 | 11510 | 3979 |
NOTCH4 | -5056 | 11286 | -3210 |
PSEN1 | 7839 | 10691 | 5400 |
PSEN2 | -7449 | -3399 | -8440 |
PSENEN | 5662 | 9702 | -1424 |
YWHAZ | 5555 | -640 | 9258 |
Formation of the ternary complex, and subsequently, the 43S complex
metric | value |
---|---|
setSize | 51 |
pMANOVA | 3.07e-23 |
p.adjustMANOVA | 9.95e-22 |
s.dist | 0.759 |
s.t0_v_pod | -0.0831 |
s.pod_crp | -0.612 |
s.t0_crp | -0.441 |
p.t0_v_pod | 0.305 |
p.pod_crp | 3.87e-14 |
p.t0_crp | 5.15e-08 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
EIF3B | -8831 | -8507 |
RPS27 | -8218 | -8994 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
EIF3L | -7724 | -8957 |
RPS17 | -7093 | -9634 |
RPS10 | -7587 | -8910 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
RPS6 | -9127 | -7094 |
RPS23 | -8292 | -7435 |
RPS21 | -6666 | -9210 |
RPS15A | -7870 | -7555 |
RPS11 | -6701 | -8383 |
RPS28 | -6389 | -8638 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8352 | 8447 |
EIF2S1 | 4235 | -3323 | 9204 |
EIF2S2 | 6091 | 297 | 8972 |
EIF2S3 | 6653 | 1299 | 9884 |
EIF3A | 2132 | -1524 | 1889 |
EIF3B | -7776 | -8831 | -8507 |
EIF3C | 285 | -3719 | -9547 |
EIF3D | 2605 | -4304 | -5425 |
EIF3E | 1902 | -8557 | 7960 |
EIF3F | 970 | -3717 | -9911 |
EIF3G | 871 | -1661 | -9388 |
EIF3H | 4677 | -5855 | -1314 |
EIF3I | 4649 | -2647 | -7649 |
EIF3J | 1885 | -5962 | 9440 |
EIF3K | 1468 | -294 | -5982 |
EIF3L | 2560 | -7724 | -8957 |
EIF3M | 4533 | -5583 | 8254 |
FAU | -359 | -1018 | -9018 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
Retrograde neurotrophin signalling
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00114 |
p.adjustMANOVA | 0.0031 |
s.dist | 0.757 |
s.t0_v_pod | 0.566 |
s.pod_crp | 0.378 |
s.t0_crp | -0.33 |
p.t0_v_pod | 0.00068 |
p.pod_crp | 0.0235 |
p.t0_crp | 0.0476 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CLTC | 8849 | 9216 |
AP2A1 | 6737 | 11502 |
AP2S1 | 7903 | 9372 |
AP2A2 | 7150 | 10268 |
CLTA | 8244 | 7587 |
AP2M1 | 8486 | 7237 |
DNM2 | 6007 | 9598 |
DNM1 | 3555 | 5772 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2A1 | 6737 | 11502 | -6569 |
AP2A2 | 7150 | 10268 | -7534 |
AP2B1 | -2641 | -3659 | -3248 |
AP2M1 | 8486 | 7237 | -8627 |
AP2S1 | 7903 | 9372 | -3704 |
CLTA | 8244 | 7587 | 492 |
CLTC | 8849 | 9216 | 1230 |
DNAL4 | 3369 | -610 | -8724 |
DNM1 | 3555 | 5772 | 7505 |
DNM2 | 6007 | 9598 | -9051 |
DNM3 | 6942 | -246 | -1342 |
NTRK1 | -7910 | -7418 | 4917 |
DNA strand elongation
metric | value |
---|---|
setSize | 32 |
pMANOVA | 2.89e-07 |
p.adjustMANOVA | 2.15e-06 |
s.dist | 0.751 |
s.t0_v_pod | -0.522 |
s.pod_crp | -0.535 |
s.t0_crp | 0.0719 |
p.t0_v_pod | 3.22e-07 |
p.pod_crp | 1.59e-07 |
p.t0_crp | 0.482 |
Gene | pod_crp | t0_v_pod |
---|---|---|
MCM3 | -9726 | -11839 |
POLA1 | -9617 | -11789 |
RPA1 | -9614 | -11644 |
POLD2 | -9699 | -10015 |
LIG1 | -8575 | -10705 |
MCM7 | -7678 | -11768 |
RFC3 | -8651 | -10151 |
MCM6 | -9254 | -9393 |
PRIM1 | -8226 | -9858 |
GINS4 | -8158 | -9903 |
RFC4 | -7694 | -10361 |
FEN1 | -7081 | -10254 |
POLA2 | -6182 | -11222 |
RPA3 | -8027 | -8609 |
MCM8 | -6098 | -10599 |
MCM4 | -7585 | -8404 |
MCM2 | -7515 | -6973 |
RFC5 | -3955 | -11357 |
GINS3 | -3967 | -10170 |
PCNA | -6800 | -5771 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CDC45 | -2594 | -5606 | 408 |
DNA2 | -2786 | -3986 | 9591 |
FEN1 | -10254 | -7081 | -1614 |
GINS1 | -4261 | -966 | 8820 |
GINS2 | -4661 | -3252 | 3986 |
GINS3 | -10170 | -3967 | 4589 |
GINS4 | -9903 | -8158 | 136 |
LIG1 | -10705 | -8575 | -5384 |
MCM2 | -6973 | -7515 | -6936 |
MCM3 | -11839 | -9726 | -2416 |
MCM4 | -8404 | -7585 | -850 |
MCM5 | -7039 | 1270 | -7307 |
MCM6 | -9393 | -9254 | 448 |
MCM7 | -11768 | -7678 | -3106 |
MCM8 | -10599 | -6098 | 3359 |
PCNA | -5771 | -6800 | 5825 |
POLA1 | -11789 | -9617 | -2014 |
POLA2 | -11222 | -6182 | 7454 |
POLD1 | 202 | 644 | -8553 |
POLD2 | -10015 | -9699 | -6885 |
POLD3 | 8737 | 11080 | 8461 |
POLD4 | 6250 | 10181 | -6882 |
PRIM1 | -9858 | -8226 | 8710 |
PRIM2 | -5389 | -5615 | 5609 |
RFC1 | -7180 | -5456 | 9242 |
RFC2 | 4890 | 4788 | -676 |
RFC3 | -10151 | -8651 | 7668 |
RFC4 | -10361 | -7694 | 9525 |
RFC5 | -11357 | -3955 | 885 |
RPA1 | -11644 | -9614 | -4577 |
RPA2 | -6094 | -4586 | 5338 |
RPA3 | -8609 | -8027 | 2201 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
metric | value |
---|---|
setSize | 114 |
pMANOVA | 1.49e-38 |
p.adjustMANOVA | 8.47e-37 |
s.dist | 0.75 |
s.t0_v_pod | -0.195 |
s.pod_crp | -0.565 |
s.t0_crp | -0.453 |
p.t0_v_pod | 0.000316 |
p.pod_crp | 1.92e-25 |
p.t0_crp | 6.13e-17 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CASC3 | 5181 | 7006 | -5031 |
DCP1A | -5260 | -7314 | 6943 |
EIF4A3 | 7166 | -906 | -5617 |
EIF4G1 | 7908 | 9779 | -6766 |
ETF1 | 7308 | 4260 | 7904 |
FAU | -359 | -1018 | -9018 |
GSPT1 | 6387 | -6536 | 7223 |
GSPT2 | -10067 | -8294 | -945 |
MAGOH | 1045 | -1915 | -9023 |
MAGOHB | -9011 | -4014 | 6918 |
NCBP1 | -5659 | -1114 | 10474 |
NCBP2 | -9239 | -8170 | 10809 |
PABPC1 | 5290 | -3454 | 4415 |
PNRC2 | -4406 | -5080 | 11232 |
PPP2CA | 8104 | 4832 | 5474 |
PPP2R1A | 4542 | 4551 | -7355 |
PPP2R2A | 4102 | -1321 | 11284 |
RBM8A | -7139 | -2954 | -5165 |
RNPS1 | -11075 | -6991 | -5614 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
SMG1 | -4341 | -1647 | 151 |
SMG5 | 5264 | -1860 | -6622 |
SMG6 | -6032 | -4410 | -5381 |
SMG7 | 6519 | 9295 | 4117 |
SMG8 | 2894 | 661 | 6082 |
SMG9 | 204 | 9094 | 223 |
UBA52 | 1112 | -1425 | -7104 |
UPF1 | 4629 | 6901 | -6523 |
UPF2 | 957 | -226 | 10140 |
UPF3A | -9509 | -7793 | -4252 |
UPF3B | -8003 | -3038 | 7886 |
Nonsense-Mediated Decay (NMD)
metric | value |
---|---|
setSize | 114 |
pMANOVA | 1.49e-38 |
p.adjustMANOVA | 8.47e-37 |
s.dist | 0.75 |
s.t0_v_pod | -0.195 |
s.pod_crp | -0.565 |
s.t0_crp | -0.453 |
p.t0_v_pod | 0.000316 |
p.pod_crp | 1.92e-25 |
p.t0_crp | 6.13e-17 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CASC3 | 5181 | 7006 | -5031 |
DCP1A | -5260 | -7314 | 6943 |
EIF4A3 | 7166 | -906 | -5617 |
EIF4G1 | 7908 | 9779 | -6766 |
ETF1 | 7308 | 4260 | 7904 |
FAU | -359 | -1018 | -9018 |
GSPT1 | 6387 | -6536 | 7223 |
GSPT2 | -10067 | -8294 | -945 |
MAGOH | 1045 | -1915 | -9023 |
MAGOHB | -9011 | -4014 | 6918 |
NCBP1 | -5659 | -1114 | 10474 |
NCBP2 | -9239 | -8170 | 10809 |
PABPC1 | 5290 | -3454 | 4415 |
PNRC2 | -4406 | -5080 | 11232 |
PPP2CA | 8104 | 4832 | 5474 |
PPP2R1A | 4542 | 4551 | -7355 |
PPP2R2A | 4102 | -1321 | 11284 |
RBM8A | -7139 | -2954 | -5165 |
RNPS1 | -11075 | -6991 | -5614 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
SMG1 | -4341 | -1647 | 151 |
SMG5 | 5264 | -1860 | -6622 |
SMG6 | -6032 | -4410 | -5381 |
SMG7 | 6519 | 9295 | 4117 |
SMG8 | 2894 | 661 | 6082 |
SMG9 | 204 | 9094 | 223 |
UBA52 | 1112 | -1425 | -7104 |
UPF1 | 4629 | 6901 | -6523 |
UPF2 | 957 | -226 | 10140 |
UPF3A | -9509 | -7793 | -4252 |
UPF3B | -8003 | -3038 | 7886 |
Cap-dependent Translation Initiation
metric | value |
---|---|
setSize | 118 |
pMANOVA | 6.71e-46 |
p.adjustMANOVA | 5.71e-44 |
s.dist | 0.748 |
s.t0_v_pod | -0.132 |
s.pod_crp | -0.581 |
s.t0_crp | -0.453 |
p.t0_v_pod | 0.0135 |
p.pod_crp | 1.02e-27 |
p.t0_crp | 1.9e-17 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
EIF3B | -8831 | -8507 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
EIF3L | -7724 | -8957 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8352 | 8447 |
EIF2B1 | -411 | 1596 | 9382 |
EIF2B2 | 3233 | 5014 | 649 |
EIF2B3 | -7934 | -4864 | 3092 |
EIF2B4 | 2685 | 6611 | -4482 |
EIF2B5 | -9484 | -2402 | 1088 |
EIF2S1 | 4235 | -3323 | 9204 |
EIF2S2 | 6091 | 297 | 8972 |
EIF2S3 | 6653 | 1299 | 9884 |
EIF3A | 2132 | -1524 | 1889 |
EIF3B | -7776 | -8831 | -8507 |
EIF3C | 285 | -3719 | -9547 |
EIF3D | 2605 | -4304 | -5425 |
EIF3E | 1902 | -8557 | 7960 |
EIF3F | 970 | -3717 | -9911 |
EIF3G | 871 | -1661 | -9388 |
EIF3H | 4677 | -5855 | -1314 |
EIF3I | 4649 | -2647 | -7649 |
EIF3J | 1885 | -5962 | 9440 |
EIF3K | 1468 | -294 | -5982 |
EIF3L | 2560 | -7724 | -8957 |
EIF3M | 4533 | -5583 | 8254 |
EIF4A1 | 7476 | 5864 | 1477 |
EIF4A2 | -10809 | -9312 | 9673 |
EIF4B | 1237 | -8286 | -6402 |
EIF4E | 4757 | 2088 | 11218 |
EIF4EBP1 | 5990 | 5279 | -4330 |
EIF4G1 | 7908 | 9779 | -6766 |
EIF4H | 7634 | 7346 | -9456 |
EIF5 | 2162 | -411 | 10513 |
EIF5B | -4487 | -5892 | 9461 |
FAU | -359 | -1018 | -9018 |
PABPC1 | 5290 | -3454 | 4415 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
UBA52 | 1112 | -1425 | -7104 |
Eukaryotic Translation Initiation
metric | value |
---|---|
setSize | 118 |
pMANOVA | 6.71e-46 |
p.adjustMANOVA | 5.71e-44 |
s.dist | 0.748 |
s.t0_v_pod | -0.132 |
s.pod_crp | -0.581 |
s.t0_crp | -0.453 |
p.t0_v_pod | 0.0135 |
p.pod_crp | 1.02e-27 |
p.t0_crp | 1.9e-17 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
EIF3B | -8831 | -8507 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
EIF3L | -7724 | -8957 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8352 | 8447 |
EIF2B1 | -411 | 1596 | 9382 |
EIF2B2 | 3233 | 5014 | 649 |
EIF2B3 | -7934 | -4864 | 3092 |
EIF2B4 | 2685 | 6611 | -4482 |
EIF2B5 | -9484 | -2402 | 1088 |
EIF2S1 | 4235 | -3323 | 9204 |
EIF2S2 | 6091 | 297 | 8972 |
EIF2S3 | 6653 | 1299 | 9884 |
EIF3A | 2132 | -1524 | 1889 |
EIF3B | -7776 | -8831 | -8507 |
EIF3C | 285 | -3719 | -9547 |
EIF3D | 2605 | -4304 | -5425 |
EIF3E | 1902 | -8557 | 7960 |
EIF3F | 970 | -3717 | -9911 |
EIF3G | 871 | -1661 | -9388 |
EIF3H | 4677 | -5855 | -1314 |
EIF3I | 4649 | -2647 | -7649 |
EIF3J | 1885 | -5962 | 9440 |
EIF3K | 1468 | -294 | -5982 |
EIF3L | 2560 | -7724 | -8957 |
EIF3M | 4533 | -5583 | 8254 |
EIF4A1 | 7476 | 5864 | 1477 |
EIF4A2 | -10809 | -9312 | 9673 |
EIF4B | 1237 | -8286 | -6402 |
EIF4E | 4757 | 2088 | 11218 |
EIF4EBP1 | 5990 | 5279 | -4330 |
EIF4G1 | 7908 | 9779 | -6766 |
EIF4H | 7634 | 7346 | -9456 |
EIF5 | 2162 | -411 | 10513 |
EIF5B | -4487 | -5892 | 9461 |
FAU | -359 | -1018 | -9018 |
PABPC1 | 5290 | -3454 | 4415 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
UBA52 | 1112 | -1425 | -7104 |
RHO GTPases Activate WASPs and WAVEs
metric | value |
---|---|
setSize | 35 |
pMANOVA | 1.74e-08 |
p.adjustMANOVA | 1.7e-07 |
s.dist | 0.739 |
s.t0_v_pod | 0.608 |
s.pod_crp | 0.419 |
s.t0_crp | -0.0253 |
p.t0_v_pod | 4.76e-10 |
p.pod_crp | 1.77e-05 |
p.t0_crp | 0.796 |
Gene | t0_v_pod | pod_crp |
---|---|---|
WASF1 | 9357 | 11312 |
CYFIP1 | 9108 | 10929 |
GRB2 | 9146 | 10742 |
ARPC1B | 9102 | 10772 |
ARPC1A | 8745 | 11015 |
WAS | 8421 | 11046 |
RAC1 | 8647 | 10726 |
ACTB | 8859 | 10253 |
NCKAP1L | 7557 | 11206 |
ARPC5 | 8544 | 9897 |
MAPK3 | 8803 | 9501 |
WASF2 | 8237 | 10101 |
BTK | 7100 | 11184 |
MAPK1 | 7381 | 10667 |
ARPC3 | 8147 | 9352 |
ACTG1 | 8423 | 8439 |
ARPC4 | 7404 | 9098 |
ARPC2 | 7280 | 9088 |
NCKAP1 | 7350 | 7775 |
ACTR2 | 7750 | 7266 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ABI1 | 6978 | 7570 | 10492 |
ABI2 | -10571 | -7769 | 1488 |
ABL1 | 224 | 4001 | -7169 |
ACTB | 8859 | 10253 | -883 |
ACTG1 | 8423 | 8439 | -7587 |
ACTR2 | 7750 | 7266 | 8225 |
ACTR3 | 7699 | 6569 | 7217 |
ARPC1A | 8745 | 11015 | 5898 |
ARPC1B | 9102 | 10772 | -7161 |
ARPC2 | 7280 | 9088 | 4584 |
ARPC3 | 8147 | 9352 | 7298 |
ARPC4 | 7404 | 9098 | -762 |
ARPC5 | 8544 | 9897 | 5412 |
BAIAP2 | -215 | -1219 | -7114 |
BRK1 | 6929 | -1993 | -8775 |
BTK | 7100 | 11184 | 8838 |
CDC42 | 7425 | 7251 | 8682 |
CYFIP1 | 9108 | 10929 | 1675 |
CYFIP2 | -10031 | -4738 | -3657 |
GRB2 | 9146 | 10742 | 73 |
MAPK1 | 7381 | 10667 | -1770 |
MAPK3 | 8803 | 9501 | -9768 |
NCK1 | -11102 | -8778 | 9958 |
NCKAP1 | 7350 | 7775 | -384 |
NCKAP1L | 7557 | 11206 | 1696 |
NCKIPSD | 326 | -6950 | -7988 |
PTK2 | 4418 | -3305 | -1920 |
RAC1 | 8647 | 10726 | 9288 |
WAS | 8421 | 11046 | -2152 |
WASF1 | 9357 | 11312 | -1299 |
WASF2 | 8237 | 10101 | -4920 |
WASF3 | 6713 | -6442 | -8154 |
WASL | 297 | -1358 | 7215 |
WIPF1 | 563 | -3502 | -5287 |
WIPF2 | 5640 | 6630 | 1702 |
RHO GTPases Activate ROCKs
metric | value |
---|---|
setSize | 18 |
pMANOVA | 0.000619 |
p.adjustMANOVA | 0.0018 |
s.dist | 0.735 |
s.t0_v_pod | 0.541 |
s.pod_crp | 0.492 |
s.t0_crp | 0.0754 |
p.t0_v_pod | 7.03e-05 |
p.pod_crp | 0.000304 |
p.t0_crp | 0.58 |
Gene | t0_v_pod | pod_crp |
---|---|---|
PAK1 | 8100 | 10529 |
MYL6 | 8436 | 9884 |
CFL1 | 8057 | 9547 |
RHOA | 8188 | 8640 |
LIMK2 | 7949 | 8071 |
ROCK1 | 7377 | 6942 |
LIMK1 | 4628 | 9134 |
MYH9 | 6594 | 6222 |
ROCK2 | 6054 | 5462 |
PPP1R12A | 5969 | 4398 |
MYL12B | 5029 | 4688 |
PPP1CB | 6960 | 2822 |
PPP1R12B | 1762 | 7010 |
RHOB | 1244 | 5855 |
MYH10 | 647 | 7120 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CFL1 | 8057 | 9547 | -7188 |
LIMK1 | 4628 | 9134 | -7403 |
LIMK2 | 7949 | 8071 | -2143 |
MYH10 | 647 | 7120 | 114 |
MYH11 | -3419 | -613 | 7159 |
MYH9 | 6594 | 6222 | -7921 |
MYL12B | 5029 | 4688 | 5113 |
MYL6 | 8436 | 9884 | -8536 |
MYL9 | 7587 | -4539 | -5216 |
PAK1 | 8100 | 10529 | 8872 |
PPP1CB | 6960 | 2822 | 9481 |
PPP1R12A | 5969 | 4398 | 9348 |
PPP1R12B | 1762 | 7010 | 895 |
RHOA | 8188 | 8640 | 7321 |
RHOB | 1244 | 5855 | 4267 |
RHOC | -11009 | 8686 | -4554 |
ROCK1 | 7377 | 6942 | 10322 |
ROCK2 | 6054 | 5462 | 6111 |
Signaling by Leptin
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.00213 |
p.adjustMANOVA | 0.00522 |
s.dist | 0.733 |
s.t0_v_pod | 0.565 |
s.pod_crp | 0.274 |
s.t0_crp | -0.379 |
p.t0_v_pod | 0.00198 |
p.pod_crp | 0.134 |
p.t0_crp | 0.0379 |
Gene | t0_v_pod | t0_crp |
---|---|---|
SOCS3 | 9315 | -9983 |
IRS2 | 8429 | -8741 |
STAT5A | 6864 | -6998 |
STAT5B | 6825 | -5878 |
IRS1 | 1728 | -9593 |
LEPR | 6397 | -1510 |
PTPN11 | 5253 | -599 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
IRS1 | 1728 | -6674 | -9593 |
IRS2 | 8429 | 9184 | -8741 |
JAK2 | 2670 | 3748 | 10899 |
LEPR | 6397 | -314 | -1510 |
PTPN11 | 5253 | 2833 | -599 |
SH2B1 | -8374 | -3069 | -4387 |
SOCS3 | 9315 | 10466 | -9983 |
STAT3 | 7972 | 8187 | 2684 |
STAT5A | 6864 | 8984 | -6998 |
STAT5B | 6825 | 4419 | -5878 |
RHO GTPases Activate NADPH Oxidases
metric | value |
---|---|
setSize | 21 |
pMANOVA | 3.51e-05 |
p.adjustMANOVA | 0.000149 |
s.dist | 0.732 |
s.t0_v_pod | 0.559 |
s.pod_crp | 0.426 |
s.t0_crp | -0.205 |
p.t0_v_pod | 9.31e-06 |
p.pod_crp | 0.000734 |
p.t0_crp | 0.104 |
Gene | t0_v_pod | pod_crp |
---|---|---|
S100A9 | 9353 | 11235 |
S100A8 | 9341 | 11121 |
PRKCD | 8856 | 11308 |
NCF2 | 9034 | 10855 |
NCF4 | 9111 | 10692 |
RAC1 | 8647 | 10726 |
MAPK14 | 8951 | 10298 |
CYBB | 8879 | 10038 |
MAPK3 | 8803 | 9501 |
MAPK1 | 7381 | 10667 |
CYBA | 6822 | 10446 |
NCF1 | 7224 | 7391 |
PRKCB | 6993 | 7023 |
RAC2 | 5104 | 5027 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CYBA | 6822 | 10446 | -6535 |
CYBB | 8879 | 10038 | 8462 |
MAPK1 | 7381 | 10667 | -1770 |
MAPK11 | 3788 | -269 | -848 |
MAPK14 | 8951 | 10298 | 4000 |
MAPK3 | 8803 | 9501 | -9768 |
NCF1 | 7224 | 7391 | -3129 |
NCF2 | 9034 | 10855 | 2089 |
NCF4 | 9111 | 10692 | -4957 |
NOXA1 | -5279 | -3222 | -6522 |
PIK3C3 | 1606 | -3264 | 6819 |
PIK3R4 | -3937 | -4378 | 5657 |
PIN1 | -3103 | 202 | -9746 |
PRKCA | 1123 | -5628 | -5853 |
PRKCB | 6993 | 7023 | -7987 |
PRKCD | 8856 | 11308 | 806 |
PRKCZ | -11275 | -6443 | -7422 |
RAC1 | 8647 | 10726 | 9288 |
RAC2 | 5104 | 5027 | -8160 |
S100A8 | 9341 | 11121 | 2853 |
S100A9 | 9353 | 11235 | 226 |
Selenoamino acid metabolism
metric | value |
---|---|
setSize | 114 |
pMANOVA | 4.37e-34 |
p.adjustMANOVA | 1.92e-32 |
s.dist | 0.731 |
s.t0_v_pod | -0.228 |
s.pod_crp | -0.552 |
s.t0_crp | -0.42 |
p.t0_v_pod | 2.52e-05 |
p.pod_crp | 1.98e-24 |
p.t0_crp | 8.73e-15 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AHCY | 460 | -2709 | -8769 |
AIMP1 | -5707 | -5053 | 11190 |
AIMP2 | -976 | -2600 | -3409 |
CBS | 6846 | 10791 | 7233 |
CTH | -7898 | -2190 | 7368 |
DARS1 | 1060 | -6717 | 10824 |
EEF1E1 | -2031 | 2193 | 9911 |
EEFSEC | -9700 | -5202 | -5033 |
EPRS1 | -3100 | -6808 | 7171 |
FAU | -359 | -1018 | -9018 |
GNMT | 2014 | 7257 | -1918 |
GSR | 9078 | 10593 | -1642 |
HNMT | 8186 | 8093 | 7009 |
IARS1 | -11539 | -8667 | 631 |
INMT | 2159 | -1929 | 2624 |
KARS1 | -5204 | -7603 | 4454 |
LARS1 | -6211 | -8836 | 9549 |
MARS1 | -2525 | 9563 | 882 |
PAPSS1 | 8852 | 9525 | 9638 |
PAPSS2 | -2738 | 11530 | 10362 |
PSTK | -9857 | -3048 | -2424 |
QARS1 | 85 | -3035 | -9161 |
RARS1 | -4641 | -1099 | 10338 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
SARS1 | -5712 | -6385 | -5849 |
SCLY | -7964 | -5853 | -6300 |
SECISBP2 | -9999 | -6029 | 7107 |
SEPHS2 | 7535 | 7158 | -56 |
SEPSECS | -10939 | -7023 | 6762 |
TXNRD1 | 8062 | 8115 | 4242 |
UBA52 | 1112 | -1425 | -7104 |
Major pathway of rRNA processing in the nucleolus and cytosol
metric | value |
---|---|
setSize | 180 |
pMANOVA | 1.52e-47 |
p.adjustMANOVA | 1.6e-45 |
s.dist | 0.725 |
s.t0_v_pod | -0.306 |
s.pod_crp | -0.591 |
s.t0_crp | -0.286 |
p.t0_v_pod | 1.3e-12 |
p.pod_crp | 9.56e-43 |
p.t0_crp | 3.47e-11 |
Gene | pod_crp | t0_v_pod |
---|---|---|
UTP4 | -9295 | -11142 |
BMS1 | -9121 | -11315 |
NOP14 | -9676 | -10522 |
LAS1L | -8458 | -11905 |
FBL | -9628 | -9855 |
NOP56 | -8304 | -11395 |
NOL11 | -9311 | -10134 |
NOB1 | -9210 | -9986 |
TSR1 | -9680 | -9409 |
NOP58 | -9323 | -9623 |
PDCD11 | -7938 | -11166 |
WDR75 | -9170 | -9593 |
EXOSC8 | -7863 | -11104 |
EXOSC2 | -8130 | -10724 |
IMP4 | -8191 | -10629 |
DDX47 | -7920 | -10949 |
RPL23A | -9339 | -9248 |
UTP15 | -8238 | -10264 |
TEX10 | -8701 | -9440 |
NCL | -9124 | -8953 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BMS1 | -11315 | -9121 | -2978 |
BOP1 | -5039 | -5105 | -9461 |
BYSL | -4316 | -5824 | -5291 |
C1D | 3484 | 530 | 10834 |
CSNK1D | 2374 | 7369 | -9414 |
CSNK1E | -9964 | -7485 | -8511 |
DCAF13 | -5386 | -4214 | -1334 |
DDX21 | 3087 | -3715 | 7759 |
DDX47 | -10949 | -7920 | 10936 |
DDX49 | 4816 | 4154 | -9489 |
DDX52 | 448 | 1493 | 11328 |
DHX37 | -7983 | -5722 | -6991 |
DIS3 | -4187 | -3885 | 11031 |
EBNA1BP2 | -3970 | -6823 | -1321 |
EMG1 | -9856 | -6694 | 4341 |
ERI1 | 5474 | 1977 | 9721 |
EXOSC1 | -979 | 2548 | 5536 |
EXOSC10 | -11028 | -5076 | 4728 |
EXOSC2 | -10724 | -8130 | -8291 |
EXOSC3 | 503 | 280 | 2174 |
EXOSC4 | 7485 | 8780 | -6432 |
EXOSC5 | -4428 | -8229 | -8152 |
EXOSC6 | -9514 | -7940 | -3133 |
EXOSC7 | -10290 | -6545 | -9416 |
EXOSC8 | -11104 | -7863 | 7938 |
EXOSC9 | -9917 | -7435 | 10177 |
FAU | -359 | -1018 | -9018 |
FBL | -9855 | -9628 | -9879 |
FCF1 | 4428 | -2984 | 7360 |
FTSJ3 | -3900 | 3485 | -5754 |
GNL3 | -8199 | -9337 | 5789 |
HEATR1 | -10009 | -7318 | 1473 |
IMP3 | -9143 | -6956 | -3753 |
IMP4 | -10629 | -8191 | -5663 |
ISG20L2 | 3737 | -42 | 1389 |
KRR1 | -8329 | -6392 | 7558 |
LAS1L | -11905 | -8458 | -7799 |
LTV1 | -4162 | -4559 | 7450 |
MPHOSPH10 | -7519 | -6550 | 11244 |
MPHOSPH6 | 2168 | -2313 | 5028 |
MTREX | -2574 | -4700 | 10249 |
NCL | -8953 | -9124 | -4545 |
NIP7 | -5682 | -8082 | 5054 |
NOB1 | -9986 | -9210 | -6132 |
NOC4L | -5298 | 7372 | -3269 |
NOL11 | -10134 | -9311 | 9550 |
NOL12 | 4887 | 5706 | -708 |
NOL6 | -10564 | -6904 | -9301 |
NOL9 | -9891 | -7152 | 4295 |
NOP14 | -10522 | -9676 | -4648 |
NOP56 | -11395 | -8304 | -926 |
NOP58 | -9623 | -9323 | 9270 |
PDCD11 | -11166 | -7938 | -6311 |
PELP1 | -10584 | -7287 | -1544 |
PES1 | -1993 | -5454 | -8799 |
PNO1 | -6627 | -7464 | 6858 |
PWP2 | -1190 | -7158 | -7255 |
RBM28 | -11316 | -5771 | -5592 |
RCL1 | -751 | -7719 | -4623 |
RIOK1 | -3702 | -3302 | 6967 |
RIOK2 | 927 | -8363 | 9267 |
RIOK3 | 8621 | 2731 | 9110 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPP14 | 2981 | -2410 | 8611 |
RPP21 | -5178 | -197 | -7267 |
RPP25 | -7963 | -7582 | -5681 |
RPP30 | -7818 | -7132 | 9074 |
RPP38 | -6833 | -6494 | 8801 |
RPP40 | -4680 | -9576 | 3718 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
RRP1 | -3003 | 872 | -2135 |
RRP36 | -1645 | 510 | -1316 |
RRP7A | -2734 | -4541 | -659 |
RRP9 | -9748 | -8079 | -9693 |
SENP3 | 2970 | 4193 | -2573 |
SNORD3A | -2477 | 11233 | 9893 |
SNU13 | -6637 | -7945 | -4150 |
TBL3 | -3341 | 55 | -8145 |
TEX10 | -9440 | -8701 | 9112 |
TSR1 | -9409 | -9680 | -814 |
UBA52 | 1112 | -1425 | -7104 |
UTP11 | 4582 | 1261 | 8086 |
UTP14A | -1788 | -3133 | 4462 |
UTP14C | -2032 | -1616 | 5210 |
UTP15 | -10264 | -8238 | 10459 |
UTP18 | 5055 | 3705 | 3978 |
UTP20 | -10191 | -6857 | 6223 |
UTP3 | -2829 | -1448 | -1947 |
UTP4 | -11142 | -9295 | -1037 |
UTP6 | -4362 | -5407 | 9675 |
WDR12 | 5156 | -1289 | 5359 |
WDR18 | -2260 | -4315 | -6073 |
WDR3 | -6394 | -7931 | -33 |
WDR36 | -3825 | -5814 | 6003 |
WDR43 | -7419 | -8808 | 3001 |
WDR46 | -10623 | -6936 | -9396 |
WDR75 | -9593 | -9170 | 7264 |
XRN2 | 9240 | 9220 | 2754 |
Activation of ATR in response to replication stress
metric | value |
---|---|
setSize | 36 |
pMANOVA | 9.68e-09 |
p.adjustMANOVA | 1.03e-07 |
s.dist | 0.724 |
s.t0_v_pod | -0.452 |
s.pod_crp | -0.506 |
s.t0_crp | 0.253 |
p.t0_v_pod | 2.73e-06 |
p.pod_crp | 1.52e-07 |
p.t0_crp | 0.0085 |
Gene | pod_crp | t0_v_pod |
---|---|---|
MCM3 | -9726 | -11839 |
RPA1 | -9614 | -11644 |
RAD1 | -9428 | -11845 |
MCM7 | -7678 | -11768 |
DBF4 | -8441 | -10581 |
RFC3 | -8651 | -10151 |
MCM6 | -9254 | -9393 |
RFC4 | -7694 | -10361 |
ORC3 | -7526 | -10371 |
ORC2 | -8055 | -9594 |
RAD17 | -7700 | -9973 |
ORC5 | -8047 | -9161 |
RPA3 | -8027 | -8609 |
MCM8 | -6098 | -10599 |
MCM4 | -7585 | -8404 |
RAD9A | -5038 | -11083 |
MCM2 | -7515 | -6973 |
RFC5 | -3955 | -11357 |
RPA2 | -4586 | -6094 |
ATR | -2758 | -10018 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATR | -10018 | -2758 | 4723 |
ATRIP | -11134 | -1507 | 2195 |
CDC25A | 2888 | -2524 | -3404 |
CDC45 | -2594 | -5606 | 408 |
CDC6 | 2356 | -5442 | 5857 |
CDC7 | -7583 | 813 | 3389 |
CDK2 | -4840 | -3663 | 2221 |
CHEK1 | -2421 | -5997 | 7494 |
CLSPN | 3606 | -175 | 9061 |
DBF4 | -10581 | -8441 | 10866 |
HUS1 | -145 | 2310 | 8792 |
MCM10 | 769 | -6736 | 2954 |
MCM2 | -6973 | -7515 | -6936 |
MCM3 | -11839 | -9726 | -2416 |
MCM4 | -8404 | -7585 | -850 |
MCM5 | -7039 | 1270 | -7307 |
MCM6 | -9393 | -9254 | 448 |
MCM7 | -11768 | -7678 | -3106 |
MCM8 | -10599 | -6098 | 3359 |
ORC1 | -2459 | -5122 | 968 |
ORC2 | -9594 | -8055 | 7100 |
ORC3 | -10371 | -7526 | 10738 |
ORC4 | -1988 | -5653 | 9250 |
ORC5 | -9161 | -8047 | 9437 |
ORC6 | 1174 | 8434 | 1504 |
RAD1 | -11845 | -9428 | 6550 |
RAD17 | -9973 | -7700 | 9580 |
RAD9A | -11083 | -5038 | -1689 |
RAD9B | 3065 | 8595 | 8891 |
RFC2 | 4890 | 4788 | -676 |
RFC3 | -10151 | -8651 | 7668 |
RFC4 | -10361 | -7694 | 9525 |
RFC5 | -11357 | -3955 | 885 |
RPA1 | -11644 | -9614 | -4577 |
RPA2 | -6094 | -4586 | 5338 |
RPA3 | -8609 | -8027 | 2201 |
rRNA processing in the nucleus and cytosol
metric | value |
---|---|
setSize | 190 |
pMANOVA | 1.28e-49 |
p.adjustMANOVA | 1.94e-47 |
s.dist | 0.723 |
s.t0_v_pod | -0.307 |
s.pod_crp | -0.587 |
s.t0_crp | -0.288 |
p.t0_v_pod | 2.77e-13 |
p.pod_crp | 1.77e-44 |
p.t0_crp | 7.7e-12 |
Gene | pod_crp | t0_v_pod |
---|---|---|
DKC1 | -9791 | -11282 |
NAT10 | -9283 | -11593 |
UTP4 | -9295 | -11142 |
BMS1 | -9121 | -11315 |
NOP14 | -9676 | -10522 |
LAS1L | -8458 | -11905 |
FBL | -9628 | -9855 |
NOP56 | -8304 | -11395 |
NOL11 | -9311 | -10134 |
NOB1 | -9210 | -9986 |
TSR1 | -9680 | -9409 |
NOP58 | -9323 | -9623 |
PDCD11 | -7938 | -11166 |
WDR75 | -9170 | -9593 |
THUMPD1 | -9268 | -9477 |
EXOSC8 | -7863 | -11104 |
EXOSC2 | -8130 | -10724 |
IMP4 | -8191 | -10629 |
DDX47 | -7920 | -10949 |
RPL23A | -9339 | -9248 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BMS1 | -11315 | -9121 | -2978 |
BOP1 | -5039 | -5105 | -9461 |
BYSL | -4316 | -5824 | -5291 |
C1D | 3484 | 530 | 10834 |
CSNK1D | 2374 | 7369 | -9414 |
CSNK1E | -9964 | -7485 | -8511 |
DCAF13 | -5386 | -4214 | -1334 |
DDX21 | 3087 | -3715 | 7759 |
DDX47 | -10949 | -7920 | 10936 |
DDX49 | 4816 | 4154 | -9489 |
DDX52 | 448 | 1493 | 11328 |
DHX37 | -7983 | -5722 | -6991 |
DIMT1 | -7711 | -9187 | 9761 |
DIS3 | -4187 | -3885 | 11031 |
DKC1 | -11282 | -9791 | -2099 |
EBNA1BP2 | -3970 | -6823 | -1321 |
EMG1 | -9856 | -6694 | 4341 |
ERI1 | 5474 | 1977 | 9721 |
EXOSC1 | -979 | 2548 | 5536 |
EXOSC10 | -11028 | -5076 | 4728 |
EXOSC2 | -10724 | -8130 | -8291 |
EXOSC3 | 503 | 280 | 2174 |
EXOSC4 | 7485 | 8780 | -6432 |
EXOSC5 | -4428 | -8229 | -8152 |
EXOSC6 | -9514 | -7940 | -3133 |
EXOSC7 | -10290 | -6545 | -9416 |
EXOSC8 | -11104 | -7863 | 7938 |
EXOSC9 | -9917 | -7435 | 10177 |
FAU | -359 | -1018 | -9018 |
FBL | -9855 | -9628 | -9879 |
FCF1 | 4428 | -2984 | 7360 |
FTSJ3 | -3900 | 3485 | -5754 |
GAR1 | -6703 | -6656 | -530 |
GNL3 | -8199 | -9337 | 5789 |
HEATR1 | -10009 | -7318 | 1473 |
IMP3 | -9143 | -6956 | -3753 |
IMP4 | -10629 | -8191 | -5663 |
ISG20L2 | 3737 | -42 | 1389 |
KRR1 | -8329 | -6392 | 7558 |
LAS1L | -11905 | -8458 | -7799 |
LTV1 | -4162 | -4559 | 7450 |
MPHOSPH10 | -7519 | -6550 | 11244 |
MPHOSPH6 | 2168 | -2313 | 5028 |
MTREX | -2574 | -4700 | 10249 |
NAT10 | -11593 | -9283 | -5917 |
NCL | -8953 | -9124 | -4545 |
NHP2 | -3373 | -5708 | -7073 |
NIP7 | -5682 | -8082 | 5054 |
NOB1 | -9986 | -9210 | -6132 |
NOC4L | -5298 | 7372 | -3269 |
NOL11 | -10134 | -9311 | 9550 |
NOL12 | 4887 | 5706 | -708 |
NOL6 | -10564 | -6904 | -9301 |
NOL9 | -9891 | -7152 | 4295 |
NOP10 | 8200 | 10614 | -3974 |
NOP14 | -10522 | -9676 | -4648 |
NOP2 | -9624 | -6235 | -7727 |
NOP56 | -11395 | -8304 | -926 |
NOP58 | -9623 | -9323 | 9270 |
PDCD11 | -11166 | -7938 | -6311 |
PELP1 | -10584 | -7287 | -1544 |
PES1 | -1993 | -5454 | -8799 |
PNO1 | -6627 | -7464 | 6858 |
PWP2 | -1190 | -7158 | -7255 |
RBM28 | -11316 | -5771 | -5592 |
RCL1 | -751 | -7719 | -4623 |
RIOK1 | -3702 | -3302 | 6967 |
RIOK2 | 927 | -8363 | 9267 |
RIOK3 | 8621 | 2731 | 9110 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPP14 | 2981 | -2410 | 8611 |
RPP21 | -5178 | -197 | -7267 |
RPP25 | -7963 | -7582 | -5681 |
RPP30 | -7818 | -7132 | 9074 |
RPP38 | -6833 | -6494 | 8801 |
RPP40 | -4680 | -9576 | 3718 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
RRP1 | -3003 | 872 | -2135 |
RRP36 | -1645 | 510 | -1316 |
RRP7A | -2734 | -4541 | -659 |
RRP9 | -9748 | -8079 | -9693 |
SENP3 | 2970 | 4193 | -2573 |
SNORD3A | -2477 | 11233 | 9893 |
SNU13 | -6637 | -7945 | -4150 |
TBL3 | -3341 | 55 | -8145 |
TEX10 | -9440 | -8701 | 9112 |
THUMPD1 | -9477 | -9268 | 8192 |
TRMT112 | 732 | -366 | -8610 |
TSR1 | -9409 | -9680 | -814 |
TSR3 | 3808 | -354 | -8970 |
UBA52 | 1112 | -1425 | -7104 |
UTP11 | 4582 | 1261 | 8086 |
UTP14A | -1788 | -3133 | 4462 |
UTP14C | -2032 | -1616 | 5210 |
UTP15 | -10264 | -8238 | 10459 |
UTP18 | 5055 | 3705 | 3978 |
UTP20 | -10191 | -6857 | 6223 |
UTP3 | -2829 | -1448 | -1947 |
UTP4 | -11142 | -9295 | -1037 |
UTP6 | -4362 | -5407 | 9675 |
WDR12 | 5156 | -1289 | 5359 |
WDR18 | -2260 | -4315 | -6073 |
WDR3 | -6394 | -7931 | -33 |
WDR36 | -3825 | -5814 | 6003 |
WDR43 | -7419 | -8808 | 3001 |
WDR46 | -10623 | -6936 | -9396 |
WDR75 | -9593 | -9170 | 7264 |
XRN2 | 9240 | 9220 | 2754 |
DNA methylation
metric | value |
---|---|
setSize | 20 |
pMANOVA | 7.18e-08 |
p.adjustMANOVA | 5.96e-07 |
s.dist | 0.722 |
s.t0_v_pod | 0.517 |
s.pod_crp | 0.109 |
s.t0_crp | -0.493 |
p.t0_v_pod | 6.35e-05 |
p.pod_crp | 0.398 |
p.t0_crp | 0.000135 |
Gene | t0_v_pod | t0_crp |
---|---|---|
H2BC12 | 8898.0 | -8447.0 |
H2AJ | 9214.0 | -7261.0 |
H2BC17 | 7178.0 | -8062.0 |
H2BC4 | 7279.0 | -7646.0 |
H3C15 | 6608.5 | -7756.5 |
H2AZ1 | 5955.0 | -8479.0 |
H2BC21 | 9125.0 | -5196.0 |
H2BC11 | 7791.0 | -5526.0 |
DNMT3B | 4250.0 | -9551.0 |
H2BC9 | 5332.0 | -6635.0 |
H2AC6 | 7813.0 | -4205.0 |
H2BC5 | 7881.0 | -2937.0 |
H2BC15 | 5251.0 | -4235.0 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DNMT1 | -11896.0 | -9160.0 | -8442.0 |
DNMT3A | -2963.0 | -4703.0 | -8387.0 |
DNMT3B | 4250.0 | 3253.0 | -9551.0 |
H2AC20 | 4913.0 | 8671.0 | 3752.0 |
H2AC6 | 7813.0 | -1814.0 | -4205.0 |
H2AJ | 9214.0 | 11405.0 | -7261.0 |
H2AZ1 | 5955.0 | 2933.0 | -8479.0 |
H2AZ2 | -1192.0 | -5862.0 | -2370.0 |
H2BC11 | 7791.0 | 3262.0 | -5526.0 |
H2BC12 | 8898.0 | 6037.0 | -8447.0 |
H2BC15 | 5251.0 | 523.0 | -4235.0 |
H2BC17 | 7178.0 | 3760.0 | -8062.0 |
H2BC21 | 9125.0 | 6114.0 | -5196.0 |
H2BC4 | 7279.0 | 4199.0 | -7646.0 |
H2BC5 | 7881.0 | 4394.0 | -2937.0 |
H2BC9 | 5332.0 | -6224.0 | -6635.0 |
H2BU1 | -6332.0 | -2185.0 | 2615.0 |
H3-3A | 8519.0 | 7532.0 | 5003.0 |
H3C15 | 6608.5 | 6537.5 | -7756.5 |
UHRF1 | 168.0 | 1689.0 | 1295.0 |
Erythrocytes take up carbon dioxide and release oxygen
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.000153 |
p.adjustMANOVA | 0.000541 |
s.dist | 0.72 |
s.t0_v_pod | 0.68 |
s.pod_crp | 0.2 |
s.t0_crp | -0.131 |
p.t0_v_pod | 9.48e-05 |
p.pod_crp | 0.251 |
p.t0_crp | 0.452 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CYB5R1 | 9299 | 10194 |
CYB5R2 | 8460 | 8847 |
CYB5R4 | 8289 | 8151 |
AQP1 | 7364 | 6140 |
CA4 | 2804 | 10269 |
CA1 | 9220 | 469 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AQP1 | 7364 | 6140 | -2835 |
CA1 | 9220 | 469 | 3952 |
CA2 | 3538 | -2886 | -1308 |
CA4 | 2804 | 10269 | -9200 |
CYB5R1 | 9299 | 10194 | -5416 |
CYB5R2 | 8460 | 8847 | 3229 |
CYB5R4 | 8289 | 8151 | 7376 |
CYB5RL | -10419 | -6905 | -7399 |
HBA1 | 8840 | -859 | 2131 |
HBB | 8901 | -76 | 1800 |
SLC4A1 | 8987 | -472 | -681 |
O2/CO2 exchange in erythrocytes
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.000153 |
p.adjustMANOVA | 0.000541 |
s.dist | 0.72 |
s.t0_v_pod | 0.68 |
s.pod_crp | 0.2 |
s.t0_crp | -0.131 |
p.t0_v_pod | 9.48e-05 |
p.pod_crp | 0.251 |
p.t0_crp | 0.452 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CYB5R1 | 9299 | 10194 |
CYB5R2 | 8460 | 8847 |
CYB5R4 | 8289 | 8151 |
AQP1 | 7364 | 6140 |
CA4 | 2804 | 10269 |
CA1 | 9220 | 469 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AQP1 | 7364 | 6140 | -2835 |
CA1 | 9220 | 469 | 3952 |
CA2 | 3538 | -2886 | -1308 |
CA4 | 2804 | 10269 | -9200 |
CYB5R1 | 9299 | 10194 | -5416 |
CYB5R2 | 8460 | 8847 | 3229 |
CYB5R4 | 8289 | 8151 | 7376 |
CYB5RL | -10419 | -6905 | -7399 |
HBA1 | 8840 | -859 | 2131 |
HBB | 8901 | -76 | 1800 |
SLC4A1 | 8987 | -472 | -681 |
Dissolution of Fibrin Clot
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00861 |
p.adjustMANOVA | 0.0175 |
s.dist | 0.715 |
s.t0_v_pod | 0.566 |
s.pod_crp | 0.436 |
s.t0_crp | 0.0151 |
p.t0_v_pod | 0.000687 |
p.pod_crp | 0.00884 |
p.t0_crp | 0.928 |
Gene | t0_v_pod | pod_crp |
---|---|---|
SERPINB2 | 9277 | 10648 |
ANXA2 | 8405 | 10984 |
PLAUR | 8292 | 10654 |
SERPINB8 | 9049 | 7618 |
SERPINB6 | 5778 | 9085 |
S100A10 | 6764 | 6786 |
SERPINE2 | 6363 | 5493 |
PLAU | 4847 | 2352 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ANXA2 | 8405 | 10984 | 6149 |
PLAT | -1225 | -1167 | 7394 |
PLAU | 4847 | 2352 | -4399 |
PLAUR | 8292 | 10654 | 598 |
PLG | -1938 | 1289 | 8597 |
S100A10 | 6764 | 6786 | 437 |
SERPINB2 | 9277 | 10648 | 2582 |
SERPINB6 | 5778 | 9085 | -8463 |
SERPINB8 | 9049 | 7618 | 4184 |
SERPINE1 | 7371 | -1072 | -4059 |
SERPINE2 | 6363 | 5493 | 1162 |
SERPINF2 | -6350 | 3505 | -4553 |
Phosphorylation of CD3 and TCR zeta chains
metric | value |
---|---|
setSize | 27 |
pMANOVA | 1.58e-05 |
p.adjustMANOVA | 7.65e-05 |
s.dist | 0.714 |
s.t0_v_pod | -0.537 |
s.pod_crp | -0.472 |
s.t0_crp | -0.00537 |
p.t0_v_pod | 1.39e-06 |
p.pod_crp | 2.21e-05 |
p.t0_crp | 0.962 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD247 | -11982 | -9454 |
LCK | -11482 | -9442 |
TRAC | -11130 | -9287 |
CD3E | -10952 | -9335 |
CD3G | -11173 | -9082 |
TRBC1 | -11646 | -8623 |
TRBV12-3 | -10099 | -9681 |
CD3D | -11049 | -8704 |
TRAV19 | -9587 | -9353 |
HLA-DPB1 | -11887 | -7068 |
HLA-DQB2 | -9085 | -8978 |
TRAV29DV5 | -9353 | -8284 |
HLA-DRA | -11649 | -6573 |
HLA-DPA1 | -11954 | -5815 |
TRBV7-9 | -9220 | -6700 |
TRAV8-4 | -7010 | -7565 |
HLA-DQA2 | -4652 | -9364 |
CD4 | -5228 | -4848 |
HLA-DQA1 | -11633 | -1453 |
HLA-DRB5 | -4806 | -1108 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD247 | -11982 | -9454 | -8935 |
CD3D | -11049 | -8704 | 2046 |
CD3E | -10952 | -9335 | 5813 |
CD3G | -11173 | -9082 | 6756 |
CD4 | -5228 | -4848 | -1251 |
CSK | 5158 | 10149 | -6693 |
HLA-DPA1 | -11954 | -5815 | 946 |
HLA-DPB1 | -11887 | -7068 | -7160 |
HLA-DQA1 | -11633 | -1453 | 9693 |
HLA-DQA2 | -4652 | -9364 | -9927 |
HLA-DQB1 | -6199 | 3626 | 5107 |
HLA-DQB2 | -9085 | -8978 | -9720 |
HLA-DRA | -11649 | -6573 | 2695 |
HLA-DRB1 | -7792 | 1344 | 9366 |
HLA-DRB5 | -4806 | -1108 | 9092 |
LCK | -11482 | -9442 | -4194 |
PAG1 | 5207 | 321 | -4633 |
PTPN22 | -1191 | 5545 | 9392 |
PTPRC | 2227 | 7455 | 9473 |
PTPRJ | 7666 | 9296 | -4702 |
TRAC | -11130 | -9287 | 8688 |
TRAV19 | -9587 | -9353 | -6593 |
TRAV29DV5 | -9353 | -8284 | 4257 |
TRAV8-4 | -7010 | -7565 | 10068 |
TRBC1 | -11646 | -8623 | -1744 |
TRBV12-3 | -10099 | -9681 | -6812 |
TRBV7-9 | -9220 | -6700 | -5268 |
Detoxification of Reactive Oxygen Species
metric | value |
---|---|
setSize | 32 |
pMANOVA | 8.18e-07 |
p.adjustMANOVA | 5.74e-06 |
s.dist | 0.709 |
s.t0_v_pod | 0.561 |
s.pod_crp | 0.431 |
s.t0_crp | -0.0481 |
p.t0_v_pod | 3.93e-08 |
p.pod_crp | 2.44e-05 |
p.t0_crp | 0.638 |
Gene | t0_v_pod | pod_crp |
---|---|---|
NCF2 | 9034 | 10855 |
NCF4 | 9111 | 10692 |
PRDX3 | 9206 | 10534 |
GSR | 9078 | 10593 |
CYBB | 8879 | 10038 |
CAT | 8970 | 9293 |
P4HB | 8307 | 9301 |
PRDX5 | 8392 | 8570 |
CYBA | 6822 | 10446 |
TXN | 8155 | 8543 |
TXNRD1 | 8062 | 8115 |
TXNRD2 | 7414 | 7792 |
ERO1A | 8793 | 6446 |
NCF1 | 7224 | 7391 |
GPX1 | 9156 | 5011 |
PRDX1 | 6927 | 5870 |
SOD2 | 4346 | 8455 |
ATOX1 | 4294 | 6523 |
TXN2 | 4601 | 5184 |
NOX5 | 1165 | 7901 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATOX1 | 4294 | 6523 | -5464 |
ATP7A | 688 | 2475 | -1131 |
CAT | 8970 | 9293 | 753 |
CCS | 1525 | 2217 | -9201 |
CYBA | 6822 | 10446 | -6535 |
CYBB | 8879 | 10038 | 8462 |
CYCS | -1315 | -4596 | 7068 |
ERO1A | 8793 | 6446 | 9877 |
GPX1 | 9156 | 5011 | -9215 |
GPX2 | -3430 | 6237 | 3879 |
GPX3 | 674 | 9213 | 940 |
GPX7 | -8599 | -9409 | -6182 |
GSR | 9078 | 10593 | -1642 |
GSTP1 | 134 | 1763 | -2320 |
NCF1 | 7224 | 7391 | -3129 |
NCF2 | 9034 | 10855 | 2089 |
NCF4 | 9111 | 10692 | -4957 |
NOX4 | 1105 | 7907 | 7547 |
NOX5 | 1165 | 7901 | 9420 |
NUDT2 | 2964 | 1821 | 6694 |
P4HB | 8307 | 9301 | -6747 |
PRDX1 | 6927 | 5870 | 9453 |
PRDX2 | 3398 | -4109 | 2558 |
PRDX3 | 9206 | 10534 | 8582 |
PRDX5 | 8392 | 8570 | -9501 |
PRDX6 | 8787 | -816 | -2927 |
SOD1 | -4704 | -5821 | 229 |
SOD2 | 4346 | 8455 | 458 |
TXN | 8155 | 8543 | 4825 |
TXN2 | 4601 | 5184 | -7333 |
TXNRD1 | 8062 | 8115 | 4242 |
TXNRD2 | 7414 | 7792 | -6709 |
Neutrophil degranulation
metric | value |
---|---|
setSize | 457 |
pMANOVA | 4.62e-105 |
p.adjustMANOVA | 6.29e-102 |
s.dist | 0.706 |
s.t0_v_pod | 0.587 |
s.pod_crp | 0.38 |
s.t0_crp | -0.0981 |
p.t0_v_pod | 1.73e-103 |
p.pod_crp | 3.14e-44 |
p.t0_crp | 0.000328 |
Gene | t0_v_pod | pod_crp |
---|---|---|
SIRPA | 9348 | 11400 |
IDH1 | 9345 | 11370 |
DOK3 | 9228 | 11511 |
HK3 | 9225 | 11490 |
RNASE2 | 9344 | 11336 |
HP | 9293 | 11371 |
ANPEP | 9190 | 11472 |
S100A9 | 9353 | 11235 |
CR1 | 9325 | 11239 |
GNS | 9200 | 11391 |
ATP6V0A1 | 9262 | 11270 |
CTSD | 9272 | 11255 |
SIGLEC9 | 9223 | 11296 |
SLC11A1 | 9014 | 11536 |
NCSTN | 9030 | 11510 |
S100A8 | 9341 | 11121 |
MCEMP1 | 9342 | 11112 |
QSOX1 | 9140 | 11347 |
CD63 | 9129 | 11350 |
CD36 | 9283 | 11160 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
A1BG | 5492 | 1353 | -9966 |
ABCA13 | 4715 | -6024 | -5520 |
ACAA1 | 8162 | 11375 | -2561 |
ACLY | 5100 | 9507 | -3222 |
ACTR10 | 7490 | 4188 | 6836 |
ACTR1B | -10176 | -4992 | -8357 |
ACTR2 | 7750 | 7266 | 8225 |
ADAM10 | 8645 | 9006 | 7606 |
ADAM8 | 5565 | 5930 | -5020 |
ADGRE3 | 403 | -1147 | -5402 |
ADGRE5 | -2508 | 9545 | -5944 |
ADGRG3 | 8074 | 10276 | -6490 |
AGA | -4482 | -5904 | -6481 |
AGL | -3052 | -2341 | 5309 |
AGPAT2 | 9099 | 11201 | -8161 |
ALAD | 8376 | 10277 | -8899 |
ALDH3B1 | 8521 | 11136 | -541 |
ALDOA | 9092 | 10754 | -4277 |
ALDOC | -3342 | -6047 | -870 |
ALOX5 | 8850 | 10963 | 897 |
AMPD3 | 8588 | 9281 | -3891 |
ANO6 | 7924 | -51 | -2013 |
ANPEP | 9190 | 11472 | -4485 |
ANXA2 | 8405 | 10984 | 6149 |
AOC1 | 6421 | -3632 | -9941 |
AP1M1 | 6619 | 9990 | -9005 |
AP2A2 | 7150 | 10268 | -7534 |
APAF1 | 8863 | 5960 | 3785 |
APEH | 989 | 4413 | -8349 |
APRT | -2695 | -6293 | -9129 |
ARG1 | 8615 | 8895 | -4015 |
ARHGAP9 | 6170 | 10501 | -5710 |
ARL8A | 8119 | 9110 | -7802 |
ARMC8 | 6310 | 184 | 8884 |
ARPC5 | 8544 | 9897 | 5412 |
ARSA | 3455 | 9475 | 5057 |
ARSB | 7459 | 10240 | 3628 |
ASAH1 | 8390 | 11216 | 7823 |
ATAD3B | -9747 | -6152 | -7139 |
ATG7 | 8007 | 6013 | 5349 |
ATP11A | 8262 | 10605 | -3941 |
ATP11B | 5982 | 4586 | 2812 |
ATP6AP2 | 7911 | 1894 | 6607 |
ATP6V0A1 | 9262 | 11270 | -184 |
ATP6V0C | 8974 | 10678 | -1938 |
ATP6V1D | 8894 | 9569 | 8256 |
ATP8A1 | -11486 | -9458 | -3080 |
ATP8B4 | 6869 | 1589 | 203 |
AZU1 | 5442 | -7180 | -7085 |
B2M | -6684 | -7304 | 9111 |
B4GALT1 | 4248 | 5054 | -5889 |
BIN2 | 5672 | 10255 | -7431 |
BPI | 6575 | -7074 | -6606 |
BRI3 | 8865 | 11091 | -4309 |
BST1 | 9319 | 10115 | 1888 |
BST2 | -7131 | 977 | 3207 |
C3 | -11900 | 1885 | 4416 |
C3AR1 | 7890 | 11427 | 10251 |
C5AR1 | 8976 | 10921 | -5891 |
C6orf120 | 6106 | 820 | -2003 |
CAB39 | 8146 | 5846 | 6332 |
CAMP | 4730 | -7595 | -6823 |
CAND1 | -6331 | -7166 | 5191 |
CANT1 | 7591 | 7579 | -3293 |
CAP1 | 7984 | 8315 | 1306 |
CAPN1 | 8424 | 10080 | -8421 |
CAT | 8970 | 9293 | 753 |
CCT2 | -8525 | -9618 | 3713 |
CCT8 | 6464 | -256 | 6853 |
CD14 | 8944 | 10372 | -5065 |
CD177 | 2440 | 10913 | -8974 |
CD300A | -2090 | 10479 | 5751 |
CD33 | 7944 | 9211 | -402 |
CD36 | 9283 | 11160 | 9413 |
CD44 | 8201 | 8363 | 1308 |
CD47 | -11753 | -8215 | 5590 |
CD53 | 7764 | 10096 | 5802 |
CD55 | 8991 | 10563 | 4478 |
CD58 | 6556 | 9896 | 10387 |
CD59 | 5783 | -3188 | -3930 |
CD63 | 9129 | 11350 | -6534 |
CD68 | 8394 | 10795 | 661 |
CD93 | 9335 | 10634 | -5548 |
CDA | 9152 | 10989 | -4053 |
CDK13 | -8104 | 32 | -5089 |
CEACAM1 | 8296 | 4278 | -552 |
CEACAM3 | 6743 | 10344 | 10654 |
CEACAM6 | 4464 | -5083 | -6228 |
CEACAM8 | 4898 | -6448 | -4844 |
CEP290 | -8867 | -6163 | 10818 |
CFD | 1971 | 2233 | 4371 |
CFP | 7333 | 9805 | -3105 |
CHI3L1 | -645 | -5514 | -4165 |
CHIT1 | 5931 | -2642 | -1870 |
CKAP4 | 9210 | 9935 | -1912 |
CLEC12A | 4490 | 2545 | 6737 |
CLEC4C | -11454 | 3076 | -1232 |
CLEC4D | 9029 | 9546 | 3993 |
CLEC5A | 8339 | 5705 | 6152 |
CMTM6 | 7771 | 7571 | 9302 |
CNN2 | 6554 | 5058 | -3616 |
COMMD3 | -1344 | 1718 | 9364 |
COMMD9 | 7845 | 8886 | 4311 |
COPB1 | 7213 | 6115 | 10995 |
COTL1 | 7812 | 10823 | 1752 |
CPNE1 | -3302 | -1124 | -4305 |
CPNE3 | 5796 | -212 | 4086 |
CPPED1 | 8225 | 10342 | 930 |
CR1 | 9325 | 11239 | 78 |
CRACR2A | -8758 | -1351 | -6790 |
CREG1 | 9322 | 7726 | -5647 |
CRISP3 | 7439 | -5435 | -2256 |
CRISPLD2 | 8953 | 10866 | 727 |
CSNK2B | 3930 | 6489 | 169 |
CST3 | 2193 | 3540 | 537 |
CSTB | 6806 | 10741 | 1243 |
CTSA | 9351 | 10347 | -5625 |
CTSB | 9204 | 11248 | 214 |
CTSC | 2312 | 9392 | 5785 |
CTSD | 9272 | 11255 | -6838 |
CTSG | 5056 | -5642 | -7628 |
CTSH | 6273 | 6681 | 241 |
CTSS | 8240 | 7109 | 5880 |
CTSZ | 8825 | 10594 | -2796 |
CXCL1 | 5749 | 35 | -7929 |
CXCR1 | 6768 | 5942 | -4296 |
CXCR2 | 5785 | 1478 | -4192 |
CYB5R3 | 8753 | 9668 | -8623 |
CYBA | 6822 | 10446 | -6535 |
CYBB | 8879 | 10038 | 8462 |
CYFIP1 | 9108 | 10929 | 1675 |
CYSTM1 | 8924 | 9339 | 1556 |
DBNL | 7633 | 9423 | -9565 |
DDOST | 6831 | 7376 | -7998 |
DDX3X | 6524 | -1636 | -394 |
DEFA1 | 5979 | -1326 | -7916 |
DEFA4 | 5976 | -3207 | -4350 |
DEGS1 | 6085 | -377 | -3072 |
DERA | 8364 | 9539 | 9162 |
DGAT1 | 5245 | 5383 | -7475 |
DIAPH1 | -848 | 2340 | -1599 |
DNAJC13 | 8133 | 9506 | 9974 |
DNAJC3 | 8302 | 8189 | 7460 |
DNAJC5 | 8537 | 9755 | -6677 |
DNASE1L1 | 8491 | 11486 | -1493 |
DOCK2 | 7609 | 10071 | -1434 |
DOK3 | 9228 | 11511 | -1549 |
DPP7 | -4437 | -4122 | -9813 |
DSC1 | -6691 | -9262 | -1990 |
DSN1 | -10430 | -3359 | 6274 |
DSP | -1779 | 2585 | -8705 |
DYNC1H1 | -7417 | -1029 | -6456 |
DYNC1LI1 | 6841 | 7785 | 8760 |
DYNLL1 | 5873 | 3157 | -957 |
DYNLT1 | 4406 | 7399 | 7711 |
EEF1A1 | -4918 | -9346 | -7605 |
EEF2 | 304 | -7032 | -9881 |
ELANE | 7212 | -5995 | -6381 |
ENPP4 | -9264 | -5181 | 3880 |
EPX | -4683 | -1900 | 1003 |
ERP44 | 6807 | 2930 | 9188 |
FABP5 | 5940 | 6410 | 3203 |
FAF2 | 5487 | 4092 | 607 |
FCAR | 8958 | 8893 | -3605 |
FCER1G | 8004 | 11307 | 6688 |
FCGR2A | 8699 | 10192 | 5608 |
FCGR3B | 4269 | -2607 | -4037 |
FCN1 | 8960 | 9070 | -663 |
FGL2 | 669 | -3982 | 8732 |
FGR | 8344 | 11409 | -3712 |
FOLR3 | 7339 | 9195 | -8003 |
FPR1 | 9137 | 11128 | -1439 |
FPR2 | 8942 | 10615 | 8911 |
FRK | -24 | 4203 | 6313 |
FRMPD3 | -11117 | -6990 | -2652 |
FTH1 | 4846 | 6298 | -896 |
FTL | 8523 | 10185 | 1590 |
FUCA1 | 7298 | 6432 | -1662 |
FUCA2 | 8173 | 6437 | 2892 |
GAA | 7846 | 8164 | -4427 |
GALNS | 6998 | 9617 | -5269 |
GCA | 9275 | 10574 | 8458 |
GDI2 | 7175 | 5201 | 7848 |
GGH | 6119 | 2669 | 7384 |
GHDC | 4117 | 3141 | -8050 |
GLA | 8430 | 10876 | 923 |
GLB1 | 8581 | 10666 | 2258 |
GLIPR1 | 7623 | 5719 | 9923 |
GM2A | 8906 | 11045 | 7136 |
GMFG | 8129 | 9415 | 685 |
GNS | 9200 | 11391 | 3599 |
GOLGA7 | 4015 | -4727 | 3414 |
GPI | 6198 | 4623 | -5172 |
GPR84 | 8980 | 10036 | 1662 |
GRN | 9150 | 10896 | -1134 |
GSDMD | 1942 | 4244 | -5496 |
GSN | 8605 | 9745 | -6892 |
GSTP1 | 134 | 1763 | -2320 |
GUSB | 7607 | 11238 | -5640 |
GYG1 | 8861 | 10131 | -768 |
HBB | 8901 | -76 | 1800 |
HEBP2 | 8266 | 5620 | -4336 |
HEXB | 8631 | 6847 | 3887 |
HGSNAT | 1854 | -3565 | -171 |
HK3 | 9225 | 11490 | 516 |
HLA-A | -2510 | -5419 | -8750 |
HLA-B | 643 | 2292 | -1943 |
HLA-C | 1010 | 3087 | 142 |
HLA-H | -3771 | -1299 | -9269 |
HMGB1 | -251 | -7642 | 4980 |
HMOX2 | -11464 | -9169 | -8180 |
HP | 9293 | 11371 | -1099 |
HPSE | 8342 | 10129 | -2829 |
HRNR | -7096 | -3485 | -3932 |
HSP90AA1 | 1316 | -5048 | 8114 |
HSP90AB1 | -6629 | -9109 | 3150 |
HSPA1A | 7946 | 6632 | -7658 |
HSPA1B | 6382 | 4388 | 4023 |
HSPA6 | 6426 | 9769 | -4167 |
HSPA8 | -10578 | -9123 | 450 |
HUWE1 | -7700 | -1644 | -5495 |
HVCN1 | 4856 | 3746 | -2268 |
IDH1 | 9345 | 11370 | 9398 |
IGF2R | 7044 | 9926 | -8671 |
ILF2 | -1939 | -4024 | 6633 |
IMPDH1 | 9136 | 11141 | -3002 |
IMPDH2 | -9588 | -9804 | -8220 |
IQGAP1 | 8024 | 8880 | -22 |
IQGAP2 | 6509 | 8781 | 5493 |
IST1 | 5786 | 7557 | 6588 |
ITGAL | -10503 | 2853 | -4573 |
ITGAM | 9238 | 11094 | -6412 |
ITGAV | 6022 | 8016 | 5164 |
ITGAX | 7227 | 11380 | -4395 |
ITGB2 | 8792 | 10785 | -8996 |
JUP | -5176 | -2038 | -86 |
KCMF1 | 7749 | 4009 | 3407 |
KCNAB2 | -101 | 7305 | -9812 |
KPNB1 | 2414 | -106 | 6972 |
KRT1 | 4492 | -7266 | -6517 |
LAIR1 | 7078 | 11275 | -2151 |
LAMP1 | 7515 | 8498 | -8622 |
LAMP2 | 8640 | 7271 | 7539 |
LAMTOR1 | 9251 | 9713 | -9592 |
LAMTOR2 | 7454 | 9183 | -8579 |
LAMTOR3 | 7461 | 2039 | 8800 |
LCN2 | 7639 | -4880 | -5370 |
LGALS3 | 8608 | 9166 | 230 |
LILRB2 | 7933 | 11537 | 1613 |
LILRB3 | 8723 | 10376 | -8473 |
LPCAT1 | -7171 | 5166 | -6116 |
LRG1 | 8532 | 9402 | -7556 |
LRRC7 | -1927 | -736 | -259 |
LTA4H | 9104 | 10873 | 5772 |
LTF | 6220 | -6500 | -6805 |
LYZ | 7107 | -780 | 712 |
MAGT1 | 2594 | 71 | 5712 |
MAN2B1 | 6781 | 6633 | -5993 |
MANBA | 7276 | 7952 | 9758 |
MAPK1 | 7381 | 10667 | -1770 |
MAPK14 | 8951 | 10298 | 4000 |
MCEMP1 | 9342 | 11112 | -5793 |
METTL7A | 6820 | 7311 | 8416 |
MGAM | 8897 | 9621 | -9363 |
MGST1 | 9321 | 9918 | 4962 |
MIF | -3748 | -6781 | -8075 |
MLEC | 2308 | -3597 | -3145 |
MME | 909 | -1728 | -4970 |
MMP25 | 8377 | 10474 | -2299 |
MMP8 | 9075 | 335 | -5785 |
MMP9 | 1677 | 10160 | -9943 |
MNDA | 9119 | 9202 | 8786 |
MOSPD2 | 8122 | 11282 | 10954 |
MPO | 7325 | -7916 | -8368 |
MS4A3 | 2347 | -5944 | 6699 |
MVP | 6950 | 9031 | -7677 |
NAPRT | 7301 | 10471 | 565 |
NBEAL2 | 6982 | 10524 | -5465 |
NCKAP1L | 7557 | 11206 | 1696 |
NCSTN | 9030 | 11510 | 3979 |
NDUFC2 | 6011 | 6708 | -5860 |
NEU1 | 8877 | 11207 | 1713 |
NFAM1 | 8933 | 10997 | -4892 |
NFASC | 859 | 6416 | 4430 |
NFKB1 | 6191 | -2146 | 1214 |
NHLRC3 | 1266 | 6966 | 9935 |
NIT2 | -11340 | -7590 | 6402 |
NME2 | 1837 | -394 | 3562 |
NPC2 | 5393 | 7468 | 6268 |
NRAS | 5302 | 1813 | 9977 |
OLFM4 | 8580 | -31 | -8934 |
OLR1 | 2469 | -6082 | -1197 |
ORM1 | 7849 | 3440 | -9868 |
ORM2 | -2501 | 4509 | -6579 |
ORMDL3 | -9667 | -8120 | -7124 |
OSCAR | 8915 | 11520 | 4280 |
OSTF1 | 7314 | 6525 | 2590 |
P2RX1 | 8303 | 11531 | 5876 |
PA2G4 | -3797 | -5507 | 4964 |
PADI2 | 9100 | 10696 | -8272 |
PAFAH1B2 | 6842 | 2339 | 6018 |
PDAP1 | 5831 | 9593 | -9354 |
PDXK | 8494 | 7567 | -2595 |
PECAM1 | 7735 | 11120 | 5659 |
PFKL | -3189 | 1182 | -9482 |
PGAM1 | 9274 | 11111 | -2886 |
PGLYRP1 | 7789 | 1980 | -9321 |
PGM1 | 5767 | 4697 | -7900 |
PGM2 | 9185 | 9410 | 3358 |
PGRMC1 | 7677 | -3729 | -2147 |
PIGR | -484 | 6471 | 4271 |
PKM | 9231 | 10377 | -2608 |
PLAC8 | 8319 | 11082 | -3448 |
PLAU | 4847 | 2352 | -4399 |
PLAUR | 8292 | 10654 | 598 |
PLD1 | 9148 | 10350 | 6144 |
PLEKHO2 | 7935 | 10786 | 1828 |
PNP | 8287 | 8496 | 2099 |
PPBP | 5961 | -5680 | -6890 |
PPIA | -6535 | -4528 | -557 |
PPIE | -8695 | -5029 | 5118 |
PRCP | 8088 | 7480 | 7688 |
PRDX4 | -144 | 5888 | 6406 |
PRDX6 | 8787 | -816 | -2927 |
PRKCD | 8856 | 11308 | 806 |
PRTN3 | 6667 | -6330 | -9828 |
PSAP | 7040 | 9870 | 1324 |
PSEN1 | 7839 | 10691 | 5400 |
PSMA2 | 5278 | -2014 | 3859 |
PSMA5 | -5853 | -6322 | 7981 |
PSMB1 | 3345 | -1943 | -880 |
PSMB7 | 8350 | 7844 | -5414 |
PSMC2 | 2579 | 4416 | 7925 |
PSMC3 | 1963 | 2166 | -5940 |
PSMD1 | 7134 | 6286 | 7596 |
PSMD11 | 6145 | 6978 | 10268 |
PSMD12 | 6467 | 5654 | 11287 |
PSMD13 | 5869 | 3735 | -2361 |
PSMD14 | 2592 | 225 | 8785 |
PSMD2 | 7300 | 5486 | -7349 |
PSMD3 | 4569 | 4137 | -9803 |
PSMD6 | 7726 | 8633 | 4780 |
PSMD7 | 5884 | 1537 | 9328 |
PTAFR | 9195 | 10579 | -6397 |
PTGES2 | -6690 | -3301 | -9202 |
PTPN6 | 6014 | 11061 | -2766 |
PTPRB | -7344 | -1883 | -8074 |
PTPRC | 2227 | 7455 | 9473 |
PTPRJ | 7666 | 9296 | -4702 |
PTPRN2 | 5122 | -2349 | -3483 |
PTX3 | 5722 | -995 | 7805 |
PYCARD | 8497 | 10906 | -3514 |
PYGB | 486 | -3041 | -7463 |
PYGL | 9257 | 10610 | -3750 |
QPCT | 9168 | 10241 | 2637 |
QSOX1 | 9140 | 11347 | -5224 |
RAB10 | 8776 | 10722 | 5688 |
RAB14 | 6991 | 2915 | 9597 |
RAB18 | 7683 | 4326 | 11226 |
RAB24 | 5293 | 10429 | 4954 |
RAB27A | 8279 | 7836 | 8565 |
RAB31 | 9196 | 9894 | 4968 |
RAB37 | -11438 | -6247 | -3878 |
RAB3A | 8006 | 1221 | -9658 |
RAB3D | 9051 | 10017 | 1582 |
RAB44 | 567 | -5800 | -1505 |
RAB4B | 3111 | 10066 | -6147 |
RAB5B | 6599 | 4884 | -1226 |
RAB5C | 8513 | 10039 | -6403 |
RAB6A | 8020 | 7487 | 7945 |
RAB7A | 8598 | 9167 | 2133 |
RAB9B | -6329 | -4634 | 2215 |
RAC1 | 8647 | 10726 | 9288 |
RAP1A | 7198 | 6943 | 11289 |
RAP1B | 3179 | 5307 | 7206 |
RAP2B | -765 | 1001 | -662 |
RAP2C | 4551 | 4998 | 7679 |
RETN | 8848 | 10349 | 5200 |
RHOA | 8188 | 8640 | 7321 |
RHOF | -11981 | -8988 | -7491 |
RHOG | 8352 | 10463 | -1690 |
RNASE2 | 9344 | 11336 | 10281 |
RNASE3 | 7359 | 1010 | 3204 |
RNASET2 | 5844 | 8694 | -2775 |
ROCK1 | 7377 | 6942 | 10322 |
S100A11 | 8796 | 10890 | 3761 |
S100A12 | 9352 | 10889 | 3333 |
S100A8 | 9341 | 11121 | 2853 |
S100A9 | 9353 | 11235 | 226 |
S100P | 8199 | 9316 | -7931 |
SCAMP1 | 1855 | -7626 | 6821 |
SDCBP | 9153 | 9404 | 8662 |
SELL | 8762 | 8713 | 625 |
SERPINA1 | 9013 | 11480 | 6681 |
SERPINB1 | 9273 | 10752 | 2537 |
SERPINB10 | 8783 | 3814 | -4112 |
SERPINB6 | 5778 | 9085 | -8463 |
SIGLEC14 | 5028 | 129 | -3738 |
SIGLEC5 | 8033 | 6183 | -793 |
SIGLEC9 | 9223 | 11296 | -2592 |
SIRPA | 9348 | 11400 | -1174 |
SIRPB1 | 7723 | 6957 | -7936 |
SLC11A1 | 9014 | 11536 | -778 |
SLC15A4 | 3690 | 9552 | -915 |
SLC27A2 | -3718 | -7230 | 9199 |
SLC2A3 | 8869 | 9612 | -6003 |
SLC2A5 | 2031 | -3120 | 5048 |
SLC44A2 | 2678 | 34 | -7769 |
SLCO4C1 | 3185 | 3073 | 2134 |
SLPI | 5237 | -947 | -2393 |
SNAP23 | 8487 | 4303 | 6932 |
SNAP29 | 6302 | 8481 | -9182 |
SPTAN1 | -11074 | -9473 | -8917 |
SRP14 | 6234 | 4952 | 6220 |
STBD1 | 5477 | -453 | 2023 |
STING1 | 4736 | -467 | -2958 |
STK10 | -3780 | 7207 | -7919 |
STK11IP | 3554 | 10226 | -8927 |
STOM | 6613 | 3408 | 836 |
SURF4 | 6954 | 5080 | -5301 |
SVIP | 2022 | -7342 | 5254 |
SYNGR1 | -4479 | -2143 | -6560 |
TARM1 | 5246 | 4590 | 2177 |
TBC1D10C | -11505 | -7229 | -9560 |
TCIRG1 | 7082 | 11503 | -5720 |
TCN1 | 6098 | -6179 | 4352 |
TICAM2 | 6249 | 5514 | 9918 |
TIMP2 | 9297 | 11124 | -5506 |
TLR2 | 8950 | 10582 | 9812 |
TMBIM1 | 8229 | 9127 | -7190 |
TMC6 | -10267 | -4664 | -7552 |
TMEM179B | 443 | 983 | -423 |
TMEM30A | 7913 | 4486 | 9463 |
TMEM63A | -8824 | -7322 | -1667 |
TNFAIP6 | 8594 | 11144 | 2592 |
TNFRSF1B | 5964 | 10836 | -3052 |
TOLLIP | 8432 | 7708 | -7962 |
TOM1 | 9044 | 10733 | -8405 |
TRAPPC1 | 7688 | 8766 | -4414 |
TRPM2 | 8949 | 10980 | -6192 |
TSPAN14 | 6870 | 10420 | -4594 |
TUBB | -6718 | -5253 | -854 |
TUBB4B | 7133 | 6509 | -5525 |
TXNDC5 | 391 | -4174 | 5239 |
TYROBP | 7427 | 10576 | -4257 |
UBR4 | -2044 | 2816 | -3205 |
UNC13D | 7492 | 11075 | -6891 |
VAMP8 | 5157 | 4210 | -6012 |
VAPA | 8881 | 8035 | 5255 |
VAT1 | 9118 | 10856 | -8461 |
VCL | 7218 | 1206 | -2715 |
VCP | 6789 | 4231 | -5183 |
VNN1 | 8939 | 11139 | 8141 |
VPS35L | 6034 | 9056 | 4608 |
XRCC5 | 5322 | -2461 | 4335 |
XRCC6 | -4326 | -7728 | 1717 |
YPEL5 | 6593 | 6479 | 4396 |
ROS and RNS production in phagocytes
metric | value |
---|---|
setSize | 31 |
pMANOVA | 1.98e-07 |
p.adjustMANOVA | 1.5e-06 |
s.dist | 0.704 |
s.t0_v_pod | 0.597 |
s.pod_crp | 0.367 |
s.t0_crp | -0.0586 |
p.t0_v_pod | 8.47e-09 |
p.pod_crp | 0.000398 |
p.t0_crp | 0.573 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ATP6V0A1 | 9262 | 11270 |
SLC11A1 | 9014 | 11536 |
ATP6V0D1 | 9088 | 11089 |
NCF2 | 9034 | 10855 |
NCF4 | 9111 | 10692 |
ATP6V0C | 8974 | 10678 |
CYBB | 8879 | 10038 |
ATP6V0B | 8458 | 10337 |
ATP6V1B2 | 8904 | 9564 |
ATP6V1D | 8894 | 9569 |
TCIRG1 | 7082 | 11503 |
ATP6V1A | 9144 | 8379 |
ATP6V1C1 | 8400 | 8697 |
CYBA | 6822 | 10446 |
ATP6V0E1 | 8456 | 8200 |
ATP6V1E1 | 7912 | 7496 |
NCF1 | 7224 | 7391 |
ATP6V1H | 7939 | 4992 |
ATP6V1F | 5802 | 5090 |
RAC2 | 5104 | 5027 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATP6V0A1 | 9262 | 11270 | -184 |
ATP6V0A2 | -11850 | -4901 | 2656 |
ATP6V0B | 8458 | 10337 | -6528 |
ATP6V0C | 8974 | 10678 | -1938 |
ATP6V0D1 | 9088 | 11089 | -1722 |
ATP6V0E1 | 8456 | 8200 | -226 |
ATP6V0E2 | -11202 | -8309 | 1787 |
ATP6V1A | 9144 | 8379 | 5839 |
ATP6V1B2 | 8904 | 9564 | 3425 |
ATP6V1C1 | 8400 | 8697 | 8360 |
ATP6V1C2 | -2175 | -2046 | -2521 |
ATP6V1D | 8894 | 9569 | 8256 |
ATP6V1E1 | 7912 | 7496 | 8195 |
ATP6V1E2 | 5657 | -5806 | -7499 |
ATP6V1F | 5802 | 5090 | -6651 |
ATP6V1G1 | 3892 | -4430 | 794 |
ATP6V1G2 | -9197 | -8007 | -1854 |
ATP6V1H | 7939 | 4992 | 5368 |
CYBA | 6822 | 10446 | -6535 |
CYBB | 8879 | 10038 | 8462 |
HVCN1 | 4856 | 3746 | -2268 |
LPO | 6414 | 2023 | 5426 |
MPO | 7325 | -7916 | -8368 |
NCF1 | 7224 | 7391 | -3129 |
NCF2 | 9034 | 10855 | 2089 |
NCF4 | 9111 | 10692 | -4957 |
NOS1 | 1355 | 7583 | 6535 |
NOS3 | -2018 | -6797 | 2341 |
RAC2 | 5104 | 5027 | -8160 |
SLC11A1 | 9014 | 11536 | -778 |
TCIRG1 | 7082 | 11503 | -5720 |
Influenza Viral RNA Transcription and Replication
metric | value |
---|---|
setSize | 135 |
pMANOVA | 1.83e-37 |
p.adjustMANOVA | 9.58e-36 |
s.dist | 0.703 |
s.t0_v_pod | -0.225 |
s.pod_crp | -0.544 |
s.t0_crp | -0.384 |
p.t0_v_pod | 6.45e-06 |
p.pod_crp | 8.94e-28 |
p.t0_crp | 1.21e-14 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AAAS | -8101 | 625 | -1546 |
DNAJC3 | 8302 | 8189 | 7460 |
FAU | -359 | -1018 | -9018 |
GRSF1 | 5110 | -3098 | 3896 |
GTF2F1 | 4893 | 5437 | -9039 |
GTF2F2 | 5371 | 5207 | 5137 |
HSP90AA1 | 1316 | -5048 | 8114 |
IPO5 | -10252 | -9795 | -1839 |
NDC1 | -11812 | -9774 | -73 |
NUP107 | -10085 | -8758 | 7683 |
NUP133 | -7491 | -5635 | 5219 |
NUP153 | -6108 | -4400 | 3509 |
NUP155 | -9900 | -7591 | 2977 |
NUP160 | -10219 | -8656 | 3162 |
NUP188 | -11270 | -7253 | -5615 |
NUP205 | -10971 | -7010 | 3379 |
NUP210 | -10384 | -4340 | -8792 |
NUP214 | 7800 | 9971 | 2007 |
NUP35 | -10272 | -9583 | 8608 |
NUP37 | 3049 | -1412 | 3817 |
NUP42 | -5378 | -2693 | 10509 |
NUP43 | -9198 | -7750 | 10186 |
NUP50 | 4476 | -1230 | 6822 |
NUP54 | -8189 | -5304 | 11136 |
NUP58 | 8674 | 7535 | 6567 |
NUP62 | 763 | 394 | -2984 |
NUP85 | -2971 | -1702 | 6335 |
NUP88 | -11046 | -9387 | 4338 |
NUP93 | -11266 | -3136 | 2920 |
NUP98 | 3075 | 175 | 2062 |
PARP1 | -11409 | -9090 | -4667 |
POLR2A | -3010 | 6319 | -6014 |
POLR2B | -2462 | -5075 | 7311 |
POLR2C | 1603 | -2543 | -2871 |
POLR2D | -3902 | -8118 | 4726 |
POLR2E | 7450 | 5182 | -8728 |
POLR2F | 4555 | 5678 | -8849 |
POLR2G | 3477 | 5635 | -7724 |
POLR2H | -2867 | -3580 | -4558 |
POLR2I | 394 | -1586 | -8884 |
POLR2J | 6580 | 7886 | -5760 |
POLR2K | -1750 | -3871 | 9561 |
POLR2L | 5244 | 3421 | -9948 |
POM121 | -8013 | -2273 | -8608 |
POM121C | -6940 | -6034 | -9057 |
RAE1 | 5105 | 4986 | 5899 |
RANBP2 | -814 | -3082 | 5483 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
SEC13 | 5675 | 6716 | -3023 |
SEH1L | -5868 | -8749 | 9484 |
TPR | -6786 | -4096 | 4769 |
UBA52 | 1112 | -1425 | -7104 |
SRP-dependent cotranslational protein targeting to membrane
metric | value |
---|---|
setSize | 111 |
pMANOVA | 5.6e-38 |
p.adjustMANOVA | 3.05e-36 |
s.dist | 0.702 |
s.t0_v_pod | -0.134 |
s.pod_crp | -0.559 |
s.t0_crp | -0.404 |
p.t0_v_pod | 0.0148 |
p.pod_crp | 2.4e-24 |
p.t0_crp | 1.86e-13 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DDOST | 6831 | 7376 | -7998 |
FAU | -359 | -1018 | -9018 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPN1 | 7902 | 4000 | -6048 |
RPN2 | 7035 | 7029 | 4420 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
SEC11A | 7799 | 7093 | 1007 |
SEC11C | -8699 | -5267 | 10431 |
SEC61A1 | 6361 | 3940 | -950 |
SEC61A2 | -10455 | -3235 | 9212 |
SEC61B | 6910 | 4481 | -2532 |
SEC61G | 4656 | -2306 | 10727 |
SPCS1 | 2996 | -1989 | 4208 |
SPCS2 | 3184 | -2426 | 10641 |
SPCS3 | 4326 | -1801 | 10410 |
SRP14 | 6234 | 4952 | 6220 |
SRP19 | 4236 | -478 | 10627 |
SRP54 | 6501 | 6398 | 11317 |
SRP68 | 2001 | -2539 | 4255 |
SRP72 | -1470 | -4790 | 6023 |
SRP9 | 4400 | -4365 | 10477 |
SRPRA | 4999 | 5439 | -5685 |
SRPRB | -9099 | -8472 | 6212 |
SSR1 | 6498 | -2621 | 7135 |
SSR2 | 2796 | -2339 | 1929 |
SSR3 | 5856 | -657 | 7929 |
SSR4 | 3109 | 1947 | -6051 |
TRAM1 | -4486 | -7869 | 9372 |
UBA52 | 1112 | -1425 | -7104 |
Platelet sensitization by LDL
metric | value |
---|---|
setSize | 16 |
pMANOVA | 0.00192 |
p.adjustMANOVA | 0.00472 |
s.dist | 0.697 |
s.t0_v_pod | 0.552 |
s.pod_crp | 0.418 |
s.t0_crp | 0.0793 |
p.t0_v_pod | 0.000131 |
p.pod_crp | 0.00383 |
p.t0_crp | 0.583 |
Gene | t0_v_pod | pod_crp |
---|---|---|
FGR | 8344 | 11409 |
MAPK14 | 8951 | 10298 |
PLA2G4A | 9025 | 9798 |
PECAM1 | 7735 | 11120 |
PPP2R5B | 6679 | 10409 |
PTPN6 | 6014 | 11061 |
LRP8 | 4522 | 10156 |
PPP2R5A | 5821 | 7421 |
PPP2CB | 7596 | 5321 |
PPP2CA | 8104 | 4832 |
PPP2R1A | 4542 | 4551 |
PTPN11 | 5253 | 2833 |
PPP2R5D | 2405 | 2534 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
FGR | 8344 | 11409 | -3712 |
LRP8 | 4522 | 10156 | -4090 |
MAPK14 | 8951 | 10298 | 4000 |
PECAM1 | 7735 | 11120 | 5659 |
PLA2G4A | 9025 | 9798 | 9511 |
PPP2CA | 8104 | 4832 | 5474 |
PPP2CB | 7596 | 5321 | 8298 |
PPP2R1A | 4542 | 4551 | -7355 |
PPP2R1B | -241 | -2878 | 3499 |
PPP2R5A | 5821 | 7421 | 4928 |
PPP2R5B | 6679 | 10409 | -2611 |
PPP2R5C | -10916 | -7637 | 3918 |
PPP2R5D | 2405 | 2534 | -2384 |
PPP2R5E | -675 | -6243 | 2034 |
PTPN11 | 5253 | 2833 | -599 |
PTPN6 | 6014 | 11061 | -2766 |
Trafficking of GluR2-containing AMPA receptors
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00172 |
p.adjustMANOVA | 0.00433 |
s.dist | 0.695 |
s.t0_v_pod | 0.469 |
s.pod_crp | 0.278 |
s.t0_crp | -0.431 |
p.t0_v_pod | 0.00491 |
p.pod_crp | 0.095 |
p.t0_crp | 0.00968 |
Gene | t0_v_pod | t0_crp |
---|---|---|
AP2M1 | 8486 | -8627 |
PRKCB | 6993 | -7987 |
AP2A2 | 7150 | -7534 |
AP2A1 | 6737 | -6569 |
PICK1 | 3562 | -8925 |
AP2S1 | 7903 | -3704 |
TSPAN7 | 6381 | -2373 |
PRKCA | 1123 | -5853 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2A1 | 6737 | 11502 | -6569 |
AP2A2 | 7150 | 10268 | -7534 |
AP2B1 | -2641 | -3659 | -3248 |
AP2M1 | 8486 | 7237 | -8627 |
AP2S1 | 7903 | 9372 | -3704 |
GRIA4 | -97 | 5796 | 6158 |
GRIP1 | -10075 | -9327 | -1211 |
NSF | 8683 | 9716 | 2271 |
PICK1 | 3562 | 5147 | -8925 |
PRKCA | 1123 | -5628 | -5853 |
PRKCB | 6993 | 7023 | -7987 |
TSPAN7 | 6381 | -1548 | -2373 |
Diseases associated with the TLR signaling cascade
metric | value |
---|---|
setSize | 23 |
pMANOVA | 0.000143 |
p.adjustMANOVA | 0.000512 |
s.dist | 0.694 |
s.t0_v_pod | 0.534 |
s.pod_crp | 0.441 |
s.t0_crp | 0.0319 |
p.t0_v_pod | 9.12e-06 |
p.pod_crp | 0.000247 |
p.t0_crp | 0.791 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD36 | 9283 | 11160 |
TLR5 | 9045 | 10806 |
TLR2 | 8950 | 10582 |
CD14 | 8944 | 10372 |
MYD88 | 8009 | 11413 |
LY96 | 8649 | 9854 |
TLR4 | 8864 | 9225 |
BTK | 7100 | 11184 |
TLR1 | 8782 | 8637 |
TLR6 | 8694 | 7538 |
TICAM1 | 6221 | 9502 |
CHUK | 7844 | 7098 |
IKBKG | 5315 | 8787 |
UNC93B1 | 4129 | 10825 |
TIRAP | 5571 | 6784 |
NFKBIA | 6712 | 3910 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BTK | 7100 | 11184 | 8838 |
CD14 | 8944 | 10372 | -5065 |
CD36 | 9283 | 11160 | 9413 |
CHUK | 7844 | 7098 | 7094 |
IKBKB | -5208 | 5101 | -4279 |
IKBKG | 5315 | 8787 | -7863 |
LY96 | 8649 | 9854 | 7645 |
MYD88 | 8009 | 11413 | 3934 |
NFKB1 | 6191 | -2146 | 1214 |
NFKB2 | -1150 | 1265 | -300 |
NFKBIA | 6712 | 3910 | -4500 |
RELA | -1770 | -2540 | -9307 |
TICAM1 | 6221 | 9502 | -881 |
TIRAP | 5571 | 6784 | -3461 |
TLR1 | 8782 | 8637 | 7301 |
TLR10 | -2886 | -6753 | -1228 |
TLR2 | 8950 | 10582 | 9812 |
TLR3 | -11172 | -9451 | 1584 |
TLR4 | 8864 | 9225 | 1420 |
TLR5 | 9045 | 10806 | 4896 |
TLR6 | 8694 | 7538 | 2941 |
TRAF3 | -5390 | -5162 | -6877 |
UNC93B1 | 4129 | 10825 | 250 |
Diseases of Immune System
metric | value |
---|---|
setSize | 23 |
pMANOVA | 0.000143 |
p.adjustMANOVA | 0.000512 |
s.dist | 0.694 |
s.t0_v_pod | 0.534 |
s.pod_crp | 0.441 |
s.t0_crp | 0.0319 |
p.t0_v_pod | 9.12e-06 |
p.pod_crp | 0.000247 |
p.t0_crp | 0.791 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD36 | 9283 | 11160 |
TLR5 | 9045 | 10806 |
TLR2 | 8950 | 10582 |
CD14 | 8944 | 10372 |
MYD88 | 8009 | 11413 |
LY96 | 8649 | 9854 |
TLR4 | 8864 | 9225 |
BTK | 7100 | 11184 |
TLR1 | 8782 | 8637 |
TLR6 | 8694 | 7538 |
TICAM1 | 6221 | 9502 |
CHUK | 7844 | 7098 |
IKBKG | 5315 | 8787 |
UNC93B1 | 4129 | 10825 |
TIRAP | 5571 | 6784 |
NFKBIA | 6712 | 3910 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BTK | 7100 | 11184 | 8838 |
CD14 | 8944 | 10372 | -5065 |
CD36 | 9283 | 11160 | 9413 |
CHUK | 7844 | 7098 | 7094 |
IKBKB | -5208 | 5101 | -4279 |
IKBKG | 5315 | 8787 | -7863 |
LY96 | 8649 | 9854 | 7645 |
MYD88 | 8009 | 11413 | 3934 |
NFKB1 | 6191 | -2146 | 1214 |
NFKB2 | -1150 | 1265 | -300 |
NFKBIA | 6712 | 3910 | -4500 |
RELA | -1770 | -2540 | -9307 |
TICAM1 | 6221 | 9502 | -881 |
TIRAP | 5571 | 6784 | -3461 |
TLR1 | 8782 | 8637 | 7301 |
TLR10 | -2886 | -6753 | -1228 |
TLR2 | 8950 | 10582 | 9812 |
TLR3 | -11172 | -9451 | 1584 |
TLR4 | 8864 | 9225 | 1420 |
TLR5 | 9045 | 10806 | 4896 |
TLR6 | 8694 | 7538 | 2941 |
TRAF3 | -5390 | -5162 | -6877 |
UNC93B1 | 4129 | 10825 | 250 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.00602 |
p.adjustMANOVA | 0.0127 |
s.dist | 0.693 |
s.t0_v_pod | 0.555 |
s.pod_crp | 0.395 |
s.t0_crp | 0.124 |
p.t0_v_pod | 0.000528 |
p.pod_crp | 0.0136 |
p.t0_crp | 0.44 |
Gene | t0_v_pod | pod_crp |
---|---|---|
RAC1 | 8647 | 10726 |
CRK | 8756 | 9243 |
RHOA | 8188 | 8640 |
DOCK1 | 7206 | 8430 |
PTK6 | 5877 | 8863 |
PXN | 6144 | 8429 |
ELMO2 | 4353 | 9704 |
RASA1 | 2093 | 6650 |
KRAS | 3668 | 3086 |
NRAS | 5302 | 1813 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ARHGAP35 | -3266 | -5145 | -7271 |
CRK | 8756 | 9243 | 8031 |
DOCK1 | 7206 | 8430 | -6510 |
ELMO1 | 6172 | -1400 | -4598 |
ELMO2 | 4353 | 9704 | 5888 |
HRAS | -3288 | -3089 | -7583 |
KRAS | 3668 | 3086 | 11151 |
NRAS | 5302 | 1813 | 9977 |
PTK6 | 5877 | 8863 | -2030 |
PXN | 6144 | 8429 | -7995 |
RAC1 | 8647 | 10726 | 9288 |
RASA1 | 2093 | 6650 | 9826 |
RHOA | 8188 | 8640 | 7321 |
rRNA modification in the nucleus and cytosol
metric | value |
---|---|
setSize | 59 |
pMANOVA | 7.21e-12 |
p.adjustMANOVA | 1.21e-10 |
s.dist | 0.691 |
s.t0_v_pod | -0.397 |
s.pod_crp | -0.556 |
s.t0_crp | -0.0986 |
p.t0_v_pod | 1.32e-07 |
p.pod_crp | 1.39e-13 |
p.t0_crp | 0.19 |
Gene | pod_crp | t0_v_pod |
---|---|---|
DKC1 | -9791 | -11282 |
NAT10 | -9283 | -11593 |
UTP4 | -9295 | -11142 |
BMS1 | -9121 | -11315 |
NOP14 | -9676 | -10522 |
FBL | -9628 | -9855 |
NOP56 | -8304 | -11395 |
NOL11 | -9311 | -10134 |
NOP58 | -9323 | -9623 |
PDCD11 | -7938 | -11166 |
WDR75 | -9170 | -9593 |
THUMPD1 | -9268 | -9477 |
IMP4 | -8191 | -10629 |
DDX47 | -7920 | -10949 |
UTP15 | -8238 | -10264 |
RRP9 | -8079 | -9748 |
WDR46 | -6936 | -10623 |
HEATR1 | -7318 | -10009 |
NOL6 | -6904 | -10564 |
DIMT1 | -9187 | -7711 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BMS1 | -11315 | -9121 | -2978 |
DCAF13 | -5386 | -4214 | -1334 |
DDX47 | -10949 | -7920 | 10936 |
DDX49 | 4816 | 4154 | -9489 |
DDX52 | 448 | 1493 | 11328 |
DHX37 | -7983 | -5722 | -6991 |
DIMT1 | -7711 | -9187 | 9761 |
DKC1 | -11282 | -9791 | -2099 |
EMG1 | -9856 | -6694 | 4341 |
FBL | -9855 | -9628 | -9879 |
FCF1 | 4428 | -2984 | 7360 |
GAR1 | -6703 | -6656 | -530 |
HEATR1 | -10009 | -7318 | 1473 |
IMP3 | -9143 | -6956 | -3753 |
IMP4 | -10629 | -8191 | -5663 |
KRR1 | -8329 | -6392 | 7558 |
MPHOSPH10 | -7519 | -6550 | 11244 |
NAT10 | -11593 | -9283 | -5917 |
NHP2 | -3373 | -5708 | -7073 |
NOC4L | -5298 | 7372 | -3269 |
NOL11 | -10134 | -9311 | 9550 |
NOL6 | -10564 | -6904 | -9301 |
NOP10 | 8200 | 10614 | -3974 |
NOP14 | -10522 | -9676 | -4648 |
NOP2 | -9624 | -6235 | -7727 |
NOP56 | -11395 | -8304 | -926 |
NOP58 | -9623 | -9323 | 9270 |
PDCD11 | -11166 | -7938 | -6311 |
PNO1 | -6627 | -7464 | 6858 |
PWP2 | -1190 | -7158 | -7255 |
RCL1 | -751 | -7719 | -4623 |
RPS14 | -5278 | -8295 | -7890 |
RPS2 | -4354 | -9592 | -9910 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS9 | 5358 | 2375 | -7391 |
RRP36 | -1645 | 510 | -1316 |
RRP7A | -2734 | -4541 | -659 |
RRP9 | -9748 | -8079 | -9693 |
SNORD3A | -2477 | 11233 | 9893 |
SNU13 | -6637 | -7945 | -4150 |
TBL3 | -3341 | 55 | -8145 |
THUMPD1 | -9477 | -9268 | 8192 |
TRMT112 | 732 | -366 | -8610 |
TSR3 | 3808 | -354 | -8970 |
UTP11 | 4582 | 1261 | 8086 |
UTP14A | -1788 | -3133 | 4462 |
UTP14C | -2032 | -1616 | 5210 |
UTP15 | -10264 | -8238 | 10459 |
UTP18 | 5055 | 3705 | 3978 |
UTP20 | -10191 | -6857 | 6223 |
UTP3 | -2829 | -1448 | -1947 |
UTP4 | -11142 | -9295 | -1037 |
UTP6 | -4362 | -5407 | 9675 |
WDR3 | -6394 | -7931 | -33 |
WDR36 | -3825 | -5814 | 6003 |
WDR43 | -7419 | -8808 | 3001 |
WDR46 | -10623 | -6936 | -9396 |
WDR75 | -9593 | -9170 | 7264 |
Insulin receptor recycling
metric | value |
---|---|
setSize | 21 |
pMANOVA | 0.000116 |
p.adjustMANOVA | 0.000431 |
s.dist | 0.689 |
s.t0_v_pod | 0.568 |
s.pod_crp | 0.383 |
s.t0_crp | -0.0651 |
p.t0_v_pod | 6.47e-06 |
p.pod_crp | 0.00236 |
p.t0_crp | 0.606 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ATP6V0A1 | 9262 | 11270 |
ATP6V0D1 | 9088 | 11089 |
ATP6V0C | 8974 | 10678 |
ATP6AP1 | 8032 | 11319 |
ATP6V0B | 8458 | 10337 |
ATP6V1B2 | 8904 | 9564 |
ATP6V1D | 8894 | 9569 |
TCIRG1 | 7082 | 11503 |
ATP6V1A | 9144 | 8379 |
INSR | 8152 | 9155 |
ATP6V1C1 | 8400 | 8697 |
ATP6V0E1 | 8456 | 8200 |
ATP6V1E1 | 7912 | 7496 |
ATP6V1H | 7939 | 4992 |
ATP6V1F | 5802 | 5090 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATP6AP1 | 8032 | 11319 | -7483 |
ATP6V0A1 | 9262 | 11270 | -184 |
ATP6V0A2 | -11850 | -4901 | 2656 |
ATP6V0B | 8458 | 10337 | -6528 |
ATP6V0C | 8974 | 10678 | -1938 |
ATP6V0D1 | 9088 | 11089 | -1722 |
ATP6V0E1 | 8456 | 8200 | -226 |
ATP6V0E2 | -11202 | -8309 | 1787 |
ATP6V1A | 9144 | 8379 | 5839 |
ATP6V1B2 | 8904 | 9564 | 3425 |
ATP6V1C1 | 8400 | 8697 | 8360 |
ATP6V1C2 | -2175 | -2046 | -2521 |
ATP6V1D | 8894 | 9569 | 8256 |
ATP6V1E1 | 7912 | 7496 | 8195 |
ATP6V1E2 | 5657 | -5806 | -7499 |
ATP6V1F | 5802 | 5090 | -6651 |
ATP6V1G1 | 3892 | -4430 | 794 |
ATP6V1G2 | -9197 | -8007 | -1854 |
ATP6V1H | 7939 | 4992 | 5368 |
INSR | 8152 | 9155 | -3492 |
TCIRG1 | 7082 | 11503 | -5720 |
Heme degradation
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.0173 |
p.adjustMANOVA | 0.0323 |
s.dist | 0.687 |
s.t0_v_pod | 0.401 |
s.pod_crp | 0.535 |
s.t0_crp | -0.156 |
p.t0_v_pod | 0.028 |
p.pod_crp | 0.00341 |
p.t0_crp | 0.392 |
Gene | pod_crp | t0_v_pod |
---|---|---|
HMOX1 | 11322 | 8148 |
SLCO2B1 | 10404 | 8317 |
GUSB | 11238 | 7607 |
BLVRB | 8056 | 9219 |
BLVRA | 10555 | 5690 |
ALB | 9318 | 3634 |
ABCC1 | 7725 | 570 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ABCC1 | 570 | 7725 | -2091 |
ABCC2 | -2037 | 5017 | -497 |
ABCG2 | -77 | 1178 | -3387 |
ALB | 3634 | 9318 | 6958 |
BLVRA | 5690 | 10555 | 7145 |
BLVRB | 9219 | 8056 | -6449 |
GUSB | 7607 | 11238 | -5640 |
HMOX1 | 8148 | 11322 | -5911 |
HMOX2 | -11464 | -9169 | -8180 |
SLCO2B1 | 8317 | 10404 | 7741 |
p130Cas linkage to MAPK signaling for integrins
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.000141 |
p.adjustMANOVA | 0.000509 |
s.dist | 0.686 |
s.t0_v_pod | 0.666 |
s.pod_crp | 0.159 |
s.t0_crp | -0.0404 |
p.t0_v_pod | 0.000132 |
p.pod_crp | 0.36 |
p.t0_crp | 0.817 |
Gene | t0_v_pod | pod_crp |
---|---|---|
APBB1IP | 8600 | 9624 |
CRK | 8756 | 9243 |
TLN1 | 8386 | 8793 |
RAP1A | 7198 | 6943 |
RAP1B | 3179 | 5307 |
ITGA2B | 8744 | 1914 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APBB1IP | 8600 | 9624 | 5781 |
CRK | 8756 | 9243 | 8031 |
FN1 | 8154 | -1733 | 4890 |
ITGA2B | 8744 | 1914 | -6113 |
ITGB3 | 8161 | -2845 | -6419 |
PTK2 | 4418 | -3305 | -1920 |
RAP1A | 7198 | 6943 | 11289 |
RAP1B | 3179 | 5307 | 7206 |
SRC | -8520 | -5490 | -4085 |
TLN1 | 8386 | 8793 | -7844 |
VWF | 6550 | -369 | -8508 |
rRNA processing
metric | value |
---|---|
setSize | 217 |
pMANOVA | 3.11e-50 |
p.adjustMANOVA | 6.05e-48 |
s.dist | 0.685 |
s.t0_v_pod | -0.289 |
s.pod_crp | -0.544 |
s.t0_crp | -0.299 |
p.t0_v_pod | 2.16e-13 |
p.pod_crp | 1.51e-43 |
p.t0_crp | 3.13e-14 |
Gene | pod_crp | t0_crp |
---|---|---|
FBL | -9628 | -9879 |
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RRP9 | -8079 | -9693 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
EXOSC2 | -8130 | -8291 |
EXOSC5 | -8229 | -8152 |
RPL37 | -6620 | -9973 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BMS1 | -11315 | -9121 | -2978 |
BOP1 | -5039 | -5105 | -9461 |
BYSL | -4316 | -5824 | -5291 |
C1D | 3484 | 530 | 10834 |
CSNK1D | 2374 | 7369 | -9414 |
CSNK1E | -9964 | -7485 | -8511 |
DCAF13 | -5386 | -4214 | -1334 |
DDX21 | 3087 | -3715 | 7759 |
DDX47 | -10949 | -7920 | 10936 |
DDX49 | 4816 | 4154 | -9489 |
DDX52 | 448 | 1493 | 11328 |
DHX37 | -7983 | -5722 | -6991 |
DIMT1 | -7711 | -9187 | 9761 |
DIS3 | -4187 | -3885 | 11031 |
DKC1 | -11282 | -9791 | -2099 |
EBNA1BP2 | -3970 | -6823 | -1321 |
ELAC2 | -11406 | -3655 | -2225 |
EMG1 | -9856 | -6694 | 4341 |
ERI1 | 5474 | 1977 | 9721 |
EXOSC1 | -979 | 2548 | 5536 |
EXOSC10 | -11028 | -5076 | 4728 |
EXOSC2 | -10724 | -8130 | -8291 |
EXOSC3 | 503 | 280 | 2174 |
EXOSC4 | 7485 | 8780 | -6432 |
EXOSC5 | -4428 | -8229 | -8152 |
EXOSC6 | -9514 | -7940 | -3133 |
EXOSC7 | -10290 | -6545 | -9416 |
EXOSC8 | -11104 | -7863 | 7938 |
EXOSC9 | -9917 | -7435 | 10177 |
FAU | -359 | -1018 | -9018 |
FBL | -9855 | -9628 | -9879 |
FCF1 | 4428 | -2984 | 7360 |
FTSJ3 | -3900 | 3485 | -5754 |
GAR1 | -6703 | -6656 | -530 |
GNL3 | -8199 | -9337 | 5789 |
HEATR1 | -10009 | -7318 | 1473 |
HSD17B10 | 4141 | 6396 | -2742 |
IMP3 | -9143 | -6956 | -3753 |
IMP4 | -10629 | -8191 | -5663 |
ISG20L2 | 3737 | -42 | 1389 |
KRR1 | -8329 | -6392 | 7558 |
LAS1L | -11905 | -8458 | -7799 |
LTV1 | -4162 | -4559 | 7450 |
MPHOSPH10 | -7519 | -6550 | 11244 |
MPHOSPH6 | 2168 | -2313 | 5028 |
MRM1 | -10179 | -7139 | -5593 |
MRM2 | 1450 | -3163 | -1074 |
MRM3 | -7261 | -5459 | -1972 |
MT-ATP6 | -2053 | 36 | -9285 |
MT-ATP8 | -2987 | 1930 | -9997 |
MT-CO1 | 678 | 506 | -664 |
MT-CO2 | 48 | 727 | -5477 |
MT-CO3 | 40 | -4216 | -8386 |
MT-CYB | -2209 | -2076 | -6754 |
MT-ND1 | -3510 | -5813 | -6341 |
MT-ND2 | -6337 | -6687 | -4767 |
MT-ND3 | -3542 | -2943 | -8163 |
MT-ND4 | 833 | 5788 | 3171 |
MT-ND4L | -1983 | 3127 | -8767 |
MT-ND5 | -2122 | -3161 | -5938 |
MT-RNR1 | -298 | -6444 | -3154 |
MT-RNR2 | 2099 | -138 | -3495 |
MT-TF | -2683 | 1005 | -8011 |
MT-TL1 | -2901 | 4971 | -3694 |
MT-TV | -3544 | 4473 | -8156 |
MTERF4 | -10547 | -9447 | -5484 |
MTREX | -2574 | -4700 | 10249 |
NAT10 | -11593 | -9283 | -5917 |
NCL | -8953 | -9124 | -4545 |
NHP2 | -3373 | -5708 | -7073 |
NIP7 | -5682 | -8082 | 5054 |
NOB1 | -9986 | -9210 | -6132 |
NOC4L | -5298 | 7372 | -3269 |
NOL11 | -10134 | -9311 | 9550 |
NOL12 | 4887 | 5706 | -708 |
NOL6 | -10564 | -6904 | -9301 |
NOL9 | -9891 | -7152 | 4295 |
NOP10 | 8200 | 10614 | -3974 |
NOP14 | -10522 | -9676 | -4648 |
NOP2 | -9624 | -6235 | -7727 |
NOP56 | -11395 | -8304 | -926 |
NOP58 | -9623 | -9323 | 9270 |
NSUN4 | -4645 | 4095 | 4554 |
PDCD11 | -11166 | -7938 | -6311 |
PELP1 | -10584 | -7287 | -1544 |
PES1 | -1993 | -5454 | -8799 |
PNO1 | -6627 | -7464 | 6858 |
PRORP | 3361 | -3583 | 5847 |
PWP2 | -1190 | -7158 | -7255 |
RBM28 | -11316 | -5771 | -5592 |
RCL1 | -751 | -7719 | -4623 |
RIOK1 | -3702 | -3302 | 6967 |
RIOK2 | 927 | -8363 | 9267 |
RIOK3 | 8621 | 2731 | 9110 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPP14 | 2981 | -2410 | 8611 |
RPP21 | -5178 | -197 | -7267 |
RPP25 | -7963 | -7582 | -5681 |
RPP30 | -7818 | -7132 | 9074 |
RPP38 | -6833 | -6494 | 8801 |
RPP40 | -4680 | -9576 | 3718 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
RRP1 | -3003 | 872 | -2135 |
RRP36 | -1645 | 510 | -1316 |
RRP7A | -2734 | -4541 | -659 |
RRP9 | -9748 | -8079 | -9693 |
SENP3 | 2970 | 4193 | -2573 |
SNORD3A | -2477 | 11233 | 9893 |
SNU13 | -6637 | -7945 | -4150 |
TBL3 | -3341 | 55 | -8145 |
TEX10 | -9440 | -8701 | 9112 |
TFB1M | -10994 | -4570 | 6526 |
THUMPD1 | -9477 | -9268 | 8192 |
TRMT10C | -4336 | -8228 | 10330 |
TRMT112 | 732 | -366 | -8610 |
TSR1 | -9409 | -9680 | -814 |
TSR3 | 3808 | -354 | -8970 |
UBA52 | 1112 | -1425 | -7104 |
UTP11 | 4582 | 1261 | 8086 |
UTP14A | -1788 | -3133 | 4462 |
UTP14C | -2032 | -1616 | 5210 |
UTP15 | -10264 | -8238 | 10459 |
UTP18 | 5055 | 3705 | 3978 |
UTP20 | -10191 | -6857 | 6223 |
UTP3 | -2829 | -1448 | -1947 |
UTP4 | -11142 | -9295 | -1037 |
UTP6 | -4362 | -5407 | 9675 |
WDR12 | 5156 | -1289 | 5359 |
WDR18 | -2260 | -4315 | -6073 |
WDR3 | -6394 | -7931 | -33 |
WDR36 | -3825 | -5814 | 6003 |
WDR43 | -7419 | -8808 | 3001 |
WDR46 | -10623 | -6936 | -9396 |
WDR75 | -9593 | -9170 | 7264 |
XRN2 | 9240 | 9220 | 2754 |
Hyaluronan metabolism
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.00396 |
p.adjustMANOVA | 0.00895 |
s.dist | 0.682 |
s.t0_v_pod | 0.513 |
s.pod_crp | 0.369 |
s.t0_crp | -0.258 |
p.t0_v_pod | 0.00137 |
p.pod_crp | 0.0213 |
p.t0_crp | 0.108 |
Gene | t0_v_pod | pod_crp |
---|---|---|
HYAL2 | 8935 | 11497 |
SLC9A1 | 7847 | 11292 |
GUSB | 7607 | 11238 |
CHP1 | 9101 | 9267 |
CD44 | 8201 | 8363 |
HEXB | 8631 | 6847 |
HYAL1 | 4123 | 8509 |
ABCC5 | 2460 | 1806 |
HYAL3 | 5168 | 304 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ABCC5 | 2460 | 1806 | -3059 |
CD44 | 8201 | 8363 | 1308 |
CEMIP | -7161 | -3195 | -4715 |
CHP1 | 9101 | 9267 | -2016 |
GUSB | 7607 | 11238 | -5640 |
HAS3 | -5989 | 259 | -2842 |
HEXA | 1251 | -437 | -3967 |
HEXB | 8631 | 6847 | 3887 |
HMMR | 3770 | -3451 | 3745 |
HYAL1 | 4123 | 8509 | 6499 |
HYAL2 | 8935 | 11497 | -6474 |
HYAL3 | 5168 | 304 | -7308 |
SLC9A1 | 7847 | 11292 | -6860 |
Lagging Strand Synthesis
metric | value |
---|---|
setSize | 20 |
pMANOVA | 0.000415 |
p.adjustMANOVA | 0.00129 |
s.dist | 0.68 |
s.t0_v_pod | -0.452 |
s.pod_crp | -0.487 |
s.t0_crp | 0.146 |
p.t0_v_pod | 0.000465 |
p.pod_crp | 0.000161 |
p.t0_crp | 0.26 |
Gene | pod_crp | t0_v_pod |
---|---|---|
POLA1 | -9617 | -11789 |
RPA1 | -9614 | -11644 |
POLD2 | -9699 | -10015 |
LIG1 | -8575 | -10705 |
RFC3 | -8651 | -10151 |
PRIM1 | -8226 | -9858 |
RFC4 | -7694 | -10361 |
FEN1 | -7081 | -10254 |
POLA2 | -6182 | -11222 |
RPA3 | -8027 | -8609 |
RFC5 | -3955 | -11357 |
PCNA | -6800 | -5771 |
RFC1 | -5456 | -7180 |
PRIM2 | -5615 | -5389 |
RPA2 | -4586 | -6094 |
DNA2 | -3986 | -2786 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DNA2 | -2786 | -3986 | 9591 |
FEN1 | -10254 | -7081 | -1614 |
LIG1 | -10705 | -8575 | -5384 |
PCNA | -5771 | -6800 | 5825 |
POLA1 | -11789 | -9617 | -2014 |
POLA2 | -11222 | -6182 | 7454 |
POLD1 | 202 | 644 | -8553 |
POLD2 | -10015 | -9699 | -6885 |
POLD3 | 8737 | 11080 | 8461 |
POLD4 | 6250 | 10181 | -6882 |
PRIM1 | -9858 | -8226 | 8710 |
PRIM2 | -5389 | -5615 | 5609 |
RFC1 | -7180 | -5456 | 9242 |
RFC2 | 4890 | 4788 | -676 |
RFC3 | -10151 | -8651 | 7668 |
RFC4 | -10361 | -7694 | 9525 |
RFC5 | -11357 | -3955 | 885 |
RPA1 | -11644 | -9614 | -4577 |
RPA2 | -6094 | -4586 | 5338 |
RPA3 | -8609 | -8027 | 2201 |
Josephin domain DUBs
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.00118 |
p.adjustMANOVA | 0.00316 |
s.dist | 0.674 |
s.t0_v_pod | 0.47 |
s.pod_crp | 0.0859 |
s.t0_crp | -0.475 |
p.t0_v_pod | 0.0101 |
p.pod_crp | 0.638 |
p.t0_crp | 0.00927 |
Gene | t0_crp | t0_v_pod |
---|---|---|
JOSD2 | -8695 | 7810 |
VCP | -5183 | 6789 |
UBB | -4745 | 6548 |
RAD23A | -4233 | 6424 |
UBC | -4004 | 4395 |
RAD23B | -1741 | 8738 |
UBA52 | -7104 | 1112 |
JOSD1 | -7775 | 225 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATXN3 | 1588 | -286 | 7221 |
JOSD1 | 225 | -434 | -7775 |
JOSD2 | 7810 | 10580 | -8695 |
RAD23A | 6424 | 2668 | -4233 |
RAD23B | 8738 | 8626 | -1741 |
RPS27A | -6700 | -8679 | -8103 |
UBA52 | 1112 | -1425 | -7104 |
UBB | 6548 | -2419 | -4745 |
UBC | 4395 | 4824 | -4004 |
VCP | 6789 | 4231 | -5183 |
Pre-NOTCH Processing in Golgi
metric | value |
---|---|
setSize | 18 |
pMANOVA | 0.000286 |
p.adjustMANOVA | 0.000943 |
s.dist | 0.673 |
s.t0_v_pod | 0.411 |
s.pod_crp | 0.399 |
s.t0_crp | -0.354 |
p.t0_v_pod | 0.00257 |
p.pod_crp | 0.00337 |
p.t0_crp | 0.00941 |
Gene | t0_v_pod | pod_crp |
---|---|---|
FURIN | 8922 | 10150 |
NOTCH3 | 7778 | 11527 |
ATP2A2 | 7915 | 9550 |
RAB6A | 8020 | 7487 |
ST3GAL4 | 5708 | 8030 |
NOTCH2 | 5211 | 8392 |
NOTCH1 | 4653 | 6904 |
SEL1L | 6751 | 4671 |
RFNG | 7126 | 4194 |
ST3GAL6 | 6610 | 3510 |
B4GALT1 | 4248 | 5054 |
TMED2 | 5971 | 962 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATP2A1 | -4516 | 8497 | -2235 |
ATP2A2 | 7915 | 9550 | -2449 |
ATP2A3 | -905 | -2587 | -8401 |
B4GALT1 | 4248 | 5054 | -5889 |
FURIN | 8922 | 10150 | -9942 |
LFNG | -8085 | 6673 | -4683 |
MFNG | -5809 | -7090 | -9987 |
NOTCH1 | 4653 | 6904 | -8024 |
NOTCH2 | 5211 | 8392 | -4852 |
NOTCH3 | 7778 | 11527 | -4938 |
NOTCH4 | -5056 | 11286 | -3210 |
RAB6A | 8020 | 7487 | 7945 |
RFNG | 7126 | 4194 | -7257 |
SEL1L | 6751 | 4671 | 4441 |
ST3GAL3 | 499 | -5146 | -5921 |
ST3GAL4 | 5708 | 8030 | -8973 |
ST3GAL6 | 6610 | 3510 | 8941 |
TMED2 | 5971 | 962 | 8999 |
Translation initiation complex formation
metric | value |
---|---|
setSize | 58 |
pMANOVA | 4.84e-23 |
p.adjustMANOVA | 1.53e-21 |
s.dist | 0.666 |
s.t0_v_pod | -0.0201 |
s.pod_crp | -0.541 |
s.t0_crp | -0.388 |
p.t0_v_pod | 0.792 |
p.pod_crp | 9.62e-13 |
p.t0_crp | 3.15e-07 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
EIF3B | -8831 | -8507 |
RPS27 | -8218 | -8994 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
EIF3L | -7724 | -8957 |
RPS17 | -7093 | -9634 |
RPS10 | -7587 | -8910 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
RPS6 | -9127 | -7094 |
RPS23 | -8292 | -7435 |
RPS21 | -6666 | -9210 |
RPS15A | -7870 | -7555 |
RPS11 | -6701 | -8383 |
RPS28 | -6389 | -8638 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8352 | 8447 |
EIF2S1 | 4235 | -3323 | 9204 |
EIF2S2 | 6091 | 297 | 8972 |
EIF2S3 | 6653 | 1299 | 9884 |
EIF3A | 2132 | -1524 | 1889 |
EIF3B | -7776 | -8831 | -8507 |
EIF3C | 285 | -3719 | -9547 |
EIF3D | 2605 | -4304 | -5425 |
EIF3E | 1902 | -8557 | 7960 |
EIF3F | 970 | -3717 | -9911 |
EIF3G | 871 | -1661 | -9388 |
EIF3H | 4677 | -5855 | -1314 |
EIF3I | 4649 | -2647 | -7649 |
EIF3J | 1885 | -5962 | 9440 |
EIF3K | 1468 | -294 | -5982 |
EIF3L | 2560 | -7724 | -8957 |
EIF3M | 4533 | -5583 | 8254 |
EIF4A1 | 7476 | 5864 | 1477 |
EIF4A2 | -10809 | -9312 | 9673 |
EIF4B | 1237 | -8286 | -6402 |
EIF4E | 4757 | 2088 | 11218 |
EIF4G1 | 7908 | 9779 | -6766 |
EIF4H | 7634 | 7346 | -9456 |
FAU | -359 | -1018 | -9018 |
PABPC1 | 5290 | -3454 | 4415 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
COPI-independent Golgi-to-ER retrograde traffic
metric | value |
---|---|
setSize | 33 |
pMANOVA | 5.17e-07 |
p.adjustMANOVA | 3.73e-06 |
s.dist | 0.661 |
s.t0_v_pod | 0.563 |
s.pod_crp | 0.341 |
s.t0_crp | 0.053 |
p.t0_v_pod | 2.13e-08 |
p.pod_crp | 0.000693 |
p.t0_crp | 0.599 |
Gene | t0_v_pod | pod_crp |
---|---|---|
DCTN2 | 9002 | 10291 |
PLA2G4A | 9025 | 9798 |
GALNT2 | 8697 | 10159 |
DCTN4 | 8255 | 9319 |
BICD2 | 8602 | 8523 |
ACTR1A | 6899 | 9916 |
CAPZB | 7893 | 8485 |
CAPZA2 | 8457 | 7902 |
DCTN6 | 7193 | 9197 |
CAPZA1 | 8008 | 7934 |
RAB6A | 8020 | 7487 |
DYNC1LI1 | 6841 | 7785 |
DCTN3 | 5913 | 7789 |
DCTN1 | 5019 | 9090 |
AGPAT3 | 4753 | 9206 |
DYNC1I2 | 7619 | 5669 |
DYNC1LI2 | 4229 | 7994 |
RAB18 | 7683 | 4326 |
ACTR10 | 7490 | 4188 |
PAFAH1B1 | 5405 | 3703 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ACTR10 | 7490 | 4188 | 6836 |
ACTR1A | 6899 | 9916 | -3005 |
AGPAT3 | 4753 | 9206 | 265 |
BICD1 | -7111 | -2457 | 1989 |
BICD2 | 8602 | 8523 | -9628 |
CAPZA1 | 8008 | 7934 | 10601 |
CAPZA2 | 8457 | 7902 | 9795 |
CAPZB | 7893 | 8485 | -1774 |
DCTN1 | 5019 | 9090 | -8825 |
DCTN2 | 9002 | 10291 | -7838 |
DCTN3 | 5913 | 7789 | -5083 |
DCTN4 | 8255 | 9319 | 8693 |
DCTN5 | -3959 | -889 | -9162 |
DCTN6 | 7193 | 9197 | 10983 |
DYNC1H1 | -7417 | -1029 | -6456 |
DYNC1I1 | 4145 | 1187 | 4638 |
DYNC1I2 | 7619 | 5669 | 8219 |
DYNC1LI1 | 6841 | 7785 | 8760 |
DYNC1LI2 | 4229 | 7994 | 3500 |
DYNLL1 | 5873 | 3157 | -957 |
DYNLL2 | -3859 | -7973 | -7679 |
GALNT1 | 6420 | 2592 | 7240 |
GALNT2 | 8697 | 10159 | -7925 |
PAFAH1B1 | 5405 | 3703 | -863 |
PAFAH1B2 | 6842 | 2339 | 6018 |
PAFAH1B3 | 4373 | -4344 | -7981 |
PLA2G4A | 9025 | 9798 | 9511 |
PLA2G6 | -11761 | -5182 | -9297 |
RAB18 | 7683 | 4326 | 11226 |
RAB3GAP1 | 5695 | 2587 | 10098 |
RAB3GAP2 | 4385 | 3283 | 9655 |
RAB6A | 8020 | 7487 | 7945 |
RAB6B | 5972 | -3767 | -9692 |
Ribosomal scanning and start codon recognition
metric | value |
---|---|
setSize | 58 |
pMANOVA | 3.07e-22 |
p.adjustMANOVA | 9.23e-21 |
s.dist | 0.657 |
s.t0_v_pod | -0.0251 |
s.pod_crp | -0.536 |
s.t0_crp | -0.378 |
p.t0_v_pod | 0.741 |
p.pod_crp | 1.54e-12 |
p.t0_crp | 6.22e-07 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
EIF3B | -8831 | -8507 |
RPS27 | -8218 | -8994 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
EIF3L | -7724 | -8957 |
RPS17 | -7093 | -9634 |
RPS10 | -7587 | -8910 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
RPS6 | -9127 | -7094 |
RPS23 | -8292 | -7435 |
RPS21 | -6666 | -9210 |
RPS15A | -7870 | -7555 |
RPS11 | -6701 | -8383 |
RPS28 | -6389 | -8638 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8352 | 8447 |
EIF2S1 | 4235 | -3323 | 9204 |
EIF2S2 | 6091 | 297 | 8972 |
EIF2S3 | 6653 | 1299 | 9884 |
EIF3A | 2132 | -1524 | 1889 |
EIF3B | -7776 | -8831 | -8507 |
EIF3C | 285 | -3719 | -9547 |
EIF3D | 2605 | -4304 | -5425 |
EIF3E | 1902 | -8557 | 7960 |
EIF3F | 970 | -3717 | -9911 |
EIF3G | 871 | -1661 | -9388 |
EIF3H | 4677 | -5855 | -1314 |
EIF3I | 4649 | -2647 | -7649 |
EIF3J | 1885 | -5962 | 9440 |
EIF3K | 1468 | -294 | -5982 |
EIF3L | 2560 | -7724 | -8957 |
EIF3M | 4533 | -5583 | 8254 |
EIF4A1 | 7476 | 5864 | 1477 |
EIF4A2 | -10809 | -9312 | 9673 |
EIF4B | 1237 | -8286 | -6402 |
EIF4E | 4757 | 2088 | 11218 |
EIF4G1 | 7908 | 9779 | -6766 |
EIF4H | 7634 | 7346 | -9456 |
EIF5 | 2162 | -411 | 10513 |
FAU | -359 | -1018 | -9018 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
Processive synthesis on the lagging strand
metric | value |
---|---|
setSize | 15 |
pMANOVA | 0.00714 |
p.adjustMANOVA | 0.0148 |
s.dist | 0.656 |
s.t0_v_pod | -0.431 |
s.pod_crp | -0.492 |
s.t0_crp | 0.0478 |
p.t0_v_pod | 0.00386 |
p.pod_crp | 0.000965 |
p.t0_crp | 0.748 |
Gene | pod_crp | t0_v_pod |
---|---|---|
POLA1 | -9617 | -11789 |
RPA1 | -9614 | -11644 |
POLD2 | -9699 | -10015 |
LIG1 | -8575 | -10705 |
PRIM1 | -8226 | -9858 |
FEN1 | -7081 | -10254 |
POLA2 | -6182 | -11222 |
RPA3 | -8027 | -8609 |
PCNA | -6800 | -5771 |
PRIM2 | -5615 | -5389 |
RPA2 | -4586 | -6094 |
DNA2 | -3986 | -2786 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DNA2 | -2786 | -3986 | 9591 |
FEN1 | -10254 | -7081 | -1614 |
LIG1 | -10705 | -8575 | -5384 |
PCNA | -5771 | -6800 | 5825 |
POLA1 | -11789 | -9617 | -2014 |
POLA2 | -11222 | -6182 | 7454 |
POLD1 | 202 | 644 | -8553 |
POLD2 | -10015 | -9699 | -6885 |
POLD3 | 8737 | 11080 | 8461 |
POLD4 | 6250 | 10181 | -6882 |
PRIM1 | -9858 | -8226 | 8710 |
PRIM2 | -5389 | -5615 | 5609 |
RPA1 | -11644 | -9614 | -4577 |
RPA2 | -6094 | -4586 | 5338 |
RPA3 | -8609 | -8027 | 2201 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
metric | value |
---|---|
setSize | 59 |
pMANOVA | 6.82e-23 |
p.adjustMANOVA | 2.11e-21 |
s.dist | 0.654 |
s.t0_v_pod | -0.00808 |
s.pod_crp | -0.525 |
s.t0_crp | -0.389 |
p.t0_v_pod | 0.915 |
p.pod_crp | 2.92e-12 |
p.t0_crp | 2.27e-07 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
EIF3B | -8831 | -8507 |
RPS27 | -8218 | -8994 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
EIF3L | -7724 | -8957 |
RPS17 | -7093 | -9634 |
RPS10 | -7587 | -8910 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
RPS6 | -9127 | -7094 |
RPS23 | -8292 | -7435 |
RPS21 | -6666 | -9210 |
RPS15A | -7870 | -7555 |
RPS11 | -6701 | -8383 |
RPS28 | -6389 | -8638 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8352 | 8447 |
EIF2S1 | 4235 | -3323 | 9204 |
EIF2S2 | 6091 | 297 | 8972 |
EIF2S3 | 6653 | 1299 | 9884 |
EIF3A | 2132 | -1524 | 1889 |
EIF3B | -7776 | -8831 | -8507 |
EIF3C | 285 | -3719 | -9547 |
EIF3D | 2605 | -4304 | -5425 |
EIF3E | 1902 | -8557 | 7960 |
EIF3F | 970 | -3717 | -9911 |
EIF3G | 871 | -1661 | -9388 |
EIF3H | 4677 | -5855 | -1314 |
EIF3I | 4649 | -2647 | -7649 |
EIF3J | 1885 | -5962 | 9440 |
EIF3K | 1468 | -294 | -5982 |
EIF3L | 2560 | -7724 | -8957 |
EIF3M | 4533 | -5583 | 8254 |
EIF4A1 | 7476 | 5864 | 1477 |
EIF4A2 | -10809 | -9312 | 9673 |
EIF4B | 1237 | -8286 | -6402 |
EIF4E | 4757 | 2088 | 11218 |
EIF4EBP1 | 5990 | 5279 | -4330 |
EIF4G1 | 7908 | 9779 | -6766 |
EIF4H | 7634 | 7346 | -9456 |
FAU | -359 | -1018 | -9018 |
PABPC1 | 5290 | -3454 | 4415 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
Golgi Cisternae Pericentriolar Stack Reorganization
metric | value |
---|---|
setSize | 14 |
pMANOVA | 0.00285 |
p.adjustMANOVA | 0.00668 |
s.dist | 0.654 |
s.t0_v_pod | 0.549 |
s.pod_crp | 0.315 |
s.t0_crp | 0.161 |
p.t0_v_pod | 0.000374 |
p.pod_crp | 0.041 |
p.t0_crp | 0.296 |
Gene | t0_v_pod | pod_crp |
---|---|---|
RAB1A | 8899 | 9776 |
MAPK3 | 8803 | 9501 |
MAPK1 | 7381 | 10667 |
RAB1B | 8182 | 9315 |
GORASP1 | 6516 | 10810 |
RAB2A | 8464 | 7935 |
GOLGA2 | 6117 | 8262 |
CCNB2 | 3649 | 3856 |
PLK1 | 2978 | 2945 |
BLZF1 | 3253 | 482 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BLZF1 | 3253 | 482 | 11272 |
CCNB1 | 461 | -2501 | 5748 |
CCNB2 | 3649 | 3856 | 5384 |
CDK1 | 1527 | -5531 | 8795 |
GOLGA2 | 6117 | 8262 | -6169 |
GORASP1 | 6516 | 10810 | 321 |
GORASP2 | -6792 | -6318 | 2542 |
MAPK1 | 7381 | 10667 | -1770 |
MAPK3 | 8803 | 9501 | -9768 |
PLK1 | 2978 | 2945 | -2313 |
RAB1A | 8899 | 9776 | 8679 |
RAB1B | 8182 | 9315 | -8932 |
RAB2A | 8464 | 7935 | 8400 |
USO1 | 4113 | -107 | 10935 |
EPHB-mediated forward signaling
metric | value |
---|---|
setSize | 32 |
pMANOVA | 8.75e-06 |
p.adjustMANOVA | 4.57e-05 |
s.dist | 0.653 |
s.t0_v_pod | 0.504 |
s.pod_crp | 0.387 |
s.t0_crp | 0.152 |
p.t0_v_pod | 8.17e-07 |
p.pod_crp | 0.000154 |
p.t0_crp | 0.136 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ITSN1 | 9131 | 10746 |
ARPC1B | 9102 | 10772 |
ARPC1A | 8745 | 11015 |
RAC1 | 8647 | 10726 |
ACTB | 8859 | 10253 |
PAK1 | 8100 | 10529 |
ARPC5 | 8544 | 9897 |
LYN | 7691 | 10712 |
CFL1 | 8057 | 9547 |
ARPC3 | 8147 | 9352 |
ACTG1 | 8423 | 8439 |
RHOA | 8188 | 8640 |
ARPC4 | 7404 | 9098 |
ARPC2 | 7280 | 9088 |
LIMK2 | 7949 | 8071 |
ACTR2 | 7750 | 7266 |
CDC42 | 7425 | 7251 |
ROCK1 | 7377 | 6942 |
ACTR3 | 7699 | 6569 |
LIMK1 | 4628 | 9134 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ACTB | 8859 | 10253 | -883 |
ACTG1 | 8423 | 8439 | -7587 |
ACTR2 | 7750 | 7266 | 8225 |
ACTR3 | 7699 | 6569 | 7217 |
ARHGEF28 | -9954 | -541 | 4640 |
ARPC1A | 8745 | 11015 | 5898 |
ARPC1B | 9102 | 10772 | -7161 |
ARPC2 | 7280 | 9088 | 4584 |
ARPC3 | 8147 | 9352 | 7298 |
ARPC4 | 7404 | 9098 | -762 |
ARPC5 | 8544 | 9897 | 5412 |
CDC42 | 7425 | 7251 | 8682 |
CFL1 | 8057 | 9547 | -7188 |
FYN | -11320 | -6579 | -4817 |
HRAS | -3288 | -3089 | -7583 |
ITSN1 | 9131 | 10746 | 8907 |
KALRN | -3584 | -8861 | -4318 |
LIMK1 | 4628 | 9134 | -7403 |
LIMK2 | 7949 | 8071 | -2143 |
LYN | 7691 | 10712 | 7722 |
PAK1 | 8100 | 10529 | 8872 |
PTK2 | 4418 | -3305 | -1920 |
RAC1 | 8647 | 10726 | 9288 |
RASA1 | 2093 | 6650 | 9826 |
RHOA | 8188 | 8640 | 7321 |
ROCK1 | 7377 | 6942 | 10322 |
ROCK2 | 6054 | 5462 | 6111 |
SDC2 | 5335 | 231 | 3734 |
SRC | -8520 | -5490 | -4085 |
TIAM1 | 645 | -2277 | -4599 |
WASL | 297 | -1358 | 7215 |
YES1 | -11781 | -5623 | 1760 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway
metric | value |
---|---|
setSize | 24 |
pMANOVA | 0.000369 |
p.adjustMANOVA | 0.00118 |
s.dist | 0.648 |
s.t0_v_pod | -0.445 |
s.pod_crp | -0.47 |
s.t0_crp | 0.0352 |
p.t0_v_pod | 0.000159 |
p.pod_crp | 6.79e-05 |
p.t0_crp | 0.766 |
Gene | pod_crp | t0_v_pod |
---|---|---|
RPA1 | -9614 | -11644 |
PARP1 | -9090 | -11409 |
POLE3 | -8881 | -11228 |
POLD2 | -9699 | -10015 |
APEX1 | -9662 | -9998 |
LIG1 | -8575 | -10705 |
RFC3 | -8651 | -10151 |
RFC4 | -7694 | -10361 |
FEN1 | -7081 | -10254 |
RPA3 | -8027 | -8609 |
POLE2 | -6619 | -9613 |
PARP2 | -5348 | -11860 |
RFC5 | -3955 | -11357 |
PCNA | -6800 | -5771 |
RFC1 | -5456 | -7180 |
POLB | -4341 | -7276 |
RPA2 | -4586 | -6094 |
POLE | -1466 | -7317 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APEX1 | -9998 | -9662 | -5836 |
FEN1 | -10254 | -7081 | -1614 |
LIG1 | -10705 | -8575 | -5384 |
PARG | -653 | 84 | -12 |
PARP1 | -11409 | -9090 | -4667 |
PARP2 | -11860 | -5348 | 9470 |
PCNA | -5771 | -6800 | 5825 |
POLB | -7276 | -4341 | 9678 |
POLD1 | 202 | 644 | -8553 |
POLD2 | -10015 | -9699 | -6885 |
POLD3 | 8737 | 11080 | 8461 |
POLD4 | 6250 | 10181 | -6882 |
POLE | -7317 | -1466 | -857 |
POLE2 | -9613 | -6619 | 10055 |
POLE3 | -11228 | -8881 | -6530 |
POLE4 | 5453 | -1174 | -1480 |
RFC1 | -7180 | -5456 | 9242 |
RFC2 | 4890 | 4788 | -676 |
RFC3 | -10151 | -8651 | 7668 |
RFC4 | -10361 | -7694 | 9525 |
RFC5 | -11357 | -3955 | 885 |
RPA1 | -11644 | -9614 | -4577 |
RPA2 | -6094 | -4586 | 5338 |
RPA3 | -8609 | -8027 | 2201 |
Generation of second messenger molecules
metric | value |
---|---|
setSize | 38 |
pMANOVA | 3.21e-06 |
p.adjustMANOVA | 1.85e-05 |
s.dist | 0.647 |
s.t0_v_pod | -0.464 |
s.pod_crp | -0.45 |
s.t0_crp | -0.0116 |
p.t0_v_pod | 7.22e-07 |
p.pod_crp | 1.59e-06 |
p.t0_crp | 0.901 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD247 | -11982 | -9454 |
LCK | -11482 | -9442 |
LAT | -11339 | -9116 |
TRAC | -11130 | -9287 |
CD3E | -10952 | -9335 |
CD3G | -11173 | -9082 |
EVL | -11846 | -8538 |
TRBC1 | -11646 | -8623 |
ITK | -10875 | -9188 |
ZAP70 | -11590 | -8619 |
TRBV12-3 | -10099 | -9681 |
NCK1 | -11102 | -8778 |
CD3D | -11049 | -8704 |
PLCG1 | -10772 | -8454 |
TRAV19 | -9587 | -9353 |
HLA-DPB1 | -11887 | -7068 |
HLA-DQB2 | -9085 | -8978 |
TRAV29DV5 | -9353 | -8284 |
HLA-DRA | -11649 | -6573 |
HLA-DPA1 | -11954 | -5815 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD101 | 4105 | 550 | 1390 |
CD247 | -11982 | -9454 | -8935 |
CD3D | -11049 | -8704 | 2046 |
CD3E | -10952 | -9335 | 5813 |
CD3G | -11173 | -9082 | 6756 |
CD4 | -5228 | -4848 | -1251 |
ENAH | -2639 | 6886 | 6088 |
EVL | -11846 | -8538 | -5843 |
GRAP2 | 4639 | -6196 | -6175 |
HLA-DPA1 | -11954 | -5815 | 946 |
HLA-DPB1 | -11887 | -7068 | -7160 |
HLA-DQA1 | -11633 | -1453 | 9693 |
HLA-DQA2 | -4652 | -9364 | -9927 |
HLA-DQB1 | -6199 | 3626 | 5107 |
HLA-DQB2 | -9085 | -8978 | -9720 |
HLA-DRA | -11649 | -6573 | 2695 |
HLA-DRB1 | -7792 | 1344 | 9366 |
HLA-DRB5 | -4806 | -1108 | 9092 |
ITK | -10875 | -9188 | -1992 |
LAT | -11339 | -9116 | -2696 |
LCK | -11482 | -9442 | -4194 |
LCP2 | -1141 | 513 | 7373 |
NCK1 | -11102 | -8778 | 9958 |
PAK1 | 8100 | 10529 | 8872 |
PAK2 | 8056 | 5729 | 8015 |
PAK3 | -4054 | -528 | 1055 |
PLCG1 | -10772 | -8454 | -1778 |
PLCG2 | 4947 | 10212 | -3380 |
TRAC | -11130 | -9287 | 8688 |
TRAV19 | -9587 | -9353 | -6593 |
TRAV29DV5 | -9353 | -8284 | 4257 |
TRAV8-4 | -7010 | -7565 | 10068 |
TRBC1 | -11646 | -8623 | -1744 |
TRBV12-3 | -10099 | -9681 | -6812 |
TRBV7-9 | -9220 | -6700 | -5268 |
VASP | 7904 | 9635 | -3011 |
WAS | 8421 | 11046 | -2152 |
ZAP70 | -11590 | -8619 | -9003 |
Mucopolysaccharidoses
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.0202 |
p.adjustMANOVA | 0.0369 |
s.dist | 0.643 |
s.t0_v_pod | 0.455 |
s.pod_crp | 0.373 |
s.t0_crp | -0.259 |
p.t0_v_pod | 0.009 |
p.pod_crp | 0.0322 |
p.t0_crp | 0.136 |
Gene | t0_v_pod | pod_crp |
---|---|---|
GNS | 9200 | 11391 |
GLB1 | 8581 | 10666 |
GUSB | 7607 | 11238 |
ARSB | 7459 | 10240 |
GALNS | 6998 | 9617 |
HYAL1 | 4123 | 8509 |
SGSH | 5835 | 1563 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ARSB | 7459 | 10240 | 3628 |
GALNS | 6998 | 9617 | -5269 |
GLB1 | 8581 | 10666 | 2258 |
GNS | 9200 | 11391 | 3599 |
GUSB | 7607 | 11238 | -5640 |
HGSNAT | 1854 | -3565 | -171 |
HYAL1 | 4123 | 8509 | 6499 |
IDS | -2558 | -4092 | -5186 |
IDUA | -5636 | -4194 | -4093 |
NAGLU | -4608 | 1834 | -9402 |
SGSH | 5835 | 1563 | -9672 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.0446 |
p.adjustMANOVA | 0.0729 |
s.dist | 0.635 |
s.t0_v_pod | 0.476 |
s.pod_crp | 0.42 |
s.t0_crp | -0.0153 |
p.t0_v_pod | 0.00629 |
p.pod_crp | 0.0159 |
p.t0_crp | 0.93 |
Gene | t0_v_pod | pod_crp |
---|---|---|
LYN | 7691 | 10712 |
IRS2 | 8429 | 9184 |
EPOR | 7117 | 10209 |
GAB1 | 5607 | 9590 |
PIK3CB | 8886 | 6045 |
PIK3CD | 5965 | 6435 |
PIK3CG | 1820 | 6282 |
JAK2 | 2670 | 3748 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EPOR | 7117 | 10209 | -3997 |
GAB1 | 5607 | 9590 | 8595 |
IRS2 | 8429 | 9184 | -8741 |
JAK2 | 2670 | 3748 | 10899 |
LYN | 7691 | 10712 | 7722 |
PIK3CA | 4580 | -1120 | 7526 |
PIK3CB | 8886 | 6045 | 5645 |
PIK3CD | 5965 | 6435 | -8659 |
PIK3CG | 1820 | 6282 | 395 |
PIK3R1 | -9187 | -9263 | -4851 |
PIK3R5 | -2255 | 6885 | -9286 |
Nucleobase biosynthesis
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.0172 |
p.adjustMANOVA | 0.0322 |
s.dist | 0.632 |
s.t0_v_pod | -0.356 |
s.pod_crp | -0.507 |
s.t0_crp | -0.121 |
p.t0_v_pod | 0.0263 |
p.pod_crp | 0.00153 |
p.t0_crp | 0.449 |
Gene | pod_crp | t0_v_pod |
---|---|---|
ATIC | -9716 | -10848 |
PPAT | -9651 | -10811 |
UMPS | -9647 | -10137 |
IMPDH2 | -9804 | -9588 |
PFAS | -8589 | -10685 |
CAD | -8282 | -9437 |
PAICS | -9083 | -5189 |
GMPS | -6546 | -5248 |
DHODH | -2252 | -5446 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ADSL | 5026 | -3176 | 2734 |
ATIC | -10848 | -9716 | 3712 |
CAD | -9437 | -8282 | -7092 |
DHODH | -5446 | -2252 | -6133 |
GART | -3463 | 5764 | 8370 |
GMPS | -5248 | -6546 | 4467 |
IMPDH1 | 9136 | 11141 | -3002 |
IMPDH2 | -9588 | -9804 | -8220 |
LHPP | 11 | 422 | -3201 |
PAICS | -5189 | -9083 | 6955 |
PFAS | -10685 | -8589 | -10001 |
PPAT | -10811 | -9651 | 5933 |
UMPS | -10137 | -9647 | -3028 |
Transferrin endocytosis and recycling
metric | value |
---|---|
setSize | 26 |
pMANOVA | 0.000131 |
p.adjustMANOVA | 0.000478 |
s.dist | 0.629 |
s.t0_v_pod | 0.509 |
s.pod_crp | 0.367 |
s.t0_crp | -0.0437 |
p.t0_v_pod | 7.03e-06 |
p.pod_crp | 0.00119 |
p.t0_crp | 0.7 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ATP6V0A1 | 9262 | 11270 |
ATP6V0D1 | 9088 | 11089 |
ATP6V0C | 8974 | 10678 |
ATP6AP1 | 8032 | 11319 |
ATP6V0B | 8458 | 10337 |
ATP6V1B2 | 8904 | 9564 |
ATP6V1D | 8894 | 9569 |
MCOLN1 | 7624 | 10948 |
TCIRG1 | 7082 | 11503 |
ATP6V1A | 9144 | 8379 |
ATP6V1C1 | 8400 | 8697 |
ATP6V0E1 | 8456 | 8200 |
STEAP3 | 5915 | 10624 |
ATP6V1E1 | 7912 | 7496 |
ATP6V1H | 7939 | 4992 |
ATP6V1F | 5802 | 5090 |
HFE | 8632 | 3038 |
TFRC | 1513 | 3020 |
TF | 1093 | 3741 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATP6AP1 | 8032 | 11319 | -7483 |
ATP6V0A1 | 9262 | 11270 | -184 |
ATP6V0A2 | -11850 | -4901 | 2656 |
ATP6V0B | 8458 | 10337 | -6528 |
ATP6V0C | 8974 | 10678 | -1938 |
ATP6V0D1 | 9088 | 11089 | -1722 |
ATP6V0E1 | 8456 | 8200 | -226 |
ATP6V0E2 | -11202 | -8309 | 1787 |
ATP6V1A | 9144 | 8379 | 5839 |
ATP6V1B2 | 8904 | 9564 | 3425 |
ATP6V1C1 | 8400 | 8697 | 8360 |
ATP6V1C2 | -2175 | -2046 | -2521 |
ATP6V1D | 8894 | 9569 | 8256 |
ATP6V1E1 | 7912 | 7496 | 8195 |
ATP6V1E2 | 5657 | -5806 | -7499 |
ATP6V1F | 5802 | 5090 | -6651 |
ATP6V1G1 | 3892 | -4430 | 794 |
ATP6V1G2 | -9197 | -8007 | -1854 |
ATP6V1H | 7939 | 4992 | 5368 |
HFE | 8632 | 3038 | 3027 |
MCOLN1 | 7624 | 10948 | -3372 |
STEAP3 | 5915 | 10624 | -4813 |
TCIRG1 | 7082 | 11503 | -5720 |
TF | 1093 | 3741 | 3826 |
TFR2 | -9464 | -1997 | -6265 |
TFRC | 1513 | 3020 | 9770 |
Pentose phosphate pathway
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.0108 |
p.adjustMANOVA | 0.0213 |
s.dist | 0.627 |
s.t0_v_pod | 0.488 |
s.pod_crp | 0.339 |
s.t0_crp | -0.202 |
p.t0_v_pod | 0.00233 |
p.pod_crp | 0.0343 |
p.t0_crp | 0.207 |
Gene | t0_v_pod | pod_crp |
---|---|---|
PGD | 9320 | 10993 |
TKT | 9183 | 10517 |
TALDO1 | 9295 | 10245 |
G6PD | 8853 | 10755 |
PGM2 | 9185 | 9410 |
DERA | 8364 | 9539 |
PGLS | 5997 | 4969 |
RPE | 2570 | 7746 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DERA | 8364 | 9539 | 9162 |
G6PD | 8853 | 10755 | -9506 |
PGD | 9320 | 10993 | -4711 |
PGLS | 5997 | 4969 | -9140 |
PGM2 | 9185 | 9410 | 3358 |
PRPS1 | -11716 | -9510 | -3761 |
PRPS2 | 3530 | -3692 | 6923 |
RBKS | -3058 | 3558 | -2088 |
RPE | 2570 | 7746 | 4702 |
RPIA | 1431 | -5639 | -5803 |
SHPK | -2467 | -743 | -914 |
TALDO1 | 9295 | 10245 | -1183 |
TKT | 9183 | 10517 | -6792 |
PCNA-Dependent Long Patch Base Excision Repair
metric | value |
---|---|
setSize | 21 |
pMANOVA | 0.00182 |
p.adjustMANOVA | 0.00457 |
s.dist | 0.624 |
s.t0_v_pod | -0.42 |
s.pod_crp | -0.461 |
s.t0_crp | 0.0274 |
p.t0_v_pod | 0.000864 |
p.pod_crp | 0.000252 |
p.t0_crp | 0.828 |
Gene | pod_crp | t0_v_pod |
---|---|---|
RPA1 | -9614 | -11644 |
POLE3 | -8881 | -11228 |
POLD2 | -9699 | -10015 |
APEX1 | -9662 | -9998 |
LIG1 | -8575 | -10705 |
RFC3 | -8651 | -10151 |
RFC4 | -7694 | -10361 |
FEN1 | -7081 | -10254 |
RPA3 | -8027 | -8609 |
POLE2 | -6619 | -9613 |
RFC5 | -3955 | -11357 |
PCNA | -6800 | -5771 |
RFC1 | -5456 | -7180 |
POLB | -4341 | -7276 |
RPA2 | -4586 | -6094 |
POLE | -1466 | -7317 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APEX1 | -9998 | -9662 | -5836 |
FEN1 | -10254 | -7081 | -1614 |
LIG1 | -10705 | -8575 | -5384 |
PCNA | -5771 | -6800 | 5825 |
POLB | -7276 | -4341 | 9678 |
POLD1 | 202 | 644 | -8553 |
POLD2 | -10015 | -9699 | -6885 |
POLD3 | 8737 | 11080 | 8461 |
POLD4 | 6250 | 10181 | -6882 |
POLE | -7317 | -1466 | -857 |
POLE2 | -9613 | -6619 | 10055 |
POLE3 | -11228 | -8881 | -6530 |
POLE4 | 5453 | -1174 | -1480 |
RFC1 | -7180 | -5456 | 9242 |
RFC2 | 4890 | 4788 | -676 |
RFC3 | -10151 | -8651 | 7668 |
RFC4 | -10361 | -7694 | 9525 |
RFC5 | -11357 | -3955 | 885 |
RPA1 | -11644 | -9614 | -4577 |
RPA2 | -6094 | -4586 | 5338 |
RPA3 | -8609 | -8027 | 2201 |
Telomere C-strand synthesis initiation
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.0159 |
p.adjustMANOVA | 0.0299 |
s.dist | 0.624 |
s.t0_v_pod | -0.361 |
s.pod_crp | -0.509 |
s.t0_crp | 0.0113 |
p.t0_v_pod | 0.0243 |
p.pod_crp | 0.00148 |
p.t0_crp | 0.944 |
Gene | pod_crp | t0_v_pod |
---|---|---|
POLA1 | -9617 | -11789 |
STN1 | -9456 | -9115 |
CTC1 | -7964 | -10458 |
PRIM1 | -8226 | -9858 |
POLA2 | -6182 | -11222 |
PRIM2 | -5615 | -5389 |
ACD | -3932 | -7528 |
POT1 | -5802 | -4217 |
TERF2 | -4892 | -4319 |
TERF1 | -3782 | -3495 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ACD | -7528 | -3932 | -6437 |
CTC1 | -10458 | -7964 | -6857 |
POLA1 | -11789 | -9617 | -2014 |
POLA2 | -11222 | -6182 | 7454 |
POT1 | -4217 | -5802 | 9768 |
PRIM1 | -9858 | -8226 | 8710 |
PRIM2 | -5389 | -5615 | 5609 |
STN1 | -9115 | -9456 | -5229 |
TEN1 | 501 | 1024 | -6572 |
TERF1 | -3495 | -3782 | 8554 |
TERF2 | -4319 | -4892 | 4689 |
TERF2IP | 4981 | -1097 | -3306 |
TINF2 | 4545 | 5884 | -4471 |
Telomere C-strand (Lagging Strand) Synthesis
metric | value |
---|---|
setSize | 34 |
pMANOVA | 1.41e-05 |
p.adjustMANOVA | 7.06e-05 |
s.dist | 0.622 |
s.t0_v_pod | -0.387 |
s.pod_crp | -0.486 |
s.t0_crp | 0.0205 |
p.t0_v_pod | 9.4e-05 |
p.pod_crp | 9.35e-07 |
p.t0_crp | 0.836 |
Gene | pod_crp | t0_v_pod |
---|---|---|
POLA1 | -9617 | -11789 |
RPA1 | -9614 | -11644 |
WRN | -9054 | -11687 |
CHTF18 | -8742 | -11774 |
POLD2 | -9699 | -10015 |
LIG1 | -8575 | -10705 |
RFC3 | -8651 | -10151 |
STN1 | -9456 | -9115 |
CTC1 | -7964 | -10458 |
PRIM1 | -8226 | -9858 |
RFC4 | -7694 | -10361 |
FEN1 | -7081 | -10254 |
POLA2 | -6182 | -11222 |
RPA3 | -8027 | -8609 |
RFC5 | -3955 | -11357 |
PCNA | -6800 | -5771 |
RFC1 | -5456 | -7180 |
DSCC1 | -7629 | -4742 |
PRIM2 | -5615 | -5389 |
ACD | -3932 | -7528 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ACD | -7528 | -3932 | -6437 |
BLM | -4539 | -4399 | 3954 |
CHTF18 | -11774 | -8742 | -9681 |
CHTF8 | -593 | -498 | -6962 |
CTC1 | -10458 | -7964 | -6857 |
DNA2 | -2786 | -3986 | 9591 |
DSCC1 | -4742 | -7629 | 3907 |
FEN1 | -10254 | -7081 | -1614 |
LIG1 | -10705 | -8575 | -5384 |
PCNA | -5771 | -6800 | 5825 |
POLA1 | -11789 | -9617 | -2014 |
POLA2 | -11222 | -6182 | 7454 |
POLD1 | 202 | 644 | -8553 |
POLD2 | -10015 | -9699 | -6885 |
POLD3 | 8737 | 11080 | 8461 |
POLD4 | 6250 | 10181 | -6882 |
POT1 | -4217 | -5802 | 9768 |
PRIM1 | -9858 | -8226 | 8710 |
PRIM2 | -5389 | -5615 | 5609 |
RFC1 | -7180 | -5456 | 9242 |
RFC2 | 4890 | 4788 | -676 |
RFC3 | -10151 | -8651 | 7668 |
RFC4 | -10361 | -7694 | 9525 |
RFC5 | -11357 | -3955 | 885 |
RPA1 | -11644 | -9614 | -4577 |
RPA2 | -6094 | -4586 | 5338 |
RPA3 | -8609 | -8027 | 2201 |
STN1 | -9115 | -9456 | -5229 |
TEN1 | 501 | 1024 | -6572 |
TERF1 | -3495 | -3782 | 8554 |
TERF2 | -4319 | -4892 | 4689 |
TERF2IP | 4981 | -1097 | -3306 |
TINF2 | 4545 | 5884 | -4471 |
WRN | -11687 | -9054 | 3951 |
Removal of the Flap Intermediate
metric | value |
---|---|
setSize | 14 |
pMANOVA | 0.0153 |
p.adjustMANOVA | 0.029 |
s.dist | 0.619 |
s.t0_v_pod | -0.399 |
s.pod_crp | -0.464 |
s.t0_crp | 0.0915 |
p.t0_v_pod | 0.00975 |
p.pod_crp | 0.00263 |
p.t0_crp | 0.553 |
Gene | pod_crp | t0_v_pod |
---|---|---|
POLA1 | -9617 | -11789 |
RPA1 | -9614 | -11644 |
POLD2 | -9699 | -10015 |
PRIM1 | -8226 | -9858 |
FEN1 | -7081 | -10254 |
POLA2 | -6182 | -11222 |
RPA3 | -8027 | -8609 |
PCNA | -6800 | -5771 |
PRIM2 | -5615 | -5389 |
RPA2 | -4586 | -6094 |
DNA2 | -3986 | -2786 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DNA2 | -2786 | -3986 | 9591 |
FEN1 | -10254 | -7081 | -1614 |
PCNA | -5771 | -6800 | 5825 |
POLA1 | -11789 | -9617 | -2014 |
POLA2 | -11222 | -6182 | 7454 |
POLD1 | 202 | 644 | -8553 |
POLD2 | -10015 | -9699 | -6885 |
POLD3 | 8737 | 11080 | 8461 |
POLD4 | 6250 | 10181 | -6882 |
PRIM1 | -9858 | -8226 | 8710 |
PRIM2 | -5389 | -5615 | 5609 |
RPA1 | -11644 | -9614 | -4577 |
RPA2 | -6094 | -4586 | 5338 |
RPA3 | -8609 | -8027 | 2201 |
Regulation of IFNG signaling
metric | value |
---|---|
setSize | 14 |
pMANOVA | 0.0106 |
p.adjustMANOVA | 0.0211 |
s.dist | 0.619 |
s.t0_v_pod | 0.396 |
s.pod_crp | 0.328 |
s.t0_crp | 0.345 |
p.t0_v_pod | 0.0103 |
p.pod_crp | 0.0337 |
p.t0_crp | 0.0256 |
Gene | t0_v_pod | t0_crp |
---|---|---|
PIAS1 | 7251 | 11245 |
IFNGR1 | 9116 | 8908 |
IFNGR2 | 9081 | 7500 |
SUMO1 | 6791 | 9971 |
PTPN2 | 7500 | 7302 |
SOCS1 | 3908 | 8555 |
JAK2 | 2670 | 10899 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
IFNG | -9944 | -5918 | 10671 |
IFNGR1 | 9116 | 10216 | 8908 |
IFNGR2 | 9081 | 11379 | 7500 |
JAK1 | -10608 | -8056 | -7913 |
JAK2 | 2670 | 3748 | 10899 |
PIAS1 | 7251 | 4527 | 11245 |
PTPN1 | 5649 | 9613 | -2841 |
PTPN11 | 5253 | 2833 | -599 |
PTPN2 | 7500 | 10261 | 7302 |
PTPN6 | 6014 | 11061 | -2766 |
SOCS1 | 3908 | 6589 | 8555 |
SOCS3 | 9315 | 10466 | -9983 |
STAT1 | -11372 | -9361 | 9559 |
SUMO1 | 6791 | 3579 | 9971 |
Signal transduction by L1
metric | value |
---|---|
setSize | 20 |
pMANOVA | 0.00318 |
p.adjustMANOVA | 0.00737 |
s.dist | 0.615 |
s.t0_v_pod | 0.438 |
s.pod_crp | 0.429 |
s.t0_crp | -0.0468 |
p.t0_v_pod | 0.00069 |
p.pod_crp | 0.000886 |
p.t0_crp | 0.717 |
Gene | t0_v_pod | pod_crp |
---|---|---|
RAC1 | 8647 | 10726 |
MAP2K1 | 8910 | 10086 |
PAK1 | 8100 | 10529 |
MAPK3 | 8803 | 9501 |
MAPK1 | 7381 | 10667 |
ITGA5 | 7543 | 10003 |
ITGA9 | 6840 | 7705 |
ITGAV | 6022 | 8016 |
CSNK2A1 | 6113 | 7887 |
MAP2K2 | 6699 | 5024 |
CSNK2A2 | 6301 | 4283 |
CSNK2B | 3930 | 6489 |
ITGA2B | 8744 | 1914 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CSNK2A1 | 6113 | 7887 | 3044 |
CSNK2A2 | 6301 | 4283 | 1985 |
CSNK2B | 3930 | 6489 | 169 |
FGFR1 | -5175 | 9868 | 7234 |
ITGA2B | 8744 | 1914 | -6113 |
ITGA5 | 7543 | 10003 | -7138 |
ITGA9 | 6840 | 7705 | -14 |
ITGAV | 6022 | 8016 | 5164 |
ITGB1 | -94 | -4816 | 8046 |
ITGB3 | 8161 | -2845 | -6419 |
L1CAM | -6144 | -1630 | 6391 |
MAP2K1 | 8910 | 10086 | -3295 |
MAP2K2 | 6699 | 5024 | -9806 |
MAPK1 | 7381 | 10667 | -1770 |
MAPK3 | 8803 | 9501 | -9768 |
NCAM1 | -11351 | -7493 | -9093 |
NRP1 | -8419 | 5434 | 8016 |
PAK1 | 8100 | 10529 | 8872 |
RAC1 | 8647 | 10726 | 9288 |
VAV2 | -3931 | 7387 | -1965 |
Gap junction trafficking and regulation
metric | value |
---|---|
setSize | 15 |
pMANOVA | 0.00695 |
p.adjustMANOVA | 0.0145 |
s.dist | 0.615 |
s.t0_v_pod | 0.414 |
s.pod_crp | 0.38 |
s.t0_crp | -0.249 |
p.t0_v_pod | 0.00554 |
p.pod_crp | 0.0108 |
p.t0_crp | 0.0944 |
Gene | t0_v_pod | pod_crp |
---|---|---|
DAB2 | 7985 | 10708 |
GJD3 | 7874 | 10701 |
CLTC | 8849 | 9216 |
CLTCL1 | 8815 | 8901 |
CLTA | 8244 | 7587 |
AP2M1 | 8486 | 7237 |
DNM2 | 6007 | 9598 |
CLTB | 6002 | 8174 |
DNM1 | 3555 | 5772 |
GJC1 | 512 | 5804 |
GJC2 | 1074 | 2370 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2M1 | 8486 | 7237 | -8627 |
CLTA | 8244 | 7587 | 492 |
CLTB | 6002 | 8174 | -8503 |
CLTC | 8849 | 9216 | 1230 |
CLTCL1 | 8815 | 8901 | -5432 |
DAB2 | 7985 | 10708 | -7018 |
DNM1 | 3555 | 5772 | 7505 |
DNM2 | 6007 | 9598 | -9051 |
GJB6 | 4708 | -4124 | -9998 |
GJC1 | 512 | 5804 | 1908 |
GJC2 | 1074 | 2370 | -2725 |
GJD3 | 7874 | 10701 | 1754 |
MYO6 | -11058 | -7648 | 6236 |
SRC | -8520 | -5490 | -4085 |
TJP1 | -6159 | 4874 | 5957 |
Influenza Infection
metric | value |
---|---|
setSize | 154 |
pMANOVA | 5.68e-35 |
p.adjustMANOVA | 2.76e-33 |
s.dist | 0.614 |
s.t0_v_pod | -0.181 |
s.pod_crp | -0.498 |
s.t0_crp | -0.311 |
p.t0_v_pod | 0.000107 |
p.pod_crp | 1.37e-26 |
p.t0_crp | 2.75e-11 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9592 | -9910 |
RPL3 | -9658 | -9541 |
RPLP2 | -8213 | -9852 |
RPS5 | -8655 | -8821 |
RPS12 | -8359 | -9089 |
RPLP0 | -8648 | -8726 |
RPS27 | -8218 | -8994 |
RPL27A | -8378 | -8710 |
RPS3 | -8813 | -8148 |
RPS16 | -7575 | -9312 |
RPS27A | -8679 | -8103 |
RPL10 | -8276 | -8457 |
RPS17 | -7093 | -9634 |
RPL29 | -7912 | -8580 |
RPS10 | -7587 | -8910 |
RPL37 | -6620 | -9973 |
RPL35 | -7668 | -8594 |
RPS29 | -6750 | -9717 |
RPS14 | -8295 | -7890 |
RPS18 | -7246 | -9006 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AAAS | -8101 | 625 | -1546 |
CALR | 6254 | 4913 | 2943 |
CANX | 5462 | -1266 | 3299 |
CLTA | 8244 | 7587 | 492 |
CLTC | 8849 | 9216 | 1230 |
CPSF4 | -9100 | -2297 | -7726 |
DNAJC3 | 8302 | 8189 | 7460 |
EIF2AK2 | -8803 | 425 | 11281 |
FAU | -359 | -1018 | -9018 |
GRSF1 | 5110 | -3098 | 3896 |
GTF2F1 | 4893 | 5437 | -9039 |
GTF2F2 | 5371 | 5207 | 5137 |
HSP90AA1 | 1316 | -5048 | 8114 |
HSPA1A | 7946 | 6632 | -7658 |
IPO5 | -10252 | -9795 | -1839 |
ISG15 | -11672 | -6773 | 9458 |
KPNA1 | 1286 | -4246 | 7790 |
KPNA2 | -6675 | -3820 | 5987 |
KPNA3 | 916 | -4231 | 8690 |
KPNA4 | 4899 | -694 | 9510 |
KPNA5 | -11535 | -7514 | 9592 |
KPNB1 | 2414 | -106 | 6972 |
NDC1 | -11812 | -9774 | -73 |
NUP107 | -10085 | -8758 | 7683 |
NUP133 | -7491 | -5635 | 5219 |
NUP153 | -6108 | -4400 | 3509 |
NUP155 | -9900 | -7591 | 2977 |
NUP160 | -10219 | -8656 | 3162 |
NUP188 | -11270 | -7253 | -5615 |
NUP205 | -10971 | -7010 | 3379 |
NUP210 | -10384 | -4340 | -8792 |
NUP214 | 7800 | 9971 | 2007 |
NUP35 | -10272 | -9583 | 8608 |
NUP37 | 3049 | -1412 | 3817 |
NUP42 | -5378 | -2693 | 10509 |
NUP43 | -9198 | -7750 | 10186 |
NUP50 | 4476 | -1230 | 6822 |
NUP54 | -8189 | -5304 | 11136 |
NUP58 | 8674 | 7535 | 6567 |
NUP62 | 763 | 394 | -2984 |
NUP85 | -2971 | -1702 | 6335 |
NUP88 | -11046 | -9387 | 4338 |
NUP93 | -11266 | -3136 | 2920 |
NUP98 | 3075 | 175 | 2062 |
PABPN1 | -522 | 2552 | -4617 |
PARP1 | -11409 | -9090 | -4667 |
POLR2A | -3010 | 6319 | -6014 |
POLR2B | -2462 | -5075 | 7311 |
POLR2C | 1603 | -2543 | -2871 |
POLR2D | -3902 | -8118 | 4726 |
POLR2E | 7450 | 5182 | -8728 |
POLR2F | 4555 | 5678 | -8849 |
POLR2G | 3477 | 5635 | -7724 |
POLR2H | -2867 | -3580 | -4558 |
POLR2I | 394 | -1586 | -8884 |
POLR2J | 6580 | 7886 | -5760 |
POLR2K | -1750 | -3871 | 9561 |
POLR2L | 5244 | 3421 | -9948 |
POM121 | -8013 | -2273 | -8608 |
POM121C | -6940 | -6034 | -9057 |
RAE1 | 5105 | 4986 | 5899 |
RAN | -6558 | -7535 | 4893 |
RANBP2 | -814 | -3082 | 5483 |
RPL10 | -6311 | -8276 | -8457 |
RPL10A | -6458 | -7947 | -4624 |
RPL11 | -6052 | -7886 | -4998 |
RPL12 | -6811 | -8646 | -7155 |
RPL13 | -3335 | -5513 | -5453 |
RPL13A | -7928 | -8645 | -5039 |
RPL14 | -6480 | -9347 | -6157 |
RPL15 | -953 | -7338 | -6665 |
RPL17 | -5249 | -8419 | -6788 |
RPL18 | -4911 | -7739 | -7441 |
RPL18A | -5869 | -7567 | -8492 |
RPL19 | -6071 | -6965 | -6447 |
RPL21 | -6241 | -8730 | -6047 |
RPL22 | -4587 | -8872 | -6349 |
RPL22L1 | -1593 | -7786 | 8002 |
RPL23 | -3223 | -6892 | -4274 |
RPL23A | -9248 | -9339 | 132 |
RPL24 | -5606 | -7584 | -3780 |
RPL26 | -6387 | -7606 | -5157 |
RPL26L1 | 7070 | 6121 | -2311 |
RPL27 | -2783 | -6028 | -8397 |
RPL27A | -6048 | -8378 | -8710 |
RPL28 | -1441 | -1935 | -5060 |
RPL29 | -3505 | -7912 | -8580 |
RPL3 | -8268 | -9658 | -9541 |
RPL30 | -6779 | -7741 | -7518 |
RPL31 | -4394 | -7479 | -7951 |
RPL32 | -6479 | -7872 | -7788 |
RPL34 | -6569 | -8446 | -2156 |
RPL35 | -7809 | -7668 | -8594 |
RPL35A | -5816 | -8004 | -6715 |
RPL36 | -5111 | -6303 | -9572 |
RPL36A | -7122 | -8088 | -5733 |
RPL36AL | 32 | -4117 | -8959 |
RPL37 | -6160 | -6620 | -9973 |
RPL37A | -3826 | -4740 | -8543 |
RPL38 | -5646 | -6549 | -9370 |
RPL39 | -2931 | -5751 | -7976 |
RPL39L | -8506 | -67 | -5602 |
RPL3L | 4458 | 5640 | 8642 |
RPL4 | -3476 | -9022 | -5587 |
RPL41 | -6632 | -6026 | -7914 |
RPL5 | -4576 | -9316 | -5226 |
RPL6 | -3262 | -8455 | 1237 |
RPL7 | -1917 | -9091 | -6390 |
RPL7A | -3557 | -7254 | -8652 |
RPL8 | -1171 | -6234 | -9415 |
RPL9 | -1837 | -7409 | -2348 |
RPLP0 | -987 | -8648 | -8726 |
RPLP1 | 19 | -3856 | -9181 |
RPLP2 | -6844 | -8213 | -9852 |
RPS10 | -5601 | -7587 | -8910 |
RPS11 | -6992 | -6701 | -8383 |
RPS12 | -5788 | -8359 | -9089 |
RPS13 | -1717 | -7333 | -4963 |
RPS14 | -5278 | -8295 | -7890 |
RPS15 | -3565 | -5306 | -7387 |
RPS15A | -5550 | -7870 | -7555 |
RPS16 | -4518 | -7575 | -9312 |
RPS17 | -6038 | -7093 | -9634 |
RPS18 | -7474 | -7246 | -9006 |
RPS19 | -6725 | -5579 | -8515 |
RPS2 | -4354 | -9592 | -9910 |
RPS20 | -8585 | -8433 | -2895 |
RPS21 | -3952 | -6666 | -9210 |
RPS23 | -6081 | -8292 | -7435 |
RPS24 | -261 | -5274 | -85 |
RPS25 | -6151 | -8789 | -5448 |
RPS26 | -1410 | -5487 | -3548 |
RPS27 | -9432 | -8218 | -8994 |
RPS27A | -6700 | -8679 | -8103 |
RPS27L | 2048 | 2760 | 9265 |
RPS28 | -4562 | -6389 | -8638 |
RPS29 | -7664 | -6750 | -9717 |
RPS3 | -5717 | -8813 | -8148 |
RPS3A | -4543 | -9214 | 3045 |
RPS4X | -6075 | -7594 | 1751 |
RPS4Y1 | 418 | 1451 | -9138 |
RPS5 | -5502 | -8655 | -8821 |
RPS6 | -5956 | -9127 | -7094 |
RPS7 | -4803 | -8005 | -6317 |
RPS8 | -2041 | -7120 | -2938 |
RPS9 | 5358 | 2375 | -7391 |
RPSA | -6110 | -4526 | 5058 |
SEC13 | 5675 | 6716 | -3023 |
SEH1L | -5868 | -8749 | 9484 |
SLC25A6 | 6178 | -5544 | -10049 |
TGFB1 | 5094 | -609 | -7809 |
TPR | -6786 | -4096 | 4769 |
UBA52 | 1112 | -1425 | -7104 |
XPO1 | -1169 | -4173 | 11053 |
Negative regulation of MET activity
metric | value |
---|---|
setSize | 18 |
pMANOVA | 0.00161 |
p.adjustMANOVA | 0.00411 |
s.dist | 0.61 |
s.t0_v_pod | 0.526 |
s.pod_crp | 0.31 |
s.t0_crp | -0.0164 |
p.t0_v_pod | 0.000112 |
p.pod_crp | 0.023 |
p.t0_crp | 0.904 |
Gene | t0_v_pod | pod_crp |
---|---|---|
GRB2 | 9146 | 10742 |
HGF | 8715 | 10153 |
PTPN2 | 7500 | 10261 |
PTPRJ | 7666 | 9296 |
SH3GL1 | 7509 | 9186 |
CBL | 7368 | 8653 |
PTPN1 | 5649 | 9613 |
HGS | 4468 | 9794 |
USP8 | 6330 | 6457 |
STAM2 | 6075 | 4706 |
UBC | 4395 | 4824 |
EPS15 | 4097 | 3818 |
SH3KBP1 | 6089 | 1663 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CBL | 7368 | 8653 | -2568 |
EPS15 | 4097 | 3818 | 11150 |
GRB2 | 9146 | 10742 | 73 |
HGF | 8715 | 10153 | 7901 |
HGS | 4468 | 9794 | -1894 |
LRIG1 | -10053 | -9333 | -2404 |
PTPN1 | 5649 | 9613 | -2841 |
PTPN2 | 7500 | 10261 | 7302 |
PTPRJ | 7666 | 9296 | -4702 |
RPS27A | -6700 | -8679 | -8103 |
SH3GL1 | 7509 | 9186 | -8172 |
SH3KBP1 | 6089 | 1663 | 3282 |
STAM | 1275 | -2469 | 3705 |
STAM2 | 6075 | 4706 | 10373 |
UBA52 | 1112 | -1425 | -7104 |
UBB | 6548 | -2419 | -4745 |
UBC | 4395 | 4824 | -4004 |
USP8 | 6330 | 6457 | 11140 |
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00104 |
p.adjustMANOVA | 0.00284 |
s.dist | 0.61 |
s.t0_v_pod | 0.478 |
s.pod_crp | 0.0954 |
s.t0_crp | -0.366 |
p.t0_v_pod | 0.00412 |
p.pod_crp | 0.567 |
p.t0_crp | 0.028 |
Gene | t0_v_pod | t0_crp |
---|---|---|
F12 | 9331 | -8919 |
GP9 | 7394 | -8439 |
VWF | 6550 | -8508 |
GP1BB | 7358 | -7237 |
GP1BA | 6193 | -6485 |
TPST2 | 5652 | -5771 |
TPST1 | 9094 | -2442 |
GP5 | 1285 | -3763 |
GGCX | 5176 | -486 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
F12 | 9331 | 11462 | -8919 |
F8 | 6919 | 4727 | 5869 |
GGCX | 5176 | 9373 | -486 |
GP1BA | 6193 | -281 | -6485 |
GP1BB | 7358 | -785 | -7237 |
GP5 | 1285 | -7884 | -3763 |
GP9 | 7394 | -2598 | -8439 |
KLKB1 | -8711 | -3785 | -3895 |
SERPING1 | -10849 | -7006 | 10802 |
TPST1 | 9094 | 11280 | -2442 |
TPST2 | 5652 | 8306 | -5771 |
VWF | 6550 | -369 | -8508 |
Diseases of hemostasis
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00104 |
p.adjustMANOVA | 0.00284 |
s.dist | 0.61 |
s.t0_v_pod | 0.478 |
s.pod_crp | 0.0954 |
s.t0_crp | -0.366 |
p.t0_v_pod | 0.00412 |
p.pod_crp | 0.567 |
p.t0_crp | 0.028 |
Gene | t0_v_pod | t0_crp |
---|---|---|
F12 | 9331 | -8919 |
GP9 | 7394 | -8439 |
VWF | 6550 | -8508 |
GP1BB | 7358 | -7237 |
GP1BA | 6193 | -6485 |
TPST2 | 5652 | -5771 |
TPST1 | 9094 | -2442 |
GP5 | 1285 | -3763 |
GGCX | 5176 | -486 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
F12 | 9331 | 11462 | -8919 |
F8 | 6919 | 4727 | 5869 |
GGCX | 5176 | 9373 | -486 |
GP1BA | 6193 | -281 | -6485 |
GP1BB | 7358 | -785 | -7237 |
GP5 | 1285 | -7884 | -3763 |
GP9 | 7394 | -2598 | -8439 |
KLKB1 | -8711 | -3785 | -3895 |
SERPING1 | -10849 | -7006 | 10802 |
TPST1 | 9094 | 11280 | -2442 |
TPST2 | 5652 | 8306 | -5771 |
VWF | 6550 | -369 | -8508 |
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
metric | value |
---|---|
setSize | 22 |
pMANOVA | 1.98e-05 |
p.adjustMANOVA | 9.28e-05 |
s.dist | 0.61 |
s.t0_v_pod | 0.471 |
s.pod_crp | 0.183 |
s.t0_crp | -0.341 |
p.t0_v_pod | 0.000132 |
p.pod_crp | 0.138 |
p.t0_crp | 0.00558 |
Gene | t0_v_pod | t0_crp |
---|---|---|
H2BC12 | 8898.0 | -8447.0 |
H2AJ | 9214.0 | -7261.0 |
H2BC17 | 7178.0 | -8062.0 |
H2BC4 | 7279.0 | -7646.0 |
H3C15 | 6608.5 | -7756.5 |
H2AZ1 | 5955.0 | -8479.0 |
H2BC21 | 9125.0 | -5196.0 |
H2BC11 | 7791.0 | -5526.0 |
H2BC9 | 5332.0 | -6635.0 |
H2AC6 | 7813.0 | -4205.0 |
H2BC5 | 7881.0 | -2937.0 |
H2BC15 | 5251.0 | -4235.0 |
AR | 4784.0 | -353.0 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AR | 4784.0 | 4607.0 | -353.0 |
H2AC20 | 4913.0 | 8671.0 | 3752.0 |
H2AC6 | 7813.0 | -1814.0 | -4205.0 |
H2AJ | 9214.0 | 11405.0 | -7261.0 |
H2AZ1 | 5955.0 | 2933.0 | -8479.0 |
H2AZ2 | -1192.0 | -5862.0 | -2370.0 |
H2BC11 | 7791.0 | 3262.0 | -5526.0 |
H2BC12 | 8898.0 | 6037.0 | -8447.0 |
H2BC15 | 5251.0 | 523.0 | -4235.0 |
H2BC17 | 7178.0 | 3760.0 | -8062.0 |
H2BC21 | 9125.0 | 6114.0 | -5196.0 |
H2BC4 | 7279.0 | 4199.0 | -7646.0 |
H2BC5 | 7881.0 | 4394.0 | -2937.0 |
H2BC9 | 5332.0 | -6224.0 | -6635.0 |
H2BU1 | -6332.0 | -2185.0 | 2615.0 |
H3-3A | 8519.0 | 7532.0 | 5003.0 |
H3C15 | 6608.5 | 6537.5 | -7756.5 |
KDM1A | -9114.0 | -5943.0 | 2112.0 |
KDM4C | -10406.0 | -1912.0 | 2431.0 |
KLK2 | 3004.0 | 4886.0 | 3997.0 |
NCOA2 | 1083.0 | 4273.0 | 1379.0 |
PKN1 | -2164.0 | 6449.0 | -8275.0 |
HDR through MMEJ (alt-NHEJ)
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.0515 |
p.adjustMANOVA | 0.0826 |
s.dist | 0.606 |
s.t0_v_pod | -0.429 |
s.pod_crp | -0.365 |
s.t0_crp | 0.225 |
p.t0_v_pod | 0.0188 |
p.pod_crp | 0.0458 |
p.t0_crp | 0.219 |
Gene | t0_v_pod | pod_crp |
---|---|---|
PARP1 | -11409 | -9090 |
FEN1 | -10254 | -7081 |
PARP2 | -11860 | -5348 |
MRE11 | -7647 | -4925 |
RAD50 | -7119 | -4034 |
LIG3 | -10676 | -1834 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
FEN1 | -10254 | -7081 | -1614 |
LIG3 | -10676 | -1834 | -1677 |
MRE11 | -7647 | -4925 | 2183 |
NBN | 2254 | 707 | 10226 |
PARP1 | -11409 | -9090 | -4667 |
PARP2 | -11860 | -5348 | 9470 |
POLQ | 590 | -5078 | 3819 |
RAD50 | -7119 | -4034 | 9994 |
RBBP8 | -4935 | 5839 | 10842 |
XRCC1 | 1927 | 379 | -8177 |
IRAK1 recruits IKK complex
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.0229 |
p.adjustMANOVA | 0.0411 |
s.dist | 0.605 |
s.t0_v_pod | 0.533 |
s.pod_crp | 0.263 |
s.t0_crp | -0.114 |
p.t0_v_pod | 0.00352 |
p.pod_crp | 0.15 |
p.t0_crp | 0.531 |
Gene | t0_v_pod | pod_crp |
---|---|---|
PELI3 | 7600 | 10850 |
CHUK | 7844 | 7098 |
IKBKG | 5315 | 8787 |
IRAK1 | 6047 | 7556 |
PELI2 | 8183 | 3231 |
PELI1 | 6623 | 1863 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CHUK | 7844 | 7098 | 7094 |
IKBKB | -5208 | 5101 | -4279 |
IKBKG | 5315 | 8787 | -7863 |
IRAK1 | 6047 | 7556 | -9167 |
PELI1 | 6623 | 1863 | 2111 |
PELI2 | 8183 | 3231 | -194 |
PELI3 | 7600 | 10850 | -9843 |
TRAF6 | -229 | -1341 | 2232 |
UBE2N | 1923 | -3127 | 8877 |
UBE2V1 | 5568 | -3400 | 5229 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.0229 |
p.adjustMANOVA | 0.0411 |
s.dist | 0.605 |
s.t0_v_pod | 0.533 |
s.pod_crp | 0.263 |
s.t0_crp | -0.114 |
p.t0_v_pod | 0.00352 |
p.pod_crp | 0.15 |
p.t0_crp | 0.531 |
Gene | t0_v_pod | pod_crp |
---|---|---|
PELI3 | 7600 | 10850 |
CHUK | 7844 | 7098 |
IKBKG | 5315 | 8787 |
IRAK1 | 6047 | 7556 |
PELI2 | 8183 | 3231 |
PELI1 | 6623 | 1863 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CHUK | 7844 | 7098 | 7094 |
IKBKB | -5208 | 5101 | -4279 |
IKBKG | 5315 | 8787 | -7863 |
IRAK1 | 6047 | 7556 | -9167 |
PELI1 | 6623 | 1863 | 2111 |
PELI2 | 8183 | 3231 | -194 |
PELI3 | 7600 | 10850 | -9843 |
TRAF6 | -229 | -1341 | 2232 |
UBE2N | 1923 | -3127 | 8877 |
UBE2V1 | 5568 | -3400 | 5229 |
MAP2K and MAPK activation
metric | value |
---|---|
setSize | 34 |
pMANOVA | 1.76e-06 |
p.adjustMANOVA | 1.1e-05 |
s.dist | 0.605 |
s.t0_v_pod | 0.516 |
s.pod_crp | 0.292 |
s.t0_crp | -0.116 |
p.t0_v_pod | 1.87e-07 |
p.pod_crp | 0.00317 |
p.t0_crp | 0.243 |
Gene | t0_v_pod | pod_crp |
---|---|---|
MARK3 | 8555 | 10797 |
ARRB2 | 8355 | 10835 |
MAP2K1 | 8910 | 10086 |
MAPK3 | 8803 | 9501 |
APBB1IP | 8600 | 9624 |
MAPK1 | 7381 | 10667 |
RAF1 | 7759 | 9678 |
TLN1 | 8386 | 8793 |
IQGAP1 | 8024 | 8880 |
LAMTOR2 | 7454 | 9183 |
CSK | 5158 | 10149 |
RAP1A | 7198 | 6943 |
KSR1 | 4126 | 10936 |
MAP2K2 | 6699 | 5024 |
WDR83 | 3684 | 7447 |
RAP1B | 3179 | 5307 |
ITGA2B | 8744 | 1914 |
LAMTOR3 | 7461 | 2039 |
ARAF | 2624 | 5660 |
YWHAB | 6298 | 2024 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APBB1IP | 8600 | 9624 | 5781 |
ARAF | 2624 | 5660 | -6907 |
ARRB1 | 1985 | 5802 | -8113 |
ARRB2 | 8355 | 10835 | -5123 |
BRAF | 1298 | 420 | 2465 |
CNKSR1 | -6846 | -6452 | 2350 |
CNKSR2 | -4628 | -2235 | 571 |
CSK | 5158 | 10149 | -6693 |
FN1 | 8154 | -1733 | 4890 |
HRAS | -3288 | -3089 | -7583 |
IQGAP1 | 8024 | 8880 | -22 |
ITGA2B | 8744 | 1914 | -6113 |
ITGB3 | 8161 | -2845 | -6419 |
KRAS | 3668 | 3086 | 11151 |
KSR1 | 4126 | 10936 | 6008 |
KSR2 | -3268 | -1010 | -3271 |
LAMTOR2 | 7454 | 9183 | -8579 |
LAMTOR3 | 7461 | 2039 | 8800 |
MAP2K1 | 8910 | 10086 | -3295 |
MAP2K2 | 6699 | 5024 | -9806 |
MAPK1 | 7381 | 10667 | -1770 |
MAPK3 | 8803 | 9501 | -9768 |
MARK3 | 8555 | 10797 | 10115 |
NRAS | 5302 | 1813 | 9977 |
PEBP1 | -10920 | -9535 | 472 |
RAF1 | 7759 | 9678 | 1415 |
RAP1A | 7198 | 6943 | 11289 |
RAP1B | 3179 | 5307 | 7206 |
SRC | -8520 | -5490 | -4085 |
TLN1 | 8386 | 8793 | -7844 |
VCL | 7218 | 1206 | -2715 |
VWF | 6550 | -369 | -8508 |
WDR83 | 3684 | 7447 | -6739 |
YWHAB | 6298 | 2024 | 10696 |
Cargo concentration in the ER
metric | value |
---|---|
setSize | 30 |
pMANOVA | 7.4e-06 |
p.adjustMANOVA | 3.97e-05 |
s.dist | 0.603 |
s.t0_v_pod | 0.52 |
s.pod_crp | 0.283 |
s.t0_crp | 0.114 |
p.t0_v_pod | 8.05e-07 |
p.pod_crp | 0.00723 |
p.t0_crp | 0.28 |
Gene | t0_v_pod | pod_crp |
---|---|---|
F5 | 9324 | 11415 |
SERPINA1 | 9013 | 11480 |
CTSZ | 8825 | 10594 |
TGFA | 8740 | 9788 |
SEC24D | 7988 | 10178 |
PREB | 6281 | 10138 |
COL7A1 | 6218 | 10019 |
LMAN2 | 6976 | 8815 |
STX5 | 7060 | 7972 |
SEC24A | 7544 | 6850 |
F8 | 6919 | 4727 |
SAR1B | 6391 | 4503 |
MIA2 | 5506 | 4261 |
CTSC | 2312 | 9392 |
SEC24B | 3576 | 4369 |
SEC23A | 7225 | 1825 |
SEC22B | 5797 | 2151 |
LMAN2L | 6837 | 1659 |
TMED2 | 5971 | 962 |
AREG | 5897 | 929 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AREG | 5897 | 929 | -8132 |
CD59 | 5783 | -3188 | -3930 |
CNIH1 | 7662 | -3128 | -2674 |
CNIH2 | 648 | 6266 | -214 |
CNIH3 | -8703 | -6297 | -8895 |
COL7A1 | 6218 | 10019 | -8651 |
CTSC | 2312 | 9392 | 5785 |
CTSZ | 8825 | 10594 | -2796 |
F5 | 9324 | 11415 | 4201 |
F8 | 6919 | 4727 | 5869 |
GOSR2 | -1435 | 2674 | 7258 |
LMAN1 | -10289 | -8956 | 10044 |
LMAN2 | 6976 | 8815 | -4647 |
LMAN2L | 6837 | 1659 | -8532 |
MCFD2 | 6995 | 658 | -1540 |
MIA2 | 5506 | 4261 | 11119 |
MIA3 | -6036 | -3950 | 8910 |
PREB | 6281 | 10138 | 447 |
SAR1B | 6391 | 4503 | 11213 |
SEC22B | 5797 | 2151 | 10635 |
SEC23A | 7225 | 1825 | 6295 |
SEC24A | 7544 | 6850 | 6438 |
SEC24B | 3576 | 4369 | 8674 |
SEC24C | -2506 | 6986 | -4040 |
SEC24D | 7988 | 10178 | 7102 |
SERPINA1 | 9013 | 11480 | 6681 |
STX5 | 7060 | 7972 | -6393 |
TGFA | 8740 | 9788 | -4955 |
TMED10 | 321 | -6827 | 1421 |
TMED2 | 5971 | 962 | 8999 |
Budding and maturation of HIV virion
metric | value |
---|---|
setSize | 26 |
pMANOVA | 4.06e-05 |
p.adjustMANOVA | 0.000167 |
s.dist | 0.602 |
s.t0_v_pod | 0.525 |
s.pod_crp | 0.284 |
s.t0_crp | -0.078 |
p.t0_v_pod | 3.5e-06 |
p.pod_crp | 0.0123 |
p.t0_crp | 0.491 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CHMP4B | 8718 | 10453 |
CHMP2A | 8635 | 10454 |
VPS37C | 7888 | 10622 |
UBAP1 | 8559 | 9210 |
NEDD4L | 7755 | 9200 |
MVB12A | 7290 | 9558 |
CHMP3 | 8217 | 6631 |
PDCD6IP | 6440 | 8445 |
CHMP5 | 4886 | 9534 |
TSG101 | 7669 | 5568 |
MVB12B | 5115 | 7206 |
VPS37A | 6379 | 5671 |
CHMP6 | 5434 | 6618 |
VPS37B | 3869 | 6452 |
UBC | 4395 | 4824 |
CHMP4A | 2384 | 6615 |
VTA1 | 6101 | 1750 |
VPS28 | 4156 | 891 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CHMP2A | 8635 | 10454 | -4083 |
CHMP2B | 5641 | -387 | 10468 |
CHMP3 | 8217 | 6631 | 2895 |
CHMP4A | 2384 | 6615 | 5051 |
CHMP4B | 8718 | 10453 | -6190 |
CHMP5 | 4886 | 9534 | 10758 |
CHMP6 | 5434 | 6618 | -8771 |
CHMP7 | -8503 | -9356 | -2659 |
MVB12A | 7290 | 9558 | -8589 |
MVB12B | 5115 | 7206 | 3878 |
NEDD4L | 7755 | 9200 | -5302 |
PDCD6IP | 6440 | 8445 | 11228 |
PPIA | -6535 | -4528 | -557 |
RPS27A | -6700 | -8679 | -8103 |
TSG101 | 7669 | 5568 | 9432 |
UBA52 | 1112 | -1425 | -7104 |
UBAP1 | 8559 | 9210 | -1245 |
UBB | 6548 | -2419 | -4745 |
UBC | 4395 | 4824 | -4004 |
VPS28 | 4156 | 891 | -8254 |
VPS37A | 6379 | 5671 | 10596 |
VPS37B | 3869 | 6452 | -8735 |
VPS37C | 7888 | 10622 | 687 |
VPS4A | 777 | -1430 | -9586 |
VPS4B | 5151 | -624 | 7717 |
VTA1 | 6101 | 1750 | 10229 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.0.3 (2020-10-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 20.04.2 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.9.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.9.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.2.0 GGally_2.1.1
## [3] beeswarm_0.3.1 gtools_3.8.2
## [5] echarts4r_0.4.0 topconfects_1.6.0
## [7] limma_3.46.0 eulerr_6.1.0
## [9] mitch_1.2.2 MASS_7.3-53.1
## [11] fgsea_1.16.0 gplots_3.1.1
## [13] DESeq2_1.30.0 SummarizedExperiment_1.20.0
## [15] Biobase_2.50.0 MatrixGenerics_1.2.0
## [17] matrixStats_0.58.0 GenomicRanges_1.42.0
## [19] GenomeInfoDb_1.26.0 IRanges_2.24.0
## [21] S4Vectors_0.28.0 BiocGenerics_0.36.0
## [23] reshape2_1.4.4 forcats_0.5.1
## [25] stringr_1.4.0 dplyr_1.0.5
## [27] purrr_0.3.4 readr_1.4.0
## [29] tidyr_1.1.3 tibble_3.1.0
## [31] ggplot2_3.3.3 tidyverse_1.3.0
## [33] zoo_1.8-9
##
## loaded via a namespace (and not attached):
## [1] colorspace_2.0-0 ellipsis_0.3.1 rprojroot_2.0.2
## [4] XVector_0.30.0 fs_1.5.0 rstudioapi_0.13
## [7] farver_2.1.0 bit64_4.0.5 AnnotationDbi_1.52.0
## [10] fansi_0.4.2 lubridate_1.7.10 xml2_1.3.2
## [13] splines_4.0.3 cachem_1.0.4 geneplotter_1.68.0
## [16] knitr_1.31 polyclip_1.10-0 jsonlite_1.7.2
## [19] broom_0.7.5 annotate_1.68.0 dbplyr_2.1.0
## [22] shiny_1.6.0 compiler_4.0.3 httr_1.4.2
## [25] backports_1.2.1 assertthat_0.2.1 Matrix_1.3-2
## [28] fastmap_1.1.0 cli_2.3.1 later_1.1.0.1
## [31] htmltools_0.5.1.1 tools_4.0.3 gtable_0.3.0
## [34] glue_1.4.2 GenomeInfoDbData_1.2.4 fastmatch_1.1-0
## [37] Rcpp_1.0.6 cellranger_1.1.0 jquerylib_0.1.3
## [40] vctrs_0.3.6 polylabelr_0.2.0 xfun_0.22
## [43] ps_1.6.0 testthat_3.0.2 rvest_1.0.0
## [46] mime_0.10 lifecycle_1.0.0 XML_3.99-0.6
## [49] zlibbioc_1.36.0 scales_1.1.1 promises_1.2.0.1
## [52] hms_1.0.0 RColorBrewer_1.1-2 yaml_2.2.1
## [55] memoise_2.0.0 gridExtra_2.3 sass_0.3.1
## [58] reshape_0.8.8 stringi_1.5.3 RSQLite_2.2.4
## [61] highr_0.8 genefilter_1.72.0 desc_1.3.0
## [64] caTools_1.18.1 BiocParallel_1.24.1 rlang_0.4.10
## [67] pkgconfig_2.0.3 bitops_1.0-6 evaluate_0.14
## [70] lattice_0.20-41 labeling_0.4.2 htmlwidgets_1.5.3
## [73] bit_4.0.4 tidyselect_1.1.0 plyr_1.8.6
## [76] magrittr_2.0.1 R6_2.5.0 generics_0.1.0
## [79] DelayedArray_0.16.0 DBI_1.1.1 pillar_1.5.1
## [82] haven_2.3.1 withr_2.4.1 survival_3.2-10
## [85] RCurl_1.98-1.3 modelr_0.1.8 crayon_1.4.1
## [88] KernSmooth_2.23-18 utf8_1.2.1 rmarkdown_2.7
## [91] locfit_1.5-9.4 grid_4.0.3 readxl_1.3.1
## [94] data.table_1.14.0 blob_1.2.1 reprex_1.0.0
## [97] digest_0.6.27 xtable_1.8-4 httpuv_1.5.5
## [100] munsell_0.5.0 bslib_0.2.4
END of report